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On the cover 
Already home to five publicly traded 
biotechnology companies, greater 
New Haven has seen the formation of 
eight new startups as the result of 
the University's recent efforts to pro¬ 
mote application of its technology 
and encourage growth in the city's 
biotech sector. Close to a dozen more 
companies are being formed around 
Yale discoveries. This emerging indus¬ 
try is increasingly information-driven, 
using massive computing power and 
microarray technology (right), for 
example, to harness genetic informa¬ 
tion in the search for new diagnostic 
tests and therapies. Page 32. 
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finish could be used? Since I 
actually treasure each issue ol 
Yale Medicine and am sure 
others must be affected as 1 
am, I hope you can find a 
solution to this devastating 
problem. 
Esther A. Savage, YUSN jy 
Midland, Mich. 
You’ve come a long way, Eli, 
in accommodating disability 
To the editor: 
Cathy Shufro’s piece on gradu¬ 
ate student Matthew Weed 
[“Bringing Science Into 
Focus,” Summer 2000] was 
inspiring. I was particularly 
pleased to read it as my hus¬ 
band works with a man who 
was denied entry to Yale Col¬ 
lege many years ago because 
he had suffered a wrestling 
accident in his senior year of 
high school and was a para¬ 
plegic. Yale could not accom¬ 
modate him and revoked his 
acceptance. As a graduate, 
this story has always saddened 
me. Now, I am heartened to 
read about the advances Yale 
has made in accommodating 
the disabled, both from a 
physical and technological 
standpoint, as well as from a 
humanistic one. 
Thank you lor your contin¬ 
ued efforts to make Yale 
Medicine interesting and fresh. 
Natalie P. Silverstein, M.P.H. ’96 
New York, N. Y. 
A new gloss on magazine’s 
design 
To the editor: 
I have long enjoyed and val¬ 
ued the copies of Yale Medi¬ 
cine xdcax have come to me in 
the mail. Fdowever, the glossy 
paper that is used in printing 
the magazine makes it almost 
impossible to read. Is there 
any possibility that a matte 
As it happens, the paper Yale 
Medicine is printed on is 
changing this issue along with 
other aspects of our design 
f5^’?From the Editor, opposite 
page.) The glare is gone! 
Debate on Lyme therapy 
should continue 
To the editor: 
The Lyme disease article on 
page 12 ol the summer edition 
[“Conventional Lyme Treat¬ 
ment Found Effective,” 
Summer 2000] appears to 
denigrate physicians who use 
longer-term antibiotic therapy, 
with the strong message given 
that “a short-term regimen of 
antibiotics is adequate to treat 
the disease.” Fdowever, the 30- 
day limit has been found to be 
unrealistic, especially when 
diagnosis and treatment are 
delayed. Patients and physi¬ 
cians will not accept that con¬ 
tinuing symptoms are due to 
“post-Lyme syndrome.” 
Nationwide evidence sup¬ 
ports longer-term therapy for 
many patients. The study 
described in the article does 
not address several questions, 
including elapsed time 
between symptoms and diag¬ 
nosis. The difficulties pre¬ 
sented by Lyme disease 
include uncertainties about 
test results with resultant 
delayed diagnosis, penetration 
of the spirochete into cells, the 
changing forms of Borrelia 
burgdorferi, and its ability to 
cloak itself in dna of the host. 
Evidence of long-term dis¬ 
ability from inadequate treat¬ 
ment of Lyme disease is 
documented. And because of 
the potential for serious dis¬ 
ability, I believe cdc treatment 
guidelines need to be re-exam¬ 
ined. 1 would also like to see 
Yale involved in the develop¬ 
ment of more effective antibi¬ 
otics for Lyme disease. 
Your article states that 
“Lyme disease has been a 
lightning rod for controversy 
for years.” My expectation is 
that Yale will provide accurate 
and balanced information on 
both viewpoints regarding 
short-term and long-term 
treatment. 
Constance A. Bean, M.P.H. ’50 
Wayland, Mass. 
Through the pages of Yale 
Medicine, a colorful past 
To the editor: 
Having also read Connecticut 
Medicine for many years, I 
enjoyed the section entitled 
“50 years ago in Connecticut 
Medicine!" The thought 
occurred, “Why not a brief 
note each issue about ‘50 years 
ago in Yale Medicine'!" 
After reviewing my stacks 
of Yale Medicine I found Vol. 
I, No. I (May 1953) of its pred¬ 
ecessor, the Alumni Bulletin— 
but alas! That is only 47 years 
ago. Nevertheless, some of our 
gray-haired alumni might 
enjoy hearing about some of 
the names and events of our 
school 47 years ago (as I may 
not be writing letters in 2003.) 
So below are items of interest 
from that first volume. 
• Communications were to be 
sent to Dr. Herbert Thoms, 
but as I recall Dr. Arthur 
Ebbert was the editor. 
• The new dean, Vernon Lip- 
pard, was featured, as well as 
the alumni association. Our 
own Sam Ktishlan is shown 
in a group photograph. The 
new dean announced that 
there would be a new med¬ 
ical dormitory built between 
the medical school and the 
new Memorial Unit of the 
hospital. There was a memo¬ 
rable photo of the Betsy Ross 
tea room. 
• Former Dean George Blumer 
gave a greeting to the new 
Bulletin (with his photo). 
• Markle Foundation awards 
were announced to Drs. 
Don Shedd and Bill Anlyan. 
• At the memorial service for 
Dean Francis Blake (June 15, 
1952) the first scholarship in 
his name was awarded to 
Gerald Klatskin. 
R. W. Breck, M.D. ’45M 
Wallingford, Conn. 
Dr. Breck’s suggestion coincides 
with our own recent explora¬ 
tion of the back issues o/Yale 
Medicine and a new depart¬ 
ment in the magazine. Archives, 
which appears for the first time 
on page 80 of this issue. The 
School of Medicine Alumni 
Bulletin, which made its debut 
in under the editorship of 
Arthur Ebbert, M.D., was suc¬ 
ceeded ^4 Yale Medicine in the 
fall of 1966. We will mine both 
sources for interesting nuggets 
from the school’s past. 
2 
FROM THE EDITOR 
Change is in the air 
Last year, as we began the process of fine-tuning Yale Medi¬ 
cine’s content and design to create a more interesting and 
better-organized magazine, we asked readers for their sugges¬ 
tions. Your responses have been an enormous help to us as 
we’ve reviewed both what we report and how we present it 
within these pages. 
On the content side, we learned that readers want to know 
more about the lives of medical students today and more about 
what their fellow alumni are doing across the country, the con¬ 
tinent and the globe.They are also interested in the past. By far, 
the greatest number of letters from readers has come in 
response to articles about the history of medicine at Yale—for 
example, the early use of penicillin that was the subject of a 
recent article. 
As a result of the comments we received, we are shedding 
more light on student life and educational issues today—as 
well as on the school’s past. We’ve devoted extra space to sto¬ 
ries about teaching and have started a regular historical 
department. Capsule, which in this issue explores medicine in 
New Haven during the Civil War years. We’re also launching a 
new department, Arch/Ves, peeking into the magazine’s early 
issues. See page 8o for the first installment. 
In addition, Yale Medicine w\\\ continue its focus on alumni, 
with 14 pages this issue devoted to alumni and reunion news. It 
is our goal to help classmates and old friends stay in touch and 
to spotlight the ways in which they are changing medicine and 
the wider world. Please let us know what you and your Yale 
School of Medicine colleagues are doing by writingto us at one 
of the addresses below. 
On the design side, readers say they find Yale Medicine 
appealing, engaging and easy to navigate, both in print and on 
the Web at http://info.med.yale.edu/ymm. We’ve taken steps 
to improve the easy readability of the magazine while keeping 
the design lively. Readers will notice a new paper stock this 
issue, and the overall design of Yale Medicine has been modi¬ 
fied to be consistent with the school’s new printed materials 
forthe offices of Admissions and Development (See page 10). A 
few changes in format will be apparent in this issue and in the 
Spring 2001 edition of Yale Medicine. 
We hope you enjoy your alumni magazine and that you will 
stay in touch with us, your classmates and your Yale colleagues. 
Michael Fitzsousa 
Editor 
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Yale’s M.D./Ph.D. Program celebrates 
a birthday and 188 promising careers 
When Donald E. Ingber 
graduated from Yale College 
in 1977, he had definite ideas 
about what he wanted to do 
in life. He was either going to 
write comedy and raise the 
standard of the television sit¬ 
com or else make his contri¬ 
bution to humanity through 
science. He admits it wasn’t a 
conventional career dilemma. 
Unfortunately perhaps for 
prime-time viewers, science 
won out. Ingbet enrolled in the 
M.D./pH.D. Program at Yale, 
spent seven more years in 
New Haven, then went on to 
discover the angiogenesis 
inhibitor TNP470, one of the 
first in a promising class of 
compounds that physicians 
hope will provide effective 
anti-cancer therapies. Ingber 
did his postdoc with angio¬ 
genesis pioneer Judah Folk- 
man, M.D., at Harvard Medical 
School, where today he is a 
professor of pathology and an 
explorer in the largely uncharted 
field of “mechanobiology,” 
studying the role of mechani¬ 
cal forces in cell regulation. 
Ingber says that it was a 
mindset cultivated at Yale that 
allowed him to connect the 
basic science of angiogenesis 
to the clinical relevance of an 
agent that might starve quickly 
multiplying tumor cells of 
their essential blood supply. 
With one foot planted firmly 
in the basic sciences and the 
other in clinical medicine, he 
was able to see each realm from 
a more practical perspective. 
“By combining them, you 
really are able to understand 
what the problems in medicine 
are and to frame the relevant 
questions,” he says. “And be¬ 
cause you’re trained by the best 
scientists around, you learn 
the procedure of attacking the 
problem and reducing it down 
to its minimum variables.” 
Yale’s M.D./pH.D. Program, 
also known as the Medical Sci¬ 
entist Training Program (mstp). 
turned 30 last year and cele¬ 
brated the anniversary with a 
reunion in November. Gradu¬ 
ates of the program, Ingber 
among them, returned to New 
Haven to attend a symposium 
and mix with classmates, 
professors and many of the 80 
currently enrolled students. 
The program’s five-year 
renewal was approved this past 
summer with a study section 
recommendation of $12.4 
million in funding over that 
period. An additional slot 
each year has also been recom¬ 
mended, which could raise 
the number of participants in 
the program to as many as 
85 by 2005 when additional 
funding from the medical 
school and other sources is 
taken into account. 
Nationally, the mstp traces 
its roots to 1964 when three 
schools—NYU, Einstein and 
continued on page 8 
“If we are to decipher... the human 
genome, if we’re to find out what 
that book means, we’re going 
to have to have medically trained 
scientists involved at the core.” 
— M.D./Ph.D. reunion speaker and former Dean Leon Rosenberg 
Oscar Colegio was one of 32 students 
who presented a research poster 
at a reunion in November celebrating 
30 years of the M.D./Ph.D. Program 
at Yale. 
4 
Med school invites neighbors to join in 
Tercentennial celebration 
The doors of the School of 
Medicine have always been 
open to those seeking medical 
care. On a Saturday in Octo¬ 
ber the school opened its doors 
to its neighbors as part of the 
University’s year-long celebra¬ 
tion of its 300th birthday. 
More than 500 people toured 
the medical school, which 
offered a lesson in virtual 
anatomy and, for children, the 
chance to dress up in medical 
gowns and pose for a snapshot 
with a 6-foot square photo¬ 
graph of an operating room as 
a backdrop. Throughout the 
University, more than 35,000 
people attended the open house. 
Celebrations started the day 
before, Friday, Oct. 20, with 
a community service award to 
Mayor John DeStefano Jr. 
from the School of Public 
Health. DeStefano was hon¬ 
ored for his support ol the 
Community Health Care Van, 
which provides medical serv¬ 
ices in underserved areas. The 
ceremony continued that day 
with the opening at the Ster¬ 
ling Hall of Medicine of 
Neighbors: Working Together 
for a Healthy New Haven, an 
exhibir of photographs by 
John Curtis showing students 
and faculty from the health 
professions working with 
local schools and community 
groups on a variety of projects, 
ranging from conflict resolu¬ 
tion workshops to organizing 
a library at a shelter for women. 
(A photographic essay based 
on the exhibit appears in this 
issue of Yale Medicine, starting 
New research effort will target 
hypoglycemia 
“Everything about diabetes 
cuts two ways,” says William 
Tamborlane, m.d., professor of 
pediatrics at the School of 
Medicine. “There are good 
parts and there are negative 
parts.” Take insulin, the heart 
of treatment regimens for the 
I million people in the United 
States who have type i, or juve¬ 
nile onset, diabetes. Even as it 
controls the level of sugar in 
the blood, insulin can increase 
the frequency and severiry of 
bouts of hypoglycemia. 
Because it denies the brain 
a normal supply of its primary 
fuel, glucose, hypoglycemia 
can cause seizures, confusion 
and abnormal behavior. In 
severe cases it can damage the 
brain and nervous system and 
can occur even under a regi¬ 
men of blood sugar monitor¬ 
ing, careful diet, exercise and 
insulin injections. 
children who visited the medical 
school during the Tercentennial year 
kickoff in October were treated to 
a special photo opportunity. Dressed 
in surgical garb, they posed against 
the backdrop of an operating room 
and took home a Polaroid photo. 
More than 500 people visited the 
medical school. 
on page 22.) Inside the 
Cushing/Whitney Medical 
Library, the medical school’s 
Web designer, Patrick Lynch, 
opened an exhibit of his art. 
And the library rotunda was 
the site of an exhibit chroni¬ 
cling Medicine at Yale 1701-186^. 
Joining Dean David A. 
Kessler, m.d., in launching the 
open house were Michael H. 
Merson, m.d., dean of public 
health, and Catherine L. Gilliss, 
D.N.sc., R.N., dean of the 
School of Nursing. Public serv¬ 
ice, Merson noted, is the force 
that drives public health. Gilliss 
recalled growing up in New 
Haven and the links between 
the University and the city. The 
medical school, Kessler said, is 
proud to be in such a vibrant 
community as New Haven. 
Now, with a $5 million, 
five-year grant from the Juve¬ 
nile Diabetes Research Foun¬ 
dation International (jdrfi), 
researchers at Yale have 
launched a new effort to study 
hypoglycemia and seek ways 
to prevent it. At a press con¬ 
ference and luncheon in early 
November, researchers at Yale 
and JDRFI officials announced 
the formation of the Center 
for the Study of Hypoglycemia 
continued on page ii 
Gifts and new pledges to the 
School of Medicine jumped to a 
record $63.5 million for fiscal year 
2000 that ended June 30. That’s 
57 percent higher than the 1999 
total of $40 million and 34 per¬ 
cent higher than the previous 
record, $47 million in fiscal 199S. 
Associate Dean Jane E. Reynolds 
attributed the record number to 
the robust stock market, a more 
aggressive development opera¬ 
tion and “the extremely high cal¬ 
iber of faculty proposals that 
were funded by gifts during the 
year.”The $63.5 million figure— 
which is included in the record 
University-wide total of $358 mil¬ 
lion for fiscal 2000—includes 
$29.2 million from foundations, 
$15.5 million from individuals, 
$13 million from agencies and 
$5.8 million from corporations. 
Says Reynolds, “I think the best 
is yet to come.” 
Rising rates of obesity among chil¬ 
dren may point to a coming surge 
in type 2 diabetes and a pressing 
need to find ways of staving off 
the disease’s clinical development, 
according to data reported at the 
American Diabetes Association 
meeting in June by Sonia Caprio, 
M.D., associate professor of pedi¬ 
atrics. She tested no obese chil¬ 
dren and found that 19 percent 
had elevated blood sugar, a condi¬ 
tion known as impaired glucose 
tolerance, putting them at risk for 
the most common form of dia¬ 
betes. Says Caprio: “We know 
there is borderline type 2 diabetes 
in these kids. Do we try to treat 
them to prevent it?” She has 
begun to look at what effect 
medical therapy, nutritional coun¬ 
seling and exercise may have in 
warding off the disease in obese 
children. 
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New Haven high school students 
spent three weeks on the Yale campus 
last summer, studying chemistry 
and biology in SCHOLAR, a three-week 
residential program that also takes 
them into laboratories on Science Hill 
for experiments. 
**\i prepares you for the next year. 
You already have a step up when you 
get to chemistry.” 
New Haven’s young 
the labs, and dorms 
In a lourth-floor laboratory in 
the Farnam Memorial Build¬ 
ing, G’Nee Herbert uses a 
pipette to prepare samples ol 
mouse DNA for analysis. Her 
task is to ensure that a certain 
gene, pkc theta, has been 
eliminated from the mouse’s 
genome. Working under the 
supervision of research techni¬ 
cian Crystal Bussey, she pre¬ 
pares an array of dna for 
testing. “There are so many 
steps,” Bussey tells Herbert. 
“From start to finish it will 
take you a solid week.” 
Unlike the others in the 
lab, Herbert is not a graduate 
student, postdoctoral lellow or 
medical student. About to 
enter her senior year at Hill 
Regional Career High School 
a few blocks from the medical 
center, she’s one of 65 students 
from the high school who 
spent three weeks this past 
summer living on the Yale 
campus while studying biol¬ 
ogy and chemistry. Herbert, 
17, joined the program in its 
SCHOLARS take to 
first year, three years ago, and 
has watched it expand from a 
two-week program with 15 stu¬ 
dents. “It prepares you for the 
next year,” Herbert says of the 
summer program, which is 
integrated into the science 
curriculum at Career. “You 
already have a step up when 
you get to chemistry.” 
A longstanding relationship 
between the two schools has 
for several years brought Career 
students to the medical school 
and Yale-New Haven Hospital 
for classes and internships. 
The summer program, called 
SCHOLAR, for Science Col¬ 
laborative Hands-On Learn¬ 
ing and Research, allows 
students to sustain their inter¬ 
est in science and follow 
Career’s health professions 
education track. 
Originally funded by the 
National Institutes of Health, 
last year the program received 
additional support from the 
Howard Hughes Medical 
Institute. 
— High school student G’Nee Herbert 
Career students who have 
just completed their freshman, 
sophomore or junior years live 
in Yale dormitories and study 
genetics, cellular and develop¬ 
mental biology, chemistry and 
biotechnology. The students 
also enjoy activities such as a 
picnic in East Rock Park in 
New Haven or a field trip to 
Branford’s Thimble Islands. 
In classrooms and laborato¬ 
ries, the students try to solve 
problems such as this: A young 
camper has been brought to 
an emergency room suffering 
from headaches, a temperature 
and a rash, followed by a 
seizure. Students must suggest 
reasons for his symptoms, 
questions to ask his fellow 
campers and possible tests. As 
more information becomes 
available, students answer new 
sets of questions until they 
go to the laboratory to test 
samples of water. “After they 
have gone through the labs, 
they come up with a final 
presentation of what it is they 
think is going on with this 
problem,” says Liza Cariaga- 
Lo, PH.D., until recently 
the director of multicultural 
affairs and scholar’s pro¬ 
gram director. 
Career Principal Charles 
Williams says students return 
to school in the fall far more 
comfortable with critical 
thinking and problem-based 
learning. “It is very, very nec¬ 
essary for them to be exposed 
to some of the strategies that 
are promoted in the summer 
program,” Williams says. 
6 
Joseph Warshaw shared a laugh 
with pediatric residents who 
led grand rounds this past spring. 
Pediatrics chair Warshaw moves north 
to become dean 
When Joseph Warshaw, m.d., 
returned to Yale in 1987 after a 
five-year stint at the University 
of Texas, he was already an 
internationally renowned 
expert in newborn care and 
development. While serving as 
chair of the Department of 
Pediatrics, he also emerged as a 
well-respected leader within the 
School of Medicine. On Aug. 
I, he moved north once again 
to become the 15th dean of the 
University of Vermont College 
of Medicine in Burlington. 
As chair of the Depart¬ 
ment of Pediatrics for 13 years, 
Warshaw built it into one 
of the nation’s foremost cen¬ 
ters for research into child¬ 
hood disorders. Yale is now 
the leading recipient of nih 
funding among medical 
school pediatrics departments 
in the country. The depart¬ 
ment has added facilities to 
handle the demands of the 
growing scientific program, 
including the Child Health 
Research Center on Congress 
Avenue. He also played a 
key role in the construction 
of the Yale-New Haven 
Children’s Hospital. 
Over the past five years, he 
guided clinical academic pro¬ 
grams for the medical school 
as deputy dean for clinical 
affairs. In that role, he oversaw 
major changes in the organiza¬ 
tion of the Yale Faculty Prac¬ 
tice, worked on the 1999 
affiliation agreement with the 
Yale New Haven Health 
System and enhanced several 
clinical programs. 
Warshaw first came to 
Yale from Harvard in 1973 and 
went to the University of 
Texas Southwestern Medical 
Center in Dallas in 1982, 
where he served as professor 
and chair of pediatrics until 
his return to Yale. He has pub¬ 
lished more than too scientific 
papers and six books on devel¬ 
opmental medicine and other 
child-health topics. He said, 
“I’ve never in my life more 
enjoyed working with and for 
a group of people than the 
people in pediatrics at Yale.” 
To recognize Warshaw’s 
contribution, the medical 
school held a symposium in 
his honor in early December. 
Congress Avenue Building 
reaches skyward 
structural steel began arriving at the 
site for the Congress Avenue Building 
in early fall and began to transform 
the landscape immediately. “In the 
next month and a half, everyone will 
begin to understand how large this 
building is,” project leader John Bollier 
said in early September. (The photo 
at left was taken November 3.) The 
project, one of the largest in Connecti¬ 
cut, remains on schedule with steel 
work scheduled for completion by 
March. The construction force of 60 
increased to 80 with the arrival of the 
steel and will rise to between 500 
and 600 during the coming year. By 
January 2002, the building should 
be completely enclosed. Detailed ren¬ 
derings of the building as well as up¬ 
dates on the project may be accessed 
at http://info.med.yale.edu/cab. 
Adding antimicrobials to con¬ 
sumer products such as hand 
lotions and soaps may not add to 
their effectiveness and could 
contribute harmfully to antibiotic 
resistance. According to Yale 
pediatrician Myron Genel, M.D., 
acquired resistance to antimicro¬ 
bials may predispose bacteria to 
resistance against therapeutic 
antibiotics as well. Genel chaired 
the American Medical Association 
Council on Scientific Affairs, 
which issued a report on antibi¬ 
otics in June. Antimicrobials, 
which kill disease-causing bacte¬ 
ria, are commonly used in hospi¬ 
tals and other health care set¬ 
tings to reduce surface coloniza¬ 
tion of bacteria, but the AMA 
council found no evidence to sup¬ 
port their addition to household 
cleansing agents. The report 
encouraged the FDA to expedite 
its regulation of antimicrobial use 
in consumer products. 
There’s an art to medicine, and 
some medical practitioners are 
also artists in their own right. Vis¬ 
itors to the Yale Physicians Build¬ 
ing can now view artwork by Yale 
doctors and others associated 
with the School of Medicine. Last 
June, a gallery area that recently 
became part of the New Haven 
artSPACE program began show¬ 
casing work by Yale faculty and 
staff, and other artists from 
greater New Haven. Featured art¬ 
work in the inaugural show 
included photographs by Amy L. 
Friedman Meguira, M.D., assistant 
professor of surgery; a bronze 
sculpture by Wayne O. Southwick, 
M.D., professor emeritus of 
orthopaedics and rehabilitation; 
and oil paintings by Barry L. Zaret, 
M.D., Robert W. Berliner Professor 
of Medicine and chief of the sec¬ 
tion of cardiovascular medicine. 
The gallery’s second show, photo¬ 
graphs by Burim Myftiu of Koso¬ 
vo, opened in September. 
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M.D./Ph.D. Program 
continued from page 4 
Northwestern—received 
money from the federal gov¬ 
ernment to encourage the 
training of physician-scientists 
who wotdd be able to leap 
nimbly from bench to bedside 
and back again. Yale joined 
the ranks in 1969 and is one of 
39 MSTPS currently funded 
by the National Institute of 
General Medical Sciences 
(nigms), according to Bert 
Shapiro, ph.d., the director of 
the MSTP at NIGMS and chief 
of the institute’s branch of cell 
biology. The mstp got off to 
a slow start and almost van¬ 
ished entirely in the early 1970s, 
when then-President Nixon 
impounded training funding 
amid concerns that much of 
the NIH training program was 
Alumnus Donald Ingber, left, talks 
with M.D./Ph.D. students during 
the program’s 30th anniversary 
celebration in November. 
ineffective. “It funded a lot 
of residents and they weren’t 
going into research,” says 
Shapiro, who says that more 
than 90 percent of current 
alumni are in research. In 1974, 
Congress passed a new act 
authorizing training grants on 
a much smaller scale; all the 
previous programs disappeared 
and were reformulated, mstp 
was one of only a few to sur¬ 
vive and grow. 
The Yale program has 188 
graduates, “98 percent of whom 
are doing funded research,” 
according to Director James 
D. Jamieson, m.d., ph.d., 
professor of cell biology. “So 
the program is doing what 
it set out to accomplish, which 
was to train physician-scien¬ 
tists to carry out basic research 
that would be applicable to 
medicine.” 
The roster of m.d./ph.d. 
alumni includes Yale profes¬ 
sors Susan J. Baserga and 
Michael J. Caplan, who admin¬ 
ister the program along with 
Jamieson and Gerald I. Shul- 
man. Others on the Yale 
faculty include Michael P. 
DiGiovanna, Peter M. Glazer, 
Robert J. Homer, Barry M. 
Kacinski, William L. Krinsky, 
Richard R. Pelker, Jordan S. 
Pober, Marc Potenza and San¬ 
dra L. Wolin, as well as a 
half-dozen recent graduates 
who are fellows and residents 
at Yale. 
These younger graduates 
are much more likely to pur¬ 
sue careers in research because 
of the funding provided by 
MSTP, said Baserga, one of the 
three associate directors of the 
Yale program and an associate 
professor of therapeutic radiol¬ 
ogy and genetics. Tuition and 
other academic expenses are 
covered, and students receive a 
stipend for six or more years, 
allowing them to keep their 
level of debt relatively low and 
thus resist financial pressures 
to enter private practice or 
industry. (According to Shapiro 
at the NIH, MSTP graduates 
leave with an average debt of 
about $10,000, compared to 
$120,000 for other medical 
graduates.) “The program was 
set up to encourage students 
to go into academic medi¬ 
cine,” says Baserga. “It’s been 
extremely successful in fulfill¬ 
ing that mandate.” 
Although the national pro¬ 
gram has grown dramatically, 
from $372,000 in annual 
funding in 1964 to $31.2 mil¬ 
lion today, some feel it isn’t 
large enough to counter a doc¬ 
umented decline in the per¬ 
centage of physician-scientists 
in the United States. “The size 
of the program should be dou¬ 
bled or tripled,” says Leon E. 
Rosenberg, m.d., who served 
as dean of the School of Medi¬ 
cine from 1984 to 1991 and is 
a highly vocal advocate of bol¬ 
stering the ranks of the physi¬ 
cian-scientist. 
“The NIH budget has risen 
hundreds of percents over the 
last 20 years. The size of the 
MSTP has gone up much more 
slowly and I think that’s short¬ 
sighted,” says Rosenberg, now 
adjunct professor of genetics 
at Yale and a professor at 
Princeton. “If we are to deci¬ 
pher the information from 
the human genome, if we’re to 
find out what that book means, 
we’re going to have to have 
medically trained scientists 
involved at the core. If we don’t 
have them, there’s going to be 
great difficulty in translating 
this fundamental information 
for the benefit of sick people.” 
Art and medicine 
During the first Tercentennial celebration weekend in late 
October, physicians and artists explored common ground 
during a symposium sponsored by the Program for Humani¬ 
ties in Medicine in conjunction with the New Haven arts 
organization artSPACE. Physicians Thomas Duffy and Irwin 
Braverman, along with students from the schools of medi¬ 
cine and nursing, joined artists represented in the compan¬ 
ion exhibit "Foreign Bodies; Art, Medicine, Technology” at the 
untitled (space) gallery on College Street. The exhibit, curated 
by Marianne Bernstein, included works by 17 artists who 
incorporate medical technology or imagery into their work. 
At left: “Yellow Microorganisms” by Eve Andree Laramee. 
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Nursing student Courtney Marsh 
makes regular visits to Tasha Aaron 
and her new daughter Aurora as 
part of Bright Beginnings. 
Bright Beginnings initiative helps 
mothers, infants at the start of life 
It started with a simple statis¬ 
tic. Eight years ago members 
of the Friends of the Children’s 
Hospital at Yale-New Haven 
learned that only 55 percent of 
the children in New Haven 
were receiving all their neces¬ 
sary immunizations by age 2. 
Over the next two years mem¬ 
bers of the Friends board, 
pediatric staff and people from 
the community identified 
other problems common to 
young mothers. 
The solution was Bright 
Beginnings, a mentoring pro¬ 
gram that has matched volun¬ 
teers one-on-one with 164 young 
mothers since its inception 
in 1994. Medical Director John 
Feventhal, m.d., says it was 
designed to ensure that the 
mother and her child had 
timely prenatal visits and well- 
baby checkups, to reduce the 
incidence of childhood injuries 
and to encourage early intel¬ 
lectual and social stimulation. 
None of the young mothers 
in the program, who range in 
age from 15 to 24, are in an 
extremely high-risk group. 
They were matched with men¬ 
tors, 40 percent of whom are 
health care professionals or stu¬ 
dents in a health field. Most of 
the mentors are parents who 
have raised their own children. 
“They are people who have 
extra energy to give support to a 
young mother,” says program 
coordinator Fyla Johnson, r.n. 
After training, the mentors sign 
on to guide young mothers 
from the last trimester of their 
pregnancy through the child’s 
first birthday. 
One of the 164 mentors is 
Courtney Marsh, a 24-year- 
old nursing student at Yale 
who plans to become a nurse- 
midwife. Since January she 
has made a weekly visit and 
several weekly phone calls 
to Tasha Aaron, who gave 
birth to her daughter Aurora 
on March ii. Aaron, 23, has a 
background in health care— 
she is certified as a nurse’s aide 
and an ekg technician—and 
is well aware of the need for 
checkups. Aaron credits Marsh 
with “being there for me when 
I needed someone to talk to. 
She was with me when I was 
admitted to the hospital.” 
“Having someone who is 
just a friend for her is a big 
part of it,” Marsh says of their 
relationship. “A lot of it is 
about plugging her into 
resources that can help her.” 
At their weekly meetings they 
may go out to lunch, visit a 
midwife, fill out forms or sim¬ 
ply talk. 
A recent pilot study of the 
program found that 99 per¬ 
cent of the infants had up-to- 
date immunizations at 12 
^*Our ultimate 
goal would be to 
see if we could 
expand this pro¬ 
gram throughout 
Connecticut.” 
— Medical Director John Leventhal 
months, compared to 80 per¬ 
cent of children in the hos¬ 
pital’s primary care popula¬ 
tion. Only 4.5 percent of teen 
mothers were pregnant again 
within one year, compared to 
45 percent of the hospital’s 
Women’s Center teen popula¬ 
tion. Successfully matched 
mothers also missed fewer 
pediatric appointments and 
made better use of the 
health care system. 
Although Feventhal has 
embarked on a more detailed 
study involving 200 young 
mothers, half of whom will be 
assigned prenatally to Bright 
Beginnings and half of whom 
will receive standard care, 
he is encouraged by the pilot 
findings. “Our ultimate goal 
would be to see if we could 
expand this program through¬ 
out the state of Connecticut,” 
Feventhal says. 
After dealing with an epidemic 
of head lice at a New Haven day¬ 
care center, Sydney Z. Spiesel, 
M.D. ’75, Ph.D., assistant clinical 
professor of pediatrics, came up 
with a shampoo that makes the 
louse eggs, or nits, visible under 
ultraviolet light. The shampoo 
contains a nontoxic fluorescent 
dye that causes the nits to glow 
brightly on the hairshaft when 
viewed under ultraviolet light. 
Spiesel, whose invention landed 
him on the pages of The New York 
Times, the local press and Time 
magazine, said that his shampoo 
will not kill the eggs, but it makes 
them easy to see and eliminate. 
Fainting spells are behind an 
increasing number of automobile 
collisions, particularly among the 
elderly. A cardiac cause of that 
fainting can often go undetected 
and should be considered by physi¬ 
cians, according to Mark H. 
Schoenfeld, M.D., associate clinical 
professor of medicine. He and his 
colleagues studied 54 patients 
who had lost consciousness for 
unknown reasons while driving 
and then been referred to the 
Yale cardiac electrophysiology 
service over a i4-year period. They 
discovered that 78 percent were 
found to have cardiac irregulari¬ 
ties. None of those who received 
treatment experienced another 
fainting spell while driving. 
Schoenfeld presented his find¬ 
ings in May at the meeting of 
the North American Society of 
Pacing and Electrophysiology. He 
advised colleagues to look at 
possible cardiac disorders when 
unexplained fainting spells occur. 
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For a group of first-year students, 
an intense week in the lab 
Exposure to some of the best 
minds in science has long been 
a benefit of studying medicine 
at Yale. For a group of 24 first- 
year students last spring, that 
experience was intensified dur¬ 
ing a week-long immersion in 
bench research and discussion 
of the broader themes in sci¬ 
ence. “The goal was to pick a 
topic and convey two things— 
how you come up with strate¬ 
gies to test a hypothesis 
and how you see the project 
through its successive steps,” 
said John N. Forrest Jr., m.d., 
HS ’67, who along with four 
other faculty members accom¬ 
panied the students to the 
Mount Desert Island Biologi¬ 
cal Laboratory in Bar Harbor, 
Maine, in May. “It was a 
very intensive week in the lab. 
They worked morning, noon 
and night. [Dean] David 
Kessler had proposed that we 
give students this intense 
pedagogical experience and it 
was successful beyond any¬ 
one’s expectations.” 
Working with shark tissue, 
the students focused their 
investigation on the structure 
and function of polarized 
epithelial cells, examining the 
topic with techniques from 
several disciplines, including 
physiology, biochemistry, 
cell biology and molecular 
biology. The faculty included 
Forrest, director of the Office 
of Student Research, and 
colleagues Michael J. Caplan, 
M.D. ’87, PH.D. ’87, Bliss 
Forbush III, ph.d., and Mark 
S. Mooseker, ph.d. 
“It was a perfect environ¬ 
ment for learning to take 
place,” said Nancy R. Angoff, 
M.p.H. ’81, M.D. ’90, HS ’93, 
associate dean for student 
affairs, who accompanied the 
group. Angoff, who wrote 
her own medical school thesis 
not on basic science but on 
an ethics topic, took the Bar 
Harbor course along with 
the students in order to bridge 
some gaps in her knowledge. 
“I ran my first gel, did pcr, 
cloned a gene. It was just 
a great learning experience,” 
said Angoff. “For the students 
who haven’t had that intro¬ 
duction to laboratory tech¬ 
niques and how to think 
scientifically, I think it was 
especially terrific.” 
The school plans to repeat 
the course in May for inter¬ 
ested members of the Class 
of 2004. 
A closer look at the medical school, 
from a new angle 
Nearly every college and univer¬ 
sity admissions office in the 
country produces a glossy book 
introducing the school to pro¬ 
spective students with the aim 
of anracting ever-higher num¬ 
bers of highly qualified appli¬ 
cants. Medical school viewbooks 
adopt much the same format, 
organizing their presentation 
around the three primary mis¬ 
sions of research, patient care 
and medical education. 
This year, Yale is breaking 
that mold, choosing instead to 
examine itself in a series of 
vignettes that make up a typical 
week at the medical school. 
2417: Medicine at Yale, pub¬ 
lished in August, takes a photo¬ 
graphic look at the life that fills 
Yale’s laboratories, classrooms 
and clinical spaces, as well as its 
involvement with the rest of 
Yale, the New Haven commu¬ 
nity and the wider world. 
Black-and-white photographs 
and accompanying text explore 
the world of medicine at Yale 
over the course of seven days, 
from a difficult childbirth on a 
Saturday morning to a discus¬ 
sion among faculty and stu¬ 
dents the following Friday 
afternoon. Altogether, more 
than 40 glimpses of medical 
school life, accompanied by 
sidebars of facts and figures, 
occupy the book’s 52 pages. 
“We wanted to do some¬ 
thing a litde different and not 
just tell the typical story,” 
says Associate Dean Jane E. 
Reynolds, who directed the 
book project and collaborated 
24/7; Medicine at Yale looks at a 
week in the life of the school. 
with Director of Admissions 
Richard A. Silverman, writer 
Catherine lino, photographer 
Franqois Robert, the Vale Med¬ 
icine staff and the design firm 
Pentagram. The book will be 
mailed to several thousand 
prospective applicants each 
year and was sent to alumni 
and friends of the school in 
October. 
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Anti-violence partnership chosen 
as model for national program 
For nine years the mental 
health professionals at the Child 
Study Center have engaged in 
an unusual collaboration with 
New Haven’s police depart¬ 
ment. Psychologists and psy¬ 
chiatrists rode in squad cars 
to learn how police worked. 
Police officers came to the 
medical school for training in 
child development. Since 
then, center staff have been on 
call 24 hours a day, seven days 
a week, to help children who 
witness or are victims of vio¬ 
lence. “It is a real triumph of 
collaboration,” says Mayor 
John DeStefanoJr. 
Since the program started, 
it has intervened in the lives of 
more than 3,000 children and 
families. The u.s. Department 
of Justice has supported the col¬ 
laboration project for the past 
six years, and this year chose 
to apply the model around 
the country. In addition, the 
department created the 
National Center for Children 
Exposed to Violence (nccev), 
based at the Child Study Cen¬ 
ter. Deputy Attorney General 
Eric H. Holder Jr. came to 
Yale in May for the dedication 
of the national center. 
Over the next five years. 
Holder said, the nccev will 
provide $7 million to similar 
partnerships in nine commu¬ 
nities around the country. 
“The Child Development- 
Community Policing Program 
will remain at the heart of the 
national center,” Holder told 
Hypoglycemia 
continued from page 5 
at Yale University. Building on 
25 years of hypoglycemia 
research at Yale, the center will 
draw on the talents of i6 
investigators in internal medi¬ 
cine, pediatrics, diagnostic 
radiology, neurosurgery, psy¬ 
chiatry, neurology and nurs¬ 
ing. “You need to bring 
together people with different 
perspectives and different 
knowledge bases to tackle the 
problem,” says Robert Sher- 
win, M.D., the C.N.H. Long 
Professor of Medicine, who 
will lead the new center and is 
the president of the American 
Diabetes Association. 
A clinical trial led by Tam- 
borlane and Margaret Grey, 
PH.D., associate dean for 
research at the School of Nurs¬ 
ing, will gauge whether new 
technologies in glucose sensing 
and insulin delivery can reduce 
the risk of severe hypoglycemia 
in children receiving insulin 
Steven Marans, left, leads the Child 
Development-Community Policing 
Program at Yale. Deputy Attorney 
General Eric Holder Jr., right, came to 
the medical school in May to announce 
the creation of a national program 
based on the local model. 
local police, government offi¬ 
cials, pediatricians and faculty 
in Harkness Auditorium. The 
program. Holder said, is one of 
the first in the nation to recog¬ 
nize that such a partnership is 
a key element of successful 
treatment. The Ghild Develop- 
ment-Gommunity Policing Pro¬ 
gram and the nccev are led by 
Steven Marans, ph.d., Harris 
Associate Clinical Professor of 
Child Psychoanalysis in the 
Child Study Center. 
The national center’s three 
objectives are to find ways to 
prevent exposure to violence, 
to intervene early and effec¬ 
tively in cases of violence and 
to ensure that perpetrators of 
violence against children are 
brought to justice. 
for type i diabetes. Three 
research projects will use 
microdialysis, nuclear mag¬ 
netic resonance and functional 
magnetic resonance imaging 
to monitor the effects of hypo¬ 
glycemia on the brain. The 
project leaders are Sherwin, 
John C. Gore, ph.d., professor 
of diagnostic radiology and 
applied physics, and Douglas 
L. Rothman, ph.d., associate 
professor of diagnostic radiol¬ 
ogy and director of the Mag¬ 
netic Resonance Center. 
Heart transplants often fail 
because the donor heart is not 
strong enough to overcome the 
lung damage common in people 
with chronic heart failure. Rec¬ 
ognizing that in most cases only 
the left side of the heart fails, 
chief of cardiothoracic surgery 
John A. Elefteriades, M.D. ’76. HS 
’83, and colleagues have come up 
with a novel technique for retain¬ 
ing the healthy right half. They 
aim to give a transplant patient 
the pumping power of a heart- 
and-a-half to overcome the lung 
damage. So far the technique has 
been attempted only in dogs, but 
the surgeons hope to apply it to 
humans soon. A description of 
the method was published in the 
June issue of The Annals of Tho¬ 
racic Surgery.The technique could 
reduce the number of deaths fol¬ 
lowing transplant and allow 
the use of weaker donor hearts to 
increase the currently limited 
number of donor hearts available. 
The schools of medicine, public 
health and law have joined forces 
to launch the Yale Journal of 
Health Policy, Law, and Ethics. The 
biannual journal will be peer- 
reviewed by a board of national 
experts; more than 70 students 
from Yale graduate and profes¬ 
sional schools will edit the publi¬ 
cation and oversee its production, 
it will publish articles on legal, 
ethical and policy issues in health 
care and related areas, including 
case studies of specific current 
policy questions and recent court 
decisions. Publication of the first 
issue will coincide with a sym¬ 
posium on racial and ethnic dis¬ 
parities in health to be held at the 
law school in February. 
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Magnetic resonance images show a 
marked difference between the brain 
of an infant born prematurely, left, 
and one born at term. Researchers at 
Yale have found that a drug commonly 
used to treat arthritis, when adminis¬ 
tered to premature infants, results in 
less brain atrophy and fewer long-term 
intellectual deficits. Ongoing studies 
of brain volume in newborn infants 
and older preterm infants are explor¬ 
ing the adaptive mechanisms of the 
developing brain. 
Drug offers hope for a brighter start 
for premature babies 
Prematurely born babies score 
lower on intelligence tests 
than their healthy, full-term 
siblings and frequently require 
special educational services 
and other assistance. One sus¬ 
pected cause of the problems 
they face later in life is bleed¬ 
ing into tissues of the brain, 
which often occurs during 
premature births. Giving them 
an anti-inflammatory drug 
that reduces the bleeding at 
birth, however, has raised hope 
that fewer prematurely born 
children will suffer significant 
long-term intellectual and 
emotional problems. 
Investigators in a multi¬ 
center study directed by Yale 
pediatric neurologist Laura R. 
Ment, M.D., administered the 
non-steroidal drug indometha- 
cin, which is generally used for 
treating adults with arthritis, 
to 431 very-low-birth-weight 
premature babies shortly after 
birth. In follow-up ultrasound 
studies, the infants who had 
been treated with the drug 
bled less and had less brain 
atrophy than babies treated 
with a placebo. In assessments 
at 6 and 8 years of age, they 
appeared to have suffered 
fewer long-term intellectual 
deficits and required signifi¬ 
cantly fewer special services 
than those children who 
had been given the placebo. 
Almost three times the num¬ 
ber of children who received 
the placebo required speech 
and language therapy when 
compared to those who 
received the medication. The 
placebo group also scored 
lower on intelligence tests and 
tests of communication skills 
and emotional status. 
The findings of the study 
were presented at the joint 
meeting of the Pediatric Aca¬ 
demic Societies and the Amer¬ 
ican Academy of Pediatrics 
in May. Ment said, “Almost all 
other studies of protective 
agents in the newborn period 
do not have long-lasting 
effects. This drug does, in fact, 
appear to protect the develop¬ 
ing brain.” 
According to Ment, approx¬ 
imately 25 percent of neonatal 
intensive care units in the coun¬ 
try use indomethacin as the 
standard of care for very-low- 
birth-weight preterm infants. 
She hopes to see that percent¬ 
age increase so that all prema¬ 
ture babies can benefit from 
the drug. 
12 
Combination therapy, acupuncture shown 
effective in curbing cocaine cravings 
Many heroin addicts also abuse 
cocaine and continue taking 
the drug even after they stop 
using heroin. Currently avail¬ 
able medications that help 
them stop using heroin do 
little to reduce their appetite 
for cocaine. Yale investigators 
have found that combining 
a drug used to treat alcoholism 
with an experimental drug to 
treat heroin addiction can help 
users abstain from using 
cocaine as well. Another study 
showed that acupuncture in 
combination with a heroin 
drug treatment regimen may 
also effectively diminish the 
desire for cocaine. 
Past studies had shown that 
buprenorphine, an experimen¬ 
tal alternative to methadone 
for treating opiate addiction, 
is effective in reducing heroin 
use, but no currently used 
medication treatment is effec¬ 
tive in reducing an addict’s 
concurrent cocaine use. When 
buprenorphine was combined 
with disulfiram—a drug for 
treating alcoholism marketed 
as Antabuse—the combina¬ 
tion worked better than 
buprenorphine alone in pro¬ 
moting three weeks of absti¬ 
nence from cocaine use in 
persons with dual heroin and 
cocaine addictions. The 
early-stage study of 20 addicts 
appeared in the Spring 2000 
issue of Biological Psychiatry. 
Tony P. George, m.d., assistant 
professor of psychiatry and an 
investigator for the study, said, 
“Addiction to heroin along 
with cocaine abuse is a horri¬ 
ble problem. Disulfiram can 
actually reduce cocaine use 
in these patients.” 
Principal investigator 
Richard S. Schottenfeld, m.d. 
’76, a professor of psychiatry, 
is now directing a trial of the 
drugs with a larger group of 
subjects and other studies 
of the combination treatment. 
He and colleagues are also 
working to correlate the med¬ 
ications’ mechanism of action 
with the genetics of drug 
addiction. “Even il disulfiram 
proves effective, it’s not an 
ideal treatment,” he said. “It 
has all sorts of associated prob¬ 
lems. By finding its mecha¬ 
nism of action, we’ll be able to 
design a new drug that refines 
its effect.” 
The acupuncture study 
tested 82 subjects in three 
groups. Among those who had 
needles inserted in acupunc¬ 
ture regions of the outer ear 
five times a week—a protocol 
already widely used in addic¬ 
tion treatment facilities—54.8 
percent tested free of cocaine 
at the end of the eight-week 
study. The second group of 
subjects received treatment 
with acupuncture needles that 
were inserted into four points 
in the ear not thought to have 
a therapeutic effect. Among 
this group, 23.5 percent of the 
subjects managed to remain 
free of cocaine during the 
study. Only 9 percent of the 
third group, who watched 
relaxation videos, abstained 
for the eight-week period. 
Arthur Margolin, ph.d., a 
research scientist in psychiatry 
and director of the study, said, 
“This was one of the most 
stringent tests of acupuncture 
to date, insofar as it compared 
the experimental treatment to 
two relatively ‘active’ control 
groups. However, further 
research is needed to replicate 
these findings, as well as to 
understand the mechanism of 
acupuncture in this applica¬ 
tion.” The study was published 
in the August issue of Archives 
of Internal Medicine. 
cetera • • • 
Use 
The use of unregulated alternative 
or complementary treatments is 
growing rapidly throughout the 
population. Yale investigators have 
found it is particularly prevalent 
among people with psychiatric dis¬ 
orders. People with illnesses such as 
depression, schizophrenia and anxi¬ 
ety disorders are 25 percent more 
likely to use alternative or comple¬ 
mentary treatments than those 
without such disorders. 
“The results suggest that a 
substantial portion of patients 
with mental conditions use these 
therapies, whether to treat mental 
or other medical conditions,” said 
Benjamin C. Druss, M.D., M.P.H. 
’95, assistant professor of psychia¬ 
try and epidemiology and public 
health, the study’s lead author. 
Published in the July issue of 
Archives of General Psychiatry, the 
findings, Druss said, speak to the 
potential importance of screening 
for these treatments, which may 
interact with prescription psychi¬ 
atric medicines.The researchers 
found that 9.8 percent of those 
reporting a psychiatric illness 
made a visit to a complementary 
or alternative practitioner, and 
about half of these people (4.5 
percent) made a visit to treat the 
psychiatric illness. Among alterna¬ 
tive treatments used for that pur¬ 
pose, herbal remedies were the 
most common. 
New clue to cocaine 
“A lot of people try drugs, but 
only some of them become 
addicted,” says David Self, 
M.D., an assistant professor of 
psychiatry at Yale. He and his 
colleagues have set out to dis¬ 
cover why this is so, and their 
most recent study points to a 
possible red flag for cocaine 
addiction. Unlike other users 
who experiment and then 
move on, prospective addicts 
tend to increase the amount of 
addiction 
the drug sharply in the early 
stages of use. 
The team provided a group 
of rats with an unlimited 
supply of cocaine for 10 days, 
allowing them to “self-admin¬ 
ister” by pressing a lever. When 
the supply was cut off, the rats 
that had shown the greatest 
escalation of cocaine use in the 
early part of the study contin¬ 
ued to press the lever with a 
persistence and intensity that 
signaled extreme cravings—a 
hallmark of addiction. 
The next step in this inves¬ 
tigation, says Self, is to locate 
this predisposition within the 
animal’s genes, a prospect that 
could lead to new ideas for 
early intervention and more 
effective treatment. The study 
was published in the June issue 
of Neuropsychopharmacology. 
’3 YALE MEDICINE fAlL 2000 | WINTER 2001 
Stress testing may hold older persons 
back from healthy exercise 
The standard recommenda¬ 
tion to get a stress test before 
starting to exercise may hinder 
efforts to keep older people 
active. According to a Yale 
study, a simple physical exami¬ 
nation may be sufficient. After 
weighing the potential benefits 
and risks of exercise among 
persons age 75 years and older, 
researchers concluded that 
current guidelines for exercise 
stress testing are not applicable 
lor the vast majority of older 
persons interested in starting 
an exercise program and may 
instead hold them back. 
Thomas M. Gill, m.d., an 
associate professor of internal 
medicine and geriatrics, and 
his collaborators reported in 
the July 19 issue of The Jour¬ 
nal of the American Medical 
Association that, “Based on a 
rigorous review of the available 
evidence, we found that the 
risk of myocardial infarction 
(mi) related to exercise among 
older persons may be over¬ 
stated.” Current guidelines 
from the American Heart 
Association and American 
College of Sports Medicine 
recommend that older people 
undergo a stress test before 
beginning a moderately 
intense exercise program. The 
purpose of testing is to detect 
asymptomatic blockages to the 
heart’s arteries that could lead 
to MI. “The problem with a 
stress test,” said Gill, “is that 
most older people can’t com¬ 
plete it, so you have to go to 
more expensive, chemical tests 
to detect asymptomatic block¬ 
ages to arteries.” Gill found no 
evidence that detecting these 
asymptomatic blockages is 
beneficial. “The risk of mi 
from exercise is very low.” 
Instead, Gill and his col¬ 
leagues recommend that older 
persons starting an exercise 
program skip the stress test 
and undergo a complete phys¬ 
ical examination including a 
health history to identify 
potential risks of exercise. And 
all previously sedentary older 
persons without symptomatic 
cardiovascular disease should 
start with a low-intensity exer¬ 
cise program such as balance 
exercises, tai chi, self-paced 
walking and lower-extremity 
muscle strengthening. 
The Yale researchers are 
following up on their study to 
learn more about the safest 
ways to get older adults into 
exercise programs. “We need 
more research on exercise 
and aging,” said Gill, “particu¬ 
larly now that the large baby 
boom population, who started 
the exercise movement, is 
growing older.” 
A stress test, Yale researchers have 
found, may discourage elderly 
people who wish to exercise. A com¬ 
plete physical exam, according to 
the researchers, may be sufficient to 
identify potential health risks for 
those over 75. 
When it comes to diet, parents weigh in 
heavily with their children 
A Yale study has found that 
children’s perceptions of their 
parents’ attitudes toward 
eating and weight have a big 
impact on them. According to 
the study, college-age women 
are particularly sensitive to 
perceived criticism from their 
mothers in forming their own 
attitudes and behaviors regard¬ 
ing food and weight. Similarly, 
male college students adopt 
attitudes toward eating and 
weight that are associated with 
their perception of their 
fathers’ attitudes and behav¬ 
iors, the study shows. 
The study, published last 
summer in Health Psychology, 
was based on research con¬ 
ducted by Ghristina Baker, 
then a graduate student in 
psychology at Yale, and Kelly 
D. Brownell, ph.d., professor 
of psychology and epidemi¬ 
ology and director of the Yale 
Center for Eating and Weight 
Disorders. They compared 
what the parents reported 
about their own attitudes and 
behaviors related to eating 
and weight with what their 
children perceived about 
their parents’ attitudes and 
behaviors. The investigators 
found some evidence that a 
discrepancy between the 
two might be a predictor of 
eating concerns. 
Baker said one problem 
with previously available data 
is that much of it is based 
solely upon parents’ reports of 
their own attitudes and behav¬ 
iors, which they might skew 
for fear of looking as if they 
passed along unhealthy eating 
and weight-loss habits. “A lot 
of people are concerned about 
blame being placed on par¬ 
ents,” said Baker. “This study 
points out that children’s per¬ 
ceptions are more important. 
The results really highlight the 
importance of good parent- 
child communication.” 
’4 
Screening for alcohol abuse with a few key questions 
There are a variety of screen¬ 
ing methods available for 
detecting alcohol problems. 
According to a review by Yale 
investigators, however, asking 
a few carefully worded ques¬ 
tions during routine medical 
appointments is the best way 
of spotting alcohol problems 
before they get out of hand. 
The study, led by David A. 
Fiellin, m.d., assistant profes¬ 
sor of medicine, reviewed 38 
previous studies of screening 
methods for alcohol problems 
in primary care physicians’ 
practices. It showed that the 
four so-called cage questions 
and the Alcohol Use Disorders 
Identification Test (audit) 
were the most effective in 
care physicians have been 
urged to screen their patients 
for alcohol problems but may 
often neglect to do so.” 
The four cage questions 
are: Have you ever tried to 
Cut down on your drinking? 
Have people Annoyed you 
by criticizing your drinking? 
Have you ever felt bad or 
Guilty about your drinking? 
Have you ever taken a drink 
first thing in the morning, 
an Eye opener, to steady your 
nerves or get rid of a hangover? 
The first three questions of 
the lo-question audit instru¬ 
ment address the quantity and 
frequency of alcohol consump¬ 
tion. These questions were 
found to be the most effective 
in showing more recent drink¬ 
ing behavior and problems. 
O’Connor said blood tests 
are not good indicators of 
alcohol problems because they 
generally only reveal markers 
of advanced alcohol abuse, 
such as liver problems. “There 
are many people with drinking 
problems who are missing 
work and getting arrested for 
driving while intoxicated who 
might not show any physical 
problems on a blood test,” 
O’Connor said. “You want to 
try to get them before they 
appear in an emergency room 
or hospital. At that point, they 
are often far advanced.” 
I 
David Fiellin 
identifying patients with alco¬ 
hol abuse and dependence 
problems and at-risk, haz¬ 
ardous or harmful drinking. 
Patrick G. O’Connor, m.d., 
M.P.H., professor of medicine 
and senior author of the study 
published in August in the 
Archives of Internal Medicine, 
said, “This is the first study to 
examine the evidence in the 
literature for the effectiveness 
of these instruments, which 
focuses specifically on their use 
in primary care settings. This 
is important because primary 
TabI* 4. ALCOHOL USE OISOROERS IDENTIFICATION TEST (AUDIT) 
(4) 4 or more limes a week 
(4) 10 or mote 
(4) Detiy Of flimosi daily 
(4] Daily or almost daily 
(4) Dally or almosi daily 
Gtrete tfw Bn$mf ttiar i$ eomaci tor you 
1. How often do you have a drink oontalnlrg alcohol? 
(0) Never (1) Monthly or leaa {2) 2 to 4 timet a month (3) 2 to 3 limes a week 
2. How many drlrfcs oontalAing alcohol do you have on a typical day when you are dhoking? 
(0)tor2 (1)3 Of 4 (2) Sore (3) 7 to 9 
3. How often do you have 6 or more drinks on one occtrtion? 
(0) Never (t) Lett than monthly (2, Monthly (3) Weekly 
4 How often during the latl year have you found lhat you ware not able to stop dnnkir>g once you had sianed? 
(0) Never *(1) Lees than mondily (2) Monthly (3) Weekly 
5. How often during the leal year have you failed to do what was normally expected from you beceuse ol drinking? 
(0) Never <1) Lest than monthly (2) Montily (3) Wetkty 
6. How often during the last year have you needed a flra' drink In the morning to gel yourteH going alter a heavy drinkxig Meeion? 
(0) Never (1) Lett than monlhfy (2) Monthly (3) Weekly (4) Daily or eimosi daily 
7. How often during the leet year have you had a feeling ol guilt or remorse after drinking? 
(0) Neve/ (1) Lees then monthly (2) Monthly (3) Weakly (4) Daily or almosi daily 
6. How often during the leal year have you been unable to remember what happened the night before because you had been drinking? 
(0) Never (1) Leet than monthly (2) Monthly (3) Weekly (4) Daily or almost dally 
9. Have you or someone else been Injured es a result otyour drinking? 
(0) No (2>'Yes, but noi in the (4) Yet, during the lost 
lati year year 
to. Has a relative or friend or a physician or other health worker been concerned about your drinking or suggested you cut down? 
(0) No (2) Yet, but not in the (4) Yes. dunng ihe last 
Iasi year year 
A few carefully worded questions such 
as those in the survey above can help 
clinicians spot alcohol problems before 
they get out of hand. 
An odd silver lining in unhappy marriages 
“Freud said that ambivalent, 
conflicted relationships would 
predispose the survivor to patho¬ 
logical grief,” said Holly G. 
Prigerson, ph.d., an associate 
professor of psychiatry. Accord¬ 
ing to a study she directed, 
Freud was wrong. “We found 
that losing a partner in a har¬ 
monious marriage puts you at 
greater risk of health prob¬ 
lems. Your health care costs are 
lower if you are widowed in 
a discordant marriage.” 
For the study, which was 
published in the June issue 
of The Gerontologist, the 
researchers interviewed 694 
people who were part of a 
longitudinal study on success¬ 
ful aging and who remained 
married between the initial 
survey and the follow-up. The 
investigators then compared 
the health care costs of the 
married people to those of the 
widowed people. They also 
looked at the health costs of 
widows and widowers from 
happy and unhappy marriages, 
as characterized by answers to 
questions posed to the couples 
before one spouse died. 
The researchers found that 
annual health care costs were 
$2,384 for widowed persons 
compared with $1,498 for those 
who were married. Health care 
costs for the surviving partners 
in happy marriages were $2,766 
compared with $2,100 for sur¬ 
vivors of unhappy marriages. 
Prigerson said the sense of 
loss for the survivor in a happy 
marriage is often so profound 
it can be defined as “traumatic 
grief syndrome,” which can 
cause an array of health disor¬ 
ders. “Doctors should realize 
that older widowed people are 
at increased risk,” Prigerson 
said. “Many widowed persons 
in the study needed mental 
health care, but few were 
receiving it.” 
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Yale researchers solve 
structure of the ribosome 
Crystallography confirms a long- 
held notion that RNA, not protein, sparks 
protein synthesis on the ribosome. 
In a landmark achievement, 
\ale researchers have deter¬ 
mined the atomic structure of 
the ribosome’s large subunit, 
paving the way for more effec¬ 
tive drugs to fight infection. 
The findings, published in 
two separate articles covering 
25 pages in the Aug. ii issue 
of the journal Science, were 
derived in Yale laboratories led 
by Thomas Steitz, the Eugene 
Higgins Professor of Molecu¬ 
lar Biophysics and Biochem¬ 
istry and an investigator at 
the Howard Hughes Medical 
Institute, and Peter Moore, 
the Eugene Higgins Professor 
of Chemistry. 
“This is like climbing Mt. 
Everest or running the four- 
minute mile,” Steitz said. “We 
have solved the structure of 
the ribosome’s large subunit, 
which is the largest unique 
structure determined. We have 
established that the ribosome 
is a ribozyme, an enzyme in 
which catalysis is done by rna, 
not protein.” 
The ribosome is the cellu¬ 
lar structure responsible for 
synthesizing protein molecules 
in all organisms. In addition 
to enhancing the understand¬ 
ing of protein synthesis, the 
research offers new clues about 
evolution and has significant 
medical implications because 
the ribosome is a major target 
for antibiotics. 
Many antibiotics cure dis¬ 
ease by selectively inhibiting 
the protein-synthesizing activ¬ 
ity of large ribosomal subunits 
in disease-causing bacteria, 
while leaving human ribo¬ 
somes alone. Unfortunately, 
over the years, many bacteria 
have become resistant to 
these agents, and the possibil¬ 
ity exists that the devastating 
bacterial diseases that were 
brought under control by 
antibiotics in the 1940s and 
1950S will once again become 
scourges. 
“Now that we know the 
structure of the large riboso¬ 
mal subunit,” Steitz said, “we 
can determine its exact struc¬ 
ture with antibiotics bound 
to it.” The same methods of 
“structure-based drug design” 
that led to the development 
of HIV protease inhibitors for 
AIDS can now be used on 
the ribosome. 
“The information that 
emerges should enable phar¬ 
maceutical companies to 
devise new inhibitors of ribo¬ 
some function that can be 
used to control bacterial dis¬ 
eases that have become 
resistant to older antibiotics,” 
said Moore. 
Although the ribosome is 
microscopic, it is gigantic in 
molecular terms. The larger of 
its two subunits is about 50 
times larger than the average 
enzyme. Its function is to read 
the genetic information 
encoded in messenger rna 
and generate the protein mole¬ 
cules that those messenger 
RNA molecules specify. The 
proteins made by an organ¬ 
ism’s ribosomes are responsible 
Yale scientists have determined the 
structure of the ribosome’s large 
subunit, a finding that offers new 
clues to evolution and could increase 
understanding of protein synthesis 
and lead to the discovery of new 
drugs. The image at left shows the 
crystal structure of the large ribo¬ 
somal subunit in H. marismortui, a 
bacterium found in the Dead Sea. 
for virtually all of its proper¬ 
ties, including how it looks 
and behaves. 
The structure of the ribo¬ 
some’s large subunit was 
determined using X-ray crys¬ 
tallography, a technique 
that can produce three-dimen¬ 
sional images at resolutions 
so high that individual atoms 
can be positioned. The 3,000 
nucleotides of rna in the 
large ribosomal subunit form 
a compact, complexly folded 
structure, and its 31 proteins 
permeate its rna. 
Enzymes composed entirely 
of protein promote virtually all 
chemical reactions that occur 
in living organisms. One of 
the most remarkable findings 
to emerge from this research 
is that the protein synthesis 
reaction that occurs on the 
ribosome derives from the two- 
thirds of its mass that is rna, 
not from the one-third that 
is protein. 
“It was suspected for many 
years that the rna of the ribo¬ 
some was the enzymatic com¬ 
ponent. We now know that 
for certain,” Steitz said. “This 
means that in the very early 
days of evolution, protein syn¬ 
thesis evolved using rna mole¬ 
cules because there were no 
protein molecules.” 
16 
The presence of Y chromosomes, 
incJicated by yellow arrows, in a liver 
transplanted from a female donor 
suggests that stem cells from the male 
recipient’s bone marrow are develop¬ 
ing into liver cells. 
Stem cells from bone marrow can help 
to repair liver 
Much of the power of self¬ 
repair in the liver comes, of 
course, from the liver’s own 
cells, but a substantial portion 
is derived from a previously 
unsuspected source outside 
the liver, according to a paper 
published in Hepatology. 
That novel source of liver 
cells is bone marrow, the pro¬ 
ducer of multipotent stem 
cells, which can develop into 
many different kinds of 
cells throughout the body. In 
the human adult, bone 
marrow stem cells have long 
been known for rheir unusual 
ability to give rise to both 
white and red blood cells, but 
their potential also to become 
nerve or muscle or epithelial 
cells has only been discovered 
in the last several years. 
Investigators including Yale’s 
Diane Krause, m.d., found 
that stem cells that travel 
through the bloodstream to 
the liver can develop into 
both hepatocytes and bile- 
duct cells, which are responsi¬ 
ble for normal liver function. 
The Hepatology paper 
describes the analysis of tissue 
samples from transplants in 
male patients who had received 
livers (but no bone marrow) 
from females, and in female 
patients who had received 
bone marrow (but not their 
livers) from males. That is, 
both groups of transplant 
patients had bone marrow 
from one sex (male) and livers 
from the other (female). 
In each case, some of the 
new cells that developed 
in the liver contained a y chro¬ 
mosome, indicating their 
male origin. The researchers 
reason that in the male trans¬ 
plant recipients, these new 
cells could only have come 
from the males’ own bone 
marrow, and in the females, 
the new cells must have come 
from the (male) donated 
bone marrow. 
“This is an exciting find¬ 
ing, and it is incredibly 
surprising, because the bone 
marrow has never been 
considered as a source of liver 
cells,” says senior author 
Krause, an assistant professor 
of laboratory medicine. Not 
only does the finding open up 
new possibilities for treating 
many kinds of liver disease, it 
also indicates that fully func¬ 
tional stem cells with a remark¬ 
able plasticity can be found 
within adult bone marrow. 
How nicotine may buffer the brain 
Smokers who claim that 
tobacco relaxes them are report¬ 
ing a documented biochem¬ 
ical effect. Nicotine, the main 
active compound of tobacco, 
lowers the perception of pain 
and physical stress by reducing 
the amount of the neurotrans¬ 
mitter dopamine that is bro¬ 
ken down by neurons in the 
prefrontal cortex, a region of 
the brain that lies just behind 
the forehead. But Yale psy¬ 
chiatrist Tony P. George, m.d., 
and his colleagues report 
in the July issue of Neuropsy¬ 
chopharmacology that the 
dopamine pathways are not 
acting on their own. It appears 
that they are regulated by 
the brain’s system of endoge¬ 
nous opioid peptides—the 
brain’s own pain relievers. 
The Yale group performed 
experiments in which rats 
were given small amounts of 
nicotine; some were also 
given naloxone, which blocks 
the action of endogenous 
opioid peptides, while others 
received an inactive saline 
solution. When the animals 
were tested by brief electrical 
shocks to the foot, the response 
of the saline group showed 
that nicotine had acted on the 
endogenous opioid peptides 
to reduce the amount of 
dopamine metabolized by pre¬ 
frontal neurons, while the 
response of the naloxone group 
showed normal (non-nicotine) 
levels of dopamine metabo¬ 
lism. This indicates that the 
endogenous opioid system 
must participate in order for 
nicotine to be able to alter 
levels of dopamine uptake and 
thereby reduce perceptions 
of pain and stress. 
Understanding the molecu¬ 
lar basis of nicotine’s effects 
in the brain may give scientists 
new tools for developing ways 
to treat nicotine dependence. 
“Furthermore,” says George, 
“our results may have implica¬ 
tions for our understanding 
of neuropsychiatric disorders 
such as schizophrenia,” in 
which smoking, excessive 
responses to stress, and some 
dysfunction of the prefrontal 
cortex all may be linked. 
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A genetic cause for hypertension 
during pregnancy 
Blood pressure normally dips 
slightly during pregnancy but, 
as every obstetrician knows, 
a spike in pressure can lead to 
a serious and potentially 
life-threatening complication. 
The reasons for this type of 
hypertension, which occurs in 
about 6 percent of pregnan¬ 
cies, remain mysterious but 
research by a Yale team has 
shed the first light on a likely 
molecular cause. 
Working with a family 
predisposed to a rare form of 
hypertension, David Geller, 
M.D., PH.D., and colleagues 
identified a mutation in a pro¬ 
tein in kidney cells that nor¬ 
mally regulates salt balance. 
The protein, known as the 
mineralocorticoid receptor, is 
normally activated by the 
steroid aldosterone. The Yale 
scientists found that, in 
patients with the mutation, it 
is also activated by the hor¬ 
mone progesterone. “The con¬ 
sequence is that when women 
with this mutation become 
pregnant, the loo-fold rise in 
progesterone levels activates 
the receptor, causing increased 
salt balance and a marked 
increase in blood pressure,” 
said the paper’s senior author, 
Richard P. Lifton, m.d., ph.d., 
a Howard Hughes Medical 
Institute (hhmi) investigator 
and professor of genetics, 
medicine, and molecular bio¬ 
physics and biochemistry. 
Researchers used the images above 
in the face, object and pattern task to 
determine how the brains of people 
with autism respond to visual stimuli. 
For each stimulus type, the pair on 
the left is different while the pair on 
the right is the same. 
Hypertension during preg¬ 
nancy can lead to preeclamp¬ 
sia, which may be fatal to 
mother, fetus or both. The 
team’s findings were reported 
in the July 7 issue of Science. 
“Our findings demonstrate 
that a normal hormone of 
pregnancy can have abnormal 
effects that can cause hyper¬ 
tension to worsen. This raises 
the possibility that more 
common forms of pregnancy- 
related hypertension may be 
attributable to similar mecha¬ 
nisms,” Lifton said. This 
information, he said, will 
motivate careful examination 
of the possibility that proges¬ 
terone is acting to promote 
increased salt balance in other 
Facial recognition is 
The developmental disorder 
autism interferes with social 
functioning—even with 
the recognition of faces, as a 
functional magnetic reso¬ 
nance imagery study now 
shows in detail. The study, 
which appeared in April in the 
Archives of General Psychiatry, 
was the work of a Yale research 
team headed by Robert T. 
Schultz, PH.D., an associate 
professor at the Yale Child 
Study Center. 
A decade of investigation 
has established that people 
with autism have more diffi¬ 
culty than unaffected indi¬ 
viduals in recognizing faces. 
Instead, they rely on perceptual 
processes typically used to 
recognize non-face objects. 
The Yale study confirms these 
observations in terms of brain 
activity patterns. When a per¬ 
son with autism examines a 
face, his or her brain reacts dif- 
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forms of pregnancy-related 
hypertension and may lead to 
clinical trials of salt restric¬ 
tion in selected groups of 
women whose blood pressure 
rises with pregnancy. 
The paper was dedicated 
to the memory of the late Paul 
B. Sigler, m.d., who died in 
January 2000. Sigler, a noted 
Yale and hhmi structural 
biologist, created a computer 
model of the mineralocorti¬ 
coid receptor and demon¬ 
strated how the mutated 
receptor might be activated 
by progesterone. The group 
then used this model to per¬ 
form further experiments 
that proved the mechanism 
of action of the mutation. 
impaired in autism 
ferently from the brain of a 
normal person. Instead of 
bursting into activity at a site 
called the fusiform gyrus, 
which normally responds pref¬ 
erentially to faces, individuals 
with autism display increased 
activity in the inferior temporal 
gyrus, which normally responds 
most strongly to objects. In 
addition, people with autism 
tend to process faces by focus¬ 
ing on a few salient features 
rather than on the overall con¬ 
figuration, as if they were pro¬ 
cessing an object. 
The new findings lead to 
a riddle. Could this abnormal 
brain activity be a cause of 
autism, or the result of a long¬ 
standing disinterest in social 
interactions that dates back to 
early childhood? “With our 
data, it is not possible to know,” 
says Schultz, but he and 
many of his fellow researchers 
look forward to finding out. 
Ferraro Fadiman Leshner Schoofs 
Another vote for women’s health research 
Former New York congresswoman Geraldine Ferraro came to 
Yale in September with a message about the importance of 
the political process to women’s health. “In the past, some dis¬ 
eases were not very interesting to those who funded research 
because they only affected women. That’s changing now,” said 
Ferraro, the first woman nominated for vice president by a 
major party when she ran with Democrat Walter Mondale in 
1984. She was the keynote speaker at “Conference 2000: 
Factoring in Gender,” sponsored by Women’s Fiealth Research 
at Yale, a day-long event that attracted more than 200 people 
to New Fiaven’s Lawn Club for lectures and presentations by 
Yale investigators. Noting that women make up more than half 
the population—and they vote—Ferraro said, “We are differ¬ 
ent biologically. Policies that don’t take this into account are 
not only unacceptable, they’re undemocratic.” 
Bridging cultural divides in medicine 
“Reality,” says writer Anne Fadiman, “not only looks different 
to different people. It is different.” Ffer acclaimed first 
book. The Spirit Catches You and You Fall Down, describes 
the linguistic and cultural gulf that separated a family of 
Ffmong refugees from Southeast Asia from the physicians 
treating the family’s epileptic infant daughter in California’s 
Central Valley. 
Caregivers, she said, need to understand the cultures of 
their patients. “Cross-cultural medicine,” she said in an address 
to the first-year class at the medical school on Sept, i, “should 
be integrated into every course. It shouldn’t be taught just in 
the first term or the first year. It is fine then, but you will need 
it more in the fourth year when the assaults on your empathy 
need to be fought more aggressively.” 
A toolbox for drug abuse treatment 
Drug abuse has been linked to 72 risk factors, including indi¬ 
vidual, family and societal issues, according to Alan I. Leshner, 
PH.D., director of the National Institute on Drug Abuse (nida). 
Yet most drug abusers, he said, fall into one of two categories. 
Some use drugs as a novelty. Others “self-medicare” to normal¬ 
ize a troubled emotional state. “We have paid far too little 
attention to the distinction between them in treatment strate¬ 
gies,” said Leshner, the keynote speaker in September at 
a symposium, “Innovations in Drug Abuse Treatment: From 
Research to Practice,” sponsored by the School of Medicine 
and the Department of Psychiatry, which is participating in two 
national studies on tobacco and drug abuse. “Treatment has 
to be tailored to individual needs,” Leshner said. “There is no 
‘one size fits all.’” 
At the symposium he unveiled the NIDA Clinical Toolbox: 
Science-Based Materials for Drug Abuse Counselors, a collection 
of therapy resources. “It is a toolbox that might be used by 
practitioners to take the science we have supported and make it 
usable in ongoing treatment,” Leshner said. 
AIDS in Africa: treating the “untreatable” 
“We cannot let a disease for which a treatment exists mow 
down millions and leave a continent of orphans,” said 
writer Mark Schoofs, who won a Pulitzer Prize in 2000 for his 
coverage of aids in Africa published in the Village Voice. 
Without treatment, he said, Africa faces a plague of “biblical 
proportions.” In sub-Saharan Africa, where 24.5 million 
people are living with aids, the disease threatens to wipe out 
10 percent of the population and make orphans of between 
10 and 15 percent of the continent’s children. 
In his keynote address at “aids in Africa,” a day-long discus¬ 
sion on Sept. 21 sponsored by the School of Public Fdealth 
at the Joseph Slifka Center for Jewish Life, Schoofs called for 
a new social contract. “In a sane, compassionate world, 
drug companies could sell their drugs for a profit in rich coun¬ 
tries and at cost in poor countries,” said Schoofs, a 1985 Yale 
College graduate. 
The goals of treatment may have to step back from the 
norm in developed countries, he said, and be as modest 
as buying parents five more years of life. “We cannot let the 
perfect suck the life out of the good,” he said. “There already 
is a different standard of care in Africa. It’s called no care.” 
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An exhibit at the Cushing/Whitney Medical Library 
throws light on a pivotal period for American hospitals . ,f] 
and New Haven’s history. 
]»(>.! rd 
.;~a le ; ur* 
ABOVE This portrait of Jonathan 
Knight by Nathaniei Jocelyn can 
be seen in the rotunda of the medical 
library. Knight was one of the found¬ 
ing professors of the Medical Institu¬ 
tion of Yale College and was president 
of the National Medical Convention 
that formed the American Medical 
Association in 1846. He was president 
of the AMA in 1853-54. u 
I :.i|t 
HISTORICAL LIBRARY, C U S H I N C / W H IT N EY MEDICAL LIBRARY (5) 
When New Haven’s first hospital opened 
in 1833, it was the product of years of political 
wrangling and a fund-raising campaign that 
swept up Yale’s small medical faculty, who 
needed a place both to teach clinical medicine 
and to build theit reputations and private prac¬ 
tices. But the State Hospital, as it was known 
at first, also had trouble finding enough patients 
to fill its 75 beds. Wealthy and middle-class 
New Haven residents could afford to be seen at 
home by their private physicians, and hospital 
care in the early 1800s offered few benefits over 
home care. Demand from patients was so low 
that, for the first few years, the fledgling hospi¬ 
tal on Yotk Street tented out rooms. 
That pictute changed dramatically with the 
onset of the Civil War, according to a recent 
exhibit on New Haven’s Hospitals at the Cush¬ 
ing/Whitney Medical Library. In 1862, the 
ditectors of the State Hospital leased the build¬ 
ing to the U.S. government to be used as a 
military hospital. Through 1865, 25,340 soldiers 
were treated at the hospital, with only 185 
deaths. During those war years, the hospital 
was known as the Knight U.S. Army General 
Hospital, after Jonathan Knight, a founding 
professor at the Medical Institution of Yale 
College and a leading surgeon in the state. 
As patients pouted into hospitals up and 
down the East Coast during the Civil War, doc¬ 
tors began to see that most deaths came not 
from bullets on the battlefield but as the result 
of infectious diseases including dysentery, 
typhoid and malaria. When the Knight Hospi¬ 
tal was directed by the military to increase its 
number of beds to 1,000, it did so by building 
pavilions. This would allow doctors to segre¬ 
gate patients into wards to prevent the spread 
of disease. 
While medical practices at the time were 
rudimentary, conditions at the hospital, 
and the petsonnel there, were vasdy superior 
to those at the front. In general, wounded 
limbs were amputated with an insttument that 
resembled a hacksaw to halt the spread of 
infection. The opetation was quick, generally 
taking no mote than 15 minutes. An author 
in the Knight Hospital Record, explaining what 
sick and wounded soldiers have to suflFet 
while en route from the battlefield, reported 
that “we ate unloaded and assigned to a 
‘bed’ on the nearest grassplot. Here we are sur¬ 
rounded by suffering in all its phases, and 
scenes most revolting. Bared wounds are on all 
sides, some of which are alive from exposure 
and lack of attention.” The report went on to 
describe the amputation table, “where the 
sutgeons cut off limbs with as much compo¬ 
sure as a butcher would saw a leg of mutton 
for your dinner table; whete legs and arms, feet 
and hands, and toes and fingers, are heaped 
together in one conglomerated mess.” 
The name of the hospital was changed to 
New Haven Hospital in 1884. It grew sig¬ 
nificantly in the late 19th century along with 
other hospitals as cities butgeoned with the 
influx of immigration and industrialization and 
as improved medical care, including aseptic 
surgery and general anesthesia, began to atttact 
middle-class and wealthy patients. In 1872, 
two wings were added. In 1882, a separate dor¬ 
mitory was built for the affiliated Connect¬ 
icut Training School for Nurses, founded in 
1873. The 1880S saw the addition of the 
Farnam Amphitheater for Surgery and the 
Gifford wings. The original State Hospital 
building was demolished in 1929 to make way 
for the Clinic Building. 
In 1945, New Haven Hospital merged with 
Grace Hospital, a homeopathic facility char¬ 
tered in 1889, to become Grace-New Haven 
Community Hospital. The York Street build¬ 
ing known as the Memorial Unit opened in 
1953 and, 12 years later, after a new affiliation 
with Yale University, the hospital became Yale- 
New Haven Hospital. 
The exhibit, which was on display from 
May to September, can be viewed at 
info.med.yale.edu/libtary/exhibits/hospitaIs. 
ABOVE Most of these men were 
graduates of the Medical Institution 
of Yale College. Back row; Unidenti¬ 
fied Army surgeon, Drs.Timothy H. 
Bishop, H.S. Pierpont, T. Beers Town¬ 
send, Charles A. Lindsley, Virgil M. Dow, 
unidentified Army surgeon. Front 
row: Drs. David L. Daggett, Levi D. 
Wilcoxson, Pliny A. Jewett, Worthing¬ 
ton Hooker and W.B. Casey. 
BOTTOM LEFT (OPPOSITE) The first 
hospital in New Haven, the State Hos¬ 
pital, opened in 1833 on a seven-acre 
plot between Cedar and Howard streets. 
The three-story stone structure could 
accommodate about 75 patients. This 
image appeared in E. Porter Belden’s 
Sketches of Yale College, New York, 1843. 
BOTTOM RIGHT (OPPOSITE) Ini862, 
the hospital was renamed the Knight 
U.S. Army General Hospital, after 
Jonathan Knight, who was president 
of the Board of Directors of the Gen¬ 
eral Hospital Society of Connecticut 
and a professor at the Medical Institu¬ 
tion of Yale College. The new name 
also reflected its new role as a military 
hospital that treated 25,340 soldiers 
during the Civil War, with only 185 
deaths. 
Pern McNerney is a writer and editor and the founder of 
Content Creation Co. in Madison, Conn. 
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For years, health professionals 
and students at Yale have worked 
with their neighbors in the 
community in partnerships that 
provide benefits to all. These 
ildgraphs, prepared for Yale’s 
milal, tell that story. 
1 & 2 
Health on wheels 
Physician associate Joy Burns takes 
the pulse of one patient, previous 
page, and checks the blood pressure 
of another, above, on the Community 
Health Care Van, which makes daily 
rounds through New Haven neighbor¬ 
hoods such as Fair Haven and The Hill 
and to soup kitchens and emergency 
shelters. Burns, two outreach workers 
and a social worker offer urgent care, 
HIV screening and counseling, sub¬ 
stance abuse services, referrals to com¬ 
munity health care sites and rehabili¬ 
tation services, and screening for preg¬ 
nancy, tuberculosis and sexually trans¬ 
mitted diseases. The van’s sponsors are 
Yale University School of Medicine, 
Yale-New Haven Hospital, the Hospital 
of St. Raphael, Hill Health Center, Fair 
Haven Community Health Care Clinic, 
the City of New Haven and its Health 
Department, and the APT Foundation. 
3 
Cuddle time 
Medical student Karen Thomas offered 
a little TLC to infants in the hospital 
when their parents couldn’t be there. 
During her first rwo years of 
medical school, Karen 
Thomas spent a few hours 
each Wednesday evening 
at Yale-New Haven Children’s 
Hospital, cuddling infants 
whose parents couldn’t be there with them. 
“It was, very literally, a way for me to lay my 
hands on a patient and contribute to their 
care,” says Thomas. “In holding, talking, and 
playing with the children I thought I could 
help give each of them something that every 
patient needs—a little tlc.” 
Her fellow medical students, along with stu¬ 
dents at the School of Nursing, spend even¬ 
ings at the Downtown Evening Soup Kitchen 
or the Columbus House homeless shelter, 
offering physical exams and checkups under 
the supervision of physicians and nurses. 
Students come to medical school laboratories 
from Hill Regional Career High School to 
learn anatomy. Public health students lead a 
workshop in self-esteem and conflict resolution 
at the New Haven Boys & Girls Club, just a 
few blocks from the medical school campus. 
The Physician Associate Program Class of 2001 
John Curtis is the associate editor of Yale Medicine 
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spent a Saturday in June working on a Habitat 
for Humanity renovation project in the city’s 
Newhallville neighborhood. 
“Being able to participate in community 
projects like Habitat helps put things into per¬ 
spective,” says Class President Ed Hahm. 
“It’s important for us to realize that there is so 
much more out there than just studying 
for weekly exams. Participating in community 
projects such as Habitat for Humanity gives 
us an opportunity to get involved with the 
community we’re learning to serve medically.” 
These are just a few of the ways in which 
students in the health professions join with 
their neighbors in building healthier communi¬ 
ties. As the University marks its 300th anniver¬ 
sary, it is looking not only to its own history 
and future, but also to its relationship with New 
Haven. The Tercentennial’s opening weekend 
in October celebrated the University’s neigh¬ 
bors with an open house. The photo essay that 
follows is adapted from a photo exhibit, 
“Neighbors: Working Together for a Healthy 
New Haven,” displayed as part of the School of 
Medicine’s celebration of the Tercentennial. 
The photo essay documents the activities of 
students and health care providers who work in 
In 1993 students and faculty contemplated 
forming an umbrella organization to coordi¬ 
nate the growing number of participating stu¬ 
dents and community service activities, 
covs, the Committee Overseeing Volunteer 
Services, was formed. It now oversees 17 activi¬ 
ties involving scores of students and has 
established three categories of programs— 
health education and youth mentoring, clinical 
intervention and community development. 
With the fotmation of covs, medical stu¬ 
dents reached out to students in nursing 
and public health, with whom they now work 
side by side at homeless shelters and soup 
kitchens. Now, about 70 petcent of medical 
students are involved in at least one com¬ 
munity activity. Both parties in these activities 
gain from the partnerships. “I came to school 
here with the goal of working with the 
homeless and low-income population when I 
graduate,” says Holly Leopold, a nursing 
student who takes blood pressure and offers 
health counseling at the soup kitchen. “I 
have loved getting to know the soup kitchen 
guests and feel that my education, both in 
life and nursing, has been greatly enriched by 
my experiences there.” 
4&5 
Making a connection 
Medical students Suneil Ramchandani, 
below left, and Pamina Kim, below right, 
spent a Friday afternoon last spring at 
Roberto Clemente Middle School teach¬ 
ing A.J. Miranda and Miriam Lopez how 
to use search engines to navigate the 
Internet. Regular Friday after-school 
meetings are part of the Youth Onward 
program, which starts with workshops 
on self-esteem and social and health 
issues before shifting to one-on-one 
mentoring sessions. 
the communities that border the medical cam¬ 
pus. When student involvement with the med¬ 
ical school’s neighbors began in its current form 
in the mid-1980s, activities focused on educa¬ 
tion—medical students held workshops in pub¬ 
lic schools to talk about drug abuse and aids. 
By the early 1990s students were serving as pre¬ 
natal health advocates for new mothers, teach¬ 
ing high school students to teach their peers 
about AIDS, and bringing fifth-graders to cam¬ 
pus for interactive lessons in medical science. 
The worth of partnerships with New 
Haven’s neighborhoods may not be felt for 
years, says Myron Genel, m.d., a faculty 
member who has worked for many years 
with student and community organizations. 
“The real rewards are going to come 10 to 
15 years downstream when we can see the 
influence these programs have had on peo¬ 
ple’s lives. They are long-term investments.” 
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6,7 & 8 
A day of caring 
For the past two years orientation for 
incoming medical students has 
included a “Day of Caring” to support 
community organizations. This 
year about 40 students, including Niya 
Jones and llene Wong, spruced up 
a garden at an adult day care center in 
Branford, Conn., bottom photo, 
and organized a basement library at 
Life Haven, a shelter for women 
and children in Fair Haven, below. “We 
had lots and lots of volumes but 
there was absolutely no sense to the 
way they were shelved," says Bar¬ 
bara Winters, M.A., center, below left, 
program director at Life Haven. 
“The students moved all the books 
and categorized them for us. Now 
when the women go down they don’t 
have to search the whole library.” 
9,10 & 11 
Medical mentors 
Every spring for the past six years, 
local high school students have given 
up io Saturday mornings to join in a 
course that touches on HIV, nutrition, 
drug abuse, domestic violence and 
other health issues. The Health Profes¬ 
sions Recruitment and Enrichment Pro¬ 
gram, a national program with 6o 
chapters around the country, fosters 
mentorships between minority med¬ 
ical and high school students and 
encourages the younger students to 
go to college. The students mark the 
end of each course with a graduation 
ceremony, and top students receive 
scholarships for college education. 
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12-15 
Beyond the healing arts 
Nursing students took part in three 
projects this year that examined New 
Haven’s history and provided prenatal 
and primary care to its residents. They 
joined with the city’s International 
Festival of Arts and Ideas to connect 
high school students with senior citi¬ 
zens and artists. The Yale students first 
trained students from Hill Regional 
Career High School in the rudiments of 
oral history (13). The high school stu¬ 
dents, including Victoria Bonaparte (12) 
then interviewed seniors at a local 
elderly housing complex and, with the 
guidance of artists, helped them make 
collages that told a story about their 
lives. The collages were displayed at 
the festival this past summer. 
As a President’s Fellow, nursing stu¬ 
dent Salma Mody (14) received a 
stipend that allowed her to spend the 
summer of 2000 working with young 
pregnant women at The Women’s 
Center at Yale-New Haven Hospital. 
Mody, who plans a career as a nurse- 
midwife, offered prenatal care and 
worked to find ways to reduce preg¬ 
nancy and sexually transmitted infec¬ 
tions among young women. 
As part of an ongoing program, nurs¬ 
ing students such as Jennifer Sargent 
(15) offer basic medical care, such as 
blood pressure screenings, and basic 
hygiene supplies four nights a week at 
the Downtown Evening Soup Kitchen. 
16 
Painting a brighter picture 
Started four years ago to encourage 
conflict resolution among teens, 
the New Haven Boys & Girls Club Vol¬ 
unteer Project has continued with 
an added focus on nutrition, personal 
hygiene and self-esteem. Once a 
month public health students lead 
younger students in discussions, 
followed by arts and crafts activities 
for teens and adolescents. Public 
health student Shoba Ramanadhan, 
above, helped a younger student 
with a painting exercise. 
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17 (this page) & i8 
A day of labor 
Members of the Physician Associate 
Class of 2001 put aside their medical 
studies on a Saturday last June to pick 
up rakes, hoes and shovels for a day 
of manual labor, left and below right. 
They joined members of the New 
Haven chapter of Habitat for Human¬ 
ity in renovating two homes in the 
city’s Newhallville neighborhood, 
where students cleaned up trash and 
helped prepare the garden of one 
home for seeding. 
^
 
'H
i: 
19,20 & 21 
Opening the campus 
Every spring students come to the 
medical school from Hill Regional 
Career High School, just a few blocks 
away, to study anatomy with faculty 
and students. The anatomy classes are 
woven into the science curriculum at 
the high school. Students may also 
advance their science studies through 
SCHOLAR, a summer residential pro¬ 
gram that brings them to the Yale 
campus for three weeks of classes in 
biology and chemistry. Anatomy pro¬ 
fessor Bill Stewart, with the help of 
medical students, led studies of the 
human body, below right. G’Nee Her¬ 
bert worked with research technician 
Crystal Bussey on ONA studies, right, 
while other students conducted exper¬ 
iments in a lab on Science Hill, far 
right. "We studied how to identify and 
clone genes and became acquainted 
with different types of iab equipment 
and how to use it,” says Tom Haggerty, 
17, a senior at Career. 
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Clusters of industry: New ||| 
Haven-area, Yale-affiliated 
biotechnology companies 
Thirteen Yaie-affiliated biotechnology 
companies are located in and around 
New Haven, and close to a dozen more 
businesses—^the majority are expected 
to locate in the city—are now in develi, 
opment with assistance from Yale’s ■ 
Office of Cooperative Research. The 
existing New Haven-based companies 
are clustered in several locations in 
the city center and in nearby Branford. 
Publicly traded companies 
Drug development for cardiovascular 
and autoimmune disorders, inflamma- 
"r ■ 3nd capcei^ 
Genomics-based drug discovery 
and development 
Population genomics and personalized 
medicine. 
Drug discovery and development 
for psychiatric, metabolic and 
inflammatory disorders 
Anti-cancer drug discovery, 
development and commercialization, 
Companies developed by 
the Office of Cooperative Research 
Founder’s names in italics 
Antiviral therapeutic discovery 
and development 
. ^ng-Chi Cheng 
. Agriculture gene discovery 
Paul Lizardi 
Proteomics and functional genomics | 
Iro Mellg/an 
'^Lyme disease diagnostics 
Erol FUTrig, Joseph Craft and 
Richard Flavell ■ 
; ■ Molecular diagnostics based on 
1 rolling circle amplification technology 
David Ward and Sherman Weissman 
PhytoCeutica 
Pharmaceutical development of *• 
traditional Chinese medicine 
Yung-Chi Cheng 
polyGenomics (now merged with 
Molecular Staging Inc.) 
Disease-associated genetic mutations 
Sherman Weissman and David Ward 
Development of novel brain 
imaging agents 
Ronald Baldwin and Robert Innis 
Recombinant Technologies 
Production and distribution of 
novel research reagents 
Pazhani Sundaram 
Companies in development 
( Anesthesiology Internet commerce 
Web site 
Keith Ruskin and Charlotte Clark 
ntffl.CTT.M.'.ffa 
Bioinformatic tools for genomics 
Gregory Cardiner - 
Phoenix Drug Discovery . r- 
Disease-associated targets for drug 
development 
Gregory Gardiner 
Development of novel antibiotics 
John Swartley 
Regeneration of CNS neurons 
Stephen Strittmatter 
and Jeffery Kocsis 
Development of antibiotics 
and novel drug targets based on 
ribosome inhibition 
Thomas Steitz and Peter Moore 
Molecular sensors for drug discovery 
Ronald Breaker 
Odorants to modify insect and pest 
behavior 
John Carlson 
Epigenix Inc. 
Transgenic animals and functional 
genomics 
Frank Ruddle and Adrian Hayday 
i Informatic tools for 
protein expression analysis 
Michael Snyder 
and Sherman Weissman 
Vaccine cassettes for rapid 
development of novel vaccines 
Ruslan Medzhitov 
and Richard Flavell 
rce Office of Cooperative Research 
Four years ago, when staff from Yaie's Office of Cooperative Research 
(ocr) went looking for scientific discoveries with commercial promise, 
they stopped first at the laboratory of Yting-Chi “Tommy” Cheng, 
PH.D., the Henry Bronson Professor of Pharmacology. Cheng is the 
inventor of eight pharmaceutical compounds with enough clinical 
promise to interest drug companies, an astounding number for one 
scientist. He is a co-discoverer of 3TC, one of the essential ingredients 
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in the standard medication cocktails for patients with aids. And. the 
OCR staff learned, he had a portfolio of other compounds with 
potential for treating viral diseases such as hiv, Epstein-Barr virus 
and hepatitis B. “Individually,” recalls Alfred E. “Buz” Brown, ph.d., 
director of the OCRs medical school office, “the clinical candidates 
were less likely to be developed by an existing company. Putting 
them together as a package, though, gave them synergies that, along 
with [Chengs] technological strength, gave us great potential for 
building a new company.” As it happened, ocr’s staff were in the 
process of forming a company around Chengs technolog)' when 
they met William Rice, ph.d. 
Marc Wortman is a contributing editor of Yale Medicine. 
Frank Poole is a photographer in New Haven. 
Rice, a former research scientist at the 
National Cancer Institute (nci), had built the 
management team for a new drug-discovery 
and development company based on prom¬ 
ising technology he had developed at the nci. 
But Achillion Pharmaceuticals, as the new 
company was called, didn’t have the clinical 
candidates or the pharmacological talent that 
Yale possessed. The Yale compounds were 
just the medicine Achillion needed to gain the 
venture capital financing necessary for its launch. 
“Yale’s assets were highly complementary 
to what we had already built,” says Rice. 
“Having Yale as a partner gave us a huge lift.” 
Yale, too, saw Achillion as an opportunity to 
bring new money and business to New Haven 
and used its faculty, staff and network of con¬ 
nections to make it happen. Says E. Jonathan 
Soderstrom, ph.d., managing director of 
Cooperative Research for Yale University, “Buz 
Brown and [Associate Director] John Swartley 
[ph.d.] in our medical school office played a 
very active role in putting the business togeth¬ 
er with Bill, raising funds and bringing scien¬ 
tific talent and the business plan together. If 
it needed doing, we did it.” Rice had originally 
intended to base his company in Princeton, 
N.J., but Yale enticed the company to come to 
New Haven. Brown and Swartley shepherded 
Rice around the medical school, showed him 
34 
Achillion President William Rice had a startup company, 
was willing to move it to New Haven, and liked Cheng’s 
clinical candidates. 
Yale pharmacologist Tommy Cheng discovered the 
compounds that showed promise as treatments for HIV, 
Epstein-Barr virus and hepatitis B. 
potential laboratory locations in town and even 
pointed out residential areas with schools that 
would be right for his young family. “They 
really made me want to be here,” says Rice. 
Together with the ocr staff and Cheng, Rice 
sought out investors. The partnership was 
so successful that, according to a report by the 
accounting firm of PricewaterhouseCoopers, 
Achillion’s more than $17.2 million in financing 
represents the largest amount ever raised by a 
startup biotechnology company. Last summer. 
Rice moved his family to the New Haven area 
and Achillion opened its doors in renovated 
space in a former telephone company building 
within sight of the School of Medicine. 
The launch of Achillion is just one of a 
growing number of successes for the biotech¬ 
nology industry in greater New Haven, 
virtually all of which are directly tied to the 
School of Medicine. Most have not involved 
the complex deal-making that was behind 
the Achillion startup, but each of the eight new 
biotechnology companies—more are on the 
way—launched by Yale as part of a strategy to 
help jump-start the New Haven economy 
has the potential to grow explosively. With five 
existing publicly traded biotech companies 
and four major pharmaceutical research centers 
in the region. New Haven has emerged as 
a new mecca for biotechnology entrepreneurs. 
Private investment returns to New Haven 
The success of the last four years is part of a 
strategy announced by Yale’s leadership in 1995 
to use the medical school’s intellectual might 
to attract private investment to New Haven. 
In the early 1990s, surrounded by a dry with a 
declining industrial base and a reputation for 
poverty and crime, Yale woke up to the realiza¬ 
tion that it could not afford to look with 
benign indifference on its local environment. 
Dramatic change was needed at Yale itself 
if New Haven was ever to regain its former 
economic vitality. Guiding the transfer of Yale 
technology to private, for-profit companies 
within the region seemed the most promising 
way to assure that the gold and diamonds 
mined in Yale laboratories would be turned 
into jewelry close to campus. In 1995, the Uni¬ 
versity tripled the ocr’s budget and staff and 
hired as its director Gregory Gardiner, ph.d., 
former worldwide director of external research 
for pharmaceutical giant Pfizer. Part of his 
mandate was to use promising Yale-licensed 
technology to build new companies that would 
locate in New Haven. As part of a wider 
effort by Yale to revitalize its surroundings, the 
OCR entered the entrepreneurial fray with 
a sharp focus on helping new businesses take 
root in the city. Gommenting in 1998 on 
one of the first flowerings of those efforts, a 
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Buz Brown, Jon Soderstrom and John Swartley are the matchmakers who pair 
Yale-discovered technology with companies that have the means to apply that 
knowledge and bring it to market. 
significant new stare investment in Science 
Park, New Haven’s once-languishing technolo¬ 
gy incubator, Yale President Richard C. Levin 
said, “There are few things that Yale can do 
that will make a larger contribution to advanc¬ 
ing the economy of this city and region than 
this expanded commitment to technology 
transfer. Yale can be seen effectively as the r&d 
engine that will spawn companies for New 
Haven’s economy.” 
Gardiner, Soderstrom (who was then head 
of the OCRS medical school office) and their 
staff met with University scientists, respected 
venture-capital investors and state business- 
development leaders. Instead of focusing exclu¬ 
sively on the licensing of its intellectual prop¬ 
erty to existing companies, Yale began to 
explore ways in which New Haven-based start¬ 
ups might be formed around technologies 
conceived in its labs. The OCR worked closely 
with faculty whose discoveries had commercial 
value, wrote business plans, found investors 
willing to back the ventures and to bring busi¬ 
ness-development expertise to the table, and 
located appropriate space for growing high- 
technology businesses. It was an unprecedent¬ 
ed effort by Yale to use technology transfer and 
in-house entrepreneurs to lure private invest¬ 
ment into its hometown, and it worked better 
and faster than anyone could have foreseen. 
The payoff has already been evident—for 
New Haven and for Yale. Among the recent 
successes, all eight new biotechnology 
companies have attracted hefty infusions of 
outside investment, together mounting 
well into the tens of millions of dollars; new 
high-technology research and development 
space has been built; and, perhaps most prom¬ 
ising for the future of New Haven, a new 
entrepreneurial culture seems to have taken 
root within and outside the University to 
exploit the region’s economic potential. During 
the first eight months of 2000, the privately 
held and publicly traded biotechnology com¬ 
panies in New Haven received more than $554 
million in new investments. This is a remark¬ 
able turnaround for a city that lost much of its 
industrial base, mostly in manufacturing, 
during the half-century following World War II. 
An engine for employment 
While it is still the new kid on the block rela¬ 
tive to the long-established giant centers of 
the biotech industry around Boston, San Fran¬ 
cisco and North Carolina’s Research Triangle, 
New Haven now boasts some of the most 
advanced and fastest-growing biotechnology 
companies anywhere. Close to 1,000 people 
are now employed by the local industry, and 
every company is hiring as fast it can. “It’s 
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Bonnie Could Rothberg, a medical school alumna, 
says drug-discovery and genomics powerhouse 
CuraCen benefits from its proximity to Yale. 
incredibly exciting,” says New Haven Mayor 
John DeStefano Jr. “We are seeing a change 
occurring in New Haven that will be defining 
the center city for decades to come. It’s a 
transformation of the city’s economy every bit 
as dramatic as that of the mercantile transi¬ 
tion of 1900. New Haven will emerge as one 
of the dozen centers of the New Economy in 
America. It’s happening as we speak.” 
As for Yale’s contribution, Gardiner describes 
the process with this metaphor: “Complex 
crystals grow spontaneously once they are 
nucleated. Our job is to nucleate, to provide a 
little push and then let nature take its course.” 
The first two companies—Molecular Staging 
Inc. and polyGenomics, both possessing novel 
genomics technologies invented at the med¬ 
ical school—opened their doors in 1997. Oth¬ 
ers quickly followed. “It was like an invest¬ 
ment that starts small but, because it grows 
exponentially, becomes very large,” says Gar¬ 
diner, who retired in 1999 but continues to 
consult for his former office, teach at Yale and 
assist with the launch of local companies. 
Without a doubt, Yale’s participation has 
been essential to the blossoming of the New 
Haven biotechnology economy. Virtually all of 
the area’s biotechnology companies are School 
of Medicine spin-offs and keep very close asso¬ 
ciations with Yale. Even for well-established 
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companies such as CuraGen Gorporation, a 
leading developer of drug-targeting technology 
using genomic information that was founded 
in 1993, the Yale connections continue to be of 
value. Bonnie Gould Rothberg, m.d. ’94, the 
company’s group leader for pharmacogenomics, 
says, “We’ve always been very tied into Yale. 
We have active research collaborations and pub¬ 
lish papers together with Yale scientists.” Sev¬ 
eral members of CuraGen’s scientific advisory 
board are Yale faculty members, including its 
chair, Richard P. Lifton, m.d., ph.d., the chair 
of the medical school’s genetics department. 
Like most companies in the area, GuraGen’s 
executive and scientific leadership is also drawn 
from the medical school. The company’s 
founder and ceo, Jonathan Rothberg, ph.d. ’91, 
received his doctorate and did his postdoctoral 
work at Yale, as did several other executives. 
Yale may possess valuable technology and 
faculty with scientific know-how, but high- 
tech business development requires enormous, 
high-risk investment. Without broader sup¬ 
port, Yale’s efforts would not have been as well 
received by investors. After a long and at times 
acrimonious history with its home city, Yale 
leaders now speak of a partnership between the 
University and New Haven. Underlining the 
importance of that partnership, Yale created a 
new officer-level post, vice president and direc- 
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“Our job is to nucleate, 
to provide a little 
push and then let nature 
take its course.” 
-Former OCR director 
Gregory Gardiner 
“It’s a transformation of 
the city’s economy every 
bit as dramatic as that of 
the mercantile transition 
of 1900. New Haven will 
emerge as one of the 
dozen centers of the New 
Economy in America.” 
-New Haven Mayor 
John DeStefano Jr. 
tor of New Haven and state affairs, two years 
ago. Bruce D. Alexander, a former high-level 
executive with the Rouse Corporation, a lead¬ 
ing urban development firm, is the first holder 
of the office. “Clearly,” says Alexander, “the 
issue of New Economy companies is one 
where the University can exercise real influ¬ 
ence. What the microchip revolution was to 
the last few decades, the life-sciences revolu¬ 
tion will be for the next few. If we can catch 
this wave, it will recast New Haven’s economic 
development in a way that hasn’t been seen 
since it became a major manufacturing center 
more than a century ago.” 
New Haven Mayor DeStefano credits Yale 
and the OCR for taking a leading role. “As the 
head of one biotech company said to me, ‘You 
have to be like a fighter pilot and react quickly 
in this business or you’ll be killed fast. Yale has 
been helping me to do just that.’” 
Recognizing the state’s strong base in bio¬ 
medical research, government and industry 
leaders have also backed investment in Con¬ 
necticut’s biomedical sector. Connecticut Unit¬ 
ed for Research Excellence Inc. (cure), a loi- 
member organization of academic and research 
institutions, health care organizations and pri¬ 
vate companies, has long sought to promote 
the sector. As part of a wider effort to coordi¬ 
nate economic resources, Connecticut Gover¬ 
nor John Rowland designated cure to be the 
state’s “Bioscience Cluster” to foster growth in 
the industry. At cure’s urging, the state legisla¬ 
ture created a $40 million fund to underwrite 
the building of new laboratory space. Managed 
by Connecticut Innovations Inc., the fund has 
benefited many companies including Yale spin¬ 
offs in Science Park and in the former tele¬ 
phone company building at 300 George Street, 
across the Oak Street Connector from the 
medical school, cure president Debra K. 
Pasquale says, “This type of coordination and 
collaboration has never occurred in the state 
before, and that makes the environment for 
our efforts all the more fertile.” 
A two-way street 
While the economic benefits for the city and 
state are apparent, it is also true that develop¬ 
ment of a thriving private biotechnology econ¬ 
omy provides significant scientific benefits for 
Yale’s own academic research and teaching mis¬ 
sions—and the school’s reputation. “There are 
tremendous advantages in having companies 
here for our own resources,” says Sterling Pro¬ 
fessor of Genetics Sherman M. Weissman, 
M.D., who has consulted for private biotech¬ 
nology companies elsewhere in the country for 
decades. “We do things of common interest 
and mutual benefit. We get analyses of our 
data we couldn’t otherwise afford.” He worked 
closely with the ocr in the formation of 
polyGenomics and Molecular Staging Inc. 
(msi), companies based on new, extremely fast 
technology to detect disease-causing gene 
mutations that his departmental colleague 
David C. Ward, ph.d., and Associate Professor 
of Pathology Paul M. Lizardi, ph.d., created. 
With MSI just a five-minute walk from his 
Boyer Center office, it’s easy to drop by to and 
from work, he says. “I can have a hands-on 
view of what’s going on there.” 
For the first time, pharmacologist Cheng 
does not need to fly somewhere distant to 
guide the development of the drugs he discov¬ 
ered and move them into the clinic. He is 
chair of the scientific advisory boards of 
Achillion and another biotech company 
founded in New Haven last year, PhytoCeutica. 
The latter company brings his knowledge of 
mainstream Western pharmacology together 
with traditional Chinese herbal medicine to 
develop drugs for improving cancer and stroke 
treatments. PhytoCeutica also possesses bioin- 
formatic tools he developed in collaboration 
with the company’s chief executive officer, 
Patrick Kung, ph.d., which will be used for 
quality control and for discovering pharmaceu¬ 
tical uses for herbal medicines. “The compa¬ 
nies have advantages being in New Haven,” 
Cheng says. “They have easy access to me for 
one. They can just walk over or call.” 
Weissman, Cheng and other faculty with 
close ties to companies can also provide stu¬ 
dents and fellows in their laboratories with a 
convenient career path outside academia. 
Cheng says, “The companies want people 
trained in the technologies they use, so they 
are very interested in recruiting people from 
my laboratories. I’m not training students as 
scientists for the companies, but the students 
do now have more options for employment 
locally.” Says Rice, “We certainly are looking at 
postdocs as they finish their fellowships. There 
are major intangibles in just being affiliated 
with Yale when it comes to recruiting. Smart 
scientists want to be associated with a place 
like Yale.” 
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Writing the “operating system” 
for the new medicine 
“(Jitimatety, our technology 
may allow physicians 
and patients to select spe¬ 
cific treatments based 
oh a patient’s genome.” 
-Cualberto Ruano founder 
and chief executive 
officer of Genaissance 
Pharmaceuticals 
As a student in the School of Medicine’s M.D./Ph.D. 
Program a decade ago, Cualberto Ruano, Ph.D. ’92, 
M.D. ’97, expected to pursue an academic research 
career. Working with Kenneth K. Kidd, Ph.D., a pro¬ 
fessor of genetics and psychiatry, he discovered and 
patented a means of coupling the amplification 
of genetic materials with sequencing that has since 
proved valuable for biotechnology research and 
clinical medicine. “I got into the applied end of the 
research spectrum early, and I just went on from 
there,” he says. As chief executive officer of Genais¬ 
sance Pharmaceuticals, a New Haven-based bio¬ 
technology firm, he licensed that same technology 
as part of his company’s strategy to develop 
new means of separating out genetic differences in 
the benefits and possible dangers people face in 
taking medications. 
Ruano’s goal is to create new medicines that 
are custom-tailored for individual patients based on 
their genetic profiles. Like many biotechnology 
companies, Genaissance is as much an information 
company as it is a laboratory-based discovery 
engine. In renovated, former industrial loft space 
in New Haven’s Science Park, some 50 software 
developers work alongside 50 more genetics 
researchers generating health care algorithms that 
will be used to analyze individual genomes and 
clinical data to come up with optimal treatment 
regimens. Ruano hopes to create the "operating sys¬ 
tem” for health care of the future. He says, “We 
foresee knowledge of each individual’s unique 
genome being used to predict disease susceptibility 
and progression as well as each individual’s 
response to a drug. Ultimately, our technology 
may allow physicians and patients to select specific 
treatments based on a patient’s genome.” 
Genaissance combines analysis of genetic varia¬ 
tion within diverse groups of people—largely drawn 
from ethnic and geographic population samples— 
with clinical data plotting individuals’ responses to 
medications.The technique allows the company to 
generate increasingly specific databases of genetic 
markers that will eventually prove useful in the 
development, marketing and prescribing of drugs. 
The Genaissance name, he says, “reflects the con¬ 
cept of moving from medieval flatness in imagery to 
the increasing awareness of depth, shape, color 
and individuality that took place in the Renaissance. 
We’re doing the same in genomics by developing 
an increasingly multi-dimensional understanding of 
disease and drug interaction.” 
In a sense, Genaissance is a direct outgrowth 
of Ruano’s time at Yale. Working with Frank H. Rud¬ 
dle, Ph.D., Sterling Professor of Molecular, Cellular 
and Developmental Biology, who now heads Genais- 
sance’s scientific advisory board and whose tech¬ 
nology the company has also licensed, Ruano 
launched the company in April 1997. Genaissance 
has grown rapidly and began selling its stock to 
the public in August. 
“Yale was a magnificent opportunity for me,” 
Ruano says. "One of the things that makes Yale 
special is exposure to leaders in different fields. I 
was able to capitalize on that experience. A lot of 
people I interacted with at Yale are now members 
of my company in some capacity.” 
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Finding the line 
Closer ties to industry raise questions about conflicts. 
“It is difficult to make the 
case that academic 
medicine is for the public 
good on the one hand 
if we are perceived as for 
sale on the other.” 
-Yale professor and CURE 
founder Myron Genel 
“The University is review¬ 
ing its conflict-of-interest 
policy and procedures 
with an eye to making 
them more robust and 
providing clearer guid¬ 
ance. We want to be 
sure that the University 
addresses the full range 
of issues that can arise.” 
-Vice President and 
General Counsel 
Dorothy Robinson 
As the boundaries separating academe and industry 
are redefined at Yale and other universities, ques¬ 
tions arise about potential conflicts of interest: 
When money talks, will faculty focus their research 
on areas with the greatest possibility for commercial 
return? Will administrators guide appointments 
into research areas with the potential for more lucra¬ 
tive licenses? Will professors shirk their teaching 
duties to focus on outside businesses? 
Underlying the questions is a concern that closer 
ties to the private sector have the potential to under¬ 
mine universities’ academic, educational, health care 
and public-service missions. Yale sometimes takes an 
equity stake in companies started by the Office of 
Cooperative Research (OCR), and licensing income— 
driven in large part by the success of dqT, an anti-HIV 
compound discovered in Yale laboratories—has 
grown rapidly, totaling more than $46 million for the 
fiscal year ending last June 30. The money, which 
goes to support research and other University activi¬ 
ties, represents more than n percent of Yale’s total 
research expenditures. 
Myron Genel, M.D., a Yale professor of pediatrics 
and the founding chair of Connecticut United for 
Research Excellence Inc. (CURE), worries that Yale and 
other universities risk harming the traditional char¬ 
acter of medical schools that makes them so intellec¬ 
tually productive. “There is increasing concern that 
excessive emphasis on the commercial potential of 
academic research may damage the collegial, tradi¬ 
tional nature of academic institutions,” says Genel. 
Perhaps more significantly for the longer-term 
health of today’s financially strapped medical cen¬ 
ters, will all of this commercial activity reduce the 
public’s willingness to support biomedical research? 
“What’s at stake,” Genel says, “is the public percep¬ 
tion of academic institutions. Nationally the academ¬ 
ic medical community is vigorously attempting to 
sustain public support for the missions of medical 
schools and teaching hospitals. I believe we must 
keep our house in order on high-profile issues such 
as conflicts of interest by academic investigators, or, 
for that matter, on the part of our institutions. It is 
difficult to make the case that academic medicine is 
for the public good on the one hand if we are per¬ 
ceived as for sale on the other.” 
To prevent the reality from arising or such a per¬ 
ception from emerging, Yale has set rules limiting 
faculty work consulting for outside companies and 
for avoiding conflicts of interest in undertaking 
research on behalf of commercial enterprises (See 
Conflict-of-interest policy, opposite page). It has also 
undertaken a review of its current policies on con¬ 
flicts of interest and commitment and on human 
subject protection to make sure they are up to date 
and appropriate. Under the existing rules, all faculty 
members must file an annual conflict-of-interest 
form that is reviewed by the provost and a standing 
committee. Faculty are at Yale to teach and carry out 
research and, to avoid so-called conflicts of commit¬ 
ment, they are permitted to work only one out of 
every seven working days for an outside organiza¬ 
tion. They also cannot undertake clinical trials on 
behalf of a company in which they hold a significant 
equity stake—one that could compromise, or appear 
to compromise, the results of the trial. 
While research findings can sometimes be scruti¬ 
nized for commercial value by sponsors prior to pub¬ 
lication—a first look in return for support—all find¬ 
ings remain Yale’s intellectual property to license out 
as it deems appropriate. Also, Yale will not accept 
any outside support that limits publication of 
research findings. “The more close ties we have with 
industry,” says Sara Rockwell, Ph.D., professor of 
therapeutic radiology and director of the Office of 
Scientific Affairs, “the more potential there is for con¬ 
flicts of interest. Everything needs to be looked at to 
make sure that our research is free of the taint of a 
potential conflict of interest. It not only protects the 
research, it protects the faculty. One of the most 
awful things that can happen is to have your 
research findings accused of being tainted because 
of bias.” 
The topic, a hot one at nearly every university 
in the United States, was the subject of a National 
Institutes of Health conference in August, with 
discussion focused on the ethical questions inherent 
in closer ties between academe and the private 
sector. At Yale, according to Vice President and Gen¬ 
eral Counsel Dorothy K. Robinson, “the University 
is reviewing its conflict-of-interest policy and proce¬ 
dures with an eye to making them more robust 
and providing clearer guidance. We want to be sure 
that the University addresses the full range of issues 
that can arise.” 
Still, most agree that the new push into biotech¬ 
nology development in New Haven need not 
undermine the core missions of the University. “We 
feel very comfortable,” says Bruce D. Alexander, 
vice president and director of New Haven and state 
affairs, “that we can reconcile the traditional 
values of the University with respect to objective 
scientific research and the commercial application 
of that research to foster new companies that 
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will improve the quality of people’s lives and cure 
human diseases.” 
OCR Director E. Jonathan Soderstrom, Ph.D., finds 
that Yale faculty are not overly concerned with pur¬ 
suing the commercial value of their work. From the 
OCR’s perspective, the danger is that, if a new finding 
does not have patent protection prior to publication, 
no outside commercial entity will develop it because 
they will not be able to prevent competitors from 
copying the idea or product. “It’s not unusual for us 
to learn about something on Friday that’s set to be 
published on Monday,” he says. "We’re always in a 
race with the faculty because they’re not going to 
wait for us. They are more worried about publishing 
and tenure. The race here is to get the next cover of 
Nature and win Nobel prizes. If their desire was to 
get rich, they wouldn’t have come to a university like 
Yale. I don’t see that culture changing, and that’s a 
good thing.” 
Sitting in his cramped pharmacology department 
office, every inch of his desk covered with papers, 
Henry Bronson Professor Yung-Chi Cheng, Ph.D., does 
not look like a captain of one of the world’s fastest- 
growing, most-high-tech industries. “The financial 
aspect is not a driving force,” he says. “My belief is 
that some of those medicines will turn out to be very 
useful for health needs which cannot be fulfilled by 
current approaches. That’s my incentive for this.” 
“We feel very comfortable 
that we can reconcile 
the traditional values of 
the University with 
respect to objective scien¬ 
tific research and 
the commercial applica¬ 
tion of that research 
to foster new companies 
that will improve the 
quality of people’s lives 
and cure human diseases.” 
-Yale Vice President 
Bruce Alexander 
T 
a 
Conflict-of-interest policy 
The following principles are among 
those that underlie the University’s pol¬ 
icy on conflicts of interest: 
• External activities should not compro¬ 
mise an individual’s ability to perform 
all the activities expected of him or her 
as a Yale employee. 
• An individual should not receive remu¬ 
neration for the conduct of his or 
her research or clinical activity at Yale or 
other Yale activity except through 
University channels (such as salary). 
• An individual should not conduct 
research or clinical activity at Yale or 
carry on other Yale business under 
circumstances in which a reasonable 
person would infer that the Yale 
activity was distorted by the desire for 
or expectation of direct or indirect 
financial advantage. 
• Yale researchers, including students and 
postdoctoral appointees, must not be 
precluded from publishing their work 
by agreements with external sponsors 
or on account of the interest of an 
external organization in which a faculty 
mentor or supervisor has an economic 
interest. 
• Graduate students must not be held to 
non-disclosure of any aspect of their 
work in their meetings with individuals 
at Yale (including members of their 
dissertation advisory committees). 
• Yale research facilities and research 
personnel should be used for Yale’s 
research and educational purposes, 
except when other uses are specifically 
authorized by the University. 
• An individual should not participate 
directly in the negotiation of research 
agreements, license agreements, 
equipment purchases or other arrange¬ 
ments between the University and an 
organization in which the individual has 
a significant economic interest. 
The policy can be reviewed in its 
entirety at http://www.info.med.yale. 
edu/ysm/research/conflict.html 
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Left; Fragments of fluorescently labeled DNA light up 
a sequencing gel. The colors correspond to the four 
bases of deoxyribonucleic acid: green for adenine, yellow 
for thymine, blue for guanine and red for cytosine. 
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“We have caught the 
first glimpses of 
our instruction book, 
previously known 
only to God.” 
-Human Genome Project 
leader Francis Collins 
jarly last summer, 
Francis S. Collins, m.d., ph.d. ’74- fw ’84, joined 
President Clinton and the ceo of Celera 
Genomics, J. Craig Venter, m.d., at the White 
House on a day that marked a turning point 
in the history of medicine. Scientists in a half- 
dozen countriesrworking together to sequence 
the 3.1 billion nucleotide base pairs that make 
up the human genome, had completed their 
first pass of the data seyetal years ahead of sched¬ 
ule and would quickly be filling in the gaps to 
finish decoding the human book of life, as the 
seemingly endless string of adenines, guanines, 
cytosines and thymines has been described. 
It was a moment in which millions of non¬ 
scientists became interested in genetics, a 
sudden curiosity reflected in front-page cover¬ 
age around the world and the roller coaster 
for biotechnology stocks that preceded and fol¬ 
lowed the announcement. If people were 
excited by the news, they were also confused— 
not only by the complexities of molecular 
genetics but by what exactly was being 
announced. If the genome was 97 percent 
mapped, 85 percent sequenced and only 24 
percent verified, what was so special about 
June 26, the day of the announcement? 
The public proclamation, like the genome 
work itself, may have been speeded up by 
the race between the government-funded proj¬ 
ect and private upstart Celera to finish what 
is a gargantuan task, made possible by auto¬ 
mated sequencing around the clock and 
massive computing power. (Venter brashly 
announced in 1998 that he would beat the pub¬ 
lic consortiums timetable and finish the job 
by 2000, five years ahead of its original target.) 
But although the working draft was not 
quite complete, the news of June 26 was indeed 
extraordinary. Not only had scientists deter¬ 
mined the exact sequence of the vast majority 
of the chemical building blocks that make up 
human dna, but they had also strung together 
this information across the entire human 
genome; despite the gaps, these overlapping 
sequences stretched from end-to-end of 
every chromosome. 
“We have caught the first glimpses of our 
instruction book, previously known only to 
God,” said Collins, who received his ph.d. in 
physical chemistry from Yale in 1974 and 
trained as a fellow in genetics and pediatrics in 
the laboratories of Sherman M. Weissman, m.d., 
and Bernard G. Forget, m.d., in the early 1980s. 
Among those called on to interpret the 
news was Richard R Lifton, m.d., ph.d., chair 
of the Department of Genetics at the School 
of Medicine and a Howard Hughes Medical 
Institute investigator. (Lifton is also a member 
of the National Advisory Council to the 
National Human Genome Research Institute 
and of the nih Oversight Committee for 
the Human Genome Sequencing Project.) “It’s 
an awesome accomplishment,” he told Jim 
Lehrer on the pbs NewsHour program the day 
of the announcement, “one that will have a 
profound impact on human biology and medi¬ 
cine for the next century. Who we are, why 
we are the way we are, why we succumb to dif¬ 
ferent diseases—these are no longer open- 
ended questions but are bounded ones.” 
So what comes next? In late summer, Lifton 
sat down with Yale Medicine Editor Michael 
Fitzsousa to discuss the impact of the genome 
project, the opportunities it provides investiga¬ 
tors seeking the causes of rare and common 
diseases, and the likely next steps in Yale labo¬ 
ratories and around the world. Lifton, who 
came to Yale from Harvard in 1993 and heads 
the newly created Center for Genetics in 
Medicine at the School of Medicine, was the 
first to define the genetic underpinnings of 
hypertension, which affects 50 million people 
in the United States alone. With his colleagues 
he has identified 12 of the 13 genes known to 
play a role in regulating blood pressure, mostly 
through studies of families with rare disorders. 
In July, he and research fellow David S. Geller, 
M.D., PH.D., reported in Science they 
had discovered a mutation responsible for an 
inherited form of hypertension during preg¬ 
nancy, a complication that affects some 8 mil¬ 
lion women and their infants each year (See 
Findings, page 18). 
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Michael Fitzsousa is the editor of Yale Medicine. 
Gale Zucker Is a corporate and editorial photographer 
based In Branford, Conn. 
Human Genome Project Direc¬ 
tor Francis Collins and his pri¬ 
vate-sector counterpart, J. Craig 
Venter, announced in June 
that the sequence of the entire 
human genome had been 
deciphered, at least in working- 
draft form. What significance 
does this have for medicine? 
This really is a monumental 
achievement. The significance 
of it is that we can begin to 
see the outlines of a new future 
for medicine. We recognize that 
virtually every human disease— 
from cancer to heart disease, 
to asthma, to neuropsychiatric 
and other disorders—has signif¬ 
icant inherited contributions. 
However, the road to identify¬ 
ing those components has been 
a narrow and twisting one. 
We haven’t known how many 
genes there are in the genome, 
what each gene itself is, where 
they are on chromosomes. 
Having the human genome 
sequence really changes the way 
one thinks. We are no longer 
walking blindfolded through the 
forest not knowing how many 
trees there are, where they 
are, or when we’re going to 
stumble. We now have a precise 
map of where we’re going. 
What exactly do the sequence 
data tell us? 
There are a finite number of 
genes—probably 35,000 
to 45,000, maybe as many as 
100,000. So the inherited 
contribution to disease has to 
reside in the DNA sequences 
of those genes or the nearby 
components that regulate the 
expression of those genes. 
And so we go from this very 
open-ended problem to a 
bounded one, where we know 
all the genes and, in short 
order, will know all the common 
variations in the genes. It really 
becomes a matter of determin¬ 
ing which variants in which 
genes contribute to the devel¬ 
opment of different human dis¬ 
eases. In many ways, it’s analo¬ 
gous to where chemistry was 
before and after the develop¬ 
ment of the periodic table of 
elements. Imagine if you were 
the chemist trying to figure 
out the composition of a com¬ 
pound before you knew what 
all of the elements were. 
Now that we have the human 
genome sequence, it’s a mat¬ 
ter of figuring out which genes 
are involved in which partic¬ 
ular diseases. 
What’s the next step for the 
gene mappers? 
The draft version of the human 
genome sequence permits us to 
begin to identify, from the 3 
billion base pairs of the human 
genome, all of the genes encod¬ 
ed in that genome. We can 
estimate that perhaps half of 
all human genes are undiscov¬ 
ered and will be identified 
by combining this raw sequence 
with other databases. 
That will be one important 
step. In parallel, we will begin 
identifying all of the common 
variations that occur in these 
genes in human populations. 
Another process will be to 
go from the draft version of the 
human genome, which is 97 
percent complete, to the full 
version, which we anticipate 
will come by the year 2003. 
Ambiguities as to the order of 
particular sequences within the 
chromosomes will then be 
resolved. We’ll have the whole 
sequence. 
What we have now has been 
compared to a book with all the 
pages in order but the letters 
on each page scrambled. Is that 
unscrambling what will take 
place over the next few years? 
Yes. In some cases we have 
pages that are complete. In oth¬ 
er cases there are words and 
letters that need to be arranged 
properly. However, the infor¬ 
mation that we have today is a 
tremendous advance for the 
investigation of the inherited 
causes of disease. Having the 
genome sequence provides 
a tremendous boost to genetic 
research all over the world. 
HHMI grant will support genetics 
research 
The Howard Hughes Medical Institute (HHMI) has 
awarded the School of Medicine $4 million over the 
next four years to establish the Center for Genetics 
in Medicine at Yale, which will support the recruit¬ 
ment of new faculty and provide core infrastructure 
to investigators throughout the school. 
“The goal of the center is to apply the tools com¬ 
ing out of the Human Genome Project and human 
genetic analysis to the understanding of human dis¬ 
ease,” said Richard P. Lifton, M.D., Ph.D., the principal 
investigator of the grant and the center’s director. 
“One of its premises is that there will be a new 
cadre of physician-scientists who are adept at per¬ 
forming these types of genetic analyses and have 
expertise in clinical medicine.” 
Yale is among 41 institutions receiving a total of 
$92 million over the next four years as part of 
HHMI’s new competition for Institutional Grants to 
Medical Schools. Ranging from $1.6 million to $4 
million, the grants will help the schools find new 
ways to combine basic biomedical research and clin¬ 
ical treatment of patients, according to HHMI. They 
will also support programs in the rapidly developing 
field of bioinformatics. Yale was one of three institu¬ 
tions to receive the maximum $4 million award. 
The funding has helped Yale to recruit two new 
faculty members thus far, Kevin White, Ph.D., and 
Valerie Rienke, Ph.D., both from Stanford, who are 
leaders in the application of microarray technology. 
Microarrays are chips that enable the monitoring of 
gene expression in normal and abnormal cells 
derived from a variety of sources, from human to 
fruit fly. 
The support from HHMI will also enable the 
expansion of Yale’s existing research facilities. The 
Keck Biotechnology Resource Center, one of the pre¬ 
mier biotechnology resources in the country, pro¬ 
vides core infrastructure for activities such as DNA 
sequencing and protein peptide synthesis. With the 
HHMI support, the center has become one of the 
first core facilities nationally to implement capillary 
DNA sequencing, a technology used in the Human 
Genome Project. In addition, funds have been used 
to establish a core microarray facility that will make 
this new technology broadly available at Yale. 
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What’s an example of that? Say 
I’m a basic scientist, how are 
my prospects as an investigator 
different than they were per¬ 
haps a year ago? 
I think there are at least three 
areas that will be strongly influ¬ 
enced by this. The first of these 
is genetic investigation. For the 
last decade, investigators have 
been mapping the chromoso¬ 
mal locations of disease genes 
by comparing the inheritance of 
chromosome segments to the 
inheritance of diseases in fami¬ 
lies. And many of these projects 
have located genes on chromo¬ 
somes but have not yet been 
able to identify the gene in 
which mutations cause the dis¬ 
ease. If you are able to refine 
the location of the disease gene 
only to a big chromosome seg¬ 
ment that may contain io mil¬ 
lion base pairs, it’s an extremely 
arduous task to identify all of 
the genes in that interval and 
then test which of them have 
mutations that cause the dis¬ 
ease of interest. Having the 
genome sequence provides a 
tremendous bypass to that 
part of the project. Now you 
know all of the genes that lie 
within this lo-million-base- 
pair interval. Rather than put¬ 
ting an army of postdocs 
on the project to go through 
the heavy lifting of identifying 
all of the genes of that inter¬ 
val, you have somebody sit 
down at a computer terminal 
and parse through the sequence 
to identify all of the genes in 
that DNA sequence. All over the 
world, this is providing tremen¬ 
dous acceleration for human 
genetic studies. Projects that 
have lain dormant for a period 
of years are suddenly going to 
be brought to completion. 
A second area will be the 
identification of new targets for 
therapeutic use. For example, 
many drugs now in clinical use 
target G-protein-coupled recep¬ 
tors, which sit at the cell surface 
and are activated by proteins or 
small molecules; nuclear hor¬ 
mone receptors, which sit inside 
the cell and regulate transcrip¬ 
tion of genes; or ion channels 
and transporters that mediate 
passage of electrolytes in 
and out of tissues. Well, we’ve 
known about a number of these 
receptors, but it has been recog¬ 
nized that there are many more 
in the human genome that are 
ripe for discovery. Because these 
different types of targets share 
common elements, it will be 
relatively simple to identify all 
of the members of these gene 
families and to think about 
which of these might be targets 
for novel therapies. This is a 
first step, but it’s important. 
A third area in which the 
genome data will be enormous¬ 
ly helpful is in identifying bio¬ 
chemical pathways that are 
altered in human disease states. 
We will have the ability to 
monitor the expression of every 
gene in a cell and to ask how 
that pattern of gene expression 
is altered in response to dis¬ 
ease—or in response to a par¬ 
ticular intervention. Up to now, 
most scientists have been able 
to deal with only one or a few 
genes at a time, having to make 
good guesses as to which path¬ 
ways might be involved in dis¬ 
ease processes. Now we can ask 
that question on a much larger 
and more comprehensive scale. 
The genome project has received 
enormous attention, it has 
affected financiai markets, and 
it seems to be affecting the 
way the public sees disease and 
health. Are great breakthroughs 
in medicine Just around the 
corner? 
In medicine we’ve done our 
best therapeutically when we 
have understood in great 
detail the underlying pathogen¬ 
esis of disease. So I am opti¬ 
mistic that this greater under¬ 
standing of human disease 
will ultimately translate into 
improved therapies.The timing 
and the pathway to achieving 
new treatments, however, are 
much harder to predict. In some 
cases we may readily identify 
new targets that are amenable 
to development of small-mole¬ 
cule agonists or antagonists. 
In other cases we may find new 
proteins that can very quickly 
lead to the development of new 
therapies. An example of that 
would be some of the growth 
factors for the hematopoietic 
lineage that are already in clini¬ 
cal use. That said, it will not 
always be the case that under¬ 
standing the biology of a dis¬ 
ease can be translated quickly 
into a treatment. A good exam¬ 
ple would be sickle cell anemia, 
where we’ve understood the 
molecular basis of the disease 
since 1953 but have yet to have 
a cure for the large majority 
of affected patients. Similarly, 
the bacterium causing tubercu¬ 
losis was identified over a 
century ago, but it took 50 years 
to develop a cure for this dis¬ 
ease. One has to recognize that 
the road from understanding 
the causation of disease to hav¬ 
ing effective treatment will 
be quite varied. In some cases 
there may be rapid successes, 
but in others it may be a very 
long process and we should 
be prepared for that and not 
falsely raise the expectations of 
the public. 
In pursuing the goal of translat¬ 
ing basic science knowledge 
into clinical interventions, what 
strategies seem to have the 
most potential? 
The obvious key to this enter¬ 
prise is increased collaboration 
between basic scientists and cli¬ 
nicians. The opportunities here 
are really unprecedented. When 
I started as a graduate student 
in 1975, it was very hard to think 
about productive projects that 
one could do at the interface 
between molecular genetics 
and human disease.Today, this 
has completely changed.There 
is tremendous opportunity in 
almost every disease area. If, 25 
years ago, you were interested 
in diabetes, productive avenues 
might have included trying to 
identify genes that are expressed 
in the pancreas or in fat cells, 
with the hope that these might 
be involved in some way in 
the pathogenesis of diabetes— 
a relatively indirect approach. 
Now we can take the clinical 
problems that we’re interested 
in, study the disease directly 
with genetic approaches com¬ 
plemented by a monitoring of 
gene expression, and expect 
that we’re actually going to 
learn something fundamental 
about the disease pathogenesis. 
This is qualitatively different 
than what we could do a gener¬ 
ation ago. What is needed to 
make that work is expertise on 
both the clinical side and the 
basic science side and bridges 
between them. 
There certainly has never 
been a time in the history 
of medicine in which there has 
been a more rapid unraveling 
of the pathogenesis of human 
disease. And this is Just an 
extraordinarily exciting time 
to be interested in human dis¬ 
ease biology. 
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‘We are no longer walking 
blindfolded through 
the forest. We now have 
a precise map of where 
we’re going.” 
•Geneticist Richard Litton 
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Steven Hebert has succeeded 
Walter Boron as chair of the 
Department of Molecular and 
Cellular Physiology. 
Vanderbilt professor 
is named 
physiology chair 
Steven C. Hebert, m.d., one of the world’s 
leading authorities on the kidney’s regulation 
of potassium and other salts, has joined the 
School of Medicine as professor and chair of 
the Department of Molecular and Cellular 
Physiology. 
Hebert arrived at Yale on July i from 
Vanderbilt University Medical School, where 
he had been the Ann and Roscoe R. Robinson 
Professor of Medicine and professor of cell 
biology, pharmacology, molecular physiology 
and biophysics. His appointment complements 
current strengths at Yale in several important 
areas of renal physiology as well as a long 
tradition of innovation in the field dating to 
the work of John Punnett Peters, m.d., here 
in the 1920s, ’30s and ’40s. 
A long-time collaborator of his Yale depart¬ 
mental colleagues Gerhard H. Giebisch, m.d., 
and Walter F. Boron, m.d., ph.d., whom he 
is succeeding as chair, Hebert received his 
medical degree in 1970 from the University of 
Florida and trained as a resident and fellow 
at the University of Alabama in Birmingham. 
He taught in Alabama, Virginia and Texas 
before joining the Harvard Medical School 
laculty in 1984 as an assistant professor of 
medicine (physiology). Hebert was a tenured 
professor at Harvard and director of the Labo¬ 
ratory of Molecular Physiology and Biophysics, 
Renal Division, at Brigham and Women’s 
Hospital when he moved to Vanderbilt in 
1997. His research has focused in part on the 
mechanisms and regulation of potassium, 
sodium and chloride transport by cells. He 
and colleagues cloned two of the major genes 
involved in potassium transport by the 
kidney, a potassium channel known as romk 
and the Na-K-zCl transporter. A mutation 
in either gene results in improper salt handling 
by the kidney and is a factor in end-stage renal 
disease and related disorders. 
Hebert’s other major research focus is on 
the roles of extracellular calcium as a “first 
messenger” regulating cell function. Working 
with Harvard colleague Edward M. Brown, 
M.D., he identified and cloned a G-protein-cou- 
pled receptor that senses extracellular calcium 
ions and provides the mechanism for extracel¬ 
lular calcium-mediated tegulation of the func¬ 
tion of parathyroid gland and of epithelial cells 
in the kidney and colon. 
Hebert received the Carl W. Gottschalk 
Award from the American Physiological Soci¬ 
ety in 1995 and the Homer W. Smith Award 
from the American Society of Nephrology and 
New York Heart Association in 1997. He is 
also a founder and board member of two 
biotechnology companies, AquaBio Products 
Sciences and Luna Pearls, both of Portland, 
Maine. His wife, Patricia R. Hebert, ph.d., is 
an associate research scientist in the Depart¬ 
ment of Internal Medicine. 
The physiology department has 17 primary 
faculty members, 17 more with secondary 
appointments, 43 postdoctoral fellows and 24 
graduate students. Hebert said he will be 
recruiting five new faculty members during the 
next five years, “bringing in people who have 
a focus in new and emerging areas of science 
such as the structure and function of proteins, 
the field of proteomics, and both physical and 
functional genomics.” 
Hebert said he has always had “one foot 
in clinical programs and the other in the basic 
sciences” and has the ability to interface 
between the two. “Particularly important in 
the post-genomic era is the translation of 
information obtained in basic sciences to clini¬ 
cal medicine,” he said. “I’m very pleased to 
have the opportunity to do this, to increase the 
size of the faculty and shape the department 
over the next few years.” 
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Six professors 
named to endowed 
professorships 
Donald Cohen named 
sterling Professor of Child 
Psychiatry 
Donald J. Cohen, m.d., who 
specializes in neuropsychiatric 
disorders of children, includ¬ 
ing autism, Tourettes syn¬ 
drome and attention disorders, 
recently achieved one of Yale’s 
highest distinctions when he 
was named Sterling Professor 
of Child Psychiatry. 
A child psychiatrist and 
psychoanalyst, he joined 
the Yale School of Medicine 
faculty in 1972 and has 
directed the Yale Child Study 
Center since 1983. 
Cohen’s clinical and research 
interests also focus on the 
interaction between biological 
and experimental factors in 
the emergence and treatment 
of psychiatric disorders, the 
early roots of personality 
development, the impact of 
psychosocial disadvantage on 
children, national policy for 
children and adolescents and 
the impact of acute and 
persistent stress on children’s 
development. 
He is co-author or co-edi¬ 
tor of a dozen books, includ¬ 
ing Handbook of Autism and 
Pervasive Developmental Disor¬ 
ders, The Many Meanings of 
Play in Child Psychoanalysis, 
Understanding Other Minds: 
Perspectives from Autism and 
Tourette’s Syndrome and Associ¬ 
ated Disorders. He has written 
more than 300 articles on 
neuropsychiatric childhood 
disorders. 
Mary Tinetti, noted for work 
on health issues of the 
elderly, assumes Crofoot Chair 
Mary E. Tinetti, m.d., the 
new Gladys Phillips Crofoot 
Professor of Medicine, has 
devoted her career to the 
health of the elderly and has 
a special interest in interven¬ 
tions that can help prevent 
older people from falling. 
Tinetti is chief of geriatrics 
at the School of Medicine and 
director of the Program on 
Aging and the Claude D. Pep¬ 
per Older Americans Indepen¬ 
dence Center. Her studies 
show that, for many older 
people, injuries from falls 
often result in a loss of both 
mobility and independence 
and can be the beginning of a 
series of health problems that 
eventually lead to death. 
Tinetti has earned national 
prominence for her work on 
fall-reduction strategies and 
her studies showing that phys¬ 
ical exercise that improves bal¬ 
ance and builds lower-body 
strength, such as dancing and 
tai chi, has a major impact on 
reducing falls. 
In recent research with Yale 
colleagues, Tinetti found that 
the problem of dizziness in 
elderly people is more often a 
result of multiple problems— 
described as a “geriatric syn¬ 
drome”—than a symptom of 
a particular illness. 
Tinetti has written or co¬ 
authored nearly a hundred 
articles on health issues affect¬ 
ing the elderly, including 
alcohol consumption, home 
vs. hospital care for chronic 
illness, the care of persons 
with dementia, and older driv¬ 
ers at risk. 
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Stephen Strittmatter is 
appointed to new Coates 
Chair in Neurology 
Stephen M. Strittmatter, m.d., 
PH.D., who has been named 
to the Vincent Coates Chair 
in Neurology, is a specialist in 
the development and regener¬ 
ation of the nervous system. 
Earlier this year, he earned 
international attention for 
leading a research effort that 
resulted in the discovery 
of a protein that prevents the 
regeneration of axons fol¬ 
lowing a traumatic injury to 
the central nervous system. 
The discovery of this pro¬ 
tein, called Nogo, may lead 
to treatments to stimulate 
regrowth of axons in order to 
reverse brain and spinal cord 
injuries. Strittmatter is now 
engaged in work to define the 
nature of Nogo receptors 
and to develop methods to 
block those receptors. 
A member of the Yale fac¬ 
ulty since 1993, Strittmatter 
continued on page so 
Stephen Strittmatter 
continued 
holds joint appointments in 
neurology and neurobiology. 
Since coming to Yale, he has 
been the principal investigator 
of a number of research proj¬ 
ects focusing on axonal regen¬ 
eration. He has received major 
grant awards for these projects 
from the National Institute of 
Neurological Disorders and 
Stroke, the Christopher Reeve 
Paralysis Foundation, the 
Donaghue Foundation and 
the John Merck Fund. 
The Coates Chair in Neu¬ 
rology was endowed with a 
gift from alumnus Vincent J. 
Coates ’46 of Sunnyvale, 
Calif He is chair and chief 
executive officer of Nanomet¬ 
rics, a company that designs 
and manufactures microscopes 
to monitor the fabrication of 
integrated circuits on wafters, 
flat display panels and mag¬ 
netic recording heads. In addi¬ 
tion to his abiding interest in 
engineering, which he studied 
as an undergraduate, Coates 
has a strong personal interest 
in the study of the chemistry 
of the brain. 
Pharmacology expert 
John Krystal is designated 
Kent Professor 
John H. Krystal, m.d., the 
newly appointed Albert E. 
Kent Professor of Psychiatry, 
is an expert on the psy¬ 
chopharmacology and neuro¬ 
biology of schizophrenia, trau¬ 
matic stress and alcoholism 
and substance abuse. 
His most recent research 
focuses on the neurobiology 
of schizophrenia and alco¬ 
holism, and he has developed 
several new investigative para¬ 
digms to probe possible neu¬ 
robiologic abnormalities in 
schizophrenia. He also estab¬ 
lished clinical research pro¬ 
grams using magnetic reso¬ 
nance imaging and magnetic 
resonance spectroscopy in 
order to study the brains of 
healthy individuals vs. those 
with psychiatric illnesses. 
Krystal is deputy chair for 
research in the School of 
Medicines Department of 
Psychiatry and is deputy direc¬ 
tor for clinical research in the 
Abraham Ribicoff Research 
Facilities at the Connecticut 
Mental Health Center. He 
is author or co-author of more 
than 100 articles on a wide 
range of subjects, including 
post-traumatic stress disorder, 
the body’s responses to cer¬ 
tain antipsychotic drugs, 
effects of sleep deprivation on 
depressed individuals and 
chronic alcohol use. He has 
also written numerous book 
chapters and reviews. 
Asthma specialist Jack Elias 
named a Waldemar Von 
Zedtwitz Professor of Medicine 
Jack A. Elias, m.d., newly 
named as Waldemar Von 
Zedtwitz Professor of Medi¬ 
cine, is a noted specialist in 
asthma and lung diseases and 
lung injury. 
One focus of his research is 
the pathogenesis of asthma, 
and he has been widely quot¬ 
ed in the national media on 
possible causes of the increase 
in childhood asthma in the 
past 15 years. 
Elias has been a professor 
of medicine and chief of pul¬ 
monary and critical care medi¬ 
cine at the School of Medicine 
since 1990. He was the princi¬ 
pal investigator of nearly 20 
research projects funded by 
major grants. In 1997 he 
became director of the Yale- 
based Specialized Center of 
Research for Asthma, one of 
seven in the nation selected by 
the National Institutes of 
Health for a five-year study 
into the causes of the disease. 
Elias writes and lectures 
widely on chest diseases, and 
he has been an invited speaker 
at many medical symposia, 
conferences and grand rounds. 
He is co-editor of the two-vol¬ 
ume textbook Fishmans Pul¬ 
monary Diseases and Disorders 
and has written several chap¬ 
ters in medical textbooks and 
other publications. 
1 . 
Keith Joiner, expert on infec¬ 
tious disease, also appointed 
a Von Zedtwitz Professor 
Keith A. Joiner, m.d., newly 
appointed as Waldemar Von 
Zedtwitz Professor of Medi¬ 
cine, is an expert on infectious 
diseases whose research has 
focused on malaria, which 
kills some two million people 
each year, and toxoplasmosis, 
a parasitic infection common¬ 
ly seen in people with aids. 
A member of the Yale fac¬ 
ulty since 1989, he is chief of 
the Section of Infectious Dis¬ 
eases and director of the 
School of Medicine’s Inves¬ 
tigative Medicine Program. 
He holds joint appointments 
in the departments of epi¬ 
demiology and public health 
and of cell biology. 
Joiner has co-authored 
nearly 200 articles in scientific 
research publications and lec¬ 
tures widely in the United 
States, Canada, Europe and 
Australia on topics ranging 
from septic shock to tropical 
diseases to bacteria-host cell 
interactions. He holds two 
patents, one as the co-inven- 
tor of a method for treating 
gram-positive septicemia, and 
the other for a quantitative 
assay for human terminal 
complement cascade. 
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Tercentennial Series 
Harvey Cushing/John Hay 
Whitney Medical Library 
Lectures, free and open to the 
public, begin at 5 p.m. in 
the Medical Historical Library, 
333 Cedar Street. Reception^^ 
follows. For information ^ 
call (203) 785-5352. Remaining 
lectures in the series: 
January 25 
Readings from the Work of 
Richard Seizer 
Richard Seizer, M.D. 
Retired Professor of Surgery 
Yale School of Medicine 
Writer 
When Cocaine and Heroin 
Were New: America’s 
First Response 
David F. Musto, M.D. 
Professor of History of 
Medicine and Psychiatry, 
Professor of Child Psychiatry 
Yale School of Medicine 
Struggling to Stay Human in 
Medicine: American Medical 
Students and Radical Health 
Movements in the 1960s 
Naomi Rogers, Ph.D. 
Director of Undergraduate 
Studies, Women’s and 
Gender Studies Program, 
Yale University 
Lecturer. History of Medicine 
Yale School of Medicine 
History of New Haven 
Medicine 
Sherwin B. Nuland, M.D. 
Clinical Professor of Surgery 
Yale School of Medicine 
A Legacy of Medicine in Art: 
the Clements C. Fry Collection 
at Yale 
Susan Wheeler, Consultant 
The Clements C. Fry Collection, 
Cushing/Whitney Medical 
Library, Yale School of Medicine 
Evolution of Infectious Disease 
53rd Annual Keynote Address 
presented by the Associates of 
the Cushing/Whitney Medical 
Library 
Joshua Lederberg, Ph.D. 
Nobel Laureate 
Emeritus President 
Rockefeller University 
New York, N.Y. 
The Program for Humanities 
in Medicine 
Lectures, free and open to 
F? the public, begin at 5 p.m. in 
the Beaumont Room, 333 
Cedar Street. For more infor¬ 
mation, call Clara Gyorgyey 
at (203) 785-4744 or 785-6102. 
Remaining lectures in the 
series: 
Words Over War: Prevention 
of Deadly Conflict 
Melanie Greenberg, J.D. 
Attorney/Author 
Washington, D.C. tel 
Marcus Weiby, A.P.R.N.: 
Paradigm Shifts in Today’s 
Caregiving? 
Linda H. Pellico, A.P.R.N. 
Director of Graduate Program 
Yale School of Nursing 
Myth, Medicine and the 
Human Body 
Sherwin B. Nuland, M.D. 
Clinical Professor of Surgery 
Yale School of Medicine 
Muscle, Motion and Art in the 
Late 19th Century 
James D. Kenney, M.D. 
Clinical Professor of Internal 
Medicine 
Yale School of Medicine 
Doctors and Patients in Visual 
Relation 
Ann Starr, M.A. 
Artist, Wellesley, Mass. 
Patient and Doctor: 
A Relationship of Healing 
The Bayer Lecture 
Eric Cassell, M.D. 
Clinical Professor of Public 
Health 
Weill Medical College, Cornell 
University, New York, N.Y. 
Living with Limits: Devising 
an Affordable, Sustainable 
Medicine 
The Howard Spiro Lecture 
Daniel Callahan, Ph.D. 
Director of international 
Programs 
The Hastings Center 
Garrison, N.Y. 
The Doctor as an 
Internationalist 
Michael H. Merson, M.D. 
Dean of Public Health 
Yale School of Medicine 
Spiritual Life of Patients 
Richard G. Druss, M.D. 
Clinical Professor of Psychiatry 
Columbia University 
New York, N.Y. 
Healer of Broken Hearts: 
Ruminations of a Cardiologist 
The Multicultural Lecture 
Forrester A. Lee, M.D. 
Associate Professor of Internal 
Medicine, Assistant Dean of 
Multicultural Affairs 
Yale School of Medicine 
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Sherwin 
Tamborlane 
Allison 
Kohorn 
Lengyel 
Yale physicians have taken on 
leadership roles in the Ameri¬ 
can Diabetes Association, the 
nation’s leading voluntary 
health organization supporting 
diabetes research, education 
and advocacy. In July Robert S. 
Sherwin, m.d., the C.N.H. 
Long Professor of Medicine, 
assumed the presidency of the 
National Board of Directors. 
William V. Tamborlane Jr., m.d., 
professor of pediatrics, and 
alumnus Donald Ross Coustan, 
M.D. ’68, HS ’73, Chace/ 
Joukowsy Professor and Chair 
of Obstetrics and Gynecology 
at Brown University School of 
Medicine, were elected to the 
board at its 60th annual meet¬ 
ing and scientific sessions, held 
in San Antonio. 
Three senior faculty members 
who came to Yale School of 
Medicine in the 1960s attained 
emeritus status this year; 
Truett Allison, ph.d. ’62, pro¬ 
fessor of neurology and psy¬ 
chology, Ernest I. Kohorn, 
M.CHIR., F.R.C.S., F.R.C.O.G., 
professor of obstetrics and 
gynecology, and Peter Lengyel, 
PH.D., professor of molecular 
biophysics and biochemistry 
and senior research scientist. 
Allison, an expert on visual 
neurophysiology and cognitive 
neuroscience, has conducted 
research in the localization of 
function in the human brain, 
the neurophysiology of the 
human and monkey somato¬ 
sensory system, the evolution 
of sleep, the location and 
functional characteristics of 
the human cortex within the 
mesial wall, and visual object 
recognition. Allison joined the 
faculty in 1963 and has held 
concurrent appointments at 
the VA Connecticut Health- 
Care System in West Haven 
since 1965. He became a full 
professor in 1980. 
Kohorn, a pioneer in the 
use of obstetric ultrasound 
and in gynecologic oncology, 
first came to Yale as an 
instructor in 1965. After a year 
in England, where he devel¬ 
oped the first ultrasound unit 
for obstetrics and gynecology 
in London, he returned to 
New Haven to set up the first 
obstetric ultrasound unit in 
New England. In 1970 Kohorn 
established what is now the 
Yale Center for Trophoblastic 
disease and was also one of 
the first gynecologists to use 
chemotherapy in the manage¬ 
ment of ovarian cancer. He 
has been president of the New 
England Association of 
Gynecologic Oncologists, the 
American Urogynecologic 
Society and the Society of 
Gynecologic Surgeons. 
Lengyel has studied the 
control of protein synthesis 
with a focus on the genetics 
and biochemistry of the action 
of interferons, the secreted 
proteins of vertebrates that 
have antiviral, cell growth 
regulatory and immunomodu¬ 
latory activities. Lengyel 
joined the faculty in 1965 as 
an associate professor and 
was appointed full professor in 
1969. He also served as direc¬ 
tor of graduate studies of 
molecular biophysics and act¬ 
ing director of the division 
of biological sciences. 
Mark R. Cullen, m.d. ’76, hs 
’80, professor of medicine in 
occupational medicine and of 
public health, was selected by 
the Semiconductor Industry 
Association in October to be a 
member of an independent 
Science Advisory Committee. 
Members provide an inde¬ 
pendent perspective on possi¬ 
ble cancer risks within the 
U.S. semiconductor manufac¬ 
turing industry. Cullen is 
also a member of the Institute 
of Medicine of the National 
Academy of Sciences. 
Vincent T. 
DeVita Jr., 
M.D., HS ’66, 
professor of 
medicine and 
of epidemi¬ 
ology and public health and 
director of the Yale Cancer 
Center, has received the first 
Saul Rosenberg Research 
Award from the Lymphoma 
Research Loundation of Amer¬ 
ica. The $50,000 prize recog¬ 
nizes DeVita’s 40 years of 
seminal contributions to the 
treatment of patients with 
Hodgkin’s lymphoma and will 
support additional research 
into diagnosis and treatment 
of the disease. The award hon¬ 
ors Saul Rosenberg, emeritus 
professor of medicine and radi¬ 
ation oncology at Stanford 
University Medical Center. 
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The Ameri¬ 
can College 
of Cardiology 
presented an 
award for 
humanitarian 
accomplishments to Nelson R. 
Mandela of South Africa at 
ceremonies held in Puerto 
Rico in May. John A. Elefteri- 
ades, M.D. ’76, HS ’83, profes¬ 
sor and chief of cardiothoracic 
surgery, was one of two Amer¬ 
ican surgeons invited to speak 
at the event. Elefteriades’ 
addresses were “Yale Perspec¬ 
tives on the Thoracic Aorta” 
and “Conventional Cardiac 
Procedures as an Alternative to 
Transplantation in Patients 
with Left Ventricular Failure.” 
Arthur C. 
Evans, ph.d., 
assistant clini¬ 
cal professor 
of psychiatry, 
has been 
named deputy commissioner 
of the Connecticut Depart¬ 
ment of Mental Health and 
Addiction Services. Governor 
John G. Rowland announced 
the appointment in June. 
Evans served as director of 
managed care for the depart¬ 
ment for the past two and 
Durland Fish, 
PH.D., associ¬ 
ate professor 
of epidemiol¬ 
ogy in micro¬ 
bial diseases, 
has been named editor of 
Vector Borne and Zoonotic Dis¬ 
eases, a new peer-review med¬ 
ical journal focusing solely on 
diseases transmitted to 
humans by insects or animals. 
The journal will be published 
both in print and online. 
Gary E. 
Friedlaender, 
M.D., HS ’74, 
the Wayne O. 
Southwick 
Professor and 
chair of orthopaedics and 
rehabilitation, became chair- 
elect of the American Acad¬ 
emy of Orthopaedic Surgeons 
(aaos) Council of Muscu¬ 
loskeletal Specialty Societies at 
its 67th annual meeting in 
Orlando in March. Friedlaen¬ 
der is chair of the Research 
Committee and Kappa Delta 
Research Award Committee 
for the AAOS. He is also a 
member of the Council on 
Education, the Council on 
Research, the Bone and Joint 
Decade Committee and the 
Task Force on Patient-Physi¬ 
cian Communication. 
Charles A. 
Greer, ph.d., 
professor of 
neurosurgery 
and neurobi¬ 
ology and 
co-director of the Interdepart¬ 
mental Neuroscience Program, 
was appointed chair of the 
National Institutes of Health 
Center for Scientific Review’s 
Integrative, Functional and 
Cognitive Neuroscience Study 
Section 4. His two-year term 
began in July. 
Lise R. 
Heginbotham, 
PH.D., assis¬ 
tant professor 
of molecular 
biophysics 
and biochemistry, was selected 
as a 2000 Pew Scholar in the 
Biomedical Sciences by the 
Pew Charitable Trusts. She 
received the award for her 
research relating to ion chan¬ 
nel structure and function and 
the relay of electrical signals 
through the membrane of the 
nervous system. 
Jeannette R. 
Ickovics, 
PH.D., associ¬ 
ate professor 
of epidemiol¬ 
ogy in 
chronic disease, and of psy¬ 
chology, received the Ameri¬ 
can Psychological Association’s 
Award for Distinguished Con¬ 
tribution to Psychology in the 
Public Interest. Her research 
focuses on women and 
hiv/aids, particularly the 
acceleration of the disease 
among women. 
Ruth J. Katz, 
J.D., M.P.H., 
associate dean 
for adminis¬ 
tration and 
assistant pro¬ 
fessor of medicine and public 
health, has been appointed to 
the National Institutes of 
Health Advisory Committee 
on Research on Women’s 
Health for a four-year term 
that ends in 2004. As counsel 
to the u.s. House of Represen¬ 
tatives Subcommittee on 
Health and the Environment 
in the early 1990s, Katz helped 
write key legislation ensuring 
that women would be better 
represented in federally 
funded clinical trials. She has 
been active in building the 
women’s health program at 
Yale since arriving at the 
school in 1997. 
Ilona S. 
Kickbusch, 
PH.D., profes¬ 
sor of public 
health and of 
political sci¬ 
ence and head of the division 
of global health, was presented 
a gold medal for meritorious 
service to the province of 
Vienna in May. The medal 
was awarded for her work at 
the World Health Organiza¬ 
tion in building a health pro¬ 
motion infrastructure in the 
city of Vienna. The work led 
to initiatives such as an overar¬ 
ching healthy cities program, a 
shift in health policy priorities 
and a series of programs to 
increase health promotion in 
schools, hospitals and women’s 
wellness centers. 
Lowell S. 
Levin, m.p.h. 
’60, professor 
emeritus and 
lecturer in 
public health, 
has been serving as a senior 
consultant to the World 
Health Organization’s new 
training and policy center in 
Venice, Italy. Levin developed 
the center’s initial operational 
plan and will remain an advi¬ 
sor during its implementation. 
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Becca Levy, ph.d., assistant 
processor of epidemiology, 
was awarded the Brookdale 
National Fellowship for Lead¬ 
ership in Aging in July. She 
was one ol four researchers in 
the country selected to receive 
the award, which is presented 
for excellence and promise in 
the field of geriatrics and 
gerontolog)^ 
Marc I. 
Lorber, m.d., 
professor of 
surgery and 
chief of organ 
transplanta¬ 
tion and immunology, was 
named president-elect, in May, 
of the American Society of 
Transplant Surgeons and will 
assume the presidency in May 
2001. He recently completed 
a three-year term as the treas¬ 
urer. Lorber was also elected a 
fellow of the American Surgi¬ 
cal Association for his accom¬ 
plishments, dedication and 
years of academic service and 
will be inducted into the asso¬ 
ciation in April. 
F.R.C.S., the 
Donald 
fessor Emeritus of Surgery, was 
elected president of the Clini¬ 
cal Society of Genito-Urinary 
Surgeons for 2000. His first 
annual meeting as president 
was held in November in 
Chicago. Lytton was also hon¬ 
ored in September at “A Trib¬ 
ute to Living Donors” in Old 
Saybrook, Conn., a celebra¬ 
tion of the successes and 
advances made in organ trans¬ 
plantation. Lytton performed 
the first kidney transplant at 
Yale in 1967. 
Ruslan M. 
Medzhitov, 
PH.D., assis- 
tant professor 
' V of immunobi- 
ology, has 
been named an assistant inves¬ 
tigator for the Howard Hughes 
Medical Institute (hhmi), 
bringing the total number of 
HHMI investigators at Yale 
to 17. HHMI, based in Chevy 
Chase, Md., with an endow¬ 
ment of $15 billion and annual 
budget of more than $600 
million, enters into long-term 
research collaboration agree¬ 
ments with universities and 
other academic research 
organizations, where its inves¬ 
tigators hold faculty appoint¬ 
ments. Medzhitov’s research 
focuses on various aspects of 
innate immunity, including 
molecular mechanisms of 
innate immune recognition, 
control of adaptive immune 
responses by innate immune 
recognition, and mechanisms 
of autoimmunity and allergy. 
Medzhitov, originally from 
Tashkent, Lfzbekistan, worked 
in the laboratory of Russell F. 
Doolittle at the University of 
California, San Diego, and 
received his ph.d. degree in 
biochemistry from Moscow 
University before being 
recruited to Yale by Charles A. 
Janeway Jr., m.d., in 1994. 
Medzhitov was among 48 sci¬ 
entists from 31 institutions 
selected as hhmi investigators 
in 2000. 
Charles W. 
Needham, 
M.D., clinical 
instructor in 
neurosurgery, 
discussed 
pacemaker systems in May at 
the McGill Neurosurgical 
Reunion. These systems, 
located at the center of the 
brain, are currently being 
investigated to account for the 
mechanisms of depression, 
obsessive-compulsive disorder, 
tinnitus, chronic pain and 
Parkinson’s disease. The meet¬ 
ing, a celebration of 100 years 
of neurosurgery, was held at 
the Montreal Neurological 
Institute. 
Sara C. Rockwell, ph.d., pro¬ 
fessor of therapeutic radiology 
and pharmacology, and in the 
Cancer Center, was appointed 
editor-in-chief of the journal 
Radiation Research at the May 
meeting in Albuquerque of 
the Radiation Research Society 
Council. Rockwell has served 
as a member of the Board of 
Editors of the interdisciplinary 
journal. 
Gastroen¬ 
terologist 
James C. 
Rosser Jr., 
M.D., associ¬ 
ate professor 
of surgery, was featured in a 
documentary entitled “Cyber¬ 
surgery” that premiered in 
July on the Discovery Health 
Channel. The documentary, 
which explored cutting-edge 
technology in medicine, fol¬ 
lowed Rosser as he taught a 
procedure through telemedi¬ 
cine to a surgical team in the 
Dominican Republic from his 
office at Yale. 
Mark J. Schlesinger, ph.d., 
associate professor of public 
health, received the Associa¬ 
tion for Health Services 
Research’s 2000 Article of the 
Year Award in June at the 
organization’s annual meeting 
in Los Angeles. Schlesinger’s 
paper, “No Exit? The Effect of 
Health Status on Dissatisfac¬ 
tion and Disenrollment from 
Health Plans,” was co¬ 
authored with Benjamin G. 
Druss, M.D., M.p.H. ’95, assis¬ 
tant professor of psychiatry 
and public health, and Tracey 
R. Thomas, research associate 
in epidemiology and public 
health. 
Marvin L. 
Sears, m.d., 
adjunct pro¬ 
fessor of oph¬ 
thalmology 
and visual sci¬ 
ence, and founder and former 
chair of the department, was 
recognized by the American 
Glaucoma Society with the 
Lifetime Achievement Award 
for contributions to the scien¬ 
tific understanding and clini¬ 
cal treatment of glaucoma. 
The society’s tribute included 
a video from former President 
Bush congratulating Sears. 
This spring, Yale University 
conferred on Sears the Merito¬ 
rious Service Award for Sci¬ 
ence and Engineering. At a 
symposium last spring, Yale 
Alumni in Ophthalmology 
and the Department of Oph¬ 
thalmology and Visual 
Science honored Sears with a 
symposium. In addition, 
benefactor Herbert Lotman 
endowed a lectureship in 
Sears’ name. 
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Howard M. 
Spiro, M.D., 
professor 
emeritus of 
medicine and 
founder of 
the Program for Humanities 
in Medicine at Yale, received 
the 2000 Julius Friedenwald 
Medal in May from the 
American Gastroenterological 
Association. The medal, the 
society’s highest formal recog¬ 
nition to an individual, honors 
a lifetime contribution to 
the field of gastroenterology. 
Marietta 
Vazquez, 
M.D., post¬ 
doctoral fel¬ 
low in pedi¬ 
atrics, has 
received support for a four- 
year fellowship under the 
Robert Wood Johnson Foun¬ 
dation’s Minority Medical Fac¬ 
ulty Development Program. 
Vazquez is currently conduct¬ 
ing research to assess the pro¬ 
tective efficacy of two recently 
approved vaccines for Lyme 
disease and chicken pox. 
Eiji Yanagi- 
sawa, M.D., 
HS ’59, clini¬ 
cal professor 
of surgery, 
received the 
Chevalier Jackson Award in 
May from the American Bron- 
choesophagological Associa¬ 
tion at its annual meeting in 
Orlando. Yanagisawa spoke 
on “Videography and Digital 
Imaging of the Larynx” in 
June at the nth World Con¬ 
gress of Bronchoesophagology 
in Yokohama, Japan. 
William Glenn and his wife, Amory, 
attended a reception in his honor in 
the Historical Library. 
Endowed chair to honor 
cardiothoracic pioneer 
Pioneering cardiovascular sur¬ 
geon William WL. Glenn, 
M.D., is being honored with a 
professorship in his name at 
the School of Medicine. Dur¬ 
ing almost 40 years on the 
faculty Glenn and his col¬ 
leagues were among the first 
to develop innovative tech¬ 
niques in cardiovascular and 
thoracic surgery. In 1948 he 
used a mechanical pump as a 
substitute for the heart’s func¬ 
tion. Six years later he devised 
a shunt to bypass a malformed 
right heart. Under Glenn’s 
leadership, in 1959, the first 
use of the radio frequency car¬ 
diac pacemaker in the Western 
Hemisphere took place at 
Yale. Glenn also invented the 
phrenic pacemaker, a diaphrag¬ 
matic pacemaker that allowed 
patients afflicted with Ondine’s 
Curse to breathe regularly. 
The list of firsts continued 
through 1985, when Glenn 
retired. He has received his 
share of honors during his 
career—including the Francis 
Gilman Blake Award for 
excellence in the teaching of 
medical sciences and a lecture 
in his honor established by the 
Council on Cardiovascular 
Surgery of the American 
Heart Association. In June the 
medical school announced the 
establishment of the endowed 
chair, the William WL. 
Glenn, m.d.. Professorship in 
Cardiothoracic Surgery. 
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The following books by alumni and faculty 
have recently been published; 
A Question of Intent: A Great American Battle 
With a Deadly Industry, by David A. Kessler, 
M.D., dean of the School of Medicine and pro¬ 
fessor of pediatrics, medicine and public health; 
PublicAffaIrs (N.Y.), 2001. The author writes 
about the chapter in his career that preceded 
his arrival at Yale as dean in July 1997. As com¬ 
missioner of the Food and Drug Administra¬ 
tion, Kessler upset the conventional wisdom 
that the tobacco industry was too big and too 
powerful to be challenged. A Question of 
Intent tells the story of his agency’s investiga¬ 
tion of the industry, its attempts to regulate it, 
and the "tobacco wars" still being waged. 
Attention-Deficit Disorders and Comorbidities 
in Children, Adolescents, and Adults, edited by 
Thomas E. Brown, Ph.D., assistant clinical pro¬ 
fessor of psychiatry and associate director of 
the Yale Clinic for Attention and Related Disor¬ 
ders; American Psychiatric Press, Inc. (Washing¬ 
ton, D.C.), 2000. In this book for professionals, 
24 internationally recognized researchers sum¬ 
marize what is currently known about treat¬ 
ment of ADHD with various high-comorbid 
disorders. The book offers research-based 
guidelines for assessment and treatment of 
these complicated cases. 
Who Am I? The 16 Basic Desires that Motivate 
Our Actions and Define Our Personalities, by 
Steven Reiss, Ph.D. '77, professor of psychology 
and psychiatry at Ohio State University and 
the director of the Nisonger Center for Mental 
Retardation and Developmental Disabilities; 
Tarcher/Putnam (N.Y.), 2000. Combining the 
methods of psychology with the ideas of phi¬ 
losophy, this book offers a new approach to 
the search for meaning and happiness as well 
as insights into romantic relationships,family 
dynamics, careers and spirituality. 
Send notices of new books by alumni and faculty to 
Cheryl Violante, Yale Medicine Publications, P.O. Box 7612, 
New Haven, CT 06519-0612. 
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A new year, 106 new careers 
Eclectic view of medicine unites first-year class. 
RIGHT First-year Student Michael 
Herce celebrates with his mother, 
Clare Herce, and aunt, Barbara Jarry. 
BELOW Milton Hwang, Edidiong 
Ikpe and Jesse James were among the 
106 members of the Class of 2004 
who began medical school with the 
symbolic donning of a white coat. 
When Dagan Coppock came to the School of 
Medicine as an applicant, he knew he would 
like it here. His interviewers seemed inrerested 
not just in his GPA or what science courses he 
had taken, but in the poetr)^ he enjoys writing. “I knew they 
were going to be supportive of other interests,” said Coppock, 
who took time off after his graduation from the Universitv' of 
Tennessee to study traditional healing in Nigeria. 
Encouragement of other activities, the independence 
offered by the Yale System and the collegial atmosphere were 
among the reasons first-year students gave for deciding to 
study medicine at Yale. “I can concentrate on whatever I want,” 
said Aaron Berger, a graduate of the University of Pennsyl¬ 
vania from Lexington, Ky. “Laboratoty research, volunteer 
work, you can go ahead and do it.” The school’s strong com¬ 
mitment to basic science research was another draw, he said. 
Richard A. Silverman, director of admissions, noted that 
applications, available electronically through the American 
Medical College Application Servdce last year for the first time, 
were up 43 percent at a time when fewer students nationally 
are applying to medical school. The increase, Silverman said, 
was higher than the admissions office had projected. He attrib¬ 
uted the increase in part to the new application system and 
in part to the attraction of Yale. 
Because of the increased applicant pool, the rate of accept¬ 
ances dropped from about 8 percent to 6 percent. “That’s a big 
difference,” he said, “for a school that’s already selective. I think 
Incoming student Nicholas 
Countryman is the grandson 
of Frank Countryman, center, 
who graduated in 1944 with 
classmate and best friend 
Nicholas Spinelli. 
the change is reflected in the quality of the class in ways that 
would be vety hard to quantify. 
“It’s not enough to be smart, to be well-grounded in the 
sciences, to be a 2;ood classroom student,” Silverman said. 
“When we look at applicants, we look for qualities in them 
that are going to make them good doctors, not just good 
students.” j\mong those qualities, he said, are interests and 
experiences outside medicine. 
The 106 members of the Class of 2004 include a former ski 
instructor, a figure skater, a ballroom dancer with a black belt 
in karate, and a researcher who spent nvo years studt’ing hfv at 
the University of California at San Francisco. Kavita Mariwalla, 
a 1998 Yale College graduate, decided to leave her job as a 
Manhattan investment banker for something more fulfilling 
than enriching other people’s portfolios. “In medicine,” she 
said, “you can say you did something to help others.” 
Coeurlida Louis worked her way through Welleslet' as a 
registered nurse before coming to Yale. Since her childhood in 
Haiti, she knew medicine would be her calling. She recalled 
going to see the countty doctor who tended to his patients 
under a huge tent. “There was the doctor looming over evety- 
one in a white coat,” she said. “I wanted to be like that. He 
was making a difference in a lot of people’s lives.” 
This year’s incoming class includes 56 men and 50 women, ii 
African-Americans, eight Latinos and 14 Asian-Americans. SLx 
students come with master’s degrees and one has a ph.d. ^Almost 
a quarter of the class, 23 students, were Yale undergraduates. 
Another ii came from Harv'ard and six came from Stanford. 
The promise of the white coat 
The first vear began, as it has for several years, in a tent on 
Harkness Lawn where faculty helped the students don the 
white coats that symbolize their promise as physicians. “YHiat 
is it about this simple white coat that provides the lifeline 
between the patient and the physician?” asked Herbert S. 
Chase Jr., m.d., in his first address as deputy dean for educa¬ 
tion. “We are promising to our patients that we will be caring, 
that we will be kind, that we will comfort them, that we will 
respect their culture, that we will be completely committed to 
them and responsible for them.” 
“YCTien you wear that white coat,” said Dean David A. 
Kessler, m.d., “people will allow you into their lives. They will 
tell you things about their lives they will tell no one else. You 
are going to have to grow into that white coat.” 
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After delivering a keynote speech at 
orientation, author Anne Fadiman 
autographed copies of her book The 
Spirit Catches You and You Fall Down 
for members of the first-year class. 
Forrester Lee, far left, assistant dean 
for multicultural affairs, led a discus¬ 
sion of the book, which examines the 
profound miscommunication that 
occurred between a Ftmong family in 
California and the doctors treating its 
youngest member. 
On the first day, an appreciation of other cultures 
The first day of class began in Room no of the Hope Building 
with an unusual exercise. On colored slips of paper, students 
used a word or two to describe themselves in each of five cate¬ 
gories. On pink slips they wrote their religion. Ethnicity went 
on violet paper. Green was for sexual orientation. Orange was 
tor race and bright pink was reserved for socioeconomic class. 
The papers were collected, sorted by color, then taped to 
the walls of the auditorium. Some answers were to the point— 
“middle class,” “heterosexual,” “Latino.” Others displayed 
some humor—“boy crazy,” “broke,” “rags to riches,” “part- 
time Sikh” and “Roman Catholic, at least my mother is.” 
The point of the exercise was to highlight the class’s diversity 
and stimulate a discussion of culture and tolerance. A few 
moments later, the class divided into groups of seven or eight 
students to discuss the doctor-patient relationship as described 
in The Spirit Catches You and You Fall Down, by Anne Fadi¬ 
man. Fadiman spent eight years documenting a tragic clash of 
cultures between a Hmong family from Southeast Asia and 
their doctors in California. While doctors looked to science to 
treat their infant daughter’s epilepsy, the Lee family sought 
answers in spirituality. 
After lunch at the Lawn Club, Fadiman gave a keynote 
speech about her experiences writing the book and the lessons 
she believes it provides for doctors (See On Campus, page 19). 
“What lay between the doctors and the family was not only a 
linguistic, but a cultural gulf,” said Fadiman. Her own first visit 
with the Lees demonstrated that gap, she said. “I had been told 
the Lees were stupid and stubborn and crazy and hated Ameri¬ 
cans. I immediately met this smart and witty and warm and 
friendly family. I perceived them differently than the doctors did 
because they perceived me differently.” She urged students and 
physicians to acknowledge their patients’ cultures and beliefs 
and try to understand illness from the patients’ points of view. 
Following Fadiman’s talk, students saw the dry language 
of a medical history translated into a flesh-and-blood human 
story. While a case history was projected on a screen, fifth-year 
student LaLisa Anderson read from oral histories she has col¬ 
lected in the South. Using the words of the people she inter¬ 
viewed, Anderson took on their characters, telling the stories. 
One, which paralleled a case history on the screen, was that of 
a young man who found his life turned upside down by the 
war in Vietnam. He came home addicted to drugs and alcohol, 
eventually to find redemption in faith. The message through¬ 
out the day was that the culture, language and beliefs held by 
patients will influence the way they interact with their doctors. 
“Why are we talking about the doctor-patient relationship 
on the first day of school?” asked Nancy R. Angoff, m.p.h. ’81, 
M.D. ’90, HS ’93, associate dean for student affairs. “Now is as 
good a time as ever to start thinking about these relationships, 
before acquiring any of the notions of how to behave that you 
are likely to pick up over the next four years.” 
Public health program welcomes 114 master’s students 
The entering class at the School of Public Health includes an 
unusually high number of women, who make up 76 percent 
of the 114 new master’s students. Usually, says Anne Pistell, 
M.A., M.B.A., associate dean for student affairs, women make 
up about two-thirds of the class. The students range in age 
from 21 to 52, with an average age of 25. The group also 
includes 14 physicians taking an abbreviated course of studies, 
one veterinarian, one lawyer and a college professor with a 
doctorate in the history of medicine. The incoming class repre¬ 
sents 76 undergraduate schools and 35 majors, the most popu¬ 
lar being biological sciences. Pistell added that the program can 
accommodate students with a very wide range of interests, 
whether it’s doing community work in Thailand, making poli¬ 
cy in Washington or managing an hmo. 
At the School of Public Health, incom¬ 
ing students were greeted with gifts of 
T-shirts from the upper classes. 
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“Don’t Throw Me the 
Knife” and other survival 
skills for the clinic 
li 
I 
In years past, third-year medical students 
entered the wards armed only with whatever 
clinical exposure they’d gleaned in their basic 
science years and at a daylong orientation con¬ 
sisting largely of lectures. The preparation 
sometimes left students ill equipped for their 
first days of clinical studies. “I remember 
someone saying ‘Go get the ekg machine, and 
not knowing what the ekg looked like, let 
alone how to attach it to a patient,” said 
Nancy R. Angoff, m.p.h. ’8i, m.d. 90, hs 93, 
associate dean for student affairs. 
To help students through the transition 
from basic to clinical science, Angoff s Office 
of Student Affairs expanded its clinical orienta¬ 
tion program this year with a two-day Survival 
Fair held on June 22 and 23. In addition to 
lectures from chief residents, hospital staff and 
others, students received lessons in how to 
conduct a pediatric ear exam, draw blood and 
take blood pressure. A session called “Don’t 
Throw Me the Knife” offered tips on operating 
room dos and don’ts. 
The Survival Fair was the brainchild of 
Angoff, Cynthia Andrien, m.s., assistant dean 
for student affairs, and Gisella Weissbach-Licht, 
director of the Office of Education. You re 
going to feel unprepared no matter what, said 
Angoff “We came up with this idea to try to 
relieve the anxiety of starting on the wards by 
introducing students to some simple, hands-on 
skills they didn’t get in great detail before.” 
Under the tutelage of clinical profes¬ 
sor Paul Goldstein, second-year stu¬ 
dents learned how to conduct a pedi¬ 
atric ear exam. 
New council officers, 
a new agenda 
The new officers of the Medical Student Coun¬ 
cil hope to address a variety of issues over 
the next academic year including producing 
a companion volume to the student guide 
known as The Kit. Treasurer Jennifer Teitel- 
batim, president Simran Singh and vice presi¬ 
dent Satish Nagula also plan to encourage 
greater faculty use of technology, explore a 
lowering of the age of financial independence, 
ask the library to extend hours at busy times 
and begin a mentoring program that would 
pair fifth-year students with first-years. 
Singh Nagula Teitelbaum 
PA Program graduates 35 
“You are entering a profession at a time when 
health care delivery is not as simple as it once 
was,” speaker William C. Kohlpepp, m.h.a., 
p.A.-c, told the 35 graduates of the Physician 
Associate Program Class of 2000 at Com¬ 
mencement on Sept. II. Managed care and 
other emerging trends mean we will have new 
rules, new obligations and new ways of doing 
business,” added Kohlpepp, chair of the board 
of the American Academy of Physician Assis¬ 
tants. Physician associates, as they are known 
at Yale, have proven successful, as has the model 
that teams them with physicians, he said. We 
must remain flexible. We must remain com¬ 
mitted to remembering that the patient is our 
number-one priority,” Kohlpepp said. 
Graduates of the Physician Associate 
Program gathered in the courtyard 
outside Harkness Auditorium before 
Commencement exercises in early 
September. 
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Commencement speaker Richard 
Belitsky joked with students before 
ceremonies began on the main 
campus. 
^^Pay attention to what is 
inside/’ Commencement 
speaker urges Class of 2000 
Richard Belitsky, m.d., remembers the day dur¬ 
ing his residency that he had to change the 
dressings on a badly burned boy. “If you are my 
doctor, why are you hurting me?” the boy asked 
him, and for Belitsky, the question opened an 
emotional vein. “I burst into tears,” he recalled 
in May, standing at the podium at the Class 
of 2000 s Commencement exercises. “The 
attending came over. He wanted to console me. 
‘Richard,’ he said, ‘if you are going to be a 
doctor you just can’t let it get to you like that.’” 
Belitsky, now an associate clinical professor 
of psychiatry and the students’ choice as 
Commencement speaker, had different advice 
for the III graduating physicians. 
“I wish he had said, ‘Richard, you are a 
doctor, of course you leel that way. We all feel 
that way sometimes,”’ Belitsky told his audi¬ 
ence. “You are going to feel these extraordinary 
things: fear, wonder, thrills, excitement, even 
terror, sadness, exhilaration. Whatever it is you 
feel, I want you to hear a voice inside that 
says, ‘You are a doctor, of course you feel way. 
We all feel that way sometimes.’” 
He urged the new physicians to maintain 
their spiritual equilibrium by staying in touch 
with their own hearts and reaching into the 
hearts of their patients. Talking to patients, he 
said, will help in their treatment. “It is through 
the telling of your stories and the listening 
to the stories of others that you will form the 
relationships that will allow you to bring your 
own individual humanity into this work.” 
In his closing words he offered more advice. 
“Take a vacation,” he said. “And I don’t just 
mean go on a vacation. A vacation is not a 
time to get caught up on journal reading. It is 
not a time to write grants. Take a book you’ve 
been dying to read and, more importantly, 
take your loved ones with you. Pay attention 
to what is inside. It is what makes you you.” 
COMMENCEMENT 
Honorary doctorate for 
Samuel Thier 
Samuel O. Thier, M.D., former chair of 
internal medicine and former chief 
of medicine at Yale-New Haven Hospi¬ 
tal, received an honorory degree 
as doctor of medical sciences at this 
year’s Commencement. Thier, who 
was on the medical school faculty 
from 1975 to 1985, was also president 
of the Institute of Medicine of the 
National Academy of Sciences, where 
he raised awareness of public policy 
issues related to AIDS and cancer 
research. He has served as president of 
Brandeis University and of Massachu¬ 
setts General Hospital. In 1996, Thier 
became chief executive officer of Part¬ 
ners Healthcare System Inc., which 
oversees Brigham and Women's Hospi¬ 
tal, Massachusetts General Hospital 
and the North Shore Medical Center. 
2 0 0 0 Melissa Wolfe and fellow graduates marched in procession from Sterling Hall of Medicine to the tent on 
Harkness Lawn for Commencement. 
The following prizes were awarded to 
School of Medicine faculty and students 
at Commencement: 
Bohmfalk Prize 
Michael J. Caplan, M.D., Ph.D. ’87, 
professor of cellular and molecular 
physiology, and George Lister Jr, M.D, 
professor of pediatrics 
Healthcare Foundation of New Jersey 
Humanism in Medicine Faculty Award 
Nancy R. Angoff, M.P.H. ’81, M.D. '90, HS 
'93, associate dean for student affairs 
Leah M. Lowenstein Prize 
Robert H. Gifford, HS '67, professor 
of medicine, and Lynn Tanoue, M.D., 
associate professor of medicine 
Francis Gilman Blake Award 
Richard Belitsky, M.D., associate clinical 
professor of psychiatry 
Betsy Winters House Staff Award 
Judd W, Landsberg, M.D., 
chief resident in medicine 
Parker Prize 
Karin L. Andersson 
Miriam Kathleen Dasey Award 
Royce G. Lin 
Norma Bailey Berniker Prize 
Azita G. Hamedani 
Dean’s Prize for Community Service 
Tanya E. Smith 
Healthcare Foundation of New Jersey 
Humanism in Medicine Student Award 
Joanna B. Sheinfeld 
Campbell Prize 
Juiie A. Davis 
Perkins Prize 
Julie V. Schaffer and 
Sereena C.Tamburri Coombes 
Merck Book Award 
Elizabeth V. Harrold and 
Masha Huseinovic 
Lange Book Award 
Patricia Nez Henderson 
M.D./Ph.D. Award 
Amy Y. Jan 
Connecticut Society of the 
American Board of Obstetricians 
and Gynecologists Prize 
Leslie R. Boyd 
New England Pediatric Society Prize 
Lisa R. Eiland 
Society for Academic Emergency 
Medicine Award 
Arvind Venkat 
Connecticut Chapter of American 
College of Surgeons Prize 
Jose M. Prince 
Peter A.T. Grannum Award 
Leslie R. Boyd 
Lauren Weinstein Award 
Jakub Svoboda 
Connecticut Academy of Family 
Physicians Award 
Angela J. Rubineau 
Endocrine Society Medical Student 
Achievement Award 
Megan C. Lisska 
The Courtlandt Van Rensselaer 
Creed Award 
Dirk C. Johnson 
ACP-ASIM Internal Medicine Award 
Maya J. Salameh 
National Health Service Corps 
Certificate of Recognition 
Leslie R. Boyd and Jennifer B. Griffiths 
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Idealism, inequity 
and public health 
As a young woman in her native India, Geeta 
Rao Gupta saw her dream of graduate studies 
in the United States dashed because of her 
gender. The men who ran the scholarship pro¬ 
gram told her she would be a poor investment; 
she would probably marry, have children and 
stop working. “I had lost a chance to pursue 
graduate studies because I was a woman,” said 
Gupta, who now holds a ph.d. and heads the 
International Center for Research on Women, 
a Washington-based non-profit organization 
that studies the roles women play in develop¬ 
ing countries. 
Discrimination against women around the 
world is a public health concern, Gupta said in 
her Commencement address to the School of 
Public Health Class of 2000. Women of color 
between the ages of 15 and 25 are at greatest 
Public health students, above, before 
Commencement ceremonies on the 
main campus. Below, some graduates 
took advantage of the occasion to 
make a statement. 
risk for hiv/aids, she said. Ailments related to 
pregnancy and childbirth claim half a million 
women each year, despite knowledge of how to 
prevent such deaths. And domestic violence is 
a “devastating reality” in the lives of women 
around the world. “Clearly there is an unequal 
power balance in society,” she said, “a power 
balance that is determined by gender as much 
as by class, race and other identities.” 
Gupta urged the new graduates not only 
to recognize but also to attempt to redress 
these social inequities. “They will undermine 
your work unless you incorporate them into 
your analyses and interventions,” she said. 
To achieve this, Gupta argued that idealism 
is essential. She suggested that public health 
workers’ efforts subscribe to three truths. 
“The first truth is that empowerment of 
women, the poor and minorities is not a 
zero-sum game,” she said. “More power to 
one does not mean less power to others. 
More power to one means more power to all. 
“The second truth is that cultural and 
social structures are not cast in stone. When 
cultural practices cause health damage, 
they must be adapted, changed, or even clev¬ 
erly co-opted. To feel, for example, that 
female circumcision is a cultural practice that 
must be tolerated because the culture can¬ 
not be changed, is unacceptable. 
“The third truth: Remember that individu¬ 
als in communities, no matter how disem- 
powered or marginalized, are actors and agents 
of change in the drama of their lives. If you 
include them, if you take the time to listen 
with humility, if you do not presume to know, 
you will be rewarded with rich insights and 
new realizations.” 
Gupta’s emphasis on the idealism funda¬ 
mental to public health echoed that of student 
speaker Jacob Harley Creswell. “So what is 
public health?” he asked. “The question could 
be, ‘What isn’t?’ There are so many different 
fields we will be entering, so many ways to 
improve health, no matter how daunting a task 
this may seem. ... Over the last 21 months we 
have heard all kinds of stories, some sadden¬ 
ing, some uplifting, some horrifying and some 
enlightening. We have learned about death 
and disease. We know what the world has to 
offer, and yet if I didn’t believe the world 
could be healthy, I would not be here.” 
The School of Public Health awarded 
master’s degrees to the 123 members of the Class 
of 2000, and one doctor of public health 
degree. The Graduate School of Arts and Sci¬ 
ences awarded 12 doctor of philosophy degrees. 
The following prizes were awarded to 
faculty and students of the School 
of Public Health at Commencement: 
Award for Excellence in Teaching 
Susan T. Mayne, Ph.D. 
Dean’s Prize for Outstanding Thesis 
Artemio Miguel Jongco III, for 
"Gonorrhea and Chlamydia 
Screening Among Jail Entrants in 
Rhode Island" 
Rowena Kerrebrock Richter, for 
"A Public Health Analysis of Herbal 
Medicine in the U.S.” 
Kelly Jen-Yi Yu, for "Patterns of Comor¬ 
bidity and Familial Aggregation of 
Cocaine Abusers" 
The Courtlandt Van Rensselaer 
Creed Award 
Kathryn Ann Finney 
Wilbur G. Downs International Health 
Student Travel Fellowships 
Jacob Harley Creswell, Erik Hett, 
Laura Anne Krech, Pamela A. Matson, 
Douglas Andrew Newton, Hilary 
Elizabeth Rosen and Shilpa Sayana 
E. Richard Weinerman Fellowships 
Subuhi Asheer, Nita B. Bellare, Rebecca 
A. Dodge, Kathryn Ann Finney, 
Nisha Gupta, Reshma Rani Mahendra, 
Benjamin K.S. Piper, Angela Denise 
Rogers, Gina N. Shin, Vivian FayeWu 
and Alexander S. Zusman 
Union School of Public Health China 
Internships 
Amy L. Arnold and Eugene E. Lee 
! 
Alvin Novick led public J 
health faculty in the l! 
procession on the main !l 
campus. 
'I 
,1 
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Top: Wayne Southwick in his sculpture 
studio in 1993, shortly after his 
retirement. The sculpture in the photo 
now stands on Cedar Street outside 
Sterling Hall of Medicine. Max Taffel, 
right, was a legendary surgeon 
on the service of the Memorial Unit, 
above, which opened in 1953. 
Surgical society gathers 
steam, honors **the great 
teachers” 
Six years ago, Yale faculty laid rhe groundwork 
for an organization they hoped would help 
keep alumni of the Department of Surgery in 
touch with one another in the years following 
residency. The first event, a reception during 
the annual meeting of the American College of 
Surgeons in Chicago in 1994, was attended by 
just a handful of Yale-trained surgeons. 
That fledgling group has grown to become 
the Yale Surgical Society (yss), which has 
attracted more than 700 members and organ¬ 
ized annual programs since 1996 as part of the 
medical school’s Alumni Reunion Weekend. 
YSS reunion activities have included tributes 
to former faculty, historical glimpses through 
the department’s past and, in 2000, a daylong 
symposium exploring current research in 
surgery at Yale. Next year’s event, a dinner on 
June I, will honor Max Taffel, m.d. ’31, clin¬ 
ical professor of surgery, and Wayne O. South¬ 
wick, M.D., professor emeritus of orthopaedics 
and rehabilitation. 
The program reflects the society’s desire 
to “honor the great teachers,” according to 
Andrew). Graham, m.d., hs ’66, a general sur¬ 
geon in New Haven who is the society’s presi¬ 
dent. Previous programs have paid tribute to 
Gustaf E. Lindskog, m.d., William WL. Glenn, 
The Yale Surgical Society Application Form 
Name Please accept my tax- 
Date of Birth 
deductible donation. 
Enclosed is my check for: 
Year Graduated from Yale School of Medicine □ One-Year Membership $ 50.00 
Year Completed Residency and/or Years of Faculty Appointment □ Lifetime Membership $ 500.00 
Residence Address □ Retired, Voluntary Donation $ 
City/State/Zip 
Residence Telephone (include area code) 
Office Telephone (include area code) 
E-mail Address 
Spouse or Significant Other 
Children's Names/Ages 
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M.D., John A. Kirchner, m.d., Jack W. Cole, 
M.D., and Bernard Lytton, m.b.b.s., f.r.c.s. 
Graham says that the June i gathering will 
focus on Taffel and other faces from the 
Memorial Unit years in Yale surgery as well as 
on Southwick and the story of the Depart¬ 
ment of Orthopaedics and Rehabilitation. 
During the 1950s and early 1960s, surgery 
in the Memorial Unit of Grace-New Haven 
Hospital functioned as a freestanding service. 
Taffel, who holds the first diploma issued by 
the American Board of Surgery, was a leg¬ 
endary figure in the Memorial Unit during 
those years. 
Southwick was chief of the orthopaedics sec¬ 
tion from 1958 to 1979 while it was part of the 
Department of Surgery. Southwick’s work in 
building the section led to its expansion as the 
Department of Orthopaedics and Rehabilitation 
in 1986 under present-day chair Gary E. Fried- 
laender, m.d., who was trained by Southwick. 
Membership in the Yale Surgical Society is 
open to former residents who trained in the 
department, current and former Yale surgery 
faculty, and Yale medical school graduates who 
have entered the field. The society has an ii- 
member board including four officers: Gra¬ 
ham, Vice President Bauer E. Sumpio, m.d., 
PH.D, HS ’86, Treasurer James M. Dowaliby, 
M.D. ’67, HS ’71, and Secretary Sanziana A. 
Roman, m.d., hs ’98. The society’s Web site 
can be found at http://yalesurgery.med.yale. 
edu/yss/yss.htm. 
How to join 
The Yale Surgical Society is open to sur¬ 
geons who trained in the department, 
current and former Yale surgery faculty, 
and Yale medical school graduates who 
have entered the field. If you would like 
to become a member, please complete 
the application to the left and mail 
with dues to Sharon Cullen, Executive 
Secretary, Yale Surgical Society, c/o Yale- 
New Haven Hospital, Clinic Building, 
Room 228,20 York Street, New Haven, 
CT 06504. 
’40s 
Donald W. 
Seldin, m.d. 
’43, HS ’46, 
who was 
instrumental 
in building 
University of Texas (ux) South¬ 
western Medical Center in 
Dallas into a major academic 
medical center, received the 
Mentorship Award from the 
University of California, San 
Diego, and the Salk Institute 
for Biological Studies in recog¬ 
nition of that integral role in 
ut’s growth. Seldin is vice presi¬ 
dent for medical center relations 
for the Southwestern Medical 
Foundation and clinical profes¬ 
sor of internal medicine at ux. 
received the David S. Friendly 
Award for 2000. This annual 
award is given to a graduate of 
the Pediatric Ophthalmology 
Fellowship program at Chil¬ 
dren’s National Medical Cen¬ 
ter in Washington, d.c., for 
outstanding original research 
and service in the field of 
pediatric ophthalmology. Ing 
writes, “The medical school 
here in Hawaii has recently 
been energized this past year 
by the arrival of Edwin C. 
Cadman, m.d., former Yale 
chair of medicine, to be the 
new dean of the school. Yale’s 
loss is Hawaii’s gain!” 
’60s 
50s 
Donnell D. 
Etzwiler, m.d. 
’53, founder 
and president 
emeritus of 
the Interna¬ 
tional Diabetes Center in 
Minneapolis, was presented 
the Shotwell Award in May by 
the Hennepin Medical Society 
(hms) in recognition of his 
dedicated service and contri¬ 
butions to the improvement of 
health care delivery. The bronze 
award, entitled Sprites, is a copy 
of a sculpture by artist Paul 
Granlund depicting a symbol of 
health and healing. Established 
in honor of Mr. and Mrs. James 
D. Shotwell by the Metropoli¬ 
tan Medical Center in 1971, the 
award is presented annually. 
HMS was selected to carry on 
the tradition when the Metro- 
politan-Mt. Sinai Medical Cen¬ 
ter closed in 1991. 
Malcolm R. 
Ing, M.D. ’59, 
HS ’63, profes¬ 
sor and chair 
of ophthal¬ 
mology at the 
University of Hawaii’s John A. 
Burns School of Medicine, 
Robert F. 
Maudsley, 
M.D., HS 
’69, was 
appointed 
dean of the 
faculty of health sciences for 
medicine and nursing at Aga 
Khan University in Karachi, 
Pakistan. Maudsley had 
been vice-dean of medicine 
at Queen’s University in 
Kingston, Ontario, from 1988 
to 1996, and associate dean 
for health sciences at McMas- 
ter University in Hamilton, 
Ontario, from 1982 to 1984. 
“Karachi is a port city of 12 
million people, and the uni¬ 
versity is situated on a beauti¬ 
ful campus with stunning 
architecture,” Maudsley wrote 
in an e-mail message to Yale 
Medicine. The school, which 
admitted its first students in 
1980, is associated with a 600- 
bed modern teaching hospital 
and is undergoing a major 
revision of its medical curricu¬ 
lum. In September, Maudsley 
received the Duncan Graham 
Award of the Royal College 
of Physicians and Surgeons of 
Canada for his outstanding 
contributions to medical 
education. 
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’60s continued SI ^ M.B.B.CHIR. 
’63, former 
chair and pro¬ 
fessor emeritus of community 
medicine at West Virginia 
University School of Medi¬ 
cine, writes to say, “I’ve been 
doing quite a bit of travel this 
year (Morocco, England, 
South Africa, Mozambique 
and Italy), as well as visiting 
our children in Baltimore, 
Maine and Tacoma. I have 
also done some general prac¬ 
tice in our local free clinic, a 
week of locum tenens in 
southern West Virginia and a 
few lectures in our m.p.h. 
courses.” The Mozambique 
trip, he adds, was in regard to 
the startup of a new medical 
school. 
Shaun Ruddy, m.d. ’61, Elam 
C. Toone Professor ol Internal 
Medicine, Microbiology and 
Immunology at the Virginia 
Commonwealth University/ 
Medical College of Virginia, 
has been named a member of 
the editorial board of T/?e 
Pharos of Alpha Omega Alpha 
Honor Medical Society. Two 
fellow Yale alumni are also 
members of the board, Robert 
A. Chase, m.d. ’47, hs ’53, and 
Robert G. Petersdorf, m.d. ’74, 
HS ’76. 
Leon C. Smith, m.d., hs ’62, 
director of medicine and chief 
of infectious diseases at St. 
Michael’s Medical Center in 
Newark, n.j., was presented a 
doctor of medical research, 
honoris causa, from Caldwell 
College in New Jersey at the 
commencement ceremonies in 
May. During his career, Smith 
co-founded New Jersey’s first 
free medical clinic and a 
weekly conference on infec¬ 
tious diseases which has con¬ 
tinued for 26 years at a hospi¬ 
tal in New York or New Jersey. 
He also established a free 
shower and clothing center for 
the homeless at St. Patrick’s 
Pro-Cathedral in Newark and 
developed a school-based 
hiv/aids prevention program. 
’70s 
Clayton A. Ajello, m.p.h. ’75, is 
president and chief executive 
officer of EearnWare Interna¬ 
tional Corp., which creates 
and distributes interactive 
multimedia courseware and 
presentations. Ajello has a 
doctoral degree in interna¬ 
tional health from The Johns 
Hopkins University School of 
Hygiene and Public Health 
and 20 years experience assess¬ 
ing national education and 
training systems. 
Joseph M. Connors, m.d. ’73, 
clinical professor of medical 
oncology at the British 
Columbia Cancer Agency in 
Vancouver, was the 2000 
recipient of the Professional 
Association of Residents of 
British Columbia’s award for 
excellence in teaching. The 
group cited Connors for his 
practice of evidence-based 
medicine and his dedication as 
a teacher who fosters an enjoy¬ 
able learning environment. 
Thomas W. Ferguson, m.d. 
’78, editor and publisher of 
The Ferguson Report, an e-mail 
newsletter, was the keynote 
speaker in May at the third 
Biennial International Confer¬ 
ence on Internet & Society at 
Harvard. In his talk, “Shifting 
the Balance of Power: Patient 
Empowerment on the Web,” 
Eerguson said increased patient 
access to medical information 
online is changing the percep¬ 
tion of the physician as sole 
medical authority. Ferguson is 
adjunct associate professor of 
health informatics at the Uni¬ 
versity of Texas Health Science 
Center in Houston. 
Otolaryngol¬ 
ogist Jeffrey 
N. Hausfeld, 
M.D. ’78, 
medical direc¬ 
tor of the 
Washington (d.c.) Center for 
Easer Medicine, was named 
chief medical officer of MD 
Productivity, an Internet med¬ 
ical services corporation in 
June. Hausfeld will play a key 
role in further developing the 
physician and patient services 
available on the company’s 
Web site, www.MDproductiv- 
ity.com. He is also on the fac¬ 
ulty in the department of 
otolaryngology at The George 
Washington University School 
of Medicine. 
Robert J. Lerer, m.d., hs ’73, a 
pediatrician for 25 years with 
Pediatric Associates of Fair- 
field, Ohio, has devoted him¬ 
self to medical and missionary 
work in Cuba during much of 
the past four years. In 1998, 
Eerer and his wife, Janis, a 
psychiatric nurse and licensed 
social worker, led a team of 24 
health care professionals and 
volunteers from the United 
States on a medical-evangelical 
missionary trip co-sponsored 
by Caring Partners Interna¬ 
tional and the Christian Med¬ 
ical and Dental Society. 
Laurence A. Tanner, m.p.h. ’72, 
president and chief executive 
officer of Central Connecticut 
Health Alliance and president 
and CEO of New Britain Gen¬ 
eral Hospital, was appointed 
in October to the board of 
directors of American Finan¬ 
cial Holdings Inc. and the 
American Savings Bank. 
Ann L. 
Elderkin, pa 
’80, has been 
appointed a 
senior health 
policy fellow 
in the Office of the Surgeon 
General. As a special advisor on 
health policy, she began her 
one-year fellowship in Septem¬ 
ber. Elderkin was the director 
of the Portland (Maine) Public 
Health Division from October 
1990 to July 2000 and director 
of the Somerville (Mass.) Health 
Department from 1990 to 1997. 
She is a former president of the 
American Academy of Physi¬ 
cian Assistants and the Physi¬ 
cian Assistant Foundation. 
David Fassler, m.d. ’82, clinical 
associate professor of psychia¬ 
try at the University of Ver¬ 
mont College of Medicine and 
clinical director of Otter 
Creek Associates, received the 
Green Ribbon Award for 
Childhood Depression Educa¬ 
tion from the National Mental 
Health Association. The 
award, presented in May at 
the National Press Club in 
Washington, recognizes 
national advocacy and educa¬ 
tional efforts on behall of chil¬ 
dren and families. 
Eric J. Nestler, ph.d. ’82, m.d. 
’83, former professor and 
director of the division of 
molecular psychiatry at Yale, 
has been appointed chair of 
the Department of Psychiatry 
at the University of Texas 
Southwestern Medical Center 
in Dallas. Nestler, the first to 
hold the Lou and Ellen 
McGinley Distinguished 
Chair in Psychiatric Research, 
will continue his research into 
the molecular basis of mental 
illness and addiction while 
leading the department of 115 
at Southwestern. 
’80s 
66 
Neil A. Solomon, m.d. ’90, has 
joined CareGuide Inc., a care 
management company for 
older adults, as senior vice 
president and chief medical 
officer. Solomon will oversee 
all customer communications, 
as well as content of the Web 
site. He formerly held execu¬ 
tive positions at the national 
headquarters of Kaiser Perma- 
nente. During the past 10 
years, Solomon concurrently 
practiced internal medicine. 
Correction 
On page 46 
of the Sum¬ 
mer 2000 
issue of Yale 
Medicine, this 
photograph 
of Harry C. Miller Jr., m.d. 
’54, was mistakenly placed 
next to an item about Leo H. 
Berman, m.d., hs ’53. Our 
apologies to both. 
Fortieth Reunion 
James J. Nora, m.d. ’54, wrote this poem after 
attending his 40th reunion with his classmates 
in 1994. Unable to attend his 45th last year, he 
sent this poem to Yale Medicine instead. 
Many of us had retired. 
Already one-seventh of our class had died. 
This was, I calculated, the last time 
when morbidity and mortality would 
be delayed enough to allow a substantial turnout. 
I thought Id like to remember us when we 
looked the way we felt—young, vigorous, optimistic. 
Most of our past histories had required no more 
than a few short sentences scribbled in—before 
beginning the longer narratives that would be tucked 
between the aluminum chart covers of our lives. 
Required supplements would eventually extend 
through many pages—many volumes. 
Was I prepared to blow the dust ojfthe records? 
It would have been easier if I had attended 
other reunions along the way. 
We could have glanced past a few 
of each other’s progress notes about 
thinning hair and thickening waistlines 
to find joys and triumphs— 
and then more gradually absorbed the reports of 
disappointments and losses and personal tragedies. 
The volumes were opened, 
the triumphs and defeats 
were accepted and chronicled. 
And within hours 
the faces of older physicians 
would for the rest of our lives 
be indistinguishable from 
the shining features of young students. 
—^James J. Nora, m.d. ’54 
Aurora, Colo. 
Contribute 
to the 
School of Medicine’s 
future and 
Invest 
in Your Own 
Yale University’s life-income 
program offers graduates of 
the School of Medicine the 
opportunity to: 
• Help ensure the future 
of a great institution 
• Receive quarterly income 
payments for life 
• Increase their income 
from low-yielding stock 
without incurring 
capital gains taxes 
• Reduce federal and 
state taxes 
• Claim a charitable income 
tax deduction 
Please call or write to see if 
you can use these benefits 
to the mutual advantage of 
yourself and the School of 
Medicine. 
YALE UNIVERSITY 
SCHOOL OF MEDICINE 
P.O. BOX 7611 
NEW HAVEN, CT 
06521-2038 
(t) 1-800-445-6086 
(f) 1-203-432-7901 
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Supporting diversity 
does not just serve the minority community. 
It serves everyone.” 
Reunion program 
explores the 
"Many Faces of Medicine.’' 
third African-American woman to 
graduate from the medical school. 
In medicine, affirmative action means more 
than simply ensuring that African-Americans, 
Native Americans and Latinos get a chance to 
become physicians. It is critical to providing 
minorities with the same quality of health care 
' that whites receive, says Augustus A. White III, 
M.D., PH.D., HS ’66. Affirmative action is also 
essential to fostering respect among the diverse 
groups of people whose paths cross in hospi¬ 
tals, doctors’ offices and medical school class¬ 
rooms, according to White, the keynote 
speaker, and panelists who joined him for a 
discussion of “The Many Faces of Medicine.” 
About too people at this year’s reunion 
attended the program exploring race, ethnicity 
and affirmative action through the experiences 
of minority alumni and students. 
White, a professor of orthopaedic surgery at 
Harvard Medical School and surgeon-in-chief 
" '■ -f- '■ 
—Panelist Yvedt Matory 
68 
2/000 
emeritus at Beth Israel Medical Center, deliv¬ 
ered the keynote address, “The Importance 
of Affirmative Action to the Health Care of Our 
Nation.” White argued that members of minor¬ 
ity groups don’t receive the same quality of 
medical care as do whites. The proof is in the 
statistics. Infant mortality, a key health indica¬ 
tor, is 2.5 times higher among African-Ameri¬ 
cans than among whites. African-Americans are 
less likely to receive pain medication for long- 
bone fractures in the emergency room and 
are less likely to receive cardiac bypass surgery. 
Minority patients, he continued, are often 
subject to disrespectful treatment such as the 
following: a physician who greeted an Asian 
woman as “Mrs. Thai Lady,” caregivers who 
failed to draw the curtains when undressing an 
African-American patient, and an Italian 
patient who heard it suggested that he must 
have a Mafia connection. Those acts of insensi¬ 
tivity were not committed by “skinheads,” said 
White, who was a professor of orthopaedic sur¬ 
gery at Yale in the 1970s. 
“We need to do some things differently,” 
White said, “Minority doctors are more likely 
to practice culturally competent medicine. 
Diverse medical care teams can educate each 
other through interpersonal relationships as 
well as relationships with patients.” 
Affirmative action has had a dramatic effect 
on minority enrollment at the medical school 
during the past 30 years, Forrester A. Lee, m.d. 
’79, told the audience. Lee, associate professor of 
medicine and associate dean of multicultural 
affairs, reported that from 1850 to 1900, only 10 
blacks received medical degrees from Yale. Dur¬ 
ing the succeeding five decades, not a single 
black graduated from the school, and from 1950 
to 1970 a black student graduated every two to 
four years. Then, with the advent of affirmative 
action in 1970, the number of black graduates 
rose sharply to 10 to 12 per year. The 105-mem¬ 
ber Class of 2003 includes 13 African-Americans, 
II Hispanics, 22 Asian-Americans and 45 
women, noted Nancy R. Angoffi m.p.h. ’81, m.d. 
’90, HS ’93, associate dean for student affairs. 
Affirmative action, however, placed pressure 
upon students to prove themselves. “I knew as 
minority students we would be asked questions. 
Are you here at Yale because you’re black, or 
are you here at Yale because you’re smart?”’ said 
panelist O’Dell M. Owens, m.d. ’76, medical 
director for United Health Care in Cincinnati. 
“I am a product of affirmative action,” 
said panelist Rashida N’Gouamba, ’02, who 
pointed out that affirmative action merely 
opens the door, without guaranteeing success. 
“Affirmative action doesn’t get you the grades 
you’re going to get. It doesn’t make you do 
anything other than work hard.” 
Doris Wethers, m.d. ’52, the third African- 
American woman to graduate from the School 
of Medicine, recalled getting along with most of 
her classmates, although she was the only 
minority student. From Yale she went to Wash¬ 
ington, D.C., where she did a one-year internship 
in a hospital that had desegregated its wards and 
staff, although the city remained segregated. 
“There was a little friction,” she said. She now 
lives in New York City, where she is a professor 
of pediatric medicine at the Columbia Univer¬ 
sity College of Physicians and Surgeons. For 
decades she has led a continuing study of sickle¬ 
cell anemia at St. Luke’s-Roosevelt Hospital. 
Owens told of returning to Cincinnati, 
where patients occasionally walked out when 
they saw their physician was black. Panelist 
Yvedt L. Matory, m.d. ’81, an assistant professor 
of surgery at Harvard Medical School, spoke 
of her time, first as a resident and now as an 
attending, as the only black woman on a staff of 
90 surgeons. “I have spent a lot of my time edu¬ 
cating my colleagues and the residents,” she said. 
White acknowledged that physicians cannot 
be well-versed in the nuances and protocols 
of each culture they encounter. “We cannot be 
cultural anthropologists for every culture, but 
there is a need for more education in this area,” 
he said. And, added Matory, there is a benefit 
for all society. “Supporting diversity,” she said, 
“does not just serve the minority community. It 
serves everyone.” 
TOP "We need to do some things dif¬ 
ferently,” said Augustus White, 
keynote speaker at a reunion program 
on diversity. White, a professor at 
Harvard Medical School, served on the 
house staff at Yale in the 1960s. 
BOTTOM O’Dell Owens chatted with 
other alumni before joining a panel to 
discuss his experiences as an African- 
American physician. 
Carolyn Slayman moderated a 
discussion of the Human Genome 
Project and its effects on the 
teaching and practice of medicine. 
The future is here 
Yale perspectives on the Human 
Genome Project. 
When the Department of Human Genetics 
was founded at Yale almost 30 years ago, the 
field was narrow: Its investigators studied a 
handful of rare genetic disorders in children. 
“Three decades later,” says Deputy Dean Car¬ 
olyn W. Slayman, ph.d.. Sterling Professor ol 
Genetics and professor ol cellular and molecu¬ 
lar physiology, “we now know that genetic 
mutations play a role in most, if not all, com¬ 
mon diseases in adults and must be taken into 
account by every practicing physician. 
During this year’s reunion, just three weeks 
before the announcement of the Human 
Genome Project’s rough draft of the human 
genome, Slayman moderated “Mapping the 
Future: The Human Genome Project, Yale Per- 
„ spectives,” a presentation by three Yale 
I researchers who discussed the genome project’s 
S profound implications for research, medicine 
t and medical education. 
Peripheral to its main goal, the project 
has spawned a variety of research technologies 
over the last six years, said David C. Ward, 
PH.D., professor of genetics and of molecular 
biophysics and biochemistry. “A lot of this is 
brand-new,” said Ward, the creator of two such 
technologies, the widely used fluorescent in 
situ hybridization, or fish, and a newer tech¬ 
nique, rolling circle amplification, developed 
with Paul M. Lizardi, ph.d., associate professor 
of pathology. Among the innovations to result 
from the genome project are new methods 
of genetic testing and microarrays that can be 
used to analyze thousands of dna samples and 
create databases with a prognostic value, Ward 
said. “While they are experimental today, they 
are heading to the clinic, and rapidly, he said. 
Richard P. Lifton, m.d., ph.d., chair of the 
almost zero understanding of the molecular 
basis of human disease to a milestone of under¬ 
standing over 1,000 human diseases at the 
molecular level,” said Lifton, who, with col¬ 
leagues, has identified several genes related to 
hypertension. Identifying gene mutations that 
are linked to specific disorders, he said, pro¬ 
vides insight into the mechanisms of disease, 
allows clinicians to identify susceptible patients 
before disease develops, helps investigators 
identify targets for therapies and allows them 
to tailor treatment to specific abnormalities. 
“We are going to know all the genes, all the 
common variations of those genes,” he said. 
“We will be able to piece together whether they 
are implicated in human disease.” 
Rapidly changing information, said Mar- 
gretta Reed Seashore, m.d. ’65, hs ’68, is noth¬ 
ing new in medicine. The development of the 
human genome, however, has increased both 
the pace and scope of new findings. The chal¬ 
lenge for medical schools is to determine what 
is core information and what is specialty 
knowledge, and to help students learn how to 
examine new information critically. And, no 
matter what their specialty, students must also 
learn how to integrate genetics into the practice 
of medicine. Seashore said. To this end, Yale 
has begun to incorporate genetics into all four 
years of study for medical students and is 
developing programs for practicing physicians 
and graduate students. 
All three speakers made clear that this new 
knowledge marks a new era in medicine. Per¬ 
haps not since Morgagni started doing surgical 
autopsies and discovered that all disease was not 
caused by the same evil humor have we been in 
a period of such rapid discovery of the funda¬ 
mental causes of human disease,” said Lifton. 
“We are in the midst of one of the really great 
revolutions m the history of medicine. 
“Mapping the Future was also presented to 
an audience at the Yale Club of New York City 
Department of Genetics and a Howard Hughes October. 
Medical Institute investigator, stressed the 
speed of new discovery (See interview, page 42). 
“Over the last five years we have gone from 
70 
2000 
Honors to Gifford 
and alumni 
The accolades for Robert H. Gifford, m.d., hs 
’67, who spent more than 30 years at the med¬ 
ical school as a resident, teacher, associate and 
deputy dean, continued with his honorary 
induction into the Association of Yale Alumni 
in Medicine (ayam) at this year’s reunion. Asso¬ 
ciation President Gilbert F. Fiogan, m.d. ’57, 
called it a “particularly special honor that is 
rarely given.” 
“We are going to induct a very special per¬ 
son as a member of the alumni association 
because of his contributions to the school,” 
Hogan said. “Bob has been a teacher, a scholar 
The Association of Yale Alumni in 
Medicine honored, from left, 
Paul Calabresi, Margretta Seashore 
and Martin Cordon with 
Distinguished Service Awards. 
Robert Gifford, right, received an 
honorary induction into the 
alumni association. 
and, in recent years, dean of students, where he 
has won the affection and love of generations 
of students.” 
The AYAM also honored three alumni with 
Distinguished Service Awards for outstanding 
contributions to the School of Medicine and 
the profession: Martin E. Gordon, m.d. ’46, 
clinical professor of medicine; Margretta R. 
Seashore, m.d. ’65, hs ’68, professor of genetics 
and pediatrics; and Paul Galabresi, m.d. ’55, 
professor emeritus of medicine at Brown 
University. 
Gordon’s award cited his dedication as a 
teacher, his treatises on global medicine and, 
over the past 20 years, his devotion to the med¬ 
ical library. As chair of the Board of Trustees of 
the Associates of the Gushing-Whitney Med¬ 
ical Library, he has contributed to the expan¬ 
sion of electronic resources and increased the 
membership of the library’s association. 
The AYAM cited Seashore for her 30 years as 
a model educator, researcher and physician. 
“Scores of medical students, residents and fel¬ 
lows have benefited from your knowledge and 
insight,” read the ayam’s citation. 
Calabresi received the ayam’s recognition for 
his services to medicine and to Yale. As a physi¬ 
cian, Calabresi was one of the pioneers of com¬ 
bination chemotherapy for treating cancer. He 
has chaired the National Cancer Advisory 
Board and served on the President’s Cancer 
Panel. Calabresi is chair emeritus of the 
Department of Medicine at Brown University 
School of Medicine. 
At its annual meeting the ayam executive 
committee named Francis M. Lobo, m.d. ’92, 
secretary of the association. Donald E. Moore, 
M.D. ’81, M.p.H. ’81, was named to his first 
two-year term as a member, and Arthur C. 
Crovatto, m.d. ’54, hs ’61, and Romeo A. 
Vidone, m.d. ’57, hs ’58, were named to their 
second two-year terms. Jocelyn Malkin, m.d. 
’51, HS ’52, and Deborah D. Desir, m.d. ’80, 
HS ’83, were named to three-year terms as ayam 
representatives to the Association of Yale Alumni. 
EPH honors the late John 
Devereaux Thompson 
John D. Thompson was a leader in the 
field of health services research whose 
expertise ranged from the design of 
health care payment systems to the 
social and architectural history of hos¬ 
pitals and the story of Florence 
Nightingale. On his death in 1992 at 
the age of 75 he was professor emeri¬ 
tus of public health and nursing 
administration. Thompson was a regis¬ 
tered nurse and in 1950 received an 
M.S. in hospital administration from 
the School of Medicine. Friends, col¬ 
leagues and family members gathered 
at this year’s reunion for the First 
Annual John D. Thompson Health Man¬ 
agement Dinner to honor his contribu¬ 
tions to the field. The Department of 
Epidemiology and Public Health has 
established the John Devereaux 
Thompson Academic Development 
Fund at Yale, an endowed fund that 
will support the academic mission of 
EPH’s Division of Health Policy and 
Administration and the division’s 
Health Management Program. Attend¬ 
ing this year’s dinner were, back row 
from left, Thompson’s son, Anthony 
Thompson; his daughter Margaret 
Thompson; son-in-law James Roberge; 
in the front row, his daughter Deirdre 
Hamilton; widow Adriana Thompson; 
sister Martha Carrick; daughter Julie 
Walpole; and daughter Siobhan A. 
Thompson. 
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Reunion 
1935 
65th Reunion 
As the only member of the 
class present, I enjoyed the 
overall reunion—one of the 
best ever—accompanied by 
my wife Ethel. Moderately 
active, I still teach four to five 
mornings a week and also 
serve as chair of planned giv¬ 
ing for the School ot Medi¬ 
cine Alumni Fund. 
Only two other Class of 
’35 alumni are still living. 
James O. Haralambie is a 
retired pediatric neurologist 
who lives at Heritage Village 
in Southbury, Conn. Howard 
H. Croskloss a retired ob/gyn 
physician, lives in Vero 
Beach, Fla. 
- Samuel D. Kushlan 
1945 
55th Reunion 
On a warm June day in 1942, 
few in our class could have 
expected that so many of us 
would be coming again to the 
Sterling Hall of Medicine on 
another lovely June day in 
2000. This reunion, as 
arranged by Dick and Verne 
Breck, was the least structured 
and most enjoyable of any of 
our get-togethers in many 
years. Not only were the 
attendees able to come, but 
they were also standing tall 
and had a spring in their step. 
Along with the Brecks, 
attending were Sandy and 
Claudine Cockerell, Ed and Das 
Daniels, with son Ben, Dick 
Dyer, Bob and Ruthie Easton, 
with lovely granddaughter 
Pearl James, Sid Feuerstein, 
Ray and Pat Cagliardi, Bob 
Hollan, Bill and Marj Jenney, 
Lee and Barbara Jones, Mike 
and Jeri Lau, Mark and Mar¬ 
garet Lindsey, George and 
Michelle Naumburg and Fitz 
and Mildred Pannill. It was sad 
to realize that since our last 
meeting we had lost Albert 
Atwood, Philip Good, Isao 
Hirata, John Howick, Hans 
Huessey, Joseph Stanton, Ken¬ 
neth Steele, Sam May and 
Dick Dyer’s wife Nat. 
Friday and Saturday were 
largely spent telling each other 
how good we looked, all 
things considered, and 
remembering old times. We 
even managed to remember 
things that never happened. 
One member recalled when 
our class voted not to take the 
Hippocratic Oath. No one 
else remembered it. As we 
talked and joked and remem¬ 
bered the fun things that 
lightened the darkness of 
those war years, we were 
reminded what an exceptional 
group of people made up the 
Class of 1945. While we didn’t 
have a program of our own, 
we enjoyed what we heard and 
saw. We were interested to 
hear the dean tell us that the 
program of promoting diversi¬ 
ty in the school was very suc¬ 
cessful. The student body now 
has 41 percent minority 
enrollment. The physical 
expansion of the medical cam¬ 
pus defies description and 
continues to make us proud. 
The meals were excellent, 
and we have a dean with an 
outstanding sense of public 
relations who made us feel 
welcome and important. 
Many classmates wanted to 
come but because of health or 
family concerns, coupled with 
prior travel plans, were unable 
to do so. Mike Allison was one 
of the travelers and, I think, 
the only one left who is still 
seeing patients. 
We were enthusiastic about 
organizing an interim reunion 
in a couple of years before our 
60th in New Haven. This was 
such a good one, we hope 
everyone can get to that one. 
You will all know the if, 
where, and when of that 
event. It will be a tough act to 
follow Breck’s performance in 
2000, but this class was never 
one to flinch or falter in the 
pursuit of excellence. 
- Raymond A. Gagliardi 
1950 
50th Reunion 
For those who came, the 50th 
reunion was a satisfying and 
memorable event; to those 
who could not be there: you 
were missed. Lodging and 
accommodations, most of 
which were arranged by Sylvia 
Axelrod and Jane Shumway, 
were at the Colony Inn, 
including a hospitality suite 
and our class dinner Friday 
night. Each of us was invited 
to speak about memories of 
our time at Yale and our sub¬ 
sequent careers, lives, losses 
and accomplishments. We 
remembered those who were 
no longer with us. It was a 
moving experience and a most 
satisfying way to bring closure 
to the half century since we 
started out together. 
Present were Sylvia Axel¬ 
rod, Mai Bagshaw, Bill and 
Ida Bucher, Al Davis, Tom and 
Justine Ferraro, Dan and Anita 
Fine, Yvette Francis, Larry and 
Rina Freedman, Dave and 
Carol Frucht, Carl Gagliardi, 
Marilyn and Barney Kritch- 
man, John and Kathleen 
LeRoy, Harold and Julia 
March, Harry and Sheila 
McClelland, Charley and Mar¬ 
garet Nugent, Bob and 
Phoebe Sceery, John Strauss 
and Jane and Clare Shumway. 
Claude Delia, who had 
planned to come, was unable 
to because of wife Jeanne’s ill¬ 
ness, and Lyal and Bonnie 
Asay went to Hawaii for their 
granddaughter’s graduation. 
Following a full day of 
activities on Saturday, we 
gathered at the hospitality 
suite for a meditation session 
led by Jane Shumway. With 
our minds at rest, we repaired 
to the Graduate Club for the 
Friends of the 50th Dinner for 
a most delicious repast. 
On Sunday, Margaret 
Lyman, who had been unable 
to come to New Haven, host¬ 
ed a delightful brunch at her 
72 
Middlebury home, a most 
pleasant country interlude, 
and a delightful finale to a 
wonderful reunion. 
- Dave Frucht 
1955 
45th Reunion 
This reunion was one of the 
best and most enjoyable for all 
the attendees. We had 18 mem¬ 
bers of the class accompanied 
by 14 significant others. 
The first event of impor¬ 
tance was the dedication of 
The Paul Calabresi Confer¬ 
ence Room in the Yale Cancer 
Center on Friday, June 2. This 
honor was bestowed on Paul 
for his work in cancer research 
and treatment. Five or six of 
our classmates arrived early 
enough to attend, along with 
Paul’s wife, Celia, and his 
brother, Guido Calabresi, the 
U.S. Court of Appeals judge 
and former dean of the Yale 
law school. 
Things really got hopping 
then with the arrival of about 
another 10 classmates for the 
Dean’s reception, where Dean 
David A. Kessler acknowl¬ 
edged that he indeed was not 
the “real David Kessler” and 
tipped his hat to our own 
David R. Kessler (see photo 
top right), and the outdoor 
clambake. This event termi¬ 
nated when a violent storm 
erupted; fortunately, we had 
already consumed all the 
food we could eat. 
The next day Paul was 
again honored as one of the 
recipients of the Distinguished 
Service Award. 
Our seminar on Saturday 
afternoon featured a fascinat¬ 
ing new approach to teaching 
students and residents the art 
of observation and description 
of patients, presented by Irwin 
Braverman. Fde brings them 
to the Yale Center for British 
Art where they observe paint¬ 
ings by the masters and are 
drilled in how to observe and 
describe details in the paint¬ 
ings. Frank Johnson brought 
us up to date on the epidemic 
of that chronic disease facing 
our nation; obesity. Rocky 
Stone gave us an in-depth 
view of the tragedy at Waco, 
Texas, from his vantage point 
as a member of the Congres¬ 
sional commission assigned to 
investigate it. 
Satutday evening’s banquet 
at the New Flaven Fiotel was 
a blast. We had a great meal 
and posed for the official class 
picture. The most enjoyable 
part was when attendees each 
spoke for three to five minutes 
and described their lives. 
Many of us are now retired 
but still living very active and 
productive lives. One, Eliza¬ 
beth Lamb of Florida, will get 
her law degree in December. 
The final event was a Sun¬ 
day motning brunch at the 
home of Sarah and Shep 
Nuland. We were blessed with 
a beautiful sunny day and the 
blooming of Sarah’s roses, rho¬ 
dodendrons, peonies and irises. 
We enjoyed an atmosphere 
of close fellowship despite 
being a diverse group of per¬ 
sonalities with many different 
interests. See you at the 50th. 
- S. Jack Landau 
i960 
40th Reunion 
The millennial reunion of the 
class of i960 was a splendid 
affair. Of the 65 remaining 
members of our class, 28 
attended, most with spouses 
or significant othets, fot an 
exttaordinary attendance rate 
of 43 percent. As has been our 
tradition, the class had its own 
reunion seminar. Es Esselstyn 
made a remarkable presenta¬ 
tion on dietary intervention in 
cardiovascular disease. Fie 
demonstrated coronary artery 
disease reversal with full 
restoration after significant 
narrowing, after as little as six 
weeks on an extremely rigor¬ 
ous diet that was devised by 
Es, which was equivalent to 
the dietary intake of the vic¬ 
tims of famine in sub-Saharan 
Africa. For our class of leaders, 
I then made a presentation on 
“When Illness Strikes the 
Leader.” This sobering one- 
two punch was followed by a 
clambake, replete with drawn 
butter, lobster, shrimp, clams, 
roast beef au jus, and straw¬ 
berry shortcake, enough to 
clog fully the healthiest of 
arterial systems. Vic Altshul, 
reunion co-chair, and I want 
to apologize to the class par¬ 
ticipants for this unfortunate 
sequence. Perhaps mindful of 
the effects of his lecture, Es 
was not able to stay for the 
evening gluttony, and the class 
admirably rose to the chal¬ 
lenge, putting a wall of denial 
in place as we gorged our¬ 
selves on this wonderfully rich 
repast. On Saturday, the class 
dinner was held in a private 
dining room at the New 
Fiaven Lawn Club, arrange¬ 
ments for this perfect venue 
courtesy of Vic. The evening 
was awash with sentiment, 
nostalgia, and zany humor as 
the members of the class 
shared stories of their profes¬ 
sional accomplishments, per¬ 
sonal journeys, and warfare in 
the arena of managed care. 
In attendance were: Vic 
and Laura Altshul, Lanny 
Ames, Jack Barchas and his 
wife Rosemary Stevens, Don 
and Nancy Buebendorf, Gerry 
and Dona Cimmino, Frank 
and Ann Cogliano, Jon and 
Carol Courtney, AAalin and 
Lenore Dollinger, Es Essel¬ 
styn, Jim Eustermann, Warren 
Fisher, Gene Gaenslen, Rick 
Kindwall, Susan Kleeman, 
Tom and Alice Kugelman, Ed 
and Linda Longo, Bob Marcus 
and Vi Simons, Gene 
McCarthy, Al and Barbara 
Newcomb, Fred and Ruth 
Palace, Jerry and Carolyn 
Post, Nancy and Bill Powell, 
Al Ross and Jane Simmons, 
Dan and Linda Rubin, John 
and Suzanne Schrogie, Fred 
Stargardter and Pat Madden, 
Bob and Judy Wallach, and 
Ron and Katherine Yankee. 
- Jerrold M. Post 
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1965 
35th Reunion 
On the Saturday evening of 
reunion weekend, Bob and 
Sue Weiner hosted a French 
Country picnic at their sum¬ 
mer cottage on Long Island 
Sound in Madison. Attending 
were Phil and Marjorie Aske- 
nase, Frank and Donna 
Grady, Reid and Ellie Heffner, 
Dave and Gretchen Hill, Cin- 
ny Burnham Johnson, Ron 
Karpick, Mohandas and 
JoAnne Kini, Mark Lischner, 
Mike and Lili Mayor, Larry 
and Linda Ossias, Bob and 
Mary Pickens, Jibby Rachleff, 
and John and Greta Seashore. 
Mark traveled the farthest 
(California), Ginny traveled 
the least (Guilford), and Jibby 
arrived by sailboat! Despite 
most of us being in practice 
30 years, I was the only one 
fully retired. Many others 
were cutting back and consid¬ 
ering joining the gainfully 
unemployed. Hopefully, by 
2005 most of the class will 
have hung up their stetho¬ 
scopes for good, and will have 
nothing better to do than 
attend our 40th reunion. 
- Robert G. Weiner 
1970 
30th Reunion 
The class reunion dinner was 
held on Saturday night at 
Anne Curtis and Jim Fischer’s 
house in Madison. Attendees 
included John Blanton and 
Katie Dyer, Romney and 
Mary Sue Burke, Michael and 
Janice Danzig, Margaret 
DeLano,Jonathan and 
Rosanne Ecker, Robert 
Epstein, Paul and Patricia 
Hessler, Jonathan and Susan 
Katz, Leonard and Ellen Mil- 
stone, Dennis and Reissa 
Shield, Richard and Laurinda 
Solomon, Philip Steeves and 
Karl Wustrack. 
Anne Lucky called to say hi 
to everyone. The evening was 
a success and a good time was 
had by all. 
- Anne McB Curtis 
1975 
25th Reunion 
Quality not quantity made for 
a good time at Adriana’s 
restaurant on Saturday night 
for the class of 1975. Paul 
Johnson and Liz Gawron took 
time off from their busy medi¬ 
cine and peds practices to stop 
by in New Haven on the way 
to a vacation in Italy and 
brought with them the official 
class picture with our 1971 
mug shots—so not only did 
we talk about you, we com¬ 
mented on your picture, too. 
Sal and Susan Romano didn’t 
have to travel far from Water- 
bury and Sal’s dermatology 
practice, and at Friday’s clam¬ 
bake, daughter and Yale med¬ 
ical student Sally joined us as 
well. Waterbury was also well 
represented by the Ruchmans, 
where Mark is an ophthalmol¬ 
ogist. Morris Westfried drove 
up from New York Gity and 
his dermatology practice, and 
updated us on his turn toward 
natural remedies. Jim Rosen¬ 
baum filled us all in on what 
rheumatology was like in 
Portland, Ore., home of many 
naturalists. Jim is still running 
marathons. Jim’s wife, Sandy, 
has a busy cardiology practice 
there as well. Sandy Hersh- 
berg came from d.c. where 
she practices psychiatry. Jamie 
Robertson came up from 
Philadelphia and his cardi¬ 
ology practice. 
Faculty cardiologist Henry 
Cabin and his wife Laura, 
whose two-year-old was in the 
care of her 20-year-old broth¬ 
er, with regular phone advice 
from Henry, represented the 
New Haven contingent. Yours 
truly is still trying to juggle 
the roles of delayed childbear¬ 
ing mother of a 10- and a 12- 
year-old, and menopause 
maven. Sid Spiesel couldn’t 
make the dinner—but some 
of you may have read in the 
Yale Bulletin and Calendar 
about Sid’s new patented lice 
discovery technique. Now 
that’s practical pediatrics (See 
page 9). 
A few of our classmates 
sent official regrets. Doug Zus- 
man sends his best. He could¬ 
n’t make the last reunion 
because of his triplets, and 
family illnesses kept him from 
voyaging from Galifornia now. 
And cardiologist Eddie 
Atwood had to stay and take 
care of his Stanford students, 
but he sends his best, too. 
Bruce McLucas couldn’t come 
at the last minute because one 
of his LA VIP patients was in 
pre-term labor. 
We all thought about the 
classmates who couldn’t be 
there with us. Buddy Lisker, 
Jim Grabman and Sandy 
Shepherd among them. But 
all present send our best to 
everyone who wasn’t able to 
come—and PJ has saved pho¬ 
tos for the next reunion. 
- Mary Jane Minkin 
1980 
20th Reunion 
A good crowd including 17 
class members and seven 
spouses converged on New 
Haven to celebrate our 20th 
reunion. On Friday evening 
we enjoyed a clambake com¬ 
plete with spectacular thun¬ 
derstorm. On Saturday night 
we gathered at Zinc, a trendy 
New Yorkish eatery on the 
New Haven Green. At the 
dinner much backslapping 
and hugging were seen as rela¬ 
tionships were renewed. Dean 
Kessler even paid a surprise 
visit as he had decided to drop 
in on some of the “younger” 
reunion classes. 
■■■ 
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Traveling farthest was Kim 
Swartz from Portland, Ore., 
where he practices general and 
vascular surgery. Kim and his 
wife, Teresa, have two young 
children, Kyle and Derek. 
Hailing from Houston were 
Alan Schlesinger and his wife, 
Paula Chandler Schlesinger, 
M.D. ’82. Alan is a pediatric 
radiologist at Texas Children’s 
Hospital. Paula is also busy 
both at home with children 
Katie, Jack and Madeline, and 
at work as a pediatrician 
at the Kelsey Seybold Clinic. 
Soon to join Alan in Texas 
will be Eric Nestler and his 
wife Sue, along with David, 
Matthew and Jane. Eric will 
be assuming the chair of the 
Department of Psychiatry at 
UT Southwestern Medical 
Center in Dallas. Mary Hill 
and Robert Wise drove in 
from Rochester, n.y., where 
Mary happily practices family 
medicine with the help of 
her husband, who doubles as 
office manager as well as being 
a massage therapist. Together 
they have four children: 
Heather, Seth, Alex and Joshua. 
Mary says she “missed seeing 
all the people who didn’t come. 
They better come next time!” 
Evangeline Franklin has 
landed in New Orleans, where 
she enjoys ballroom dancing 
and needlepoint as well as 
being network medical direc¬ 
tor for Aetna U.S. Healthcare. 
For those interested in the 
management side of medicine 
she recommends a Web site, 
www.acpe.org, maintained 
by the American College of 
Physician Executives. David 
Gowdy lives in Alpharetta, 
Ga., along with his wife, 
Stephanie. They have two 
children, Brandi and Brienna, 
as well as a young grandchild 
by Brandi, Taylor Haynes. 
David is involved in occupa¬ 
tional medicine with Health 
South, a “rehab” company, as 
well as being medical director 
at a hotel and at a local jail. 
Completing our m.p.h. 
roundup is Donald Moore, 
one of the panelists for “The 
Many Faces of Medicine” (See 
page 68). Donald practices 
family medicine in Brooklyn 
and is also on the clinical fac¬ 
ulty of Weill Medical College 
of Cornell University. Donald 
and wife, Christine, have two 
children, Ashley and Crystal. 
The Northeast/Mid-Atlantic 
contingent included a rash of 
dermatologists. Notably pres¬ 
ent were Jean Bolognia (our 
beloved, honorable dinner 
chairperson) and her husband, 
Dennis Cooper. Dennis 
reports that Jean’s hobby is 
dermatology! Both are on the 
faculty at Yale. Ethan Lerner 
and wife Lisa dropped in from 
Boston. Ethan is on the facul¬ 
ty at Harvard Medical School 
and describes himself as a 
“full-time dad.” Lisa is also 
busy with dermatopathology 
and is an instructor in pathol¬ 
ogy at Harvard Medical School. 
The Lerners have three chil¬ 
dren, Max, Sofia and Larissa. 
Patricia Brown practices gener¬ 
al dermatology, solo in subur¬ 
ban Maryland. When not 
dodging HMOs, she keeps busy 
with church and community 
activities. 
David Adelberg joined us 
from South Dartmouth, 
Mass., where he and his wife, 
Linda, live on the water with 
their two young children, 
Ashley and Jake. David enjoys 
private practice orthopaedics 
and being managing partner 
for his group. Marc Glickstein 
drove in for Saturday dinner 
from South Glastonbury, 
Gonn., where he lives with 
Sylvie and their children Sam 
and Emma. Marc is a partner 
in the Jefferson X-Ray Group 
and is section chief for mri at 
Hartford Hospital. Howard 
Telson came up from the Big 
Apple, where he is a psychia¬ 
trist on the faculty at nyu and 
is involved in “legal, legislative 
and policy stuff.” His life 
partner is also a psychiatrist. 
Finally we were graced by 
the presence of a number of 
folks who have not yet 
escaped New Haven’s warm 
embrace. Larry Young is on 
the medical faculty at Yale in 
cardiovascular medicine. He 
reports it is interesting to be 
near the top end of the clini¬ 
cal chain of command after 
having been, not so long ago, 
in its lower reaches. Larry was 
accompanied by his wife. 
Lynn Tanoue, m.d. ’82, also 
on the faculty at Yale in pul¬ 
monary medicine. They have 
three children, Robert, Maris- 
sa and Grant. Gary and Debo¬ 
rah Dyett Desir live in Wood- 
bridge and are busy with four 
boys, Alexander, Ghristopher, 
Matthew and Carl. Gary is on 
the medical faculty at Yale 
specializing in nephrology. 
Deborah is a rheumatologist 
in private practice. Ann Hoef- 
fer (a.k.a. Henderson) with 
husband Ben Bradburn com¬ 
pleted our dinner group. 
Together they live in New 
Haven, sharing responsibility 
for two adolescent children, 
Charlotte and Sophie. Ann 
enjoys practicing with Guil¬ 
ford Pediatrics while Ben con¬ 
tinues orthopaedic private 
practice in New Haven. And 
so until the 25th. Be there or 
be square! 
- Patricia C. Brown 
1985 
15th Reunion 
Continuing the trend set at 
the lo-year class reunion, 
avoiding New Haven appears 
to be a class trait. Those few 
of us who did choose to gath¬ 
er enjoyed an evening remi¬ 
niscing about the rest of you. 
Four class members and their 
partners and children spent a 
pleasant evening at JoAnne 
Burger’s house in Wood- 
bridge. 
Sam Goos, committed der¬ 
matologist, arrived at our sun¬ 
ny home armed with enough 
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sunscreen to keep our entire 
graduating class pale and 
healthy. His wife, Sarah Goos, 
and their two children shared 
with us news about their horse 
farm in Concord, Mass. Jay 
Cates, who is practicing 
pathology at Dianon Systems 
in Connecticut, was accompa¬ 
nied by Ruth Schuler. He 
would be happy to read any¬ 
one’s slides for a second opin¬ 
ion and says “I miss you, 
send me your tissue.” This has 
been a year of many changes 
for Barbara Guillette, who 
attended with her husband, 
Curtis Perry, and their two 
boys. Barbara recently merged 
her ENT practice with two 
partners and was thrilled not 
to be carrying a beeper to 
the reunion. Among the few 
members of our class who 
never seemed to manage to 
leave scenic New Haven are 
JoAnne Burger and husband 
Michael Caplan, m.d., ph.d. 
’87. JoAnne continues to 
enjoy her pediatric practice at 
Yale Health Plan and Michael 
proudly reports that he gives 
the defecation lecture in the 
physiology course at ysm. 
Others whom we remem¬ 
bered included Peter Rubin, 
who was married last year to 
Laura Kelly, a dermatologist. 
The wedding was attended by 
Detroit transplant surgeon 
Bob Higgins and Rich Garber, 
a Boston-area pediatrician. 
Sam Goos, who dished the 
“derm dirt,” also shared that 
Victor Hsu, a rheumatology 
researcher, had the good taste 
to marry a fellow dermatolo¬ 
gist. Barbara mentioned 
enjoying Cleveland pediatri¬ 
cian Robert Needleman’s 
columns in Parents magazine. 
A personal communication 
from Julie Danaher, ob/gyn in 
Wyoming, who could not 
attend due to a speaking 
engagement, passed along the 
happy news that Sara Schutz- 
man, Boston pediatrician, 
will be married this summer. 
Michael Gilbert, family practi¬ 
tioner in California, spent the 
weekend driving his daughter 
to take the sats. (Remember 
when Meghan was born in 
our third year?) Jay and Ruth 
reported that they enjoyed a 
lovely weekend with Robby 
Aronowitz and Jane Mathies- 
son. Robby continues to write 
about the history of medicine 
and Jane practices psychiatry 
in Philadelphia. Personal com¬ 
munications reveal that Brian 
Lombardo continues to be 
busy with his family and his 
family practice in pastoral Ver¬ 
mont and Mary Nakamura 
continues to enjoy her two 
children and rheumatology 
practice in San Francisco. We 
still have lots of leftover food 
and hope to share it with a 
larger group of returnees at 
the 20th. 
- JoAnne Burger 
1990 
loth Reunion 
The Class of 1990 was well 
represented at the reunion and 
benefited from a sunny New 
Haven weekend. Susan Ander¬ 
son and Kristen Hepler were 
applauded by the group (or 
traveling from San Francisco. 
Susan is at Stanford University 
and is actively involved in a 
tropical medicine Web site. 
Kristen is an ent in the Bay 
area and is married to an 
investment banker. 
Nancy Angoff, Yale’s associ¬ 
ate dean for student affairs, 
helped host our class dinner 
on Saturday evening at the 
Graduate Club. Will Andrews, 
married with a son, is practic¬ 
ing internal medicine near 
Boston. Chander Sarny is mar¬ 
ried and is a retinal surgeon in 
Ocala, Fla. Vinita Sehgal is a 
nephrologist in New York 
City and is married to Elan 
Louis, M.D. ’89, and has two 
boys. Sam Colin is married 
and is busy managing a health 
care investment fund on Wall 
Street. Jonathan Foster, mar¬ 
ried with three children, is an 
ob/gyn in Waterbury; he has 
kindly offered to host a wel¬ 
come party at the 15th year 
reunion around his new pool. 
Alan Hilibrand is a spinal 
surgeon at Thomas Jefferson 
Hospital in Philadelphia and 
is married to Gittel (Yale Col¬ 
lege ’90) with a daughter. Lau- 
rie-Ann Nessralla, an anesthe¬ 
siologist who recently moved 
back to Connecticut, is mar¬ 
ried with one daughter. Bever¬ 
ly Stoute is a psychiatrist in 
New York City; she and her 
husband are expecting their 
first child this summer. Bruce 
Baker remains at Yale (sur¬ 
prise!) as a faculty member in 
the Department of Psychiatry. 
As for myself, I am married 
with three children and prac¬ 
tice pharmaceutical medicine 
and dermatology. 
Dean Kessler and his wife 
toasted the class members pri¬ 
or to dinner at the Graduate 
Club. Dr. Nicholas Spinelli 
and Connie Tolliver were also 
present. Dean Gifford told us 
of his “retirement” and his 
plans to teach science to New 
Haven youth and also consult 
for an Internet medical educa¬ 
tion company. Finally, for 
those of us who left Yale in 
’91 or ’92, Sharon McManus, 
director of alumni affairs, 
kindly reminds us to check 
our class status to ensure that 
we are affiliated with the class 
of 1990. See you at the 15th 
reunion. 
- Ercem S. Atillasoy 
1995 
5th Reunion 
For all those who missed the 
reunion, definitely make plans 
for the loth! It is sure to be 
even more fun than the fifth. 
We enjoyed all of the planned 
events, as well as an evening 
at Mory’s that brought back 
many memories. 
i 
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The reunion weekend 
brought a record turnout of 
fifth-year alumni! Many local 
alums were spotted, including 
Jon Driscoll, who is complet¬ 
ing his ortho residency at 
YNHH and preparing for a 
sports fellowship at New Eng¬ 
land Baptist, and Chris Wahl, 
who is about to begin a chief 
year in ortho at ynhh. (They 
both missed the great dinner 
Saturday night due to their 
department party.) Sung Lee 
made a brief appearance at 
the clambake wearing scrubs 
as proof of his continued sta¬ 
tus as a neurosurgery resident. 
Marty Mayse was at the 
Friday events and reports that 
when he finishes his pul¬ 
monary/critical care fellow¬ 
ship at YNHH, he plans to 
abandon clinical medicine for 
the rewards of industry. Amy 
Knorr tells us she is finishing 
up her neurophysiology fel¬ 
lowship and will be joining a 
private practice in Norwalk. 
Pla All-Salaam joined us at the 
dinner Saturday and appeared 
delighted to inform us that 
she has only one year of plas¬ 
tic surgery training remaining. 
Dara Thomas is still living in 
New Haven and has been prac¬ 
ticing in a pediatrics clinic in 
Bridgeport since completing 
residency at Yale. Steve Craig 
has also been in practice in 
pediatrics for two years but has 
hung his shingle in Hartford. 
Others made a journey to 
New Haven. The greatest dis¬ 
tance traveler was Christine 
Brozowski, who flew in from 
California. She has been in 
general practice in Berkeley 
for over two years after com¬ 
pleting only a total of 13 
months of residency (and 
most of an mba) since gradua¬ 
tion. Tim Kinkaid drove north 
from the Carolina coast where 
he is already making plans to 
move after finishing the 
remaining year of his ortho 
residency at Duke. Dierdre 
Reynolds came in from New 
York, where she is practicing 
psychiatry at Mt. Sinai. Nick 
Schwartz also came from Mt. 
Sinai, where he is an er 
attending and doing acute 
pain research. Farzad 
Mostashari won the “coolest 
job” award as an epidemiolo¬ 
gist for the CDC investigating 
outbreaks in New York City. 
He and his wife are expecting 
a baby in July. Jake Roth 
drove down from Boston, 
where he is completing his 
psychiatry internship at Har¬ 
vard after working as a con¬ 
sultant for some time. Unfor¬ 
tunately, his wife Emily 
(Rosenberg) Roth was unable 
to come due to commitments 
with her pediatrics fellowship. 
Jake was, however, proud to 
announce the impending 
arrival of their first child this 
summer. The pediatric waters 
in Boston must be fertile, 
because Barbara (Garcia) Pena 
and husband Tino Pena, m.d. 
’94, are also expecting a baby 
later this year. Barbara is com¬ 
pleting her peds er fellowship 
and will be staying on at 
Boston Children’s as a chief 
resident this year. Larry 
Solomon flew in from Chica¬ 
go, where he is a cardiology 
fellow. Eric Gomes made the 
trip from Lawrenceville, n.j., 
where he has had a private 
internal medicine practice 
since finishing residency at 
Yale. My husband Brian 
Adams and I enjoyed the 
weekend getaway from 
Cincinnati, where Brian is 
director of dermatology at the 
VA and I am about to begin a 
research fellowship in pedi¬ 
atric rehabilitation medicine. 
The reunion gave us a 
chance to gather reports about 
othet classmates unable to 
attend. Jeff Algazy couldn’t 
return due to commitments in 
California, where he is a 
Robert Wood Johnson scholar. 
New Haven locals who were 
missed include Henry Hsia (a 
plastic surgery resident), Eliza¬ 
beth Claus (in neurosurgery), 
Eric Hughes (new daddy and 
relatively new resident!) and 
Lynn Sullivan (a three-time 
mom and chief resident in 
internal medicine, about to 
join the Yale faculty). In 
Boston, Alice Chang just 
switched gears from medicine 
to an “Internet job” at Har¬ 
vard while Cathleen (Green¬ 
berg) London is in family 
practice in Brookline. Tigist 
Hailu finished internal medi¬ 
cine at Penn and is about to 
start a cardiology fellowship at 
Cornell. Nora Canty finished 
her radiology residency and is 
in practice in Oakland, Calif 
Perhaps she runs into Becky 
Shoemaker-Zorovic, currently 
an endoctinology fellow at 
Stanford. Rumor has it that 
Todd Alamin and Artis (Tague) 
Montague will be relocating 
to San Francisco from San 
Diego this summer, bringing 
along children Healey and 
Spencer. Ben and Erin (Seal- 
ley) LeBlanc finished residency 
at Stanfotd and relocated to 
Portland, Ore. 
We would love to report 
news from anyone else out 
there, so drop me a line at 
jvargusadams@pol.net. Please 
also send me your e-mail 
addresses, because Dr. Gifford 
(who was at the teunion and 
marvelously hasn’t changed an 
iota) is planning a study com¬ 
paring our career goals as first- 
year students with our current 
occupations. I’ll forward a 
class list of e-mail addresses to 
him. 
- Jilda Vargus-Adams 
Photographs by Peter Casolino 
and John Curtis 
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In memoriam 
In June the Columbia Hospi¬ 
tal for Women in Washington, 
D.C., dedicated The Michael 
A. Puzak, M.D., Continence 
Center to honor the late urol¬ 
ogist and genito-urinary sur¬ 
geon who graduated from the 
medical school in 1942. The 
Continence Center, the hrst 
of its kind in the Washington, 
D.C., area, was founded in 
1986 by one of Puzak’s former 
students at Georgetown Uni¬ 
versity Medical School. Under 
a grant from Puzak’s family, 
the expanded services of the 
center will emphasize aware¬ 
ness of sports-related inconti¬ 
nence and the newest treat¬ 
ment for pregnancy-related 
and older-age incontinence. 
Michael Puzak 
James M. Bunce, m.d. ’42, 
died of cancer on Aug. 30. He 
was 82. 
Born in Hartford, Conn., 
Bunce graduated from the 
Loomis School. After under¬ 
graduate and medical studies 
at Yale, he completed his 
internship and residency train¬ 
ing at Johns Hopkins Univer¬ 
sity Hospital and Hartford 
Hospital. For his service in the 
Army Medical Corps in 
Europe during World War II 
he received the Bronze Star for 
Valor. 
Bunce, a West Hartford 
resident, practiced obstetrics 
and gynecology at Hartford 
Hospital for 32 years. He was a 
fellow of the American Col¬ 
lege of Obstetrics and Gyne¬ 
cology and a supporter of the 
anatomical gift program of the 
University of Connecticut 
School of Medicine. 
Sanford Roy Dietrich, m.d. ’44, 
of Santa Barbara, Calif., died 
Aug. 10 at home. He was 80. 
Born in Kansas City, Mo., 
Dietrich attended the Univer¬ 
sity of Kansas for two years 
before transferring to Yale to 
complete his bachelor’s and 
medical degrees. He was 
enrolled in the Navy v-12 Col¬ 
lege Program at Yale and 
served as a physician during 
World War II with the rank of 
lieutenant junior grade. He 
then completed his residency 
at Barnes Hospital in St. 
Louis, Mo. 
Dietrich practiced plastic 
and reconstructive surgery in 
California until his retirement. 
He also served as president of 
the Santa Barbara County 
Medical Society. 
John L. Ooppman, m.d. ’53, 
died of cancer Aug. 21 at the 
National Institutes of Health 
(nih) Clinical Center in 
Bethesda, Md., where he 
served as chief of diagnostic 
radiology for 25 years. 
A resident of Potomac, 
Md., Doppman graduated 
from Holy Cross College. 
After he received his medical 
degree from Yale, he com¬ 
pleted his internship at Mercy 
Hospital in Springfield, Mass. 
He served in the Navy from 
1954 to 1957 and went on to 
residency training in radiology 
at the Hospital of St. Raphael 
in New Haven. Doppman 
worked in research at the Post¬ 
graduate Medical School at 
Hammersmith Hospital in 
London and at the Karolinska 
Institute in Stockholm, before 
joining the nih as deputy 
chief of the diagnostic radiol¬ 
ogy department in 1964. 
During his career, Dopp¬ 
man developed and performed 
various semi-surgical radio- 
logic procedures, including 
angiography. He also did 
research on vascular malfor¬ 
mations of the spinal cord 
and developed ways to visual¬ 
ize and treat them. His later 
research concentrated on 
endocrinology and techniques 
for locating ectopic or elusive 
glandular tumors. 
James M. Ciffin, m.d. ’61, 
retired surgeon and author, 
died of leukemia on May 12 at 
his home in Ridgway, Colo. 
He was 64. 
Born in New York City, 
Giffin graduated from 
Amherst College, received his 
medical degree from Yale and 
trained in surgery at Barnes 
Hospital in St. Louis, Mo. He 
went on to become the chief 
of surgery at Beach Army 
Hospital in Mineral Wells, 
Texas, and at the 45th must 
Hospital at Tay Ninh, Viet¬ 
nam. He was awarded a 
Bronze Star. 
Giffin practiced surgery for 
It years in Springfield, Mo., 
before moving to Colorado in 
1978 to serve on the staff of 
Delta County Memorial and 
Montrose Memorial hospitals. 
In 1991, during Operation 
Desert Storm, he was called to 
active duty and served at the 
Fitzsimmons Army Hospital 
in Denver, the Fox Army Hos¬ 
pital in Huntsville, Ala., the 
24th Evac Hospital in Seoul, 
Korea, and Darnall Army 
Hospital in Fort Hood, Texas. 
Giffin retired in 1995 with the 
rank of lieutenant colonel and 
moved to Ridgway. 
Giffin wrote a book on the 
Great Pyrenees breed of dog, 
which he raised and showed, 
and wrote several books on the 
care of dogs, cats and horses. 
Malcolm Hill, M.D. ’57, of 
New York City, died of cancer 
July 16. He was 70. 
Hill was a graduate of 
Swarthmore College and 
received his medical degree 
from Yale. He was an associate 
clinical professor of psychiatry 
at Weill Cornell Medical 
College and was known by 
colleagues as a gifted and sen¬ 
sitive therapist and teacher. 
T. Dennie Pratt, m.d. ’37, died 
June 8 in Bar Harbor, Maine. 
He was 88. 
Pratt, born in Brookline, 
Mass., graduated from Phillips 
Andover Academy in 1930 and 
from Harvard University in 
1934. He received his medical 
degree from Yale in 1937 and 
completed his internship and 
residency training at Boston 
Hospital and the Mallory 
Institute of Pathology. 
Pratt was a surgical fellow 
at the Massachusetts General 
Hospital and later had a prac¬ 
tice in New York City. He 
served in the Army Medical 
Corps in World War II. After 
his retirement in 1977 at age 
65 he enjoyed sailing, garden¬ 
ing and tennis. 
Roy C. Robison, m.d. ’36, 
died Sept. 12 at his home in 
Tucson, Ariz. He was 91. 
After serving in the Army 
Medical Corps during World 
War II, Robison opened a 
practice of obstetrics and 
gynecology in Stamford, 
Conn. He also served as vice 
president of St. Joseph’s Hos¬ 
pital in Stamford. Robison 
lived in Noroton, Conn., until 
his retirement and enjoyed 
sailing, skin diving and tennis 
and was a member of the local 
yacht club. He also enjoyed 
music, especially jazz. 
Nathan E. Ross, m.d. ’28, of 
Hollywood, Fla., died April 
23. He was 95. 
Ross, who graduated from 
Yale College in 1925, spent 
much of his career as a family 
practitioner in Beechhurst, n.y., 
with his wife Hilda at his side as 
his office manager. During 
World War II, Ross served in 
Italy and North Africa. In 1946 
he returned to New York to 
practice in Astoria. At age 55, he 
left his busy family practice to 
receive residency training in 
anesthesiology, which he prac¬ 
ticed until his retirement to 
Florida in 1975. 
Robert Treat Rowe, m.d. ’40, 
an Ohio native, died April 2. 
He was 86. 
Rowe graduated from Har¬ 
vard University in 1935 and, 
after receiving his medical 
degree from Yale, served his 
internship and residency at 
Akron City and Akron Chil¬ 
dren’s hospitals. He was coro¬ 
ner of Medina County, Ohio, 
from 1941 to 1945, then moved 
to Grosse Pointe Woods, 
Mich., to practice pediatrics. 
He was an attending at Henry 
Ford Hospital and the Her¬ 
man Kiefer Hospital for Infec¬ 
tious Diseases. He practiced in 
Akron from 1949 until 1952, 
when he joined the u.s. Air 
Force as a major, serving at 
Nellis Air Force Base in 
Nevada. In 1954 Rowe 
resumed his career in Akron, 
where, with a colleague, he 
founded The Pediatrics of 
Akron practice. He also held 
the positions of chief of staff at 
the Akron Ghildren’s Hospital 
and clinical associate professor 
emeritus of pediatrics at the 
Northeastern Ohio Universi¬ 
ties of Medicine. He retired in 
1980. 
Douglass Willey Walker, m.d. 
’39, died Aug. 20 at the Penob¬ 
scot Bay Medical Genter in 
Rockport, Maine He was 87. 
Walker received his under¬ 
graduate degree from Bowdoin 
Gollege in 1935 before begin¬ 
ning his medical studies and, 
later, a residency at Yale. His 
residency was interrupted dur¬ 
ing World War II, when he 
joined the Army Medical 
Gorps and was assigned to the 
preventive medicine division 
of the Surgeon General’s office 
in Washington. He became 
executive officer and received 
the Legion of Merit for his 
performance there. Walker 
returned to Yale for a fellow¬ 
ship in pediatrics and then 
joined the Laconia Glinic in 
New Hampshire for 17 years. 
He also worked in the allergy 
department at The Ghildren’s 
Hospital Medical Genter in 
Boston. 
In 1963 he was named assis¬ 
tant dean for administration 
of the Johns Hopkins Medical 
School in Baltimore and assis¬ 
tant professor of pediatrics. He 
was later promoted to associ¬ 
ate dean. Walker was 
appointed as the Maine Med¬ 
ical Genter’s first medical 
director in 1970 and was 
named vice president of med¬ 
ical affairs in 1975. 
Henry M. Williams, m.d. ’52, 
died Aug. 29 at his home in 
Avon, Gonn. He was 74. 
Williams’ undergraduate 
schooling at Yale was inter¬ 
rupted by World War II, in 
which he served as an 
infantryman in France and 
Germany. A bullet cut short 
his military career and he was 
awarded a Purple Heart. He 
returned to Yale to complete 
his premedical studies, gradu¬ 
ating from Yale Gollege in 
1946, and continued on to the 
medical school. He served his 
internship and residency at 
Hartford Hospital from 1952 
to 1956 and spent a year as a 
special fellow in medical neo¬ 
plasia at Memorial Sloan-Ket- 
tering. 
In 1957 Williams entered 
practice in Hartford as one of 
the first medical oncologists in 
the state of Gonnecticut. 
What followed was a 28-year 
career in the field of medical 
oncology that was finally rec¬ 
ognized as a subspecialty by 
the American Board of Inter¬ 
nal Medicine in 1967. He was 
an assistant clinical professor 
of medicine at Yale from 1963 
to 1986. After retiring in 1986, 
he worked as a medical con¬ 
sultant, area medical director, 
director of medical policy and 
consultant in technology 
assessment at Aetna Life and 
Gasualty until 1996. Williams 
enrolled at the University of 
Hartford in a business/medi- 
cine program in 1997 and 
received an e.m.b.a. degree in 
1999 at the age of 73. 
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Archives 
The case of the CIA and butter clam toxin 
“While much of America is viewing the Senate hearings on 
the activities of the Central Intelligence Agency with some 
dismay,” Yale Medicine reported in its Fall 1975 issue, “J. 
Murdoch Ritchie, ph.d., d.sc., Eugene Higgins Professor of 
Pharmacology, is watching them with considerable concern. 
“The object of Dr. Ritchie’s concern is a supply of the poison, 
saxitoxin, which the agency kept in violation of a Presidential 
order in 1969 to halt the development of biological and chemi¬ 
cal weapons, and to destroy existing stockpiles. The Senate 
Select Committee on Intelligence, chaired by Senator Frank 
Church, learned this summer that a middle-level official of the 
CIA had failed to destroy supplies of saxitoxin and cobra venom. 
“Saxitoxin, which is derived from tissues of butter clams and 
other shellfish, was developed by the cia for various possible 
covert activities. In testimony that seems more likely from a 
James Bond novel than a Senate hearing, one source claimed 
that the agency considered using the poison in suicide pills so 
that u.s. agents could kill themselves if they were caught by 
enemy agents. ... According to Dr. Ritchie, the amount of saxi¬ 
toxin retained by the cia, if properly administered, could kill up 
to 5,000 persons.” 
The article went on to say that Ritchie had asked the agency 
and the Senate Committee to prevent the destruction of the 
shellfish toxin on the ground that it could be “extremely valu¬ 
able for medical research on diseases of the nervous system and 
for our understanding of how the nervous system normally 
works.” 
“The toxin,” he wrote in a letter to Church, “reacts in 
extremely small concentrations with a critical component of the 
nerve membrane, to block conduction in nerves. It can, there¬ 
fore, be used to study the functional integrity of the nervous 
system.” 
Asked about the outcome of 
the case, Ritchie (who contin¬ 
ues to conduct research in the 
Department of Pharmacology 
as the Eugene Higgins Profes¬ 
sor) told the rest of the story 
in a letter to Yale Medicine in 
September. “In the end the 
toxin was not destroyed,” he 
wrote. “At first, it was sug¬ 
gested that I take charge of the 
cia’s saxitoxin, with the idea 
that I would be responsible for 
its appropriate distribution to 
scientists who asked for it. 
However, I realized that there 
would be very many appli¬ 
cants for the toxin, which was 
in somewhat limited supply. 
So I would be forced to ration 
it, or even deny some applica¬ 
tions, and would surely make 
enemies. I therefore declined 
the offer but strongly sug¬ 
gested it be held by the nih, a 
recommendation that was 
indeed accepted. 
“My work did not come up 
with any method of counter¬ 
acting the effects of the poison 
saxitoxin or the development 
of new kinds of anesthetics— 
neither has anyone else’s. It 
did, however, account for the 
main defect in multiple sclero¬ 
sis, which is the inability of 
nerves that have demyelinated 
to conduct nerve impulses.” 
Nerve conduction fails and 
paralysis ensues. 
“Unfortunately, the ulti¬ 
mate cause of the demyelina- 
tion leading to ms remains 
unknown.” 
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LETTERS 
Keep up the good work 
To the Editor: 
Yale Medicine has certainly 
gone upscale. It is quite a 
magazine—and also I suspect 
a great marketing tool. Keep 
up the good work. 
Dwight F. Miller, M.D. yd, 
HS )8 
Waterbary, Conn. 
Visit Yale Medicine 
on the Web 
The content of Yale Medicine 
is available on the Web in 
html and pdf formats. Visit us 
at info.med.yale.edu/ymm 
to view the current issue as 
well as a searchable archive 
dating to 1998. Alumni notes 
will appear on the Web 
starting with this issue. Addi¬ 
tional online content includes 
video excerpts from Anna 
Deavere Smith’s performance 
of Rounding It Out in Harkness 
Auditorium (See page 20). 
No compliments for 
alternative care 
To the Editor: 
I date way back from the class 
of 1942. In my class were 
members Michael Puzak and 
James Bunce, noted on the 
In Memoriam pages of the 
Yale Medicine, that recently 
arrived in my mailbox. 
In the same issue, I read 
ol the growing popularity 
ol unregulated alternative or 
complementary treatments 
(“Use ol alternative medicine 
widespread among mentally 
ill,” Et cetera. Fall 2000 I 
Winter 2001). I would prefer 
to call them unscientific 
or unproven. 
My particular interest in 
retirement has been the expo¬ 
sure of the alternative care 
known as chiropractic. There 
are some 70,000 practicing 
chiropractors, legally called 
doctors, with 4,000 new grad¬ 
uates every year, compared to 
15,000 medical graduates. In 
a survey of medical college 
deans, 27 termed the subluxa¬ 
tion and adjustment theory 
to be false. I witnessed a stu¬ 
dent perform an adjustment 
of the neck and back at one 
chiropractic college, and was 
appalled. I have written a 
book to challenge this treat¬ 
ment titled Chiropractic: The 
Greatest Hoax of the Century? 
Yet the practice flourishes. 
Things were not so, way back 
in my student days of 42. 
Perhaps the time is appro¬ 
priate for Yale and other col¬ 
leges of science to speak out 
on this subject. 
LudmilA. Chotkowski, M.D. 42 
Kensington, Conn. 
Snow falling on Cedar Street 
A wet snow clings to the branches 
of a cedar tree outside Sterling Hall of 
Medicine in late February. 
FROM THE EDITOR 
“I had to fight, I had to advo¬ 
cate for myself to get doctors 
to listen to me.” Page 22 
“The whole idea of longitudi¬ 
nal care struck me as being 
an awfully important one. I 
wanted to have a relationship 
with people.” Page 31 
“In outlying country hospitals, 
the [surgeon’s] pay might be 
a home-cooked meal followed 
by toasts of vodka brought 
to the hospital by the family 
to celebrate a successful 
operation.” Page 38 
Building relationships 
in the classroom and the clinic 
When we chose the lineup of feature stories 
for this issue of Yale Medicine, we didn’t make 
a conscious decision to focus on the doctor- 
patient relationship.True, performer and play¬ 
wright Anna Deavere Smith had made this 
topic the focus of her one-woman show, 
Rounding It Out, for which she interviewed sev¬ 
eral dozen patients, physicians and staff (See 
Cathy Shufro’s story, "A Dramatic Turn,” page 
20). Good communication—between doctor 
and patient, mentor and medical student— 
is also an idea running through John Curtis’ 
portrait of the Wednesday Evening Clinic 
(“Learning for the Long Run,” page 28). But the 
issue’s theme was completed when fourth- 
year medical student Sharon Chekijian filed 
her letter from Armenia (“Adrenaline and 
the Ordinary, in Varying Proportions,” page 34), 
describing the state of health care in her 
family’s ancestral homeland. Her observations, 
gathered over the course of a decade and a 
half-dozen visits to Yerevan, reveal a different 
rhythm for medicine in this ex-Soviet state, 
where doctor and patient may toast the 
success of the operation together and where 
the surgeon’s fee may be paid in livestock 
or potatoes. 
Is the doctor-patient relationship alive 
and well where you practice medicine? What 
do medical students and young physicians 
learn from the profession about listening and 
communicating well? Drop us a line at 
ymm@yale.edu or the address below and 
tell us what you think. 
Michael Fitzsousa 
Editor 
michaeLfitzsousa@yale.edu 
How to reach us 
Yale Medicine welcomes news and commentary. Please send letters 
to the editor and news items to Yale Medicine, P.O. Box 7612, New Haven, 
CT 06519-0612, or via electronic mail to ymm@yale.edu, and include 
a daytime telephone number. Submissions may be edited for length, 
style and content. 
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CHRONICLE 
The cry for less-expensive AIDS drugs 
was heard in the streets of Pretoria, 
right, and in New Haven after Doctors 
Without Borders asked that d4T be 
made available in South Africa at low 
prices. Yale and Bristol-Myers Squibb, 
the drug’s licensee, reached an 
agreement for price and patent relief 
in late March. 
After an uproar, price of 
AIDS drug falls in Africa 
A drug discovered in a Yale 
laboratory made headlines this 
spring in the ongoing debate 
about the provision of AIDS 
medications in the Third 
World. The physicians’ group 
Doctors Without Borders called 
on the University, which 
holds the patent for d4T, and 
Bristol-Myers Squibb (bms), 
which has a license to market 
it, to allow cheaper or generic 
versions to be sold in Africa. At 
a cost of between $10,000 and 
$15,000 a year, antiretroviral 
therapy is out ol the reach of 
most of the 25 million people 
in sub-Saharan Africa who 
have AIDS and the 3.8 million 
who are infected with HIV. 
BMS said in mid-March, 
after discussions with the Uni¬ 
versity, that it would make its 
two AIDS drugs, dqT and ddl, 
available throughout Africa for 
$i per day and allow generic 
versions to be sold as well. 
The issue surfaced when an 
Indian pharmaceutical com¬ 
pany, Cipla, made an offer to 
provide triple-therapy AIDS 
cocktails at $350 per year per 
patient in developing coun¬ 
tries. That package included 
dqT at 5 cents a tablet. Doctors 
Without Borders, however. 
was unwilling to distribute the 
generic drug because of con¬ 
cerns over infringement of 
patent rights in South Africa. 
The humanitarian group 
pressed both the University and 
BMS for a solution, and Yale 
students later joined in calls for 
price relief The discussions 
reached senior levels of the Uni¬ 
versity and BMS, which mod¬ 
ified the license agreement in 
order to make the drug more 
affordable and widely available. 
Although BMS was free to set 
the price of the drug, the com¬ 
pany also sought permission 
from the University to offer 
patent relief in Africa. In 
recent years the drug, known 
generically as stavudine and 
marketed as Zerit, has brought 
Yale about $40 million a year 
in royalty income. 
Joining the voices clamor¬ 
ing for low-cost drugs was 
William Prusoff, PH.D., emeri¬ 
tus professor of pharmacology, 
who with his collaborator, the 
lateTai-Shun Lin, ph.d., dis¬ 
covered the drug’s value as an 
antiviral in 1986. “We weren’t 
doing this to make money. We 
were interested in developing a 
compound that would be a 
benefit to society,” Prusoff said. 
“Topping off ” the Congress Avenue Building 
“It’s one thing as a parent to watch 
your own children grow,” Dean David 
Kessler told the crowd gathered out¬ 
side the Congress Avenue Building on 
March 21,“but I must say, as dean, it is 
quite another to watch this baby 
grow.”The dean thanked city and com¬ 
munity leaders and iron workers, who 
gathered with faculty members, stu¬ 
dents, alumni and project staff as the 
workers lifted the highest piece of 
structural steel in the 4so,ooo-square- 
foot building’s massive frame into 
place. An American flag and an ever¬ 
green tree were welded to the i,ooo- 
pound beam for good luck, and iron 
workers and others signed the beam, 
right, before it shot skyward at the end 
of a crane. All told, 7,000 pieces of steel 
weighing 3,500 tons went into the 
framing, which was completed during 
the course of several exceptionally 
snowy months. “It seemed like the win¬ 
ter didn’t want us to finish this Job,” 
said Otto Del Medico, the superintend¬ 
ent of Iron Workers Local 424. “We 
fought the weather every day.” When 
completed in March 2003, the build¬ 
ing will house disease-oriented 
research programs, greatly expanded 
teaching space, a magnetic reso¬ 
nance center and an animal care 
facility. Kessler’s remarks from the 
“topping off” ceremony and updates 
on the project may be accessed at 
http://info.med.yale.edu/cab. 
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No time to lose 
A high-profile panei criticizes national efforts to fight AIDS/HIV. 
Last year, a committee of i6 
scientists and academics began 
evaluating the nation’s efforts 
to prevent the spread of AIDS 
and HIV. What it found was 
unsettling: a lack of coordina¬ 
tion among federal agencies, 
funding of interventions that 
showed no evidence of success, 
reliance on political rather than 
scientific criteria for funding 
and, perhaps most startling, 
no clear goal for prevention. 
“Despite the fact that we 
know so much about how to 
prevent HIV,” said Michael H. 
Merson, M.D., dean of public 
health and one of two Yale fac¬ 
ulty members on the panel, 
“we can’t get the job done.” 
The Committee on HIV 
Prevention Strategies in the 
United States concluded that 
the nation’s public health sys¬ 
tem needs to set the obvious 
yet previously unstated goal of 
averting as many new HIV 
infections as possible with the 
resources available. Under cur¬ 
rent funding, the committee 
estimated that a reallocation 
of resources could reduce new 
infections by 30 percent. And 
interventions currently denied 
federal funding, such as needle 
exchange programs and com¬ 
prehensive sex education, could 
prevent even more infections. 
“That is probably the most 
important thing to realize,” said 
the other Yale faculty member 
on the committee, Edward H. 
Kaplan, PH.D., a professor of 
both management sciences 
and public health. “You can 
get better results not only by 
increasing the budget, but also 
by changing the allocation.” 
The committee was estab¬ 
lished by the Institute of Med¬ 
icine at the request of the Cen¬ 
ters for Disease Control and 
Prevention, which wanted to 
have a prevention framework 
in place before the 2000 presi¬ 
dential election, Merson said. 
One of the national effort’s 
main failures, the report said, is 
in the allocation of HIV preven¬ 
tion resources. Money for pre¬ 
vention follows reports of AIDS 
cases, but because HIV incu¬ 
bates for 10 years, this approach 
yields old data. “It rewards peo¬ 
ple for counting cases of aids 
instead of preventing HIV 
infections,” Kaplan said. 
The report proposed a six¬ 
pronged prevention strategy. 
Allocation of resources should 
target not reported AIDS cases, 
but estimates of new HIV in¬ 
fections through anonymous 
testing of “sentinel groups,” 
such as drug users in treatment. 
Evaluations of existing pro¬ 
grams should determine 
whether interventions work. 
HIV prevention counseling 
should reinforce prevention 
messages among those already 
infected. Research and inter¬ 
ventions should strengthen 
local capacity to implement 
effective programs. Federal 
agencies should continue to 
invest in HIV prevention. Final¬ 
ly, the committee recommend¬ 
ed overcoming social barriers to 
HIV prevention, such as oppo¬ 
sition to syringe exchanges, 
comprehensive sex education 
and condom availability in 
schools, and facilitation of pre¬ 
vention efforts in prisons. 
“This is the greatest public 
health crisis the world has 
faced since the bubonic plague 
pandemic of the Middle Ages,” 
Merson said, adding that years 
from now people will ask a 
simple question: “Idow did a 
country that had all the know¬ 
ledge it needed about the virus 
and the resources required to 
prevent its spread allow such a 
tragedy to occur, killing so 
many people?” 
“Despite the fact that we know so 
much about how to prevent HIV infec¬ 
tion, we can’t get the job done,” said 
public health Dean Michael Merson, 
top, one of two Yale faculty members 
on a committee that examined the 
nation’s AIDS prevention strategy. A 
reallocation of existing resources, the 
panel found, could reduce the number 
of new infections by 30 percent.“You 
can get better results not only by 
increasing the budget, but by changing 
the allocation,” said Edward Kaplan, 
above, the other faculty member on 
the committee. 
FIRST AFRICAN-AMERICAN GRAD¬ 
UATE HONORED The first African- 
American to graduate from the 
School of Medicine has been hon¬ 
ored with a new scholarship, 
which once fully endowed will 
help recruit and support outstand¬ 
ing students from underrepre¬ 
sented groups entering public 
health. After his graduation in 
1857, Cortlandt Van Rensselaer 
Creed, M.D., became a prominent 
New Haven physician and a Civil 
War surgeon. He was consulted in 
the shooting of President Garfield 
in 1881, and his forensic work in 
the investigation of a New Haven 
woman’s murder played a part in 
Virginia A. McConnell’s novel 
about Victorian New Haven, 
Arsenic under the Elms. The Creed/ 
Patton/Steele Scholarship Cam¬ 
paign was initiated with gifts by 
alumnus Robert E. Steele, M.P.H. 
’71, Ph.D. ’75, and also honors 
Creed historian Curtis L. Patton, 
Ph.D., professor of epidemiology 
(microbiology) and public health. 
To date, $64,000 of the $100,000 
fund goal has been raised. 
what’s in a name? Physicians 
at medical schools around the 
country usually provide their serv¬ 
ices through umbrella faculty prac¬ 
tice organizations that streamline 
administration, financial services, 
compliance programs and practice 
standards. Yale is no exception. 
But in recent years the Yale Facul¬ 
ty Practice, which represents the 
medical school’s 650 full-time 
clinical practitioners, has evolved 
into a more complex organization 
in order to accommodate the 
changing landscape of academic 
medicine. Reflecting this, the prac¬ 
tice announced in March that it is 
changing its name to the Yale 
Medical Croup. According to 
Director David J. Leffell, M.D., HS 
’86, the school’s senior associate 
dean for clinical activity, “the words 
‘faculty practice’ suggested to 
some people that care was deliv¬ 
ered by interns and residents who 
were practicing to become physi¬ 
cians. The new name conveys a 
clear message about our academic 
medical group and the clinical 
care we provide.” 
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Pioneer in tobacco research 
receives first Winslow Medal 
Sir Richard Doll, 
“the epidemiologist’s 
epidemiologist.” 
Last fall when the World Health 
Organization began negotiat¬ 
ing a new global treaty aimed 
at curbing tobacco use, partic¬ 
ularly among young people, 
Sir Richard Doll, M.D., D.SCI., 
looked on with a great deal 
of satislaction. 
In 1950, Doll published the 
first convincing evidence that 
smoking was the cause ol lung 
cancer. This was during an 
era when a physician might try 
to calm a patient’s nerves by 
offering a cigarette. Doll, a 
smoker at the time, had specu¬ 
lated that rising lung cancer 
rates might have to do with the 
increase in the number of cars 
on the road. Through pain¬ 
staking epidemiological work, 
however, he and his colleague 
Sir Austin Bradford Hill 
found and documented the 
link to tobacco. 
This and Doll’s lifelong con¬ 
tributions to epidemiology and 
public health — including the 
In 1950, Doll published the 
first convincing evidence 
that smoking was the cause 
of lung cancer.This was 
during an era when a 
physician might try to calm 
a patient’s nerves by 
offering a cigarette. 
understanding of peptic ulcer 
disease, the health effects of oral 
contraceptives and the role ion¬ 
izing radiation plays in causing 
leukemia—prompted the Yale 
University School of Public 
Health to make Doll the first 
recipient of the C-E.A. Wins¬ 
low Medal in mid-October. 
The medal is given in honor 
of Charles-Edward Amory 
Winslow, who established Yale’s 
Department of Public Health, 
as it was known when it was 
founded in 1915, and is regarded 
by many in the United States 
as the founder of the modern 
discipline of public health. Dur¬ 
ing his tenure at Yale, Winslow 
expanded the definition of pub¬ 
lic health from the narrow 
confines of public hygiene to 
include the prevention and 
control of heart disease, can¬ 
cer, stroke, mental illness and 
diseases associated with pover¬ 
ty. According to Dean Michael 
H. Merson, m.d., many im¬ 
portant changes occurred dur¬ 
ing Winslow’s tenure. Bacteriol¬ 
ogy evolved into microbiology 
to include parasitology and 
virology, and public health 
experts began to recognize the 
social aspects of sickness. 
Merson said Doll was 
selected as the first recipient of 
the medal because he is the 
“foremost epidemiologist of 
the second half of the 20th 
century.” Doll’s papers, which 
are “classics because of the 
rigor in their study design, the 
elegance of their analysis, and 
the clarity of their reporting,” 
established his reputation as 
the “epidemiologist’s epidemi¬ 
ologist,” Merson said. 
During the course of his 
career, Doll refrained from 
speaking out against tobacco 
companies because, as he said 
in an interview, “my job was to 
do the research and make evi¬ 
dence. ... The active research 
worker has to disassociate him¬ 
self from the steps that are taken 
as a result of his research.” But 
now that he is no longer 
actively researching the tobac¬ 
co issue, he is happy to give his 
opinion on the continued 
efforts of those in the tobacco 
industry who market their 
products to youth. 
“It’s like selling heroin,” he 
said. “One happens to be legal 
and the other isn’t, but they 
are both equally morally evil. I 
don’t object to the manufacture 
of it. We’re not going to stop 
that overnight. What I object 
to is its promotion, encourag¬ 
ing people to use it.” 
Doll, who received his 
medical degree in 1937 and his 
doctor of science in 1958 
from the University of Eondon, 
considers his work on tobacco 
to be his greatest professional 
accomplishment, formerly 
the director of the United 
Kingdom Medical Research 
Council’s Statistical Unit, Doll 
was appointed the Regius Pro¬ 
fessor of Medicine at the Uni¬ 
versity of Oxford in 1969. At 
Oxford he also directed the 
Cancer Epidemiology and Clin¬ 
ical Trials Unit, and has con¬ 
tinued to work with the unit 
since his retirement as a pro¬ 
fessor in 1983. 
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Managing complex 
data about the brain 
In recent years, the state of 
knowledge about the human 
brain—whether at the level of 
molecules, cells, or entire signal¬ 
ing pathways—has increased so 
much that it has given rise to a 
whole new field of study. The 
science of neuroinformatics 
looks for ways to sort and store 
these floods of data that will 
keep them widely accessible, 
open to interaction with other 
data and amenable to continu¬ 
al revisions and updates. A big 
step forward took place in 
October, when the NiH-sup- 
ported Human Brain Project 
awarded a $4.6 million grant 
to the School of Medicine for 
the establishment of a multi¬ 
purpose, neuronal database on 
the World Wide Web. 
The four-year effort of 
developing the site, known as 
SenseLab (senselab.med.yale. 
edu), is headed by Gordon M. 
Shepherd, M.D., D.PHIL., pro¬ 
fessor of neurobiology, along 
with colleagues Perry L. Miller, 
M.D., PH.D., professor of anes¬ 
thesiology and director of the 
Yale Center for Medical Infor¬ 
matics, and Michael Hines, 
PH.D., research scientist in the 
departments of Neurology and 
Computer Science. “The pur¬ 
pose of the site is to support re¬ 
search on the integrative actions 
of neurons and circuits, in the 
same way that the Human Ge¬ 
nome Project has so effectively 
supported research on genes 
and proteins,” said Shepherd. 
Within this Web site, users 
can work with data from each 
of SenseLab’s five databases 
interactively. The databases 
focus on neuronal models 
(including models that can be 
manipulated onscreen), mem¬ 
brane properties of neurons, 
neurotransmitter receptors and 
ion channels, olfactory genes 
and their proteins, and odor 
"The purpose of the site 
is to support research 
on the integrative actions 
of neurons and circuits, 
in the same way that 
the Human Genome 
Project has so effectively 
supported research 
on genes and proteins.” 
— SenseLab Director Gordon Shepherd 
molecules. In addition, users 
may search the databases by 
neuron or category of neuron, 
as well as by neurotransmitter, 
receptor or electrical current. 
Efforts are now under way to 
enhance the site with links to 
brain atlases on the Web and 
to other databases, such as 
archives of brain images and of 
the anatomy of different types 
of neurons. The Yale scientists 
are also developing more effec¬ 
tive ways to add data from elec¬ 
tronically published journal 
articles into the SenseLab data¬ 
bases by means of automatic 
search tools. In Shepherd’s 
view, “It’s an exciting time to be 
in on the creation of a new field 
that will be crucial to future 
research in neuroscience.” 
PARENTAL PROSPECTS A national 
survey of 3,000 adults, one-third 
of them parents of young chil¬ 
dren, found a surprising lack of 
understanding about basic princi¬ 
ples of child development. Accord¬ 
ing to the survey, many parents 
spank their children although 
they know it doesn’t work and 
expect a 15-month-old to share, 
even though that doesn’t happen 
until children are at least two. 
“Parents seem to think develop¬ 
ment is some sort of race. It’s a 
dance, not a race,” says Kyle D. 
Pruett, M.D., a clinical professor at 
the Child Study Center and past 
president of Zero to Three, the 
child development advocacy and 
expertise organization that con¬ 
ducted the survey. One finding he 
found particularly disturbing was 
“the lack of understanding adults 
have about the enormously active 
absorption abilities of the very 
young within the first months of 
life, both of the good and the bad 
in their surrounding environment.” 
CAFFEINE STUDY QUELLS 
TEMPEST IN A COFFEEPOT The 
caffeine in over-the-counter pain 
relievers won’t get you hooked, 
according to a review of the litera¬ 
ture by an international commit¬ 
tee of scientists chaired by Alvan 
R. Feinstein, M.D., HS ’54, Sterling 
Professor of Medicine and Epi¬ 
demiology. Fears percolating in 
Europe that caffeine in analgesics 
such as aspirin and acetaminophen 
might lead to dependency had 
spurred groups in Germany, Aus¬ 
tria and Switzerland to seek pro¬ 
tective regulations. Federal drug 
authorities in the three countries, 
along with the pharmaceutical 
industry, assembled the commit¬ 
tee, which reported its findings in 
the November issue of Clinical 
Pharmacology and Therapeutics. 
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Yale scientists can now visualize the 
previously unviewable with upgraded 
imaging facilities in the Sterling Hall of 
Medicine. At an open house in January, 
Frederick Sigworth explained the use 
of a new electron cryomicroscope, 
which can produce images such as the 
one below of gap junction membrane 
channels. These channels connect adja¬ 
cent cells and allow the exchange of 
ions and signaling molecules. Using 
electron crystallography, one of four 
principal approaches supported by the 
new electron cryomicroscopy facility, 
Vinzenz Unger calculated this image, 
the first to show the arrangement of 
membrane-spanning alpha helices on 
one side of the channel. 
New facility brings cell imaging 
down to the molecule 
Until March of this year, when¬ 
ever Frederick]. Sigworth, 
PH.D., needed electron cryo¬ 
microscopy to view the mem¬ 
brane proteins he studies, he 
sent a graduate student on the 
train to New York with a ther¬ 
mos that maintained samples 
in liquid nitrogen at minus 
200 degrees Celsius. Now Sig¬ 
worth, a professor ol cellular 
and molecular physiology, need 
go no further than the lower 
level of Sterling Hall of Medi¬ 
cine. There, in newly renovat¬ 
ed space, is a cluster of core 
resources that allows scientists 
to apply the latest microimag¬ 
ing techniques to their work. 
The Center for Cell and 
Molecular Imaging and the 
Core Computing Facility for 
Bioinformatics and Image 
Analysis offer electron micro¬ 
scopy, electron cryomicroscopy, 
confocal microscopy and core 
computing facilities for data 
analysis and interpretation. 
“These technologies are too 
complicated and too expensive 
for any one faculty member or 
laboratory to manage on their 
own,” said Carolyn W. Slay- 
man, PH.D., deputy dean for 
academic and scientific affairs. 
“Core facilities offer access to 
specialists and to equipment 
costing anything from hun¬ 
dreds of thousands to millions 
of dollats.” 
The upgraded facilities are 
the result of three years of plan¬ 
ning that began in 1998, when 
Dean David A. Kessler, M.D., 
convened a committee to 
review the medical school’s 
plans for structural biology. 
The committee came to the 
realization that, “more and 
more, state-of-the-art medicine 
is dependent on knowing the 
structure of these molecules,” 
said Sigworth, one of its mem¬ 
bers. The school has since 
recruited faculty members with 
expertise in the new imaging 
technologies, upgraded exist¬ 
ing hardware and purchased 
new equipment, such as addi¬ 
tional electron microscopes, 
confocal microscopes, electron 
cryomicroscopes and a two- 
photon microscope. The new 
microscopes provide a variety 
of imaging possibilities for a 
broad array of specimens at a 
range of different resolutions. 
An open house in late Jan¬ 
uary officially inaugurated the 
new facilities. Vinzenz M. 
Unger, PH.D., assistant profes¬ 
sor of molecular biophysics 
and biochemistry, coordinates 
the electron cryomicroscopy 
laboratory and provides train¬ 
ing for new users. Marc 
Pypaert, PH.D., associate 
research scientist in cell biolo¬ 
gy, provides training and use 
of electron microscopes. 
Michael H. Nathanson, M.D., 
PH.D., associate professor of 
medicine, is in charge of con¬ 
focal microscopy. The bioin¬ 
formatics facility, managed by 
Anne Marie Quinn, M.P.H. 
’00, is a place where scientists 
and students can take data for 
analysis and interpretation or 
search for genomics data on 
the Internet. The next phase of 
the facility is an expanded X- 
ray crystallography laboratory 
at the medical school. 
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To those who gave their bodies 
to medicine, a gesture of gratitude 
As they begin to study medi¬ 
cine, students who aspire to be 
physicians or physician associ¬ 
ates meet their first “patients” 
in the anatomy lab. “These 
patients had a wish,” said Law¬ 
rence Rizzolo, PH.D., professor 
of anatomy, “that a hard-work¬ 
ing, dedicated student would 
take their remains and use them 
to advantage.” The students 
know little about these patients 
at first—no more than their 
age, sex and race. Over the 
course of six months, however, 
the students become intimate¬ 
ly familiar with them as they 
chart the geography of the 
human body. They learn from 
the calluses on their hands, the 
scars from prior surgeries, tat¬ 
toos on their skin and the 
signs of disease and repair they 
may find inside. 
On Feb. 28, students and 
faculty held a Service of Grati¬ 
tude in the Historical Library 
to thank the donors for rheir 
gift to science. During most of 
the 15 years students have or¬ 
ganized the service, it was 
styled, in the words of anato¬ 
my professor William Stewart, 
PH.D., on a Quaker meeting. 
People gathered and offered 
their thoughts on their first 
patients. About five years ago 
students decided to present a 
more formal program, Stewart 
said. The 75-minute ceremony 
this winter included songs and 
poems as well as remarks by 
students. Medical student 
Kavita Mariwalla tried to 
imagine her patient’s personal 
life in two poems she wrote. 
“When I examine your heart 
as a structure,” she said, “I will 
remember that you kept 
secrets in it.” 
The service, Rizzolo said, 
allows students to express the 
frustrations, angst and other 
emotions that come with the 
experience of exploring a 
cadaver. “It is really their first 
experience with a patient, even 
though the patient is dead,” he 
said. “It raises a lot of thoughts 
about their own mortality and 
their lives as clinicians.” 
Each year, when the anato¬ 
my class ends, the bodies are 
cremated. About every five 
years, when ashes have accu¬ 
mulated, they are interred in a 
common grave at Evergreen 
Cemetery in New Haven. This 
year, medical students plan to 
inscribe headstones for each of 
the five common graves that 
hold the remains of the bodies. 
They learn from 
the calluses 
on their hands, 
the scars from 
prior surgeries, 
tattoos on their 
skin and the 
signs of disease 
and repair they 
may find inside. 
15 YEARS LATER, A SURPRISE 
FROM CHERNOBYL During the 
1995-1996 academic year. Jack 
van Hoff, M.D., HS ’84, associate 
professor of pediatric oncology, 
took a sabbatical leave from the 
School of Medicine to coordinate 
pediatric data for a cancer registry 
project in Belarus, the former 
Soviet republic.That was where 
the heaviest fallout occurred out¬ 
side of the immediate area sur¬ 
rounding the Chernobyl power 
station following the meltdown of 
one of its nuclear reactors 15 years 
ago this spring. Along with Clini¬ 
cal Professor of Medicine Nicholas 
Dainiak, M.D., van Hoff has since 
worked with the international 
Consortium for Research on the 
Health Effects of Radiation to 
study childhood leukemia in the 
region. The results have been sur¬ 
prising. "While the social effects 
on people within the area have 
been very significant,” says van 
Hoff,"the physical impact of radia¬ 
tion exposure has been small. 
There has been a remarkable 
increase in rates of thyroid cancer 
for individuals exposed as chil¬ 
dren. However, there has been no 
detectable effect on the rates of 
other cancers to date.” 
RACE NOT A FACTOR Race did not 
affect the quality of psychiatric 
care or clinical outcomes in a 
study of white and African-Ameri¬ 
can patients who were homeless 
and mentally ill.The study, report¬ 
ed in the October issue of Psychi¬ 
atric Services, also showed that 
the race of case managers made 
no difference, said author Robert 
A. Rosenheck, M.D., HS ’77, profes¬ 
sor of psychiatry and public health. 
The findings depart from those of 
other studies showing that non¬ 
whites may have less access to 
medical care or poorer outcomes 
than white patients, "it is difficult 
to generalize from these findings to 
other areas of health care,” Rosen¬ 
heck said. "The kinds of people who 
work with the homeless are gener¬ 
ally those who have a special com¬ 
mitment to fairness and social jus¬ 
tice, so these results don’t 
necessarily translate elsewhere.” 
Ilene Wong, a first-year medical stu¬ 
dent, and Meredith Blodget, a student 
in the Physician Associate Program, lis¬ 
tened as their anatomy classmates 
paid homage in February to the donors 
who made possible their first insights 
into the workings of the human body. 
"From the start,” Wong read from her 
essay. Remembering Tony, “our teacher 
impressed upon us that anatomy is 
about ways of seeing. Thank you, Tony, 
for allowing me to see yourself, and 
myself reflected.” 
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Most patients believe that angio¬ 
plasty can prevent heart attacks 
and prolong their lives, but physi¬ 
cians need to do a better job of 
informing them of the risks and 
benefits, according to a Yale study. 
It can relieve chest pain, 
but there is no definite 
evidence to date that 
elective angioplasty will 
lower the risk of a future 
heart attack. 
Patients underestimate 
risks, overestimate benefits 
of elective angioplasty 
When it comes to electing to 
undergo angioplasty, many 
patients believe that the proce¬ 
dure to open up clogged blood 
vessels can prevent heart 
attacks and prolong their lives 
without any significant danger. 
According to Yale investigators, 
this is a misperception and 
patients need a better under¬ 
standing of the potential risks 
and benefits from their health 
care providers well before they 
undergo the procedure. 
Angioplasty is an invasive 
procedure in which a balloon 
is inflated inside a blood ves¬ 
sel, most often a coronary 
artery, to flatten any plaque 
that blocks flow through the 
vessel. A metal device called a 
stent is often inserted to help 
keep the artery open. It can 
relieve chest pain, but there is 
no definite evidence to date 
that it will lower the risk of a 
future heart attack. Moreover, 
angioplasty itself poses risks of 
inducing a heart attack or 
stroke, as well as hemorrhage 
and infection. Eric Holmboe, 
M.D., assistant professor of 
medicine, and his colleagues 
interviewed 52 patients, ages 39 
to 87, on the eve of the proce¬ 
dure about their views of the 
potential benefits and risks. 
Three-quarters believed the 
procedure would prevent a 
future heart attack, and almost 
as many thought it would pro¬ 
long their lives. When asked 
about risks, less than hall 
could recall a single risk associ¬ 
ated with angioplasty. Results 
of the study appeared in the 
Journal of Internal Medicine in 
October. 
“Our findings show that 
patients do not have the infor¬ 
mation they need in a format 
they can use to make the best 
decision about angioplasty for 
themselves,” says Holmboe. 
“In my opinion, patients need 
to have a discussion about the 
benefits and risks a good week 
before any elective procedure 
in order to think about the 
risks and benefits.” To achieve 
this goal, Holmboe plans to 
create a multifaceted approach 
to help inform patients and 
answer their questions and to 
set up a program to train 
young physicians to provide 
risk explanations patients can 
understand. 
10 
study knocks popular cough and cold 
medication ingredient off the market 
A study by Yale investigators of 
phenylpropanolamine, or PPA, 
one of the most frequently used 
ingredients in many cough and 
cold medications, found that it 
leads to increased risk of hem¬ 
orrhagic stroke in women. Men 
may also be at a lesser risk. The 
findings provoked the Food 
and Drug Administration (fda) 
in October to advise ending 
the marketing and distribution 
of PPA, prompting manufac¬ 
turers to withdraw many of the 
most popular over-the-counter 
(OTC) products using PPA, such 
as AJka-Seltzer Plus, Dimetapp 
Elixir and Robitussin. 
The study took place at lour 
research centers and was coor¬ 
dinated by the Yale investigators 
under a grant from two manu¬ 
facturers of PPA. The results 
made front-page headlines 
worldwide because of the pop- 
Public health experts decry 
health care conditions that re¬ 
sult in 20 percent of the Amer¬ 
ican population not getting 
routine examinations, preven¬ 
tive inoculations and screen¬ 
ings. They often cite barriers 
to entry into the health care 
system, such as lower econom¬ 
ic status, language difficulties 
and lack of education. A study 
of physicians directed hy a Yale 
investigator came up with the 
surprising result that doctors 
seem even less likely than the 
rest of the population to have 
a regular source of care (rsoc) 
such as a primary physician. 
ularity of the products affected. 
Walter N. Kernan, M.D., asso¬ 
ciate professor of medicine, 
one of four co-investigators at 
Yale, says of the OTC products, 
“They’re essentially gone.” 
The paper detailing the 
five-year, $5 million study did 
not appear in the New Eng¬ 
land Journal of Medicine until 
Dec. 14, but the results were 
released earlier on the journal’s 
Web site because of their 
importance to public health. 
“I think the FDA decision was 
cautious but very appropriate,” 
says Kernan. “There are alterna¬ 
tive OTC medications for relief 
of cough and cold symptoms.” 
The study was undertaken 
because of case reports associ¬ 
ating PPA with hemorrhagic 
stroke—bleeding between the 
cerebral lobes or around the 
edges of the brain—an 
The study was done while 
Assistant Professor of Medi¬ 
cine Cary P. Gross, m.d., was 
a fellow at The Johns Hopkins 
School of Medicine. Of 915 
physicians who graduated from 
Hopkins between 1948 and 
1964, some 35 percent had no 
RSOC during a seven-year sur¬ 
vey period. While doctors may 
have other sources of care, those 
without an RSOC were much 
less likely to get cancer screen¬ 
ing or an influenza vaccine. 
Gross speculates that doc¬ 
tors don’t go to doctors 
because of what he terms a 
“fallacious” belief in their 
capacity for self-care com¬ 
bined with the time demands 
uncommon form of stroke, 
especially in the 18- to 49-year- 
old age group that was the 
focus of the study. The study 
did not look at ischemic 
stroke, hy far the most com¬ 
mon form of stroke. 
The investigators examined 
702 people who had suffered a 
hemorrhagic stroke and com¬ 
pared them to twice that num¬ 
ber of control subjects who 
had not had a stroke. That 
database is the largest of its 
kind. The investigators are 
now using it to study other 
risk factors for stroke. “We 
expect to find new and more 
precise information about 
other risk factors for hemor¬ 
rhagic stroke, including other 
drug products,” says Kernan. 
“These additional analyses 
may have important public 
health implications as well.” 
of their medical careers. As is 
true of those who do not seek 
preventive care, he found that 
these physicians often also 
exhibit a “fatalistic” attitude, 
attributing health outcomes to 
chance. Gross says of the 
findings, which appeared in 
November in the Archives of 
Internal Medicine, “You have 
to wonder why we’re not heed¬ 
ing our own advice.” He does 
not know whether Yale gradu¬ 
ates are more or less likely 
than other physicians to go to 
the doctor. 
ENDOSCOPIC SURGERY IS EASIER 
TO SWALLOW People with a com¬ 
mon swallowing disorder can now 
be treated at Yale using a procedure 
that is markedly less invasive than 
the conventional surgery through 
the neck.The surgery is used to 
treat Zenker’s diverticulum, which 
occurs when the lining of the 
mucous membrane protrudes 
through the muscular wall just 
below the voice box in the high 
esophagus. Food easily becomes 
trapped in the pouch, making it 
difficult to swallow. Using an endo¬ 
scopic procedure popularized at 
Duke called stapler-assisted diver- 
ticulostomy,the surgeons remove 
the pouch through the mouth and 
repair the lining with a stapler. 
The procedure is a breakthrough, 
according to Douglas A. Ross, 
M.D., associate professor of sur¬ 
gery and otolaryngology, who per¬ 
forms the surgery along with col¬ 
league Clarence T. Sasaki, M.D. 
’66, HS ’73, the Charles W. Ohse 
Professor of Surgery and chief of 
the otolaryngology section. 
NEW TAKE ON TUBAL TRANSFERS 
The two standard procedures for 
in vitro fertilization involve transfer 
of the embryo to either the uterus 
or the fallopian tube. A national 
database published by the Centers 
for Disease Control and Preven¬ 
tion (CDC) has supported the long- 
held belief that tubal transfer has 
a higher pregnancy success rate 
although it is more invasive, 
expensive and prone to complica¬ 
tions. An analysis directed by 
Steven F. Palter, M.D., assistant pro¬ 
fessor of obstetrics and gynecolo¬ 
gy, of all previously published 
studies found that uterine trans¬ 
fers have just as great a likelihood 
of success as tubal transfers. Pal¬ 
ter suggested that fertility clinics, 
which are required to publish 
their success rates, select which 
patients to accept or direct toward 
certain therapies based on their 
likelihood of success. That, he 
believes, skewed the database. Flis 
findings, presented at the Ameri¬ 
can Society of Reproductive Medi¬ 
cine meeting, contradict statistics 
published by the CDC and the 
Society for Assisted Reproductive 
Technology, he believes. 
Third of doctors don't practice 
what they preach 
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Psychiatrist Dan Oren and colleagues 
in Israel say their findings on the 
effects of light on free radicals in the 
bloodstream bolster the notion that 
the body has light receptors other 
than those in the eyes. 
The protein produced by a gene called 
survivin may be a marker for bladder 
cancer, according to Dario Altieri, 
who discovered the gene. The protein 
appears in the urine of those with 
chronic or recurring bladder cancer but 
not in healthy individuals or those 
with other forms of cancer. 
Shedding new light 
on depression 
A Yale investigator and his 
Israeli colleagues have shown 
for the first time that the body 
has light receptors other than 
those in the eye’s visual system. 
That finding may help explain 
why using artificial light as 
therapy helps people with sea¬ 
sonal affective disorder (sad), 
a form of depression believed 
to result from light depriva¬ 
tion, occurring most common¬ 
ly during winter. It could also 
help lead to the development 
of light therapies for other 
forms of depression, according 
to the paper’s senior author. 
Associate Professor of Psychiatry 
Dan A. Oren, m.d. 
For the study, which ap¬ 
peared in the March i issue of 
A molecular clue for 
bladder cancer 
Discovered three years ago, a 
gene called survivin holds 
promise as a diagnostic marker 
for bladder cancer, according 
to a study published by Profes¬ 
sor of Pathology Dario C. 
Altieri, M.D., of the Yale Can¬ 
cer Center, and several col¬ 
leagues in the Jan. i6 issue of 
JAMA: The Journal of the 
American Medical Association. 
The sixth most common can¬ 
cer in the United States, blad¬ 
der cancer has a 5-year survival 
rate of 93 percent if it is dis¬ 
covered and treated early. 
The current means of diag¬ 
nosis, cystoscopy and biopsy, 
are accurate but also expensive 
and painful. What the Yale 
the journal Biological Psychia¬ 
try, light from a type of light 
box commonly used to treat 
SAD was directed on skin cells 
grown in culture. Within 10 
minutes, the light stimulated 
production of molecules con¬ 
taining so-called free radicals, 
which are gases that can deliv¬ 
er energy through the blood¬ 
stream. This may help explain 
why light can help treat SAD, 
which affects as many as 20 
million Americans, and pro¬ 
vides, said Oren, “a new path¬ 
way toward understanding 
how the brain works.” 
Oren is also principal inves¬ 
tigator for a study using light 
to treat pregnant women 
suffering from depression. 
detecting 
study found may lead to a 
noninvasive approach, examin¬ 
ing cells that the body abun¬ 
dantly sloughs off every day 
into the urine. In an analysis 
of urine samples from 16 
healthy volunteers and 60 vol¬ 
unteers with various types of 
cancer, the protein product of 
the survivin gene appeared in 
the samples from patients with 
new or recurring bladder can¬ 
cer— but not in those from 
the healthy volunteers or vol¬ 
unteers with prostate, renal, 
cervical or vaginal cancer. 
“The potential outlook for 
a test like this would be to im¬ 
prove the follow-up measures” 
for patients after treatment, 
says Altieri. Since bladder can¬ 
cer all too often does recur, he 
adds, “We hope to see this 
urine-cell analysis develop into 
an alternative, safe, noninva- 
Oren and C. Neill Epperson, 
M.D., assistant professor of 
psychiatry and of obstetrics 
and gynecology, are testing 
women to see whether light 
therapy will allow them to 
avoid antidepressant medica¬ 
tions, because of concerns 
about the drugs’ potential side 
effects and/or toxic effects on 
the fetus. According to Oren, 
an open-treatment trial had 
“very encouraging” results. Yale 
and two other research centers 
are now pursuing a pilot study 
in hopes of undertaking a 
larger-scale investigation. 
sive and reliable approach at 
the first line of diagnosis.” 
The lead author of the 
study was Shannon Smith, 
M.D., a urology fellow who 
died in March after a five-year 
struggle with brain cancer. “Her 
spirit was strong and inspiring 
and her commitment to this 
experimental work, even in the 
midst of the progressing disease, 
was admirable,” Altieri said. 
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Radiation multiplies Salmonella*s 
anti-tumor properties 
Traditional radiation therapy, 
when combined with a geneti¬ 
cally modified form of the 
deadly bacterium Salmonella, 
could help some cancer patients, 
Yale scientists have found. 
Writing in the European 
Journal of Cancer, the scientists 
say they have developed a non¬ 
toxic strain of the dangerous 
“wild type” of Salmonella and 
used it in conjunction with 
X-rays to fight tumors in mice. 
The study, done in collabora¬ 
tion with Vion Pharmaceuti¬ 
cals, showed a remarkable gain 
in the ability to halt, although 
not completely eliminate, 
tumor growth. 
Initial results from a Phase 
I clinical trial indicated that the 
bacterium can safely be used in 
humans. Yale scientists John 
M. Pawelek, PH.D., K. Brooks 
Low, PH.D., and David G. 
Bermudes, PH.D., who is also 
director of biology at Vion, 
have received a patent for the 
cancer vector. 
Pawelek, a senior research 
scientist in the Department of 
Dermatology, said the team 
was surprised at the effective¬ 
ness of the two therapies 
rogether. While either radia¬ 
tion or Salmonella alone pre¬ 
vented cancer growth for as 
much as three weeks, the com¬ 
bination stopped the tumors 
for more than twice as long. 
While treating cancer 
patients with forms of bacteria 
has been done for at least too 
years, the reasons for its occa¬ 
sional success have eluded sci¬ 
entists. New ways of altering 
Salmonella and combining it 
with radiation are the novel 
aspects of the current work. 
“You can go into great detail 
about why X-rays and Salmo¬ 
nella are so effecrive together, 
but that is really speculation at 
this point,” Pawelek said. “We 
have discovered a novel thera¬ 
py, and one of the things we 
are doing now is trying to 
understand how it works.” 
With chest pain, need for treatment 
can be a matter of perspective 
Chest pain is not the same for 
everyone. It keeps some 
patients from enjoying daily 
activities. For others, despite 
identical diagnoses, the pain 
does little to reduce their qual¬ 
ity of life. According to a Yale 
study, physicians will provide 
patients with better care by 
considering that difference 
before recommending invasive 
procedures, such as angioplas¬ 
ty, to improve blood flow to 
the heart to reduce the pain. 
“There can be an important 
discordance between a patient’s 
objective capacity and the 
patient’s quality of life,” says 
Harlan M. Krumholz, M.D., 
associate professor of medicine 
and of epidemiology and pub¬ 
lic health. “For an Olympic 
swimmer, a minor injury could 
be devastating, but for some¬ 
one who is mostly sedentary it 
might be barely noticed.” 
He directed the study, 
which was undertaken by Jen¬ 
nifer A. Mattera, M.P.H. ’95, 
director of the Center for Out¬ 
comes Research at Yale-New 
Haven Hospital, for her mas¬ 
ter’s thesis, along with other 
researchers at Yale. The investi¬ 
gators compared the results 
from patients’ diagnostic 
tests — exercise elecrrocardio- 
gram treadmill testing and 
myocardial perfusion imaging 
—with the patients’ views of 
their physical functioning and 
general health gathered from a 
questionnaire. The researchers 
found that the test results cor¬ 
related with the patients’ per¬ 
ceptions of their quality of life 
most of the time, but that in 
many cases patients’ percep¬ 
tions of their health and physi¬ 
cal functioning differed 
markedly from what the test 
results showed. 
“It highlights the impor¬ 
tance of talking to the patient,” 
says Krumholz. “We can have 
all these sophisticated tests, 
but the ultimate measure of 
quality of life and functioning 
should be understood from the 
patient’s own perspective. 
There needs to be a connection 
between their goals of therapy 
and our goals of therapy. If our 
therapy is intended to help 
them live better, then we 
should be sure that we are 
treating the patient and not 
just their test results.” 
SHORTER STAYS, BUT WHAT 
ABOUT OUTCOMES? Managed 
care has reduced the time older 
patients with pneumonia spend in 
the hospital and has led to a corre¬ 
sponding drop in the costs and hos¬ 
pital death rates associated with 
the illness. But according to a 
study by researchers at Yale and 
other institutions, more patients 
are dying in the month after they 
leave the hospital, and many of 
the discharged hospital patients 
are being sent to nursing homes 
rather than home. Thomas P. Mee¬ 
han, M.D., M.P.H., assistant clinical 
professor of medicine, was senior 
author of the study, which 
appeared in the Archives of Inter¬ 
nal Medicine in December. The 
researchers found that the rate of 
mortality within 30 days after dis¬ 
charge increased from 6.9 percent 
to 9.3 percent during the six-year 
study of pneumonia patients 65 
and older who were discharged 
from Connecticut hospitals. Dur¬ 
ing that period, fall 1991 to fall 
1997. the length of stay dropped 
from a mean of n-i2 days to 7-8 
days. Said Meehan,“We can’t con¬ 
tinue to decrease the length of 
stay and not have an eye as to the 
consequences.” 
HIGHER RISKS FOR YOUNGER 
WOMEN Women under the age of 
60 face a higher risk of dying dur¬ 
ing the two years following a 
heart attack than do men in the 
same age group, according to a 
study by a Yale researcher and col¬ 
laborators. These sex-based differ¬ 
ences in mortality rates were 
independent of the severity of the 
heart attack and other health 
problems, and were found only in 
the under-60 group of patients, 
the authors wrote in the Feb. 6 
issue of Annals of Internal Medi¬ 
cine. The women’s survival rate 
might have been affected more 
than the men’s by “behavioral, 
psychosocial, and social factors 
such as continuing to smoke, 
social isolation, emotional stress 
and depression,” said Harlan 
Krumholz, M.D., a co-author of the 
article and associate professor of 
internal medicine. “The next chal¬ 
lenge is to understand why these 
differences exist.” 
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JEFFERY KOCSIS 
Stem cell transplant shows promise 
for spinal cord repair 
For the first time, Yale scientists 
have transplanted stem cells 
from an adult primate brain to 
repair the insulating sheath sur¬ 
rounding spinal cord axons in 
the same animal. These results, 
reported at the annual meeting 
of the Society for Neuroscience 
in November, raise hopes that 
patients’ own stem cells might 
one day be used to help them 
recover from spinal cord 
injuries or multiple sclerosis. 
For the experiment, which 
was directed by Jeffery D. 
Kocsis, PH.D., professor of 
neurology and neurobiology, a 
small quantity of cells was re¬ 
moved from the subventrical 
zone in the frontal lobe. The 
neural precursor, or stem, 
cells were then cloned and 
expanded in the laboratory 
before being transplanted into 
a region of the spinal cord from 
which myelin, the protective 
coating around the nerve fibers 
that increases impulse conduc¬ 
tion speed, had been removed. 
The stem cells formed new 
myelin to cover the nerve cells. 
The use of a subject’s own 
stem cells could circumvent the 
ethical and practical issues sur¬ 
rounding the use of fetal tissue, 
from which stem cells can 
readily be derived, and the 
problems associated with 
immune suppression that arise 
when transplanting foreign tis¬ 
sue. In the January issue of 
Experimental Neurology the in¬ 
vestigators further reported 
that similar cells derived from 
the adult human brain can 
repair axons in a rodent model 
of demyelination and improve 
impulse conduction. 
“The concept is not ready 
for application in patients, but 
the fact that it can be achieved 
in a primate and that the stem 
cells can be developed from 
adult human brain is signi¬ 
ficant. There’s a lot of excite¬ 
ment here about the potential 
of putting cells to work to 
repair the injured nervous sys¬ 
tem,” said Kocsis. But, he 
warned, “There are so many 
cell types and so many safety 
issues. This is the very first step 
in a long process for develop¬ 
ing new clinical treatments.” 
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Ronald Duman led a team that found 
evidence of new cell growth in the 
hippocampus among patients taking 
iong courses of antidepressant 
medications. 
« 
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Antidepressants shown to promote 
new cell growth in the hippocampus 
Continued use of antidepres¬ 
sants leads to new cell growth 
in an area of the brain known 
to suffer cell death and atro¬ 
phy as a result of depression 
and stress, a study by Yale 
researchers shows. 
Chronic administration of 
antidepressants increases the 
number of neurons in the adult 
hippocampus, which could 
help explain how antidepres¬ 
sants produce their therapeutic 
response, according to Ronald 
S. Duman, PH.D., professor of 
psychiatry and pharmacology. 
Duman was senior author of 
the study, published Dec. 15 in 
The Journal of Neuroscience. 
The hippocampus is the 
part of the limbic brain that is 
involved in learning, memory, 
mood and emotion. It is one 
of only a few regions of the 
adult brain where production 
of neurons occurs in animals, 
including humans. Previous 
studies have demonstrated 
that stressful experiences, 
both physical and psychologi¬ 
cal, lead to neuronal loss in 
the hippocampus and that 
antidepressants can block this 
cell loss. 
Duman’s laboratory has 
been studying the mechanism 
of action of antidepressants in 
rodents for over 15 years. The 
researchers have focused on 
cellular actions of antidepres¬ 
sants, looking at the role of the 
intracellular signal transduc¬ 
tion pathways that control 
neuronal function. They have 
identified several actions of 
antidepressants that indicate 
that they influence the survival 
or the number of neurons in 
the hippocampus. 
This study was intended to 
look at whether antidepressants 
increased the birth of neurons 
in the hippocampus. The re¬ 
searchers tested several differ¬ 
ent classes of antidepressant 
drugs, as well as electroconvul¬ 
sive seizure therapy (ecs) and 
an antipsychotic medication. 
ECS is clinically the most 
effective treatment for cases of 
depression that are resistant to 
available drug treatments. As 
expected, repeated administra¬ 
tion of ECS increased the num¬ 
ber of neurons in the hippo¬ 
campus of the brain by 50 
percent. The chemical antide¬ 
pressants tested increased the 
number of neurons in the same 
area by 20 percent to 40 per¬ 
cent. The antidepressants that 
were administered included a 
monoamine oxidase inhibitor 
(tranylcypromine), a sero¬ 
tonin-selective reuptake inhibi¬ 
tor (fluoxetine) and a norepi¬ 
nephrine-selective reuptake 
inhibitor (reboxetine). 
Acute administration of the 
antidepressants (one to five 
days) did not lead to any sig¬ 
nificant cell change. Results 
were seen after 14 to 28 days of 
administration, which is con¬ 
sistent with treatment regimens 
for the therapeutic response to 
antidepressants. These studies 
suggest that increased neuro¬ 
genesis in the hippocampus 
could counter the effects of 
stress on hippocampal atrophy 
and contribute to the actions 
of antidepressant treatments. 
A SCHOLARLY ARCHIVE, IN BITS 
AND BYTES As morejournals 
move to electronic format and 
more scholars access information 
using these online databases, seri¬ 
ous questions have arisen about 
how to preserve knowledge that 
in some cases may exist only in 
digital form. To address the dilem¬ 
mas of digital preservation, the 
Yale University Library and 
Elsevier Science are collaborating 
to create the infrastructure for a 
model archive for the 1,100 jour¬ 
nals published electronically by 
Elsevier, the world’s largest scien¬ 
tific, technical and medical infor¬ 
mation provider. Their goal is to 
have the model infrastructure 
developed within two years. They 
have already begun studying 
how people use digital collections 
and are investigating formats for 
encoding content in digital form; 
one challenge is predicting which 
formats are likely to remain stable 
over time. The planners hope that 
the archive will serve as a model 
for other publishers. 
BREASTFEEDING REDUCES 
CANCER RISK Breastfeedingfor 
two or more years reduces a 
woman’s risk of developing breast 
cancer by 50 percent, according to 
a study conducted in China by a 
Yale researcher.Tongzhang Zheng, 
Sc.D., associate professor of epi¬ 
demiology and public health, said 
he conducted the study in China 
because, unlike in Western nations, 
long-term breastfeeding is part of 
the Chinese culture. Zheng’s group 
found a 50 percent reduction in 
breast cancer risk among women 
who had breastfed for more than 
24 months per child, compared to 
women who breastfed for less 
than 12 months. Studies in Western 
countries showing that breastfeed¬ 
ing does not play a significant role 
in reducing breast cancer risk 
might be explained by the fact 
that many women in the West 
breastfeed for weeks or months 
rather than years. The study was 
published in the Dec. 15 issue of 
American Journal of Epidemiology. 
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FINDINGS 
Probing the genetic 
In separate studies, Yale re¬ 
searchers have demonstrated 
that the genes that code for 
interleuken-13 (IL-13) and 
gamma-interferon cause pul¬ 
monary emphysema. 
Using transgenic mice that 
were genetically engineered to 
express these genes in the adult 
mouse lung, Jack A. Elias, 
M.D., section chief of pulmon¬ 
ary and critical care medicine, 
and a team of researchers in¬ 
cluding Zhou Zhu, M.D., 
PH.D.; Tao Zheng, M.D.; Chun 
Guen Lee, M.D.; Bing Ma, 
M.S.; and Qingsheng Chen, 
M.D., have demonstrated that 
these genes, which are known 
to cause inflammation, also 
cause pulmonary emphysema 
similar to the kind seen in 
patients with chronic obstruc¬ 
tive pulmonary disease (COPD). 
COPD affects 16 million people 
in the United States alone and 
Magnified 400 times, this cluster of 
dopamine cells was photographed 
using light microscopy in the substan¬ 
tia nigra region of the midbrain, 
where the loss of dopamine neurons 
is associated with Parkinson’s disease 
and dementia. 
basis of emphysema 
is the fourth leading cause of 
death worldwide. 
The first study, published in 
the November issue of The 
Journal of Clinical Investigation, 
highlighted the potential im¬ 
portance of IL-13 In the devel¬ 
opment of emphysema and in 
the exaggerated mucus produc¬ 
tion seen in these disorders. 
Since IL-13 B also thought to 
contribute to asthma, this study 
also demonstrated that com¬ 
mon mechanisms might under¬ 
lie the development of both of 
these lung disorders. 
The second study, published 
in the December issue of The 
Journal of Experimental Medi¬ 
cine, shed light on the potential 
role of gamma-interferon in the 
development of COPD. Elias 
notes that the symptoms in the 
two transgenic systems used in 
the studies can vary from one 
person to another. 
“We saw different types of 
inflammation, differences in 
mucus production and different 
rates of emphysema develop¬ 
ment in the two different trans¬ 
genic systems,” said Elias. 
“These differences recapitulate, 
in many ways, the individual- 
to-individual differences seen in 
groups of patients with COPD 
and may explain why only some 
patients have exaggerated 
mucus production while others 
have rapidly progressive or 
slowly progressive disease.” 
Elias adds, “The results also 
provide a mechanistic explana¬ 
tion for the observation that 
asthmatics who smoke ciga¬ 
rettes have the most rapid rates 
of loss of lung function.” 
In the normal lung, there 
is a fine balance between pro¬ 
teins that degrade lung tissue, 
called proteases, and proteins 
that inhibit protease function. 
called antiproteases. Researchers 
have assumed that emphysema 
develops when the activity 
of the proteases overwhelms 
the controlling capacity of 
the antiproteases. 
“Pulmonary inflammation 
is a characteristic feature of 
lungs from patients with COPD. 
However, the way that inflam¬ 
mation causes emphysema has 
not been defined until now,” 
said Elias. “Our studies demon¬ 
strate that IL-13 ^nd gamma- 
interferon, gene products that 
regulate inflammation, can also 
trigger emphysema.” The stud¬ 
ies also demonstrated that IL-13 
and gamma-interferon caused 
impressive increases in two 
classes of proteases called matrix 
metalloproteinases and cathep- 
sins. They also caused selective 
decreases in antiproteases. 
Estrogen deprivation associated 
with loss of dopamine cells 
Estrogen deprivation leads to 
the death of dopamine cells in 
the brain, a finding by Yale sci¬ 
entists that could help explain 
why Parkinson’s disease is 
more likely to develop in men 
than in premenopausal women 
and why it increases in women 
after menopause. 
“Without estrogen, more 
than 30 percent of all the dopa- 
° mine neurons disappeared in a 
" major area of the brain that 
“ produces the neurotransmitter 
dopamine,” said D. Eugene 
Redmond Jr., M.D., professor of 
psychiatry and neurosurgery 
and director of the Neural 
Transplantation and Regenera¬ 
tion Program. 
The discovery was made 
after a team led by Redmond 
removed the ovaries of female 
monkeys, thereby depleting 
their bodies of estrogen and 
other gonadal hormones. 
Within 10 days, key neurons in 
the brain that protect against 
Parkinson’s disappeared. After 
30 days the cells appeared to 
be permanently lost. The sci¬ 
entists were able to regenerate 
the cells by administering 
estrogen within 10 days. 
Redmond said monkeys 
were used in the study because 
they have menstrual cycles and 
many other close similarities 
to humans. The researchers 
were interested in sexual diff¬ 
erences in dopamine neurons 
in the substantia nigra area of 
the midbrain, whose destruc¬ 
tion is associated with Parkin¬ 
son’s disease and dementia. 
The study was published 
in the December issue of The 
Journal of Neuroscience. The 
principal investigator was Csaba 
Leranth, M.D., PH.D., profes¬ 
sor of obstetrics and gynecolo¬ 
gy and of neurobiology. 
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McKay Verghese 
A lesson while dying 
The dying young men of Johnson City, Tenn., taught Abraham 
Verghese, M.D., something about the meaning of life. A professor 
of medicine at Texas Tech University in El Paso and a contributor 
to The New Yorker, Verghese is the author of the award-winning 
My Own Country, his account of treating men who returned 
from large cities to their Tennessee homes after contracting HIV. 
Speaking at medical grand rounds in November, Verghese said 
that as his patients faced death, they told him that wealth, 
power and appearance mattered little. “Instead, they found that 
meaning consistently resided in the successful relationships that 
they had negotiated over a lifetime, particularly with parents.” 
—Cathy Shufro 
Clinical research “riddled with conflicts” 
Protection of human subjects and the integrity of clinical trials are 
in jeopardy from the new economics of drug development, 
according to Marcia Angell, m.d., a lecturer on medical ethics at 
Harvard Medical School and a former editor of the New Eng¬ 
land Journal of Medicine. While editor of the journal, she issued 
an apology to readers for 19 instances in which the journal had 
published reviews of treatments even though the review authors 
had informed the editors of financial connections to drug compa¬ 
nies. The editors admitted failing to apply journal policy, which 
prohibits review authors from having a financial interest in a 
company that makes a product discussed in the article. 
As more scientists and institutions have financial stakes in 
research, she told faculty and students at a meeting of the Medical 
School Council in February, the drug approval system has 
become “riddled with financial conflicts of interest.” She suggests 
making drug company funding, clinical testing and ethical 
oversight independent of each other. “The result would be a sys¬ 
tem of checks and balances in which the influence of industry 
funding would be minimized,” she said. 
—John Curtis 
■jai 
The ethics of stem cell research 
In 1838, before publishing his theory that tissue is made up of tiny 
particles he called cells, German physiologist Theodor Schwann 
sought permission outside the realm of science. “He asked the 
religious authorities whether it was OK,” said Ronald D.G. McKay, 
PH.D., chief of the laboratory of molecular biology at the Nation¬ 
al Institute of Neurological Disorders and Stroke, where he stud¬ 
ies stem cell differentiation. “The current controversy over stem 
cells,” said McKay at a meeting of the Medical School Council 
last fall, “is nothing new.” Embryonic stem cells offer the prom¬ 
ise of cures for such diseases as Alzheimer’s and Parkinson’s, but 
they must be extracted from embryos that are destroyed in the 
process. “For certain people,” said McKay, “if you take cells out 
of an early embryo you commit an act of ethical impropriety. 
We have people who might benefit from these cells, and that is 
another moral issue. There is no way of moving forward with¬ 
out making ethical decisions.” 
—John Curtis 
The healing power of music 
Twenty-five years ago, Oliver Sacks, m.d., tore off his left 
quadriceps while mountaineering in Norway and was saved by 
reindeer hunters. Following the accident, “the clumsy limb 
didn’t seem to be mine. It was as if I had no internal sense of 
pacing,” he said last fall during “Neurotherapeutic Effects of 
Music,” a symposium at the School of Medicine that explored 
the effectiveness of music in treating neurological disorders. 
Music, he said, helped him recover his “kinetic melody” and 
walk again. “Suddenly ... Mendelssohn started playing in my 
mind and in some unconscious way I found myself walking to 
it.” Sacks, a neurologist and the authot of Awakenings and other 
books, was experiencing the connection between music and 
healing that he had observed among patients with Parkinson’s 
disease. Although they could not initiate speech or walk, some 
were able to sing or dance when music was played. One patient 
stayed absolutely still with a finger on her eyeglass for most 
of the day, but came alive playing Chopin on the piano. Said 
Sacks: “I saw music as a mysterious, liberating power with 
these people who were otherwise virtually inaccessible.” 
— Rachel Engers 
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CAPSULE LEFT The first M.D.granted by an Ameri¬ can university was an honorary degree 
from Yale College to Daniel Turner (1667- 
1741), a popular and controversial London 
practitioner. Turner answered a general 
call for gentlemen to donate books to 
Yale College and, with his gift of 25 titles, 
requested that he be awarded an hon¬ 
orary M.D. Yale agreed and presented 
it to him in 1723. Shown here is Turner’s 
The Art of Surgery, the first edition 
of which was part of his gift to Yale. 
II 
The first 200 years j 
An exhibit prepared for Yale’s Tercentennial explores the landscape j 
of New Haven medicine from 1701-1901. 
I |l 
18 
I 
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Today, medical students attending Yale have 
access to close to i,ooo full-time faculty mem¬ 
bers, modern labs and classrooms and a library 
containing more than 400,000 volumes and 
journals. It wasn’t always that way. In the early 
days, according to a description from a medical 
apprentice at the time, the curriculum was 
made up of “books on the shelf, the skeleton in 
the closet, the pestle and the pill-slab in the 
back room, roaming the forests and fields for 
roots and herbs, and following astride ... the 
horse which was honored with the saddlebags.” 
How the medical school got started was the 
subject of Medicine at Yale, i/oi-ipoi, the first 
in a series of exhibits at the Cushing/Whitney 
Medical Library in celebration of the Universi¬ 
ty’s Tercentennial this year. Based in part on a 
forthcoming history of the school by its 14th 
dean, Gerard N. Burrow, M.D., the exhibit 
touches on early events in medicine at Yale, 
including the awarding of the first M.D. degree 
by an American university in 1723 (albeit an 
honorary one) and the contributions to medi¬ 
cine of such notable Yale College graduates as 
lexicographer Noah Webster—whose book A 
Brief History of Epidemic Disease was hailed by 
William Osier as “the most important medical 
work written in this country by a layman”— 
and Eli Smith, a founding editor of the nation’s 
first medical journal. 
The history of the medical school itself 
begins with the opening of the Medical Institu¬ 
tion of Yale College in 1813 on Grove Street, 
more than a hundred years after the founding 
of Yale College, and its robust early years that 
were due largely to the reputations of two of its 
four founding professors, Benjamin Silliman 
and Nathan Smith. “They were two absolutely 
outstanding individuals,” says historian Bur¬ 
row, “and at the time, there was no other med¬ 
ical school in Connecticut or even close by.” 
The school flourished throughout the first half 
of the century. 
Around the 1850s, however, it became harder 
to attract students. More schools had opened, 
increasing the competition. It was also a dark 
period for mainstream medicine, as the num¬ 
ber of unorthodox practitioners multiplied. 
“There were a lot of charlatans” trying to 
pass for doctors. Burrow says. “Medicine didn’t 
seem to be going anywhere.” To distinguish 
itself from the competition—and distance itself 
from the quacks—the medical school raised 
its standards. But enrollment suffered, as did 
the school’s finances. Rather than retreat, the 
faculty members, all of whom were part-time, 
diverted their Yale salaries to the school and 
took lOUs. “That is what is remarkable about 
the medical school, that people who were not 
getting a great amount of money donated their 
time and effort,” says Historical Librarian 
Toby A. Appel, ph.d., m.l.s., who curated the 
exhibit. “It was like a mission for them. They 
really wanted it to be good.” 
The first 200 years of medicine at Yale, 
especially the 19th century, can be summed 
up as “a strong start and a weak finish,” says 
Burrow, adding that numerous efforts to raise 
standards almost cost the school its existence 
at the start of the 20th century. But the best 
years were yet to come. 
— Pern McNerney 
Next: 1901 to 1951, 
a period of tremendous growth 
for the medical school. 
ABOVE The medical school flourished 
in its early years especially due to the 
reputations of Nathan Smith, right, 
professor of the theory and practice of 
physic and surgery, and Benjamin 
Silliman, left, professor of chemistry. 
Background: Lecture notes taken 
by a student of Smith during the 1819- 
20 academic year. 
OPPOSITE PACE Harry Burr Ferris, 
M.D. (1865-1940), third from left, an 
1887 graduate of Yale College and 
1890 alumnus of the medical school, 
joined the faculty as an instructor in 
anatomy in 1891. He served as profes¬ 
sor of anatomy from 1895 to 1933. 
It was customary at the turn of the 
century for medical students to pose 
with the body they were dissecting. 
This photograph was taken in March 
1899 by William Blackwood, the janitor. 
BELOW The Medical Institution of 
Yale College, chartered in 1810, opened 
in 1813 in this building on Grove 
Street, left, as a joint project of Yale 
and the Connecticut Medical Society. 
This relationship to the state society 
was unusual among medical colleges 
and proved beneficial to the college 
in its early years. The school moved to 
150 York Street, right, in i860. 
The exhibit Medicine at Yaie, 7707-7907 may be viewed online. 
See http://info.med.yale.edu/library/exhibits/yalemedi/. 
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A dramatic turn 
The doctor-patient relationship takes center stage 
in performer An 113 D03V0r0 Smith S 
interpretation of medicine at Yale. 
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I didn’t trust anyone. Doctors wasn’t listening. I had to fight. I had to advocate for myself to get doctors to 
listen to me. I had to learn to say, “What’s the side effects of this?” Learn to say, “No, I’m not takin’that, 
give it to someone else, let someone else try it first.”... I am very conscious and very responsible for other 
people’s health when it comes to my virus. And I says [to the doctor], “Look, before you examine me put 
some gloves on. I have the virus.” She went out of the room and she never came back. She never came back. 
When you’re listening to a patient tell you things that you have to integrate into a whole body of 
knowledge you have, it’s hard to listen well, because your mind is trying to filter out what they’re saying. 
And consider alternate diagnoses and so forth. So you’re really not listening; you’re trying to solve the 
puzzle... and so it just sort of goes by you that they said something very, very important. You didn’t hear it. 
The playwright and actress Anna Deavere Smith stands in 
the well of Fitkin Amphitheater musing about how patients and doctors manage 
to communicate under pressure when she slips on a white coat and transforms 
herself into Yale physician Asghar Rastegar, m.d. 
story by Cathy Shufro 
Photographs by 
Michael Marsland 
To view video clips from 
Anna Deavere Smith’s 
performance of Rounding it 
Out, please visit our Web 
site, info.med.yale.edu/ymm. 
“I have looked at every single patient as being 
a phenomenal new experience,” says Smith, 
using Rastegar s words and his Farsi accent. 
“Excited to walk in that room. Oh yeah, oh 
yeah, no question about it. Phenomenally 
excited. Every time, every time, every time.” 
Moments later. Smith portrays another 
doctor, Forrester A. Lee Jr., M.D. ’79, HS ’83, a 
cardiologist and the school’s assistant dean for 
multicultural affairs, who calmly and deliberately 
describes how medical training itself can block 
vital avenues of communication. “When you’re 
listening to a patient tell you things that you 
have to integrate into a whole body of knowl¬ 
edge you have, it’s hard to listen well, because 
your mind is trying to filter out what they’re 
saying. And consider alternate diagnoses and so 
forth. So you’re really not listening; you’re try¬ 
ing to solve the puzzle ... and so it just sort of 
goes by you that they said something very, very 
important. You didn’t hear it.” 
Sitting down in a chair. Smith becomes a 
patient, speaking with a trace of a Southern 
accent. She is Frankie Harris, a woman with 
HIV who has been treated at Yale. 
“I didn’t trust anyone. Doctors wasn’t listen¬ 
ing. I had to fight, I had to advocate for myself 
to get doctors to listen to me. I had to learn to 
say, ‘What’s the side effects of this?’ Learn to 
say ‘No, I’m not takin’ that, give it to someone 
else, let someone else try it first.’ ... I am very 
conscious and very responsible for other peo¬ 
ple’s health when it comes to my virus. And I 
says [to the doctor] ‘Look, before you examine 
me put some gloves on. I have the virus.’ She 
went out of the room and she never came back. 
She never came back.” 
The physicians who crowded into Fitkin for 
medical grand rounds in mid-November had not 
come to hear a colleague discussing a disease but 
rathet to watch an outsider make a case for the 
potential richness of doctor-patient communi¬ 
cation. Playwright and actress Anna Deavere 
Smith used the words of physicians and patients 
from the Yale community to create Rounding It 
Out, a 90-minute examination of how doctors 
and patients view one another. 
The recipient of a MacArthur Foundation 
fellowship for creating a new genre of docu¬ 
mentary theater. Smith has appeared in film and 
on television in The American President, The 
West Wing2ind The Practice but is best known 
for her solo stage performances depicting com¬ 
munities in turmoil. In Fires in the Mirror: 
Crown Heights, Brooklyn and Other Identities, 
Smith portrays two dozen real people, from city 
bureaucrats to housewives, to explore the 1991 
clash between black and Jewish residents of 
Crown Heights. In Twilight: Los Angeles, 1992, 
she examines the riots sparked by the Rodney 
King verdict. 
A less obvious crisis brought Smith to the 
medical school: the erosion of intimacy 
between patient and physician. In 1997 Ralph 
1. Horwitz, M.D., chair of the Department of 
Internal Medicine, and Rastegar, the subject of 
the opening scene and the department’s associ¬ 
ate chair for medical education, had been dis¬ 
cussing how to train novice doctors to listen 
better. WTien they heard Smith speak on campus 
on Martin Luther King Day in 1998, “it struck 
us that she is probably the best listener we had 
ever seen,” Rastegar recalls. And so Smith came 
to Yale last summer and fall to interview 21 
physicians, nurses, and patients and their fami¬ 
lies to create what she calls “a first draft,” weav¬ 
ing together excerpts from the interviews with 
her own commentary and songs sung by Lynette 
Dupre and Suzzy Roche. In Fitkin and again 
the next day in Harkness Auditorium, Smith 
performed for packed houses that included the 
five physicians and six patients whose words 
she spoke from the stage. Noting that “the inti¬ 
macy of transactions is dissolving” in our socie- 
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Cathy Shufro is a contributing editor of Yale Medicine 
and a tutor in the Bass Writing Program at Yale. 
Michael Marsland is the University photographer. 
Listening with open ears 
Fundamental to listening well, says playwright Anna 
Oeavere Smith, is “to understand that what you’re 
hearing from a person is not something you’ve ever 
heard before.” For a doctor, that means listening to 
each new patient “every time, every time like it’s the 
first time, because it’s the first time for the patient,” 
says Smith.The diagnosis may be familiar, even rou¬ 
tine, but the illness is unique to the patient. 
"The doctor’s job is not only to have the answers. 
Sometimes as patients we want doctors to hear the 
spectacular thing we just said as if they had never 
heard it before, because they haven’t.That would be 
one of the hardest things for a doctor to under¬ 
stand,” says Smith. A professor at New York Universi¬ 
ty, Smith has made a career of listening to people 
under pressure and using their words and ways of 
speaking to create documentary theater. Her Obie- 
winning piece Fires In the Mirror; Crown Heights, 
Brooklyn and Other Identities grew out of in-depth 
interviews with 50 people, of whom she portrayed 
26. Smith developed her presentation at Yale by 
interviewing 21 people and incorporating excerpts 
from 11 of the interviews. 
“The people I interviewed in Crown Heights, on 
the heels of a race riot, were really quite like the 
patients I heard here. They had a certain urgency. 
They really wanted to be heard and felt they had not 
been. I have a particular interest in worlds that are 
upside down. When a person is ill, that’s their iife 
upside down,” she says. 
Smith distinguishes between empathizing with a 
person and identifying with that person. “It is the 
most precious moment to realize that the person sit¬ 
ting in front of me is not me. To listen or to have 
empathy means being able to remain present as a 
witness to something that is happening that is 
unusual to me” as the listener, she says. A physician ... 
or anyone ... who connects deeply with others does 
not remain unaffected, however."None of us who 
are doing our work well really can say that we just 
observe what is happening around us and just move 
on. The older we get, the more experienced we get 
having it affect us, using it as a resource in helping 
us connect with others more and more. People can 
see whether you have experienced suffering, experi¬ 
enced joy. The more they can see that in you, the 
more they can share their lives with you, the more 
they can open up and feel they are giving their lives 
into good hands.” 
Faced with another person’s pain, we can rise to 
the occasion and “absorb it as part of a iarger under¬ 
standing of who we all are and the predicament we 
are all in: that life is transient, and it is a gift.” 
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You’re most available to the most demanding people.... In my practice the most demanding peopie are 
highly educated white women with Internet access and actually have more minor problems than some of 
the other people I see.... And I spend more time with them than I might actuaily with a much sicker 
person. But I hope that... in a way I’m sort of helping them all equally, that what those people need is time 
to taik about their problems and figure their way through the maze of options. And what other people 
need is the treatment that wili work best for their cancer, and they can accept it with a lot less discussion.” 
I’m a dangerous patient because i’m the one that aiways gets dismissed with,“Oh, she’ii be okay, 
i don’t need to make that extra effort.” I’m scared of dying. I need them. I need them a lot more than they 
think. They can ask me about depression and they don’t. The thing is they think I’m an easy patient. 
For a long time medicine took the view that if you perfected yourself as a physician, you wouid have a full 
and complete life. That everything else would fall into place. That the perfect doctor would be the perfect 
person. And there’s nothing more arrogant. And nothing iess true.... You’re hearing this from a person that 
spends far too little time at home with my family. 
As much faith as you have in this place, every time they give you chemotherapy.... I had a friend there 
with me to make sure the bag of chemotherapy with that stuff in there that they were about to pump into 
me was exactly what I was supposed to get. No more. No less. 
ty, she told the audience: “I am stunned to 
learn here that a patient-doctor interaction is 
assumed to happen in 15 minutes. That would 
have to be a kind of haiku. Are the doctors pre¬ 
pared for that? The patients?” 
In her portrayal of Horwitz, Smith brings to 
life the physician’s conflict between work and 
personal life. “For a long time medicine took 
the view that if you perfected yourself as a 
physician, you would have a full and complete 
life. That everything else would fall into place. 
That the perfect doctor would be the perfect 
person. And there’s nothing 'more arrogant. 
And nothing less true. ... You’re hearing this 
from a person that spends far too little time at 
home with my family.” 
Smith’s journey through the medical school 
and hospital took her again to Lee, as he 
described the excruciating wait for a heart. “All 
the kinds of encouraging and supporting things 
the patient wants to hear from me largely center 
around ‘When am I going to be transplanted?’ 
And it’s the one question I cannot answer. ... 
Most of my patients will tell you I am very 
quiet, I don’t have many words.” He describes 
telling an African-American patient that he 
needed a new heart. “And he looked at me and 
said, ‘They don’t transplant black people,’ and 
I looked at him and I said, ‘You’re kidding, do 
you really believe that?’ And he did. So it was a 
very, very joyous day in my life to walk into his 
room and say: ‘We have a heart for you today. 
Believe it.’ ” 
Smith portrayed Associate Dean Ruth Katz, 
M.P.H., J.D., recalling her treatment for cancer. 
“As much faith as you have in this place, every 
time they give you chemotherapy ... I had a 
friend there with me to make sure the bag of 
chemotherapy with that stuff in there that they 
were about to pump into me was exactly what 
I was supposed to get. No more. No less.” In a 
moment of comic relief, Katz recalls the day an 
oncology fellow reported that Katz’s chart had 
been lost and that he had to take a new history 
from the very beginning. He came to the ques¬ 
tion of her occupation and learned that Katz 
was associate dean of the medical school. “Now 
he looks up and he said, ‘At this medical school?’ 
And I said, ‘At the Yale School of Medicine.’ 
He found my flies within a half an hour.” 
The last patient portrayed on the stage was 
Karina Danvers, a woman with HIV: “People 
think that just because you have a terminal ill¬ 
ness, or chronic or whatever they want to call 
it, all of a sudden every day is just precious and 
wonderful. I still beep my horn when some¬ 
body’s at the red light for too long.” She paus¬ 
es. “I wish sometimes people would feel sorry 
for me. Ya know? Because it’s really tough liv¬ 
ing this ... I am a young woman ... dying.” 
The presentation was “an affirming reminder of 
how valuable and privileged our connections 
with patients are,” said Stephen J. Huot, M.D., 
PH.D., HS ’87, associate professor of medicine. 
“It was wonderful to see humanity as part of 
medical grand rounds.” First-year medical stu¬ 
dent Michael Shapiro said watching Smith por¬ 
tray Yale doctors made him ask himself again 
how well he listens. “Anna Deavere Smith in 
essence was holding a mirror up to the audi¬ 
ence and saying, ‘Look at you, look at what 
you’re doing.’ ” 
Shapiro’s classmate, Jenny Yiee, said that 
by inviting Smith to campus, the medical 
school administration had validated Yiee’s belief 
that doctor-patient communication is vital. 
Some students, Yiee said, believe that under¬ 
standing science is more valuable than under¬ 
standing patients. They regard the required 
first-year course known as “The Doctor-Patient 
Encounter” as a “blah-blah-blah class,” saying, 
“Let’s go study biochem now.” 
Musician Roche, formerly of The Roches, 
said she felt elated after performing a script 
about medicine for an audience of physicians. 
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Tick tock tick tock. Which was going to come first, his death or a donor organ? [The wait] is absolutely the 
most diffcult part of the job, absolutely the most diffcult part. If I had to face every patient on the waiting 
list and talk to them about their waiting I could not do this. The stresses that are put on the physicians 
and nurses and other caregivers are absolutely phenomenal.... Patients want the answer today or want the 
solution today.... But I have no control over when an organ is going to be available. 
“It’s what theater could really be. Instead of big 
stars and People magazine, it could be relevant 
to people’s lives in their own community.” 
For third-year resident Christopher Ruser, 
M.D., Rounding It served as an antidote to 
the effects of residency. “I think residency has a 
tendency to depersonalize patients because of 
pressures, time limitations, fatigue. Watching 
Smith reminds us why we chose this career. ... 
We are privileged to be able to sit in a room 
and hear everything, to find out what their ill¬ 
ness means to them as a complete person.” 
Seeing the senior physicians depicted by Smith 
gave him hope that as he becomes more adept 
at reaching diagnoses, he will increasingly find 
ways to use the patient interview to become 
acquainted with the whole person. Because of 
the performance, Ruser said, “I would go in 
and really try to understand the person who 
was in that bed, and not just what I had to do 
for the patient in the next 24 hours.” 
Smith said in an interview that she’d come 
to understand that “the diagnostic procedure 
with a patient could by necessity—particularly 
for a younger doctor—require that they not 
see the whole person.” She hoped her work 
would help doctors “reflect on how, over time, 
to allow the whole person and the person who’s 
being inspected [by the physician] to both live.” 
Establishing that kind of connection with a 
patient is essential to good care, according to 
Rastegar. “People recognize quickly if you see 
them as a whole human being or are just treat¬ 
ing them as a disease. Despite all the wonderful 
therapeutic modalities we have developed, 
there are many diseases we cannot cure. So our 
role is helping them adjust to the illness and go 
on with their life. You need to know the whole 
person to do that. It’s in a marriage between 
scientific understanding and understanding of 
the human being in his or her totality that we 
can provide the best care.” 
Smith’s presentation and her discussions 
with students and house staff were part of what 
Horwitz describes as “a larger effort to refocus 
attention on the medical profession’s civic 
responsibility.” ffer visit was funded by a bequest 
from Daniel James, a patient and friend of 
Horwitz who died in 1998. Horwitz hopes to 
find money to bring Smith back to campus 
periodically, to continue the discussion begun 
last fall. 
Smith has not decided whether she will 
develop Rounding It Out into a full-fledged the¬ 
atrical production. That depends in part on 
finding a gtant to support the project. She 
describes the work as, “at best, an offering. I 
wanted it to be a provocation and a cause for 
conversation.” Rastegar said Smith’s visit has, 
indeed, made “a different kind of dialogue 
totally acceptable, a discussion of the patient’s 
narrative and their view of their illness.” 
The experience of having her story told in 
a public forum was fulfilling for patient 
Frankie Harris, whose painful account of being 
pimped by her mother made some people in 
the audience cry. “There was a time I felt that 
I was always alone, and there was a time that 
I felt that I deserved all that happened to me. 
It was healing to let go of the blame and let go 
of the shame.” 
-'.t 
It’s tough. It’s like playin’ God to say who is gonna live and who’s gonna die. So I was lucky. I passed all their 
tests. So then comes the waiting and that’s the hardest part. You get there and you’re wondering. They tell 
you, "You’re on the list now.” You’re waiting for this heart to come. Gender, race, nothing makes a difference. 
People think that just because you have a terminal illness, or chronic or whatever they want to call it, 
all of a sudden every day is Just precious and wonderful. 1 still beep my horn when somebody’s at the red 
light for too long. I wish sometimes people would feel sorry for me. Ya know? Because it’s really tough 
living this.... I am a young woman ... dying. 
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story and photographs 
by John Curtis 
For a quarter-century the Wednesday 
Evening Clinic has offered steady 
care to patients and an unequaled lesson 
in medicine to Yale students. 
At the Wednesday Evening Clinic, 
medical students provide the first line 
of care, taking histories and exam¬ 
ining patients before presenting their 
cases to the attending physicians in 
the clinic. Here, Sarah Nikiforow goes 
over the details of a case and her 
proposed treatment plan with Morris 
Dillard, right, one of the clinic’s 
founders and, until five years ago, 
its director. 
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In the conference room that serves as 
meeting place, dining room, lounge, 
office and consulting room for the 
Wednesday Evening Clinic, director 
Kathleen White and student director 
Fran Balamuth discuss one of the 
evening’s cases. 
“Don’t stop exercising,” Sarah Niki- 
forow tells her patient, Mary Jacob, 
who’s in for a checkup. Nikiforow, who 
monitors Jacob’s cerebral palsy, tests 
her patient’s arm strength. 
i 
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Kathleen White, m.d., likes to tell the story of the clinic patient who worried 
that her doctor was not there to care for her. Although surrounded by people in 
white coats with stethoscopes dangling from their necks, none of them was 
the person who knew and understood her medical history and with whom she 
had established a bond. They were doctors, but 
they were not her doctor. Her doctor was a med¬ 
ical student, working under the supervision of 
attending physicians. And the patient had been 
receiving her primary care at the Wednesday 
Evening Clinic. 
Since the mid-1970s, the clinic has provided 
care to the New Haven community while giving 
students a chance to practice “longitudinal,” or 
long-term, medicine and learn how to connect 
with their patients. “This is the only place in 
med school,” said Fran Balamuth, the clinics 
student director, “where you get to see the same 
patient again and again.” 
This is no small thing. Typically medical 
students spend no more than four weeks on each 
of their clinical clerkships. That time is often 
spent watching residents work, with an occa¬ 
sional chance to practice hands-on medical care 
under supervision. Some schools offer longitu¬ 
dinal preceptorships in the first two years of 
medical school, and some student-run clinics 
provide opportunities to assist in emergency care 
or serve as patient advocates. The University of 
Connecticut places first-year medical students 
with practicing clinicians, a match that contin¬ 
ues through the third year of medical school. 
White said. But in general, at Yale and around 
the country, medical students have few oppor¬ 
tunities to follow patients over time. 
At the Wednesday Evening Clinic, the stu¬ 
dents are the first to see patients, the first to take 
histories and the first to conduct physical exami¬ 
nations. “The whole idea of longitudinal care 
struck me as being an awfully important one,” 
said John E. Whitcomb, M.D. ’77. one of the 
clinics earliest student participants, who now 
practices emergency medicine in Milwaukee. 
“I wanted to have a relationship with people.” 
Added Lynn E. Sullivan, M.D. ’96, HS ’00, 
who spent 18 months in the clinic when she 
took time off from medical school to have her 
second child, “It isn’t the fleeting kind of expe¬ 
rience you have on your clerkships. My patients 
would ask for me by name and only want to see 
me.” Sullivan, now an assistant clinical professor 
of medicine, is also one of the clinic’s attendings. 
A year ago the clinic’s student practitioners 
honored the man they credit not only with 
founding the clinic a quarter-century ago, but 
with keeping it going and making it a warm 
and welcoming place to learn medicine. They 
held the first lecture in recognition of G. Morris 
Dillard, ph.d., m.d., who served as the clinic’s 
director until five years ago. Howard K. Koh, 
M.D. ’77, M.P.H., now Commissioner of Public 
Health for the Commonwealth of Massachusetts, 
was the first speaker at the Morris Dillard 
Honorary Lecture, in January 2000. “On rare 
occasions, one has the incredible fortune to 
gain a mentor who changes your life,” Koh said 
of Dillard. “Dr. Dillard believed in us and in 
our full potential. He encouraged us to become 
doctors in our own way. When he adopted you 
as a student, he would stand by you forever.” 
Dillard has counseled students, nurtured 
them and bucked up their flagging spirits. Each 
Thanksgiving he cooks one of his legendary 
gourmet dinners for the clinic. “He has made it 
a very warm, friendly and cohesive group of 
people,” said White, who succeeded Dillard as 
the clinic’s medical director five years ago. “He 
is the heart and soul of the clinic,” said Wendy 
Garrett, who is in her seventh year of the 
M.D./ph.d. Program and until recently served 
as the clinic’s student director. 
The clinic started in the mid-1970s, when 
students asked the medical school administra¬ 
tion for a longitudinal primary-care experi¬ 
ence. The administration declined, but invited 
students to organize their own program. 
“They gave the students the responsibility for 
forming the clinic, running the clinic and 
obtaining the appropriate support from the 
faculty,” recalled Dillard. Students found space 
John Curtis is the associate editor of Yale Medicine. 
This IS the only plac In ned 
school where you get to 
see the same patient „gain 
and again. 
— Fran Baiamuth, student 
director of the Wednesday 
Evening Clinic 
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in the Primary Care Center, which was closed 
evenings, and enlisted the support of physi¬ 
cians, nurses and support staff willing to vol¬ 
unteer their time. “At first it was very difficult 
to get patients,” said Dillard. “But we were the 
only clinic open at night in the hospital. We 
were the first clinic to have an on-call physi¬ 
cian. We could be contacted 24 hours a day, 
seven days a week, every day of the year.” 
Then, as now, patient population came 
largely through the Primary Care Center, the 
emergency department and self-referrals. 
Although it had the virtue of being open at 
night, the clinic also acquired a stigma it has 
since overcome. “The students endured the 
discrimination of being a student clinic, 
despite the presence of attendings,” said Dil¬ 
lard, who, along with clinic director White, 
leads a rotating cadre of faculty and communi¬ 
ty physicians who supervise the students. 
A white-haired, bespectacled doctor who 
listens quietly as students present cases, Dillard 
seems, the students say, to know everything 
about everything. And he also appears to know 
things without being told. “I was having a bad 
night,” recalled Nir Modiano, a fifth-year 
student in the M.D./PH.D. Program. It was half 
an hour past closing time and patients were 
still waiting to be seen. “Without knowing 
what was going on he came up to me, put both 
his hands on my shoulders and stood there for 
a few seconds. I don’t think he said a word. 
Then he turned around and walked away, and 
I felt better.” 
The clinic’s caregivers get to know each other 
over dinner every Wednesday. They take turns 
providing the evening meal, often a stack of piz¬ 
zas on the conference room table. As they eat, 
students and faculty discuss clinic business, such 
as a plan to obtain free samples for their patients 
from pharmaceutical companies. They may 
review an unusual case—one night it was a 
patient from the Sudan with a calcified worm 
under her skin. Often the group breaks up into 
two or three smaller sessions for case reviews with 
an attending. By 6 p.m. the students are ready 
for the two to four patients each of them will see. 
“We do a thorough history,” said Modiano. 
“We do a physical exam and formulate our 
own thoughts, then present the patient to the 
attending.” The student returns to the exami¬ 
nation room with the attending, who may 
obtain more history or conduct another physi¬ 
cal exam. “The student may have already come 
up with a plan of treatment,” said White, “and 
the attending will verify specific exam findings 
and confirm the plan or alter or add to it.” 
Some nights, when attendings are in short 
supply, the students wait their turn for a con¬ 
sult. Some students huddle with attendings in 
a corner or the doorway as others squeeze into 
the conference room to look for patient charts 
or grab a slice of pizza. Their cases run the 
gamut—a 76-year-old woman with a lung 
obstruction, a patient with diabetes, a woman 
suffering from osteoporosis, a patient with 
chest pain, a refugee from Sierra Leone with 
post-traumatic stress disorder. 
One evening Sarah Nikiforow’s patient was 
Mary Jacob, a 35-year-old with cerebral palsy. 
With five years at the clinic (she’s in her eighth 
year of the M.D./PH.D. Program), Nikiforow is 
the clinic veteran. Jacob, who has arthritis and 
occasional muscle spasms, has been her patient 
for years. “Don’t stop exercising,” Nikiforow 
told her, after a physical exam. “That’s what’s 
keeping you in such good shape.” 
Ongoing relationships with patients are but 
one of the benefits of the clinic for students. 
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FAR LEFT In One of the examination 
rooms, Nir Modiano interviews a 
new patient. 
MIDDLE Every Wednesday, after din¬ 
ner and before the clinic opens, the 
students break up into small groups 
led by an attending for a case review. 
Dillard meets with students Leo Kim, 
Wendy Garrett and Dita Cratzinger. 
LEFT With space scarce, Jackie William 
uses the counter at a nurses’ station to 
fill out a patient’s chart. 
Another is the chance to work with a network 
of physicians they will see repeatedly over the 
course of a year or longer. During their time at 
the clinic the students observe a variety of 
styles, including Dillards. “He steps back and 
does nothing at times and the students take 
over and make a decision,” said clinic director 
White. “He has made it a very academically 
challenging place.” Such longitudinal clinics. 
White said, provide an obvious benefit to med¬ 
ical students. “You watch them start as clumsy 
ducklings and then blossom into competent 
and caring clinicians.” 
The clinic blends elements of the real world 
and an idealized vision of medicine. With their 
limited case loads and no need to make a living 
from clinical practice, students have the luxury" 
of time denied many physicians. They are on 
call and often accompany their patients to 
other medical appointments or the hospital. 
“Its a great opportunity for the patients,” said 
Shelly Harrigan, R.N., who’s worked at the 
clinic for three years. “The students do excel¬ 
lent follow-up.” 
“Patients who have medical students help¬ 
ing to take care of them are some of the best- 
cared-for patients,” said Sullivan. “The stu¬ 
dents are just aching to see patients and start 
being doctors. This is a way in which they can 
do it in a very organized, safe and nurturing 
environment.” 
Dorothy Mosley, a patient at the clinic since 
1981, has never thought twice about being seen 
by medical students. “I had all good ones,” she 
said. “I knew if I had a problem I could call 
someone. They are helping me through my cri¬ 
sis right now. When my husband passed away 
in May, Dr. Dillard was right there for me. 
Wendy Garrett was right there for me.” 
The students themselves. White said, have 
asked for some changes in the program. They 
want more constructive criticism from the 
attendings and more detailed instruction in 
giving a physical examination. “The nature of 
the clinic is that we attempt to give feedback at 
the time, as difficult as it is,” White said, 
adding that Herbert S. Chase Jr., M.D., deputy 
dean for education, is planning an evaluation 
of the clinic’s value as a teaching tool. 
A year in the clinic replaces a month-long 
primary-care clerkship, making it very attrac¬ 
tive to students in the M.D./PH.D. Program, 
who have filled most of the 14 student staff 
positions for the past three years. The clinic lets 
them advance their clinical skills while they 
work on their research projects and it provides 
a welcome break from days in the lab. Students 
in the clinic are trying to broaden their out¬ 
reach and recruit more students outside the 
M.D./PH.D. Program. 
By 9 p.m. the students are seeing their last 
patients of the evening. Long after patients 
have left, the students will stay on, writing up 
their notes from the evening’s cases. Few leave 
before 10 p.m. and some stay until midnight, 
filling out charts. “There is no doubt in my 
mind that the cate our patients receive is sur¬ 
passed by no other clinic,” said Dillard. “The 
original clinic was designed by students to 
meet one time a week throughout the entire 
year, to be responsible for patients every day 
throughout the year. In return, the students 
receive an educational experience equal to the 
clinical responsibility.” 
Students in the Wednesday Evening 
Clinic are assembling a registry of 
the clinic's alumni. Alumni are encour¬ 
aged to send their address, phone 
number, e-mail address and a brief 
note describing their current activities 
to kathieen.white@yale.edu. 
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Letter from Armenia Story and photographs 
by Sharon Anoush Chekijian 
“Adrenaline and the ordinary, 
in varying proportions” 
A student's exposure to medicine in this former 
Soviet republic reveals a different rhythm in 
the OR and a vastly different take on relations 
between doctor and patient. 
ABOVE A woman walks past the 13th- ‘ ti 
century Katoghike, right, the oldest / 
surviving church in Yerevan, Armenia's 
capital. Armenia is bordered by Ceor- 
gia,Azerbaijan, Iran and Turkey. The 
author, second from right, poses with ^ ' 
medical staff during her second trip 
to Armenia in 1995. 
OPPOSITE An anesthesiologist in 
Cyumri, Armenia’s second-largest city, 
looks up from his work. 
II 
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It is not unheard of to receive 
a ton of potatoes, or even a cow, 
from a patient unable to pay 
in cash.... In outlying country 
hospitals, the pay might be 
a home-cooked meal followed 
by toasts of vodka brought 
to the hospital by the family to 
celebrate a successful operation. 
ABOVE Surgeon Gevork Yaghjyan in 
front of the military hospital in 
Stepanakert, the capital of Nagorno- 
Karabakh. During the worst of the 
fighting there in the early 1990s, 
Yaghjyan made dozens of trips to the 
region by helicopter to perform 
reconstructive surgery. 
OPPOSITE, CLOCKWISE FROM TOP 
LE FT A young girl stands in a doorway 
in the village of Karindagh; an older 
woman tends to her vines; a quarry- 
man uses wooden poles to break up a 
boulder; a mother in Armenia’s earth¬ 
quake region holds her newborn infant. 
On the surgical service at First Hospital in 
Yerevan, the Republic of Armenia’s only teach¬ 
ing hospital, rounds begin each morning at 
9:15. This might seem late to a doctor from 
New Haven, where residents and students “pre- 
round” at 4:30 a.m. in preparation for the daily 
ritual two hours later. But here in Yerevan the 
surgeons virtually live at the hospital and there 
is little need to catch up each morning. 
Rounds are conducted in Russian, the lin¬ 
gua franca of professional and intellectual life 
in this former Soviet state, and consist mostly 
of a seated discussion in a smoky room. There is 
no operative schedule as such, no operating- 
room start time. The operating room is reserved 
on a first-come, first-served basis by alerting the 
nurse in charge that there will be a patient arriv¬ 
ing shortly, after which begins the process of 
negotiating for staff to assist in the surgery. 
Emergencies are numerous and take priority, but 
the hospital has no emergency room. Patients are 
evaluated in the driveway, the hall or the doctors’ 
offices depending on the severity of their illness. 
On this hot, dry morning, Gevork 
Yaghjyan, M.D., PH.D., and I are back in his 
office by 10:15, the bme when patients and doc¬ 
tors begin to file in for the day’s consultations. 
The door opens without a knock: “Gevork 
Vigenovitch, ais deh a?" 
“Is Gevork Vigenovitch here?” 
An assistant professor, Gevork is the youngest 
faculty member at Yerevan State Medical Univer¬ 
sity, and at the age of 31 he has already earned his 
patronym, a sign of respect. Gevork is one of 
eight microsurgeons in Armenia, a country of 
3.3 million inhabitants bordered by Azerbaijan, 
Georgia, Iran and Turkey. 
Every day is different: no clinic days, no 
operative days, just a combination of adrenaline 
and the ordinary in varying proportions. There 
is no call every third or fourth night. There is 
call whenever you are lucky to be on the sched¬ 
ule. And if you are one of the only specialists in 
the country, call is every day. Doctors here ask 
for extra duty. It is their only true source of 
income, not counting the official pay of about 
$20 a month. How many of us would enter a 
profession with numbers like that? 
In addition to what they earn from the hos¬ 
pital, the surgeons receive fees from their grate¬ 
ful patients. What they are paid depends on the 
means of the patient’s family. It is not unheard 
of to receive a ton of potatoes, or even a cow. 
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Sharon Chekijian graduated from the School of Medicine in 
May and will begin a residency in surgery this summer at 
the Hospital of the University of Pennsylvania. 
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It was dijficultfor me to imagine 
American surgeons sitting down 
to a meal with the patient’s family. 
They laughed when the doctors 
told them that I was not used to 
such close relations between patient 
and doctor. 
from a patient unable to pay in cash. It falls to 
Gevork as surgeon to make sure that the anes¬ 
thesiologist, nurses and others who assisted 
receive fair compensation—a matter that can 
become quite complicated when the currency is 
livestock. Remuneration comes in other forms, 
too. In outlying country hospitals, the pay might 
be a home-cooked meal followed by toasts of 
vodka brought to the hospital by the family to 
celebrate a successful operation. It was difficult 
for me to imagine American surgeons sitting 
down to a meal with the patient’s family. They 
laughed when the doctors told them that I 
was not used to such close relations between 
patient and doctor. 
The personal touch in Armenian medicine 
is apparent in other ways as well. Apartment 
buildings usually have a doctor living there. So 
that even when doctors are home, for all intents 
and purposes they are on call. Any emergency is 
their responsibility—not a legal or an adminis¬ 
trative responsibility but an ethical and human 
one that everyone takes for granted. 
Once a medical student named Artur 
was traveling in the mountains of Nagorno- 
Karabakh, six hours away from Yerevan. 
Nagorno-Karabakh is an historically Armenian 
land and a focus of Armenian art and culture. 
Under the Soviets, Stalin redrew maps of 
the region and included Nagorno-Karabakh in 
the Soviet Republic of Azerbaijan. Fighting 
broke out there in 1988, shortly after the region 
asked to be annexed to the Soviet Republic 
of Armenia, and the conflict intensified in 1991 
when Nagorno-Karabakh asked to become 
an independent state, as had Armenia and 
Azerbaijan. A cease-fire has been in effect since 
1994, with Nagorno-Karabakh now function¬ 
ing as an independent republic. 
Artur was among a group of medical students 
traveling to the region when soldiers stopped 
their bus at a checkpoint. The worried students 
stepped out onto the road to be searched. Artur 
recognized the scarred hand of one of the sol¬ 
diers from a photo he had seen in a lecture in 
Yerevan. “Was Gevork your surgeon?” Artur 
asked, thinking quickly. The soldier said, “No, 
Gevork was not my surgeon.” He paused and 
looked at Artur, sizing him up, then wrapped 
his huge arms around the student in a bear 
hug. “Gevork,” he declared, “is my brother.” 
With that, Artur and his fellow travelers were 
sent on their way. 
Our scrupulous avoidance of treating one’s 
own family or friend is unthinkable in a coun¬ 
try where all business is conducted on the basis 
of personal contacts and many patients and 
doctors become friends for life. Gevork is well 
known in Nagorno-Karabakh. During the 
peak of the fighting in the early 1990s, he made 
dozens of trips by helicopter to perform 
reconstructive surgery. The first time Gevork 
invited me to the hospital in Yerevan, it was 
to help him change the bandages of a soldier 
from Nagorno-Karabakh who had been flown 
to the capital after a land-mine explosion. 
Each day in First Hospital brings new surgi¬ 
cal challenges. One day, a girl from a region 
near ex-Soviet Georgia was brought in. Local 
doctors had treated her after a bad car accident, 
but her leg became so infected that the skin 
had to be removed from the knee to the ankle. 
We treated her with antibiotics and then skin 
was grafted from both hips to cover the defect. 
There was the patient with a gunshot wound to 
the buttocks that had severed the sciatic nerve. 
Another gunshot victim arrived with the third 
and fourth metacarpal bones of the hand frac¬ 
tured beyond recognition. There was a young 
girl with a facial nerve severed by a small injury 
who looked fine until she smiled and her face 
took on a twisted shape. For the longest time I 
forgot about what we commonly think a plastic 
surgeon does. In the middle of the relative chaos 
of First Hospital, there are the rare few who seek 
cosmetic surgery, breast augmentation, rhino¬ 
plasty or facelifts. These seem frivolous in a place 
where every induction of anesthesia and every 
operation bear an unbelievable risk compared to 
those done in the vasdy more controlled settings 
of the operating rooms back home. 
Gevork knows that world as well. Early last 
year, he came to Yale to study the physiology of 
surgical flaps with J. Grant Thomson, M.D., an 
associate professor in the section of plastic and 
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TOP PHOTO Young brothers pose 
for a photograph in the kitchen of their 
home in Yerevan. 
ABOVE Children in the village of 
Gogaran take a break from their play. 
1. 
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reconstructive surgery. Gevork, back in Armenia 
since last May, will return to Yale later this year as 
a Plastic Surgery Education Foundation lellow. 
Yale’s involvement in Armenia has been 
steady since the earthquake in 1988. Staff from 
the Erebuni Hospital have been training at Yale. 
One of Armenia’s recent ministers of health, 
Gagik Stamboltsyan, trained at Yale before 
assuming his new position. Under the direction 
of then-Chief of Plastic Surgery Stephan Ariyan, 
M.D., the Yale Center for Plastic and Recon¬ 
structive Surgery was built at the Erebuni Hos¬ 
pital in Yerevan to accommodate the increased 
need for reconstructive surgery during the 
clashes in Nagorno-Karabakh. Several operating 
rooms were completed and Armenia was also 
chosen as one of four sites for the Yale/NASA 
telemedicine project that links doctors around 
the world in a network meant for teaching and 
consultation. More recently, Artoum Sedrakian, 
M.D., a young cardiac surgeon from Yerevan, 
came to New Haven as a Fulbright scholar to 
conduct clinical outcomes research with cardi¬ 
ologist Harlan M. Krumholz, M.D. 
My father was born in Jerusalem to Armenian 
parents. My grandmother and grandfather 
came from the Armenian cities of Marash and 
Zeytoon, in what is today eastern Turkey, and 
fled as children in the wake of the massacres 
of Armenians in 1915. My grandmother was 
orphaned as a result of the massacres and was 
sent to an orphanage for Armenian children 
in Lebanon. She grew up in the orphanage and 
became one of their best students. There, she 
became a teacher. At a teachers’ conference in 
Lebanon she met her future sister-in-law, who 
hastily arranged for her to marry my grand¬ 
father. My grandfather lived at that time in 
Allepo, Syria. They married in 1933. 
Their first child, my aunt Hermine, was 
born in 1934. That same year, my grandfather 
went to Jerusalem in search of a better life for 
his growing family. Jerusalem boasted a large 
Armenian community until the late 1950s, and 
part of our family was already living and work¬ 
ing there. My grandmother and aunt followed 
him in 1935. My grandfather made shoes and, 
in time, came to run his own factory, employ¬ 
ing over 20 men. He lost everything during the 
Arab-Israeli War, when Jerusalem was parti¬ 
tioned and his family was sequestered in the 
Armenian Quarter of the Old City of Jerusalem. 
He could no longer travel throughout the 
Middle East as he had done, taking orders for 
his products. Many families began looking 
for sponsors in the United States. A grade- 
school Iriend of my grandfather, long settled in 
Boston’s Armenian community, had seen his 
name and photograph in a church publication, 
and offered to sponsor his relocation to Ameri¬ 
ca. In October of 1957, my family set sail from 
Beirut on the SS Corinthia, bound for the 
United States. They arrived on Christmas Eve. 
My father was 16 when the family arrived in 
Massachusetts. After high school, he went to 
Boston University, then served in the Army. At 
Fort Bragg in North Carolina, he met my moth¬ 
er, and they married and moved to Phoenix after 
he left the service so that he could attend gradu¬ 
ate school. They returned to Boston in 1973, 
where he pursued his career in the hotel industry 
and where I grew up. 
My curiosity about Armenia grew while I 
was in college. I wanted to explore a land I had 
heard described in mythic terms throughout 
my childhood. After my junior year in France 
in 1991, I applied to the University of Michigan 
Summer Language Institute in Yerevan and left 
the labyrinth-like streets of Paris for the unpaved 
mountain roads of a truly foreign country. When 
I arrived, many French, American and Armen¬ 
ian-born doctors were still providing earthquake 
relief Almost four years later, determined to 
become a doctor, 1 attended the Armenian 
Medical Congress in Boston as part of a plan to 
visit Armenia in July 1995. I had graduated from 
Smith in 1992 and worked in the pubic health 
field in New York City for several years, on 
projects designed to improve prenatal care and 
boost immunization rates. 
The Congress served as a crash course in the 
current status of health care. Armenians from 
all over the world had come to listen to then- 
Minister of Health Ara Babloyan, M.D., and 
see how they might help fortify the country’s 
health care system. I phoned a friend, Alain 
Hovnanian, M.D., a physician in Paris, to tell 
him about my trip and to ask how I might be 
helpful to him while in Armenia. There was a 
notable pause and a sigh of relief He had just 
received a letter from a woman named Assia, 
whom he had met in the village of Gogaran, 
where he had helped in the reconstruction of 
an 11th-century church. Assia was on chronic 
dialysis and, given the state of the hospitals and 
pharmacies, was unable to buy necessities such 
as fistulas, filters and tubing. Although kidney 
disease is a serious health problem in Armenia, 
as it is in the United States, organ transplanta¬ 
tion has not yet been established as a wide¬ 
spread therapy. Alain asked if I would be able 
to transport supplies to Assia and communicate 
his concern. I did so, and four years after I had 
first met Alain in Paris, I found myself on a 
back road in the village of Gogaran looking for 
Assia’s house, which I had been told lay some¬ 
where past the beekeeper’s house but before the 
potato fields. 
It was during this trip in 1995 that I met 
Gevork. I asked him if I could observe in the 
operating room. There I witnessed my first oper¬ 
ation, the setting of a woman’s broken femur. To 
my surprise, I loved surgery. I watched as a car¬ 
diac surgeon from Oregon augmented the ven¬ 
tricle of a i2-year-old girl. Hrair Hovagumian, 
M.D., had come to Armenia for a month to 
instruct other surgeons and ended up taking an 
indefinite leave of absence from his university 
post. He remained in Armenia, where he is now 
performing three open-heart surgeries a day and 
was grinning widely when I last saw him. 
Since arriving at Yale as a first-year medical 
student in 1997, I have had five more opportu¬ 
nities to return to Armenia. Each trip has been 
a chance to reformulate plans, to re-evaluate 
decisions and to reflect. These trips have been a 
break from the ordinary and a chance to under¬ 
stand how truly fortunate we are. For me, travel 
has served as both a buffer and a catalyst between 
periods of contemplation and intervening peri¬ 
ods of hard work. I began my thesis. Legal, Pro¬ 
fessional, Public and Policy Barriers to the Develop¬ 
ment of Organ Donation and Transplantation in 
the Republic of Armenia, in 1998 in cooperation 
with the Armenian Ministry of Health. 
My initial contact with the Department of 
Plastic and Reconstructive Surgery at the Uni¬ 
versity Teaching Hospital in Yerevan in 1995 led 
to repeated visits over the last six years and an 
education in reconstructive surgery that has 
continued despite the distance. Gevork and his 
colleagues have shared their work with me 
long-distance, e-mailing images of their most 
interesting cases. I have spent long hours with 
Gevork and the other surgeons, traveling by road 
to the military hospital in Nagorno-Karabakh. 
We have visited every hospital in the Republic of 
Armenia, checking on the progress of flaps creat¬ 
ed earlier in the day. 
The patients I have seen in Armenia have 
provided the most vivid reminders of why we 
practice medicine. One was a young boy whose 
forehead was burned so badly by an electric 
shock that there was no flesh to cover his skull. 
Another was a little boy holding his severed 
finger in a dirty dishtowel. There was a boy 
whose nose was all but removed by the bite of a 
dog, a young woman whose breast was recon¬ 
structed after a mastectomy, and a woman whose 
Our scrupulous avoidance of 
treating one’s own family or friend 
is unthinkable in a country 
where all business is conducted on 
the basis of personal contacts 
and many patients and doctors 
become friends for life. 
lips and nose were eaten away by a basal cell car¬ 
cinoma, neglected for years due to lack of money. 
Despite limited resources, Gevork has been 
able to form a small laboratory in Yerevan 
where he is investigating the factors that allow 
his patients to heal. All the reagents in the lab 
are painstakingly prepared from scratch by the 
students and residents. He purchases rats him¬ 
self from a man who breeds them for medical 
research. In New Haven I don’t think Gevork 
ever got used to ordering rats from a catalog or 
seeing animals treated better than most of his 
patients in Yerevan. The true mark of luxury to 
him was that a veterinarian would be called 
should a lab rat fall ill. Indeed, Gevork’s experi¬ 
ence at Yale has been a far cry from his life at 
home. He is constantly amazed by the organi¬ 
zation of things, by the operative schedule, by 
the way an instrument magically appears when 
a surgeon calls for it, by the orderly progress of 
clinic and follow-up visits, by the labs and by 
our easy ability to sequence DNA, make radio¬ 
active tags for molecules and measure ischemia. 
He is amazed but I also think he feels the same 
way that I do, that we give up something in 
return. There is a bond with patients in Arme¬ 
nia, a sense of urgency and vitality that often 
seems to be missing here. 
An ambulance waits outside Erebuni 
Hospital in Yerevan. 
A knock on the door brings a new patient 
eagerly peering past the crowd of residents and 
patients that routinely fill Gevork’s office and 
spill out into the hall. I hear the familiar 
“Gevork Vigenovitch, ais deh a?" and wonder 
what the day will bring. 
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FACULTY NEWS 
Schlessinger 
Udelsman 
Edelson 
Leffell 
Siegel 
New chairs appointed in 
three departments; clinical 
leadership changes 
Dean David A. Kessler, M.D., has announced 
the appointment of three new chairs to lead the 
departments of Cell Biology, Pharmacology 
and Surgery. 
Ira Mellman, ph.d., became chair of the 
Department of Cell Biology in December. 
Mellman, who earned his doctoral degree in 
genetics from Yale in 1978, has been on the fac¬ 
ulty since 1981. He is a member of the Ludwig 
Institute for Cancer Research, which provides 
research support to his laboratory and increas¬ 
ingly to Yale as a whole, and serves as editor-in- 
chief of The Journal of Cell Biology and on the 
editorial boards of Cell and The Journal of 
Experimental Medicine. He is also a professor of 
immunobiology and the founding director of 
Yale’s interdepartmental graduate Program in 
the Biological and Biomedical Sciences (bbs). 
Mellman’s research focuses on how cells 
control the composition of their intracellular 
membranes. He is credited with the discovery 
and definition of cell organelles known as 
endosomes, which enable cells to take up 
macromolecules such as hormones, and with 
the identification of mechanisms enabling indi¬ 
vidual cells to generate and maintain the asym¬ 
metries required to produce complex multicel¬ 
lular structures such as organs and tissues. His 
laboratory group is now investigating the cellu¬ 
lar basis of the immune response and has 
revealed the inner workings of dendritic cells, 
which are uniquely responsible for initiating 
virtually all known immune responses. Lynn 
Cooley, PH.D., associate professor of genetics 
and cell biology, will succeed Mellman as direc¬ 
tor of the BBS. 
Joseph Schlessinger, PH.D., arrived at Yale 
on Feb. i as the new chair of the Department 
of Pharmacology. Schlessinger, who headed the 
pharmacology department at New York Uni¬ 
versity School of Medicine and directed the 
Skirball Institute of Biomolecular Medicine, is 
one of a handful of scientists leading the signal 
transduction field. For the past 25 years he has 
been the single most visible figure in the area 
of signal transduction via receptor tyrosine 
kinases, molecules at the cell surface that tell 
cells when to grow or stop growing. 
Schlessinger, who was elected a member of 
the National Academy of Sciences last year, is 
one of the most frequently referenced authors 
in biomedical science and a co-founder of 
SUGEN Inc., a biotech company in South 
San Francisco that was acquired in 1999 by 
Pharmacia and Upjohn. He serves on the 
boards of a dozen journals, including The 
EMBO Journal Cell and Molecular Cell In con¬ 
junction with Schlessinger’s arrival, the school 
will renovate portions of the B-wing of Sterling 
Hall of Medicine and build a 15,000-square- 
foot addition. 
Robert Udelsman, M.D., M.S.B., m.b.a., 
will become chair of the Department of Surgery 
on June i. Udelsman is currently the Richard 
Darnall Professor of Surgery at Johns Hopkins, 
where he is also director of endocrine and 
oncologic surgery. 
Udelsman completed his medical training at 
George Washington University School of Med¬ 
icine and Health Sciences and his surgical resi¬ 
dency and chief residency at the Johns Hop¬ 
kins Hospital. In addition, he has completed 
fellowships in surgical oncology at the National 
Cancer Institute, in endocrinology at the 
National Institute of Child Health and Human 
Development, and in gastrointestinal surgery at 
Johns Hopkins Hospital. His research and clin¬ 
ical interests focus heavily on endocrine sur¬ 
gery, particularly endocrine oncology. His clini¬ 
cal practice focuses on surgery of the thyroid, 
parathyroid, adrenal gland and endocrine pan¬ 
creas. His clinical research focuses on outcome 
research, particularly on innovative techniques 
for minimizing the trauma of surgery. These 
are particularly relevant to laparoscopic adrena¬ 
lectomy and outpatient minimally invasive 
parathyroidectomy. 
Dean’s office appointments 
Several key administrative appointments were 
announced recently as well. 
Richard L. Edelson, M.D. ’70, professor and 
chair of the Department of Dermatology, 
was named deputy dean for clinical affairs. His 
responsibilities include activities related to 
research, training and services for the entire clin¬ 
ical enterprise. He will also serve as the chief 
clinical liaison between the dean’s office and the 
clinical leadership of Yale-New Haven Hospital. 
David J. Leffell, M.D., HS ’86, professor 
of dermatology and director of the Yale Med¬ 
ical Group, was promoted to senior associate 
dean for clinical activities and strategic plan¬ 
ning. Leffell will help to develop, initiate and 
carry out plans necessary for the ongoing 
growth and sustained health of the medical 
school’s clinical programs. 
Norman J. Siegel, M.D., professor of pedi¬ 
atrics and medicine and chair of the Yale Med- 
42 
ical Group’s finance committee, was named 
senior advisor for planning and priorities. 
Siegel will lead the school’s ad hoc committee 
on long-term financial planning. He will also 
become the school’s chief liaison to its affiliated 
hospitals in Connecticut, especially in regard to 
the implementation of the 1999 affiliation 
agreement between the medical school and the 
Yale New Haven Health System. 
Searches are under way for new chairs for 
the departments of Obstetrics and Gynecology 
and of Pediatrics and for a section chief in 
medical oncology. 
—Michael Fitzsousa 
Aghajanian, Hostetter elected 
to Institute of Medicine 
George K. Aghajanian, M.D., professor of psy¬ 
chiatry and pharmacology, and Margaret K. 
Hostetter, M.D., professor of pediatrics, chief of 
the section of pediatric immunology and director 
of the Yale Child Health Research Center, were 
elected in October to the Institute of Medicine. 
Aghajanian was named a senior member and 
Hostetter a member. 
Aghajanian is best known for his basic 
research on drugs and chemical neurotransmis¬ 
sion in the brain. His recent work on serotonin 
and glutamate has influenced investigations 
into treatments for neuropsychiatric disorders. 
Hostetter’s research focuses on virulence fac¬ 
tors in two important pathogens; Streptococcus 
pneumoniae, the leading cause of death from 
respiratory infections, and Candida albicans, 
the predominant cause of fatal fungal infec¬ 
tions in patients with compromised immune 
function. Hostetter co-founded the first clinic 
specializing in the medical and developmental 
evaluation of internationally adopted children 
and has transplanted this model to Yale. She 
serves on the Gouncil of the National Institute 
of Ghild Health and Human Development. 
Aghajanian Hostetter 
Thomas Steitz 
honored with Sterling 
Professorship 
Thomas A. Steitz, PH.D., 
internationally known for his 
work in X-ray crystallography, 
has been honored with an 
appointment as Sterling Pro¬ 
fessor of Molecular Biophysics 
and Biochemistry. 
Steitz’s research interests 
include the molecular structure 
of proteins and nucleic acids, 
the structural basis of enzyme 
mechanisms, and protein- 
nucleic acid interactions. He 
and his research team recently 
made a landmark scientific 
stride in determining the atom¬ 
ic structure of the ribosome’s 
large subunit (See Findings, Fall 
2000 I Winter 2001, page 16). 
Steitz joined the Yale facul¬ 
ty as an assistant professor in 
1970 and currendy serves as 
chair of the Department of 
Molecular Biophysics and Bio¬ 
chemistry. Steitz has been a 
Howard Hughes Medical 
Institute Investigator since 
1986 and is a member of the 
National Academy of Sciences, 
the American Academy of Arts 
and Sciences, and the Gon- 
necticut Academy of Science 
and Engineering. 
Patricia Goldman-Rakic 
named Eugene Higgins 
Professor of Neurobiology 
Patricia S. Goldman-Rakic, 
PH.D., a world leader in the 
study of the brain’s cellular 
mechanisms for memory and 
cognition, has been appointed 
the Eugene Higgins Professor 
of Neurobiology. 
Goldman-Rakic has con¬ 
ducted much of her research 
on the prefrontal cortex, the 
brain area most concerned 
with reasoning and thought. 
She has studied such issues as 
the development and organiza¬ 
tion of this area’s neural cir¬ 
cuitry and its physiological 
and pharmacological proper¬ 
ties in relation to its memory 
functions. Her work has 
shown how the modular struc¬ 
ture of neural connections 
constrains these functions. 
Before joining the Yale fac¬ 
ulty in 1979, Goldman-Rakic 
was chief of the section of 
developmental neurobiology at 
the National Institute of Men¬ 
tal Health. She is a fellow or 
member of the National Acade¬ 
my of Sciences, the Institute of 
Medicine, the American Acade¬ 
my of Arts and Sciences, the 
American Association for the 
Advancement of Science and 
the Society for Neuroscience. 
She served as president of the 
latter organization in 1990. 
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Faculty Notes 
Jennifer A. 
Doudna, 
PH.D., the 
Henry Ford II 
Professor of 
Molecular 
Biophysics and Biochemistry 
and an associate investigator at 
the Howard Hughes Medical 
Institute, has been chosen to 
receive the 2001 Eli Lilly Award 
in Biological Chemistry. This 
award, one of three to be pre¬ 
sented by the American Chem¬ 
ical Society’s Division of Bio¬ 
logical Chemistry in August, 
recognizes an individual who 
has accomplished outstanding 
research in biochemistry that 
reflects unusual independence 
and originality. Doudna’s work 
is aimed at determining the 
structural basis of rna cataly¬ 
sis using X-ray crystallography 
and biochemistry. 
Thomas M. 
Gill, M.D., 
associate 
professor of 
medicine and 
director of the 
Yale Fellowship in Geriatric 
Medicine and Clinical Epi¬ 
demiology, has been chosen to 
receive the 2001 Outstanding 
Scientific Achievement for 
Clinical Investigation Award 
from the American Geriatrics 
Society. Gill’s research is 
directed toward understanding 
the mechanisms underlying 
the development of functional 
decline and disability among 
community-living older persons 
and toward developing preven¬ 
tive strategies to forestall the 
onset and progression of dis¬ 
ability among at-risk elders 
who are frail. 
Elaine E. 
Grant, m.p.h. 
’92, PA-C, 
assistant dean 
and director of 
the Physician 
Associate Program, began a 
one-year term in January as 
president of the National Com¬ 
mission on Certification of 
Physician Assistants (nccpa). 
Grant is the NCCPa’s first 
female president and the first 
Association of Physician Assis¬ 
tant Programs appointee to 
serve in that role. She is current¬ 
ly serving her fourth four-year 
term on the NCCPA’s board. 
Dean David A. 
Kessler, m.d., 
^ received the 
' National 
y Academy of 
jH Sciences (nas) 
Public Welfare Medal in April 
at the NAS award ceremony 
in Washington. Kessler was 
recognized “for his courageous 
approach to public health 
issues, including insistence on 
the validity of drug labeling; 
protection of the impartiality 
of review boards; institution of 
mechanisms for fast-tracking 
drug approval, especially for 
orphan drugs and terminal 
malignancies; implementation 
of nutrient food labeling, and 
recognition that the addictive 
effects of tobacco require a 
more active intervention on 
the part of society and govern¬ 
ment. His legacy as commis¬ 
sioner of the Food and Drug 
Administration affects the lives 
of all Americans.” The medal 
was established to recognize 
distinguished contributions in 
the application of science to 
the public welfare and has 
been presented since 1914. 
K.J. Lee, m.d., 
associate clini¬ 
cal professor of 
surgery (oto¬ 
laryngology) 
and managing 
partner of the Southern New 
England Ear, Nose, Throat and 
Facial Plastic Surgery Group in 
New Haven, is president-elect 
of the American Academy of 
Otolaryngology Head and 
Neck Surgeons and will 
assume the presidency in Sep¬ 
tember. Lee is the author of 
Essential Otolaryngology. 
William H. 
Prusoff, PH.D., 
professor 
emeritus and 
senior research 
scientist in 
pharmacology, has been hon¬ 
ored by the creation of the 
William Prusoff Young Investi¬ 
gator Lecture Award. The 
award, supported by an endow¬ 
ment by the Bristol-Myers 
Squibb Company, will be given 
annually by the International 
Society for Antiviral Research. 
Its intent, the two organiza¬ 
tions said in a statement, is to 
honor “one of the most talent¬ 
ed and beloved members of 
the society and a loyal member 
since its inception. His contri¬ 
butions to the development of 
antivirals and their clinical use 
are legendary, and his dedica¬ 
tion to mentoring young sci¬ 
entists makes this award in his 
name truly appropriate.” 
Robert A. 
Rosenheck, 
M.D., HS ’77, 
professor of 
psychiatry and 
of epidemiol¬ 
ogy and public health, has 
received the Carl A. Taube 
Award for Distinguished Con¬ 
tributions to the Field of Men¬ 
tal Health Services Research 
from the Mental Health Sec¬ 
tion of the American Public 
Health Association. Rosenheck 
is a leading authority on home¬ 
lessness and post-traumatic 
stress disorder among veterans. 
The award is named in memory 
of Taube, a former staff mem¬ 
ber of the National Institute of 
Mental Health, who played a 
major role in creating the field 
of mental health services and 
M.Bruce 
Shields, m.d., 
professor and 
chair of 
ophthalmolo¬ 
gy and visual 
science, has been honored by 
the Duke University Eye Cen¬ 
ter with a professorship in his 
name. The endowed chair was 
made possible by a $1.2 mil¬ 
lion bequest by two grateful 
patients. Shields served on the 
faculty at Duke for 25 years 
before coming to Yale in 1997. 
policy research. 
Heping 
Zhang, PH.D., 
associate 
professor of 
epidemiology 
W and a member 
of the Child Study Center fac¬ 
ulty, has been named a fellow 
of the American Statistical 
Association (asa). Zhang was 
recognized at the Joint Statisti¬ 
cal Meetings in Indiana last 
summer “for significant contri¬ 
butions to methodology in 
non-parametric classification 
and non-linear regression, for 
influential work in statistical 
genetics, and for applications 
in epidemiology and psychia¬ 
try.” Zhang earned his doctor¬ 
ate at Stanford in 1991 and has 
been a member of the ASA 
since 1992. 
-Claire Bessinger 
Send faculty news items to: 
Claire Bessinger, Yale Medicine Publica¬ 
tions, P.O. Box 7612, New Haven, CT 
06519-0612 
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New Books 
The following books by or about alumni and 
faculty have recently been published. 
Descriptions are provided by the publisher. 
Clinical Urography, 2nd Ed., edited by Bruce L. 
McClennan, M.D., professor and chair of diag¬ 
nostic radiology, and Howard M. Pollack; W.B. 
Saunders (Philadelphia), 2000. This book is the 
standard textbook in genito-urinary radiology, 
a compilation of modern day imaging and 
intervention, and has been the reference book 
of choice for urologists and radiologists. 
Fragile Success:Ten Autistic Children, 
Childhood to Adulthood, 2nd Ed., by Virginia 
Walker Sperry, M.A., research affiliate in the Child 
Study Center, and the late Sally Provence; Paul H. 
Brookes Publishing Co. (Baltimore), 2001. For more 
than three decades, Sperry meticulously traced 
test results, experiences, social habits, family life, 
and work arrangements of lo individuals with 
autism. Her book offers a unique child-to-adult- 
hood look at autism — a severe developmental 
disorder characterized by social withdrawal and 
an inability to relate toothers—and is an invalu¬ 
able source of support to parents. 
International Public Health: Diseases, Pro¬ 
grams, Systems, and Policies, edited by Michael 
H. Merson, M.D., dean and professor of public 
health, Robert E. Black and Anne J. Mills; Aspen 
Publishers Inc. (Gaithersburg, Md.), 2001. By 
emphasizing diseases, programs, health sys¬ 
tems, and health policies, this textbook helps 
students understand the scope and depth of 
challenges of global public health issues and 
the various approaches nations adopt to deal 
with them. 
Leonardo da Vinci, by Sherwin B. Nuland, M.D. 
’55, HS ’6i, clinical professor of surgery; Upper/ 
Viking (New York), 2000. Being a physician, 
Nuland is particularly interested in Leonardo’s 
pioneering anatomical dissections and drawings. 
In this book, he completes his 20-year quest to 
understand an unlettered man who was painter, 
architect, engineer, philosopher, mathematician 
and scientist. 
Nutrition in Clinical Practice: A Comprehensive 
Evidence-Based Manual for the Practitioner, by 
David L Katz, M.D., M.P.H. ’93, associate clinical 
professor of public health; Lippincott Williams & 
Wilkins (Philadelphia), 2000. Comprehensive 
and sufficiently detailed to be of value to nutri¬ 
tionists, dietitians and clinical specialists, the 
book is intended to serve as the one nutrition 
reference non-specialists can rely on to answer 
almost all of the questions that come up in clin¬ 
ical practice. It is designed to help bring a con¬ 
sistent and meaningful dialogue about the role 
of nutrition in disease prevention and health 
promotion into the doctor-patient relationship. 
PC, M.D.: How Political Correctness is Corrupt¬ 
ing Medicine, by Sally Satel, M.D., HS '88; Basic 
Books (New York), 2000. Satel shows how politi¬ 
cal correctness has infected the world of medi¬ 
cine and public health—with results that may 
actually threaten everybody’s well-being. She 
begins by describing the presumption of some 
health professionals that because the sickest 
people in society are also disproportionately 
the poorest, the practice of medicine must 
address matters of social justice. She feels this 
has led to the diversion of resources away from 
what the medical profession does best—the 
treatment and prevention of injury and disease. 
Send notices of new books by or about 
alumni and faculty to Cheryl Violante, 
Yale Medicine Publications, P.O. Box 7612, 
New Haven, CT 06519-0612. 
Physician: The Life of Paul Beeson, by Richard 
Rapport, M.D.; Barricade Books (New York), 
2001. No contemporary figure has had more 
influence on the way Western-trained doctors 
practice medicine than Paul Beeson. One of 
the founders of the discipline of infectious dis¬ 
ease, Beeson discovered the first vital class of 
cellular proteins now called cytokines. He was 
chair of medicine at Yale from 1952 to 1965 and 
has been celebrated by dozens of awards, 
including the naming of the Yale-New Haven 
Hospital Medical Service in his honor. Medical 
students, house officers and doctors around the 
world recognize Beeson as a model for the 
ideals of medicine. 
Runner’s Blood, by James J. Fischer, M.D., Ph.D., 
HS ’65, chair and Robert E. Hunter Professor of 
Therapeutic Radiology; Word Association 
Publishers (Tarentum, Penn.), 2000. Fischer is a 
cancer specialist and marathon runner who 
has written a tale of mystery and deception 
based on a discovery made in his own medical 
laboratory.This finding, developed to treat can¬ 
cerous tumors, is so sophisticated that it makes 
blood doping seem primitive. The novel focus¬ 
es on a fictional marathoner and his realization 
that his main rivals are illegally enhancing 
their performance. 
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STUDENT NEWS 
The first major renovation of E.S. 
Harkness Hall since its construction 
in 1955 has brought high-speed 
Internet access and a homier feel to 
the n-story dormitory building, 
which houses Marigolds dining hall, 
a day-care center and the offices 
of student affairs and education on 
its first three floors. 
Harkness renovations 
heralded 
High-speed Internet access, 
other amenities bring aging dormitory 
up to snuff. 
A $20 million renovation of E.S. Harkness Hall 
has brought new plumbing, heating and electri¬ 
cal wiring to the aging dormitory as well as 
such amenities as high-speed Internet access and 
lounges with modern kitchenettes. The renova¬ 
tions are the ii-story building’s first major over¬ 
haul since its construction in 1955 as a residence 
lor students in the health professions. 
The improvements complete a process that 
began in 1995, when the School of Medicine 
took over management of medical school hous¬ 
ing and dining services from the University 
Graduate Housing Office and the Yale Univer¬ 
sity Dining Services. Changes to the building’s 
aging infrastructure—plumbing was built with 
World War II scrap metal that became brit¬ 
tle—include not only repairs, but a new con¬ 
duit for telephone lines, cable television and 
computer cables. Also, dormitory rooms on the 
third floor gave way to space for an expanded 
office of education, as well as other offices deal¬ 
ing with student issues, such as student 
research, the M.D./PH.D. Program, internation¬ 
al health and multicultural affairs. The renova¬ 
tions provided a single destination for students 
for handling their educational and support 
needs. “The building was worn out,” said Eric 
Schonewald, associate director of resident life 
at the medical school. “Technology had accel¬ 
erated to the point where we needed to 
upgrade, and the old housing was a turnoff to 
prospective students.” 
Work started in the mid-1990s with the 
construction of Marigolds, a new cafeteria and 
dining area that opened in 1997 with a broader 
choice of meals and expanded hours. A facelift 
of the building’s exterior followed, including 
the replacement of more than 250 windows 
and frames, and starting in June 1999, floor- 
by-floor renovations brought the building 
into compliance with modern fire, safety and 
handicapped-access codes. “As floors were 
completed we moved the students up one 
level and leapfrogged up through the build¬ 
ing,” Schonewald said, adding that the 
School of Medicine’s Office of Project Manage¬ 
ment and Construction oversaw the work. 
“They had to plan a renovation around an 
occupied building.” 
“That was the greatest challenge: People 
were living in the building,” said Peggy 
Rubens-Duhl, project architect with Svigals 
Associates, the firm that designed the renovated 
space. The architects consulted with students 
to design more efficient rooms with more 
conveniently placed electrical and data outlets 
and new wardrobes and sinks that took up 
less space. Doorways were recessed to give each 
room the appearance of a private entrance. 
“We know that the students are working 
in medical facilities, which tend to be sterile, 
so we wanted it to be like a home,” said 
Rubens-Duhl. 
Two rooms on alternating floors were sacri¬ 
ficed to create new lounges, the building’s first 
common spaces on the residential floors. Pour 
of the eight residential floors have kitchenettes 
built off of the lounge areas, two floors have 
lounges with televisions and two floors have 
quiet study areas. 
Rooms, each averaging about 15 feet by 10 
feet, are equipped with a sink, a closet, a chest 
of drawers, a single bed and a desk. 
The dormitory keeps about 12 of its 180 
rooms available for visitors, such as medical 
school applicants. Although a number of 
rooms were kept vacant during renovations, 
Schonewald expects the building to be full in 
the next academic year. “We have created a liv¬ 
ing space that is competitive with any dormito¬ 
ry at Yale, and we are offering a product that 
welcomes our first-year students,” said 
Schonewald. 
—John Curtis 
46 
student Notes 
Benefit for the hungry and 
homeless raises $25,000 
New Haven’s mayor, deans 
Merson and Chase take bids 
at eighth annual auction. 
The eighth annual Hunger and Homelessness 
Auction achieved a number of firsts in 
November as it raised more than $25,000 for 
New Haven charities. For the first time, 
organizers recruited an auctioneer from out¬ 
side the medical school—New Haven 
Mayor John DeStefano Jr. The auction had 
its own Web site, and it expanded from 
a one-day to a four-day event, including two 
days of bidding. 
“We wanted to create awareness,” Miriam 
Parsa, a public health student and one of five 
auction coordinators, said of the expanded 
schedule. Over the course of the four days activ¬ 
ities included a canned-food drive sponsored 
by the Tercentennial committee at the School 
of Public Health, the screening of a movie on 
homelessness, a fast involving approximately 40 
medical and public health students, and silent 
and live auctions offering 234 items and servic¬ 
es. Bidding on the silent auction began the day 
before the live auction. On the block were “12 
hours of babysitting,” “editing for two major 
papers by Yale English Lit. degree holder” and 
lessons in everything from piano to rock climb¬ 
ing to figure skating. 
Coordinators also had practical reasons for 
spreading the bidding over two days. “We figured 
it would be a more efficient way of collecting the 
money,” said Parsa. As a result, said medical stu¬ 
dent Matt Kronman, the coordinators had 
$15,000 in hand the day of the live auction. 
DeStefano solicited bids on the first item, a 
plane ride over New Haven piloted by Fred S. 
Kantor, M.D., HS ’60, the Paul B. Beeson Pro¬ 
fessor of Medicine. “You can go over the sub¬ 
urbs, too, if you really want to,” DeStefano 
said. The flight went for $200. 
This year also marked the auctioneering 
debuts of public health Dean Michael H. Mer¬ 
son, M.D., and Herbert S. Chase Jr., M.D., 
deputy dean for education. “What could be 
more romantic than a July weekend on Martha’s 
Vineyard for two?” Merson asked, while solicit¬ 
ing bids on the getaway home of Frederick J. 
Sigworth, PH.D., professor of cellular and 
molecular physiology. A question from the 
audience brought laughter: “Is this a romantic 
weekend with Dr. Sigworth?” 
Proceeds went to the Cook and Care Walk- 
A-Thon, Community Soup Kitchen, New 
Haven Home Recovery, Loaves and Fishes, and 
Douglas House. 
—John Curtis 
The Hunger and Homelessness Auction 
in December had its own Web site for 
the first time, but students also resort¬ 
ed to old-fashioned chalk for this 
advertisement on the driveway in front 
of Sterling Hall of Medicine. 
Diana Bojorquez, a third-year 
medical student, received the 
Herbert W. Nickens, M.D., 
Minority Medical Student 
Scholarship for 2000, which 
was announced in the fall by 
the Association of American 
Medical Colleges. The scholar¬ 
ships honor the work of Nick¬ 
ens in promoting justice in 
medical education and health 
care and are given to outstand¬ 
ing minority medical students 
who have demonstrated lead¬ 
ership in eliminating inequities 
in those areas. 
Corey Martin, 
a third-year 
medical stu¬ 
dent, was one 
of six scholars 
selected from 
applicants representing 55 U.S. 
medical schools to receive a 
2000 scholarship from the Pis- 
cano Leadership Foundation 
Inc., the philanthropic foun¬ 
dation of the American Board 
of Family Practice Inc. The 
scholarships, valued at up to 
$50,000 each, provide educa¬ 
tional programs, leadership 
training, and funding for out¬ 
standing third- and fourth- 
year medical students who 
have been identified as future 
leaders in the field of family 
practice. Martin is helping to 
establish a Tar Wars Program 
at Yale to discourage children 
from smoking, implementing 
a long-term family physician 
shadowing program for inter¬ 
ested medical students, and 
was a delegate to the Con¬ 
necticut Academy of Family 
Physicians. 
—Claire Bessinger 
Send student news items to; 
Claire Bessinger, Yale Medicine Publica¬ 
tions, P.O. Box 7612, New Haven, CT 
06519-0612. 
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STUDEN* NEWS 
Reports from Suriname, 
East Timor and Vietnam 
Students return with insights on 
traditional healing in the Amazon, the 
effects of war in East Timor and a 
needle exchange program in Vietnam. 
Second-year medical student Christopher 
Herndon spent last summer in Suriname’s Ama¬ 
zon jungle working on a project that seeks to 
improve the health care of indigenous people 
while preserving the skills of their traditional 
healers. Shamans, Herndon said, possess a wealth 
of information about medicinal plants and herbs 
in the Amazon. Yet the Westernization ol their 
cultures has led to a loss of that knowledge. 
“Many of these shamans are over 70 years old,” 
Herndon said during a presentation in October. 
“Most don’t have apprentices to whom they can 
transmit this knowledge that has been accumu¬ 
lated for generations.” 
Medical Mission Suriname, which delivers 
primary care to remote regions of the country, 
has begun a pilot program in which shamans 
practice alongside primary care physicians. 
Shamans and physicians refer patients to each 
othet and participate in joint workshops to learn 
about their respective healing systems. “This is 
an unprecedented opportunity to create a model 
for the integration ol traditional medicine into 
primary care delivery in indigenous communi¬ 
ties throughout tropical America,” Herndon said. 
He was one of three students to make pre¬ 
sentations at the Fall Symposium, Poster Ses¬ 
sion and Reception sponsored by the Commit¬ 
tee on International Health. The annual event, 
held on Oct. 18 last year, highlights the work of 
students in medicine, public health, nursing 
and the Physician Associate Program who have 
conducted research abroad. Joining Herndon 
in making presentations in the Hope Building 
were Bahar Firoz, a second-year medical stu¬ 
dent who studied the effects of war and human 
rights violations on mental health in East Timor, 
and Laura Phan, a public health student who 
studied a needle exchange program in Vietnam. 
The three were among 18 students who trav¬ 
eled abroad last summer on Downs Interna¬ 
tional Health Student Travel Fellowships, which 
honor Wilbur G. Downs, M.D., M.P.H., a Yale 
faculty membet and expert in tropical diseases 
who encouraged students to learn by doing. 
“In all of you who traveled abroad to do re¬ 
search, he would have found a kindred spirit,” 
said Curtis L. Patton, PH.D., professor of epi¬ 
demiology (microbiology) and director of the 
Downs program. 
Firoz surveyed the mental health of patients 
in the Bairo-pite Clinic in Dili, the capital of 
East Timor. After Indonesia invaded and occu¬ 
pied the country in 1975, the East Timorese 
population lived under martial law in a land 
where assassinations, kidnapping, rape and tor¬ 
ture were commonplace. Violence increased in 
late 1999 after East Timor, in internationally 
monitored elections, voted fot independence. 
Firoz recounted the story of a 27-year-old 
woman who fled to the mountains during an 
attack by militias opposed to independence. 
After three weeks in hiding, the woman 
returned to her village to find her home and 
possessions burned. “This is very common in 
the lives of most people I spoke with,” Firoz 
said. Of the more than too patients she inter¬ 
viewed, 95 percent had experienced similar 
trauma and lost family members in the vio¬ 
lence. A preliminary data analysis found 
depression in about 40 percent and symptoms 
of post-traumatic stress disorder in about 7 per¬ 
cent of those she interviewed. “The timing of 
this was very important,” Firoz said of her 
study, which was done on-site within months 
of the trauma. “Most studies on mental health 
are done a couple of years after the event.” 
Phan, who was born in the United States to 
Vietnamese parents, traveled to Ho Chi Minh 
City, home to almost a third of Vietnam’s 
100,000 injecting drug users. The Hope Cafe is 
one of two sites in the city offering clean syringes 
to drug users, who are most at risk for infection 
in the country’s growing AIDS epidemic. “It is 
the first big step at embracing harm reduction,” 
Phan said of the cafe. 
Most of the 195 drug users who responded 
to Phan’s survey reported that heroin was their 
preferred drug and that they did not share nee¬ 
dles. Despite high levels of syringe hygiene, they 
reported low levels of sexual-risk reduction. Pre¬ 
vention efforts, Phan said, should be expanded 
to all II districts in the city, and their scope 
should include prevention of sexual trans¬ 
mission of HIV. 
—John Curtis 
48 
Chase scenes 
Second-year show an initiation of sorts 
for new education dean. 
Anyone who has met the relentlessly upbeat 
deputy dean for education, Herbert S. Chase Jr., 
M.D., knows that he’s nothing like the grumpy 
schemer depicted in 2001: A Chase Odyssey, the 
Class of 2003’s second-year show. As most fac¬ 
ulty members will attest, being lampooned in 
the show is a rite of passage, a sign of acceptance. 
For Chase, who took up his duties in July, this 
show was his initiation. 
The plots of most recent shows revolve 
around an erranr faculty member engaged in 
shenanigans for the perceived betterment of the 
medical school. This show was no exception. It 
has Chase arriving at Yale after two decades at 
Columbia only to be horrified by what he finds 
—boring lectures, low attendance at classes and 
widespread apathy among students, all things 
which surely never happen here. His scheme to 
subvert the hallowed Yale System by suborning 
students to fail exams goes awry when a copy 
of the plan finds its way into The Kit, the ori¬ 
entation guide for first-years. With the help of 
Yale’s own Charlie’s Angels, Chase succeeds in 
confiscating all but one of the kits. The plot then 
detours through the medical school as it follows 
the remaining kit, poking fun along the way at 
targets such as Britney Spears, medical students. 
Top Gun, the med school dining hall, Japanese 
cooking shows and, of course, the Yale System. 
In the end Chase comes to realize the 
virtues of the Yale System and all is forgiven. 
Erik Weiss, the medical student who portrayed 
Chase, was joined onstage by three deans who 
bought their way into the show at the annual 
auction to benefit the homeless and hungry. 
Associate Dean Ruth Katz, j.D., m.p.h., and 
Associate Dean for Student Affairs Nancy R. 
Angoff, M.P.H. ’81, M.D. ’90, HS ’93, appeared 
onstage as a ladybug and bumblebee. Dean 
David A. Kessler, M.D., hopped onstage in a 
bunny suit, with his microphone disguised as a 
carror. “At this year’s auction, I bid some mon¬ 
ey,” sang Kessler, to the tune of Louis Arm¬ 
strong’s Wonderful World. “That’s why I’m here, 
dressed as a bunny. And I think to myself, what 
a wonderful school.” 
2001: A Chase Odyssey, the Class of 
2003’s second-year show, lampooned 
new Deputy Dean for Education 
Herbert Chase Jr. and many other 
familiar campus figures, often with 
their participation. Dean David Kessler 
appeared dressed as a bunny, with 
a microphone hidden in his carrot. 
One of the show’s producers, bare- 
midriffed Clare Drebitko, mimicked 
singer Britney Spears singing "I’m 
not that competent.” 
—John Curtis 
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Alumni Notes 
’40s 
This dispatch arrived recently 
from A. Harry Chapman, m.d. 
’47. “At the age of 77, I am 
still active in my specialties of 
neurology and psychiatry; my 
major responsibility is the 
administration of an electro- 
encephalographic service in a 
hospital in the inland Brazilian 
city of Bahia, population 
350,000. In recent years I have 
authored two books and vari¬ 
ous articles on psychiatry and 
neurology in The Lancet, The 
British Journal of Psychiatry and 
three Brazilian medical jour¬ 
nals; the books were published 
by an American medical pub¬ 
lisher. I have four children, 
ranging in age from 13 to 49 — 
Miriam Celeste, Americo 
Araujo, Marcelo Arthur and 
Jose Henrique—and numer¬ 
ous grandchildren. Life for me, 
like most people in Brazil, goes 
on largely in the context of a 
large extended family of 
cousins, in-laws and others. 
My wife, Elza Mendes de 
Almeida Chapman, and I are 
in reasonably good health. I 
was last in the States in 1965, 
but I would be interested in 
hearing from anyone who 
remembers me. Any letter sent 
to Chapman, CP 98, 45000- 
000 Conquista-BA, Brazil, will 
reach me.” 
'50s 
KristapsJ. Keggi, m.d. ’59, HS 
’63, received an honorary doc¬ 
torate of humane letters from 
Quinnipiac University last 
May for his work as an ortho¬ 
paedic surgeon. Quinnipiac 
president John L. Lahey said, 
“His medical and administra¬ 
tive skills have been tested 
from prestigious American 
hospitals to the battlefields of 
Vietnam. But above all, Keggi 
has been instrumental in re¬ 
newing understanding between 
NEWS 
the peoples of the former Soviet 
Union and the West. He also 
has brought a sense of hope, 
self-reliance and self-respect 
to people nearly engulfed by 
economic crisis and national 
emergency.” In 1988, Keggi 
founded the Keggi Ortho¬ 
paedic Foundation, which pro¬ 
vides professional exchanges 
and training opportunities for 
orthopaedic surgeons in the 
former Soviet republics. 
Amilcar 
Werneck 
de C.Vianna, 
HS ’59, a den¬ 
tal surgeon in 
Rio de Janeiro, 
writes to say that he has been 
named a fellow of the Interna¬ 
tional College of Dentists and 
a member of the board of the 
College’s chapter in Brazil. 
Carl R. Woese, 
PH.D. ’53, a 
microbiologist 
at the 
University of 
Illinois (UI) 
at Urbana-Champaign, was 
among 12 scientists and engi¬ 
neers to receive the National 
Medal of Science in December. 
Woese, who was a doctoral 
student and postdoctoral fellow 
in biophysics at Yale in the 
1950S, changed the way scien¬ 
tists classify life on Earth with 
his discovery of the archaea in 
the 1970s. Collaborating with 
microbiologist Ralph S. Wolfe, 
Woese overturned one of the 
major dogmas in biology. Until 
that time, biologists believed 
that all life belonged to one of 
two primary lineages, the 
eukaryotes and the prokary¬ 
otes. Woese and Wolfe showed 
the existence of a third group 
of organisms, the archaea, 
which are very simple in genetic 
makeup and tend to exist in 
extreme environments thought 
to resemble that of Earth in its 
early stages. “I am a molecular 
biologist turned evolutionist,” 
says Woese, who holds the 
Stanley O. Ikenberry Endowed 
Chair at UI. He calls the study 
of the archaea “central to the 
understanding of the nature 
of the ancestor common to 
all life.” 
’60s 
Stephen C. 
Schimpff, 
M.D. ’67, HS 
’69, chief 
executive 
officer of the 
University of Maryland Med¬ 
ical Center and executive vice 
president of the University of 
Maryland Medical System, was 
named chair of the board of 
governors of the Warren Grant 
Magnuson Clinical Center at 
the National Institutes of 
Health last June. Schimpff, a 
member of the board and its 
executive committee since their 
inception four years ago, was 
formerly the chair of the finance 
working group. 
Michael L.J. 
Apuzzo, M.D., 
HS ’72, will be 
the honored 
guest laureate 
at the annual 
meeting of the Congress of 
Neurological Surgeons in San 
Diego in late September. The 
theme of the meeting, “Rein¬ 
venting Neurosurgery,” will be 
explored in concert with Apuz- 
zo’s contributions and innova¬ 
tions in numerous areas that 
have helped to redefine the 
scope and state of international 
practice. Apuzzo is the Edwin 
M. Todd/Trent H. Hells Jr. 
Professor of Neurological Sur¬ 
gery, Radiation Oncology, Bio¬ 
logy and Physics at the Keck 
School of Medicine at the 
University of Southern Cali¬ 
fornia in Eos Angeles. A native 
of New Haven, Apuzzo began 
his undergraduate studies at 
Yale with a primary interest in 
architecture. As a work study 
student, he was assigned to 
catalog books at the Harvey 
Cushing Medical Historical 
Library under the direction of 
Madeline Stanton, former sec¬ 
retary to Cushing, who is con¬ 
sidered the father of modern 
neurosurgery. This experience 
helped redirect his goals, lead¬ 
ing him into medicine. Since 
medical school he has devoted 
himself to the refinement of 
cerebral surgery concepts, 
advanced neuro-oncology and 
the development and transfer 
of complex technology initiat¬ 
ed within the aerospace and 
defense industries to the oper¬ 
ating room and other areas of 
patient care. Apuzzo has been 
a pioneer in the clinical areas of 
deep cerebral microsurgery, 
neuro-endoscopy, imaging- 
directed stereotaxy, radiosurgery 
and the emerging field of cellu¬ 
lar and molecular neurosurgery 
with neurorestoration. 
David L. Coulter, m.d. ’73, 
e-mailed us in March to say, 
“After 15 years as associate pro¬ 
fessor and director of child 
neurology at Boston University 
School of Medicine, I moved 
across town in January to join 
the departments of Neurology 
and Social Medicine at 
continued on page 
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After 6o years, 
“I've never left” 
Nicholas Spinelli, a devoted son of Yale, finds 
that dedication is a two-way street. 
In 1941 Nicholas P.R. Spinelli, M.D. ’44, 
crossed the campus from Yale College, where 
he had spent his undergraduate years, to begin 
the next phase of his education at the School 
of Medicine. Six decades later, he would say, 
“I’ve never left.” 
Born in Stratford, Conn., Spinelli never 
strayed far from his roots. After service in the 
Army he returned to his hometown and to 
Yale, where he completed a residency in inter¬ 
nal medicine. He always found time for his 
alma mater. He taught and counseled medical 
students, helped them with scholarships and, 
years later, provided funds for the first White 
Coat ceremony, which has become an annual 
event to welcome the first-year class. 
In honor of his contributions to the medical 
school, two rooms were dedicated in Spinelli’s 
honor on Nov. 20, one at the pva/epva Neuro¬ 
science Research Center at the VA Connecticut 
Healthcare System in West Haven and the oth¬ 
er at the medical school. 
In his remarks to faculty, students, alumni 
and his sister Viola Spinelli, who holds an M.P.H. 
degree from Yale, Spinelli said the school’s mis¬ 
sion was to have “bright, brilliant students ad¬ 
mitted and matched with bright, brilliant 
teachers. So I opted to support aid to the dean.” 
When Spinelli entered Yale College in 1937, 
times were lean. His father had lost his con¬ 
tracting business during the Great Depression 
and later opened a gas station on the Boston 
Post Road. As a freshman Spinelli waited on 
tables in the college dining room. As a sopho¬ 
more he worked in a biology laboratory, where 
he found a mentor in Edgar J. Boell, a biology 
professor. “He was determined that I was going 
to medical school and that I should go to Yale,” 
Spinelli recalled. 
On the night of December 7, 1941, instead 
of studying for an anatomy exam he was glued 
to the radio. “FDR came on and told us about 
Pearl Harbor and that we were at war,” he said. 
The Spinelli Office of Alumni Affairs 
was named in honor of Nicholas 
Spinelli in November, as was a room at 
the neuroscience research facility at 
the West Haven VA. 
He and his 42 classmates were inducted into 
the Army as privates first class and had their 
medical education abbreviated to three years. 
After the war, Spinelli practiced internal med¬ 
icine in Stratford, Conn., until 1958, when heart 
problems forced him to retire. He became direc¬ 
tor of medical education at Bridgeport Hospital. 
In the early 1970s he chaired the medical school 
Alumni Fund, helping to increase awareness of 
the financial aid needs of medical students. He 
also served as president of the Association of Yale 
Alumni in Medicine (ayam) from 1981 until 
1985, when he was named director of alumni 
affairs by then-Dean Feon Rosenberg, M.D. 
Since retiring as director in 1990, Spinelli has 
remained active in alumni affairs. He received 
the ayam’s distinguished alumni service award 
in 1987 and the Peter Parker Medal in 1994. 
“You only get to meet someone like Nick 
once in a lifetime,” said Stephen G. Waxman, 
M.D., chair of the Department of Neurology, 
during the ceremony at the VA. Spinelli, he 
said, “devoted most of his life to young people 
and to helping them.” 
Later that day came the dedication of The 
Spinelli Office of Alumni Affairs at too Ghurch 
St. South. Sharon R. McManus, director of 
alumni affairs, recalled meeting Spinelli in 1985 
on her first day on the job at the Yale Alumni 
Fund for Graduate and Professional Schools. 
“He said there was nothing better and more 
gratifying than raising money for Yale,” 
McManus recalled. “I didn’t realize it at the 
time, but he really meant it.” 
—John Curtis 
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Samuel Kushlan, pictured above 
at his 65th reunion last year, 
received the medical school’s highest 
honor, the Peter Parker Medal, 
in February. 
“It’s like having 
a mystery story every 
morning...” 
Drop in on medical grand rounds or morning 
report and you’re likely to encounter 
Samuel Kushlan, 89, an enduring represen¬ 
tative of the Class of 1935. 
Before the advent of antibiotics, chemotherapy, 
open heart surgery, dialysis or effective treat¬ 
ments for diseases that are easily cured today, 
Samuel D. Kushlan, M.D. ’35, was ready to follow 
in the footsteps of the family doctor in New 
Britain who had inspired him, a man known for 
his compassion and respect for patients. 
Almost seven decades later, Kushlan, who 
has dedicated his life to Yale and New Haven, 
was awarded the medical school’s highest honor, 
the Peter Parker Medal. Kushlan, who celebrat¬ 
ed his 89th birthday on Feb. 17, has never 
retired from medicine. His desire to help stu¬ 
dents and his curiosity about science make him 
a familiar figure on campus and particularly in 
the Department of Internal Medicine, where he 
attends grand rounds every Thursday and morn¬ 
ing medical report nearly every day. 
“It’s like having a mystery story every morn¬ 
ing. It’s extremely interesting,” he said. “My 
fonction, as I see it, is to toss in a pearl from time 
to time to pay my way.” 
As an undergraduate at Yale College, where 
he was one of the top 10 scholars in the Class 
of 1932 and a member of the basketball team, 
Kushlan persuaded then-Dean Milton C. Win- 
ternitz, M.D., to admit him to the medical school 
at age 19. When he graduated three years later, 
he remembers, “we thought [medicine] was very 
advanced, but as you look back it was very prim¬ 
itive. It was really very simple—there was noth¬ 
ing you could do for strokes or heart attacks.” 
Only four medicines — aspirin, digitalis, 
phenobarbital and quinine—were commonly 
used to treat illnesses. And as polio patients 
Hooded the hospital each summer, Kushlan and 
the house staff hoped that “prayer and good 
luck” would help them escape the contagion. 
A Connecticut native, Kushlan ventured 
only once from his alma mater, going in 1938 to 
Harvard University and Massachusetts General 
Hospital, where he worked under Paul D. 
White, M.D., a cardiologist to President 
Dwight D. Eisenhower. “After a short while, I 
decided the grass was not greener there and 
when I came back I was content,” he said. 
From World War II until the late 1960s, 
Kushlan practiced internal medicine and gas¬ 
troenterology in New Haven and taught as a 
member of the clinical faculty. He served from 
1967 until 1982 as associate physician-in-chief 
at Yale-New Haven Hospital and also as clinical 
professor of medicine. After retiring from the 
latter post in 1987, he reviewed cases at Yale’s 
medical and legal office for the next five years. 
An active member of the alumni association 
since 1936, its bequest and endowment officer 
and a resident of New Haven, “My life is really 
centered around Yale,” Kushlan said. 
The Peter Parker Medal, which Kushlan calls 
the capstone of his medical career, is named for 
a 19th century medical missionary to China edu¬ 
cated at Yale’s medical and divinity schools. The 
medal is not the first recognition Kushlan has 
received at Yale. The Samuel D. Kushlan Lec¬ 
tureship, established 32 years ago, brings some of 
the best and brightest names in the field of gas¬ 
troenterology to campus annually. 
And about a decade ago, the Department of 
Internal Medicine named one of its hospital 
medical services after him, putting him in the 
same league as Allan Goodyer, Elisha Atkins, 
John Punnett Peters and Gerald Klatskin. “The 
other services were named after world-class 
physicians and I’m a local-class physician. But I 
was told that teaching and supporting the 
community for more than 50 years—that’s 
worth something.” 
— Rachel Engers 
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Harvard Medical School and 
Children’s Hospital Boston. 1 
am also affiliated ivith the In¬ 
stitute for Community Inclu¬ 
sion at Children’s Hospital, 
where I am involved in research 
and teaching on developmen¬ 
tal disabilities. My research 
focuses on ethics, spirituality 
and disability. I am co-editor 
of the Journal of Religion, Dis¬ 
ability and Health, which pub¬ 
lishes articles on the intersec¬ 
tion of spirituality and health 
in caring for and being with 
people with disabilities. My 
research also involves work on 
the etiology, definition, clas¬ 
sification, treatment and pre¬ 
vention of intellectual disabili¬ 
ty (mental retardation).” 
the Medical College of Wis¬ 
consin, reports that he was the 
only psychiatrist appointed to 
the Wisconsin Turning Point 
Initiative, a large-scale effort 
to transform the state’s public 
health system and create a 
healthier Wisconsin. Moffic 
also received a state grant to 
establish a mental health pro¬ 
gram for refugees in Milwau¬ 
kee, who number about 
20,000 and come from South¬ 
east Asia, Eastern Europe, 
Africa and other regions. 
Richard L. 
Neubauer, 
M.D. ’76, 
medical staff 
education 
director at 
Alaska Regional Hospital, has 
been elected governor of the 
Alaska chapter of the Ameri¬ 
can College of Physicians- 
American Society of Internal 
Medicine (acp-asim). He was 
installed in the post at the 
national organization’s annual 
meeting in Atlanta last April. 
His responsibilities during the 
four-year term will include 
planning scientific meetings, 
credentialing new members 
and disseminating college poli¬ 
cy. Neubauer will also repre¬ 
sent Alaskan members by serv¬ 
ing on the national ACP-ASIM 
board of governors. 
Carroll 
Schilling, 
M.P.H. ’77, is 
chief executive 
officer of The 
Enterprise 
Center, a non-profit organiza¬ 
tion cteated in 1999 by Yale 
University, the United Illumi¬ 
nating Co. and New Haven 
Savings Bank to help small 
businesses. The center provides 
young companies with such 
services as business planning, 
market research, financial struc¬ 
turing, capital source develop¬ 
ment and management assis¬ 
tance. Schilling was formerly 
the entrepreneur-in-residence 
at the Yale School of Manage¬ 
ment, helping students in the 
M.B.A. program to evaluate the 
business potential of discoveries 
made at Yale and in the com¬ 
munity. Schilling also serves on 
the business and industry com¬ 
mittee of the Association of 
Yale Alumni in Public Health. 
Elston Seal Jr., 
M.D., HS ’79, 
was inducted 
in October 
into the 
Alumni Hall 
of Fame of the North Plainfield 
(N.J.) High School for a life¬ 
time of achievement in the 
field of medicine. Seal, a com¬ 
missioned officer in the U.S. 
Public Health Servdce at the 
rank of medical director, is 
detailed to the Human Studies 
Division of the U.S. Environ¬ 
mental Protection Agency in 
Chapel Hill, N.C., where he is 
special assistant to the director 
of the division, chief of the 
research support staff and 
director of the medical staff. 
Alicia I. 
Barela, m.d. 
’81, an obste¬ 
trician and 
g)mecologist 
at Kaiser 
Santa Theresa in California, 
received the Alumnae Medal 
of Honor from Mount Holyoke 
College in South Hadley, Mass., 
at its 2000 reunion celebration 
last June. The medal recognized 
Barela’s service to the college 
and her work as a member of 
its board of trustees. Barela has 
been chosen by the People to 
People Ambassador Programs 
of Spokane, Wash., as a dele¬ 
gate to China for two weeks 
beginning June 8. The pro¬ 
gram sponsors groups in vari¬ 
ous professions to meet with 
colleagues in other countries. 
This group will be touring 
hospitals, attending round¬ 
table discussions and learning 
about Chinese medicine. 
Thomas D. Fogel, m.d., hs ’85, 
reports that he is president of 
the Coastal Radiation Oncol¬ 
ogy Medical Group Inc., which 
owns and operates eight free¬ 
standing radiation oncology 
centers in California. Fogel is 
also past president of the 
American Cancer Society’s 
California division and is a 
member of the organization’s 
national board of directors. 
’90s 
Susan G. Anderson, m.d. ’90, 
served as an expedition physi¬ 
cian and lecturer on two 
around-the-world trips in 
November and Januar}t The 21- 
and 24-day trips via private 757 
jet were planned and guided 
byTCS Expeditions in Seattle. 
The “Around-the-World Mil¬ 
lennium Trip” began in Los 
Angeles and went from Easter 
Island to Samoa through New 
Guinea, Cambodia, Nepal, 
India, Oman, Tanzania, Jor¬ 
dan, Timbuktu, Mali and 
Morocco. The “Ancient Cross¬ 
roads Trip,” sponsored by the 
Museum of Natural Historv' in 
New York, included stops in 
London, Jordan, Iran, Burma, 
Cambodia, Mongolia, China 
and Syria. vLnderson is clinical 
assistant professor of medicine 
in the division of infectious 
disease and geographic medi¬ 
cine at Stanford University 
School of Medicine and co¬ 
director of a new travel medi¬ 
cine service that is being devel¬ 
oped at Stanford. “One of my 
main roles at Stanford is to 
assist medical students and 
undergraduates in pursuing 
clinical, research and public 
sertdce-oriented international 
health projects. Another role is 
[performing] pre-travel and 
post-travel evaluations,” 
Anderson wrote in an e-mail 
message. Serving as an expedi¬ 
tion physician “was an incredi¬ 
ble opportunity to practice 
travel medicine in the field and 
help people of all ages with all 
types of medical histories travel 
safely to remote places.” 
—Claire Bessinger 
Send alumni news items to: 
Claire Bessinger, Yale Medicine Publica¬ 
tions, P.O. Box 7612, New Haven, CT 
06519-0612. 
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Institute of Medicine adds 
alumni to its rolls 
Four alumni of the School of 
Medicine and its training pro¬ 
grams have been elected to the 
Institute of Medicine. New 
members are nominated by 
incumbent members based on 
their distinguished professional 
achievement in a field related 
to medicine and health. Yale 
alumni added to the roll last 
fall were; 
George K. Aghajanian, 
M.D. ’58, HS ’61, professor of 
psychiatry and pharmacology, 
Yale University School of 
Medicine, elected as senior 
member (See Faculty News). 
Dennis S. Charney, m.d., hs 
’77. chief. Mood and Anxiety 
Disorder Research Program, 
National Institute of Mental 
Health, National Institutes 
ol Health. 
Shimon (Seymour) M. Click, 
M.D., HS ’57, professor of in¬ 
ternal medicine and director. 
Center for Medical Education, 
Ben-Gurion University of the 
Negev, Beer-Sheva, Israel. 
John A. Parrish, m.d. ’65, 
professor and chair. Depart¬ 
ment of Dermatology, Harvard 
Medical School, and chief, der¬ 
matology service, Massachu¬ 
setts General Hospital. 
Archives 
Yajejyiedicine 
From the Winter 1975 issue of 
Yale Medicine: “Dr. George 
Palade, chairman of the section 
of cell biology, was awarded 
the 1974 Nobel Prize for Physiol¬ 
ogy or Medicine,for his discov¬ 
eries concerning the structural 
and functional organizations of 
the cell. He shares the honor 
with Dr. Albert Claude, his for¬ 
mer professor and colleague at 
Rockefeller University, and Dr. 
Christian de Duve.... [Palade’s] 
skill and his enthusiasm for 
unraveling the intricacies of the 
fine structures of cells attracted 
many students and research 
associates to his laboratory.... 
There is seemingly no letup in 
the pace at which new and 
important observations emerge 
from the Palade laboratory.” 
From the Winter 1976 issue: 
“Yale-New Haven Hospital is 
one of the first hospitals in the 
nation to use a computerized 
axial tomographic scanner.This 
new diagnostic instrument, 
which is similartothe brain 
scanner, is capable of produc¬ 
ing extremely detailed images 
of any part of the body. ...Com¬ 
bining X-ray and computer 
technology, the scanner pro¬ 
duces a television image of the 
body in cross section, which is 
actually a computer-recon¬ 
structed image of a selected 
area of the body, seen on two 
television screens, one color and 
one black and white.The colors 
represent different densities of 
body tissue, such as the differ¬ 
ence between blood and brain. 
The scan image also shows the 
relationship of the body parts 
in depth.This is an advance 
over conventional X-ray films, 
which cannot “see” a differ¬ 
ence between body structures 
aligned over one another.” 
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Louis V. Avioli, m.d. ’57, the 
Sidney M. Shoenberg Professor 
of Medicine, professor of ortho¬ 
paedic surgery and director of 
the Division of Bone and Min¬ 
eral Diseases at Washington 
University School ol Medicine, 
died of cancer at his home on 
Nov. 21. He was 68. 
Avioli graduated magna 
cum laude from Princeton 
University. After receiving his 
medical degree at Yale he 
trained at the University of 
North Carolina at Chapel Hill 
and the National Institutes of 
Health. In 1961 he joined the 
faculty of the New Jersey Col¬ 
lege of Medicine and in 1966 
began his career at Washington 
University as an assistant pro¬ 
fessor of medicine. 
Avioli served on the NASA 
Skylab Project, The Endocrine 
Society Council and the board 
of the Paget’s Disease Founda¬ 
tion and as a consultant to the 
Public Health Services of Chi¬ 
na, Finland, Australia and 
Canada. In 1979 he founded 
the American Society of Bone 
and Mineral Research, and in 
1994 he founded the Associa¬ 
tion of Osteobiology. 
James F. Ferguson Jr., m.d. ’40, 
died July 3. He was 61. 
Born in New Haven, 
Ferguson graduated from Yale 
College in 1936 before entering 
the School of Medicine. After 
his graduation he served his 
internship in New Jersey, then 
returned to Connecticut in 1949 
to be a family doctor in 
Wallingford. He was in prac¬ 
tice there until his retirement 
in 1978. 
During nearly three 
decades of practice, along with 
his partner Robert Boyd, 
M.D., Ferguson also served as 
the Wallingford school doctor. 
He was a member of the Con¬ 
necticut Medical Society and 
the American Medical Associ¬ 
ation. He was also a member 
and past president of the 
Wallingford Rotary Club and 
was named Rotarian of the Year 
in 1969 and a Paul Harris Fel¬ 
low in 1980. 
Louis S. Goodman, m.d., a 
former Yale faculty member, 
co-author of one of medicine’s 
leading pharmacology texts and 
discoverer of the first effective 
anticancer chemotherapy, died 
Nov. 19 in Salt Lake City. He 
was 94. 
Goodman also pioneered 
the use of an obscure drug 
from the Amazon named 
curare. He founded and edited 
pharmacology journals, was a 
member of the National Acad¬ 
emy of Sciences, consulted for 
pharmaceutical firms and 
served on committees of the 
National Institutes of Health. 
It was during World War II 
that Goodman, working at 
Yale with his friend and col¬ 
league Alfred Gilman, PH.D., 
investigated chemical warfare 
agents for the war effort. They 
found that nitrogen mustard 
produced abnormally low levels 
of white blood cells in those 
exposed to it. He successfully 
applied this finding to cancer 
therapy, and chemotherapy 
joined radiation and surgery as 
standard treatments. 
Goodman graduated from 
Reed Gollege in 1928, received 
his medical degree from the 
University of Oregon Medical 
School in 1932 and interned at 
Johns Hopkins Hospital. He 
came to New Haven to study 
and ultimately teach pharma¬ 
cology, becoming an assistant 
professor at Yale in 1937. 
In response to the outmod¬ 
ed textbooks of the time, he 
and Gilman wrote a text for 
their students in which they 
correlated pharmacology with 
other medical sciences. The 
Pharmacological Basis of Thera¬ 
peutics, now in its ninth edi¬ 
tion, remains a standard clini¬ 
cal reference. 
In 1943 Goodman left Yale 
for the University of Vermont. 
A year later he became the 
founding chair of the depart¬ 
ment of pharmacology at the 
University of Utah. He retired 
as chair in 1971. 
Dorothy M. Horstmann, m.d., 
the first woman appointed a 
full professor at the School of 
Medicine and a scientist who 
helped make polio vaccines 
possible, died Jan. ii in New 
Haven. She was 89. 
Horstmann’s research into 
polio countered the prevailing 
belief that the virus attacked 
the nervous system directly. 
She showed that the virus 
reached the brain by way of 
the blood. Horstmann’s team 
detected the polio virus in the 
blood of infected monkeys 
and chimpanzees before signs 
of paralysis appeared. They 
found that by the time paraly¬ 
sis developed, antibodies 
had eliminated the polio virus 
from the blood. 
Horstmann’s work con¬ 
tributed to the licensing of an 
oral polio vaccine developed 
by Albert Sabin, M.D., from 
live, weakened virus. 
Horstmann was born in 
Spokane, Wash., on July 2, 
1911. She earned her under¬ 
graduate degree from the Uni¬ 
versity of California at Berke¬ 
ley and her medical degree 
Irom the University of Califor¬ 
nia at San Francisco. In 1942, 
she moved to Yale as a Com¬ 
monwealth Fund fellow to per¬ 
form research with John R. 
Paul, M.D. The following year, 
she joined the Yale polio¬ 
myelitis unit and helped battle 
a polio epidemic in New 
Haven. At midcareer 
Horstmann became a pediatri¬ 
cian, and in 1961 was the 
first woman at the medical 
school named to the John 
Rodman Paul Professorship, 
an endowed chair in epidemi¬ 
ology and pediatrics. 
William Kaufman, m.d., a 
research fellow at Yale in the 
1940S, died Aug. 24 at Forsyth 
Memorial Hospital in Win¬ 
ston-Salem, N.C. He was 89. 
Kaufman, a graduate of the 
University of Pennsylvania, 
received an M.A. in chemistry 
in 1932, a PH.D. in physiology 
in 1937 and an M.D. cum 
laude in 1938 from the Univer¬ 
sity of Michigan. He was also 
awarded the Sternberg Memo- 
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rial Medal for Excellence in 
Preventive Medicine. He came 
to Yale in 1940 as the Dazian 
Foundation Fellow in Physiol¬ 
ogy and remained a research 
fellow in physiology until 1942. 
Kaufman was in private prac¬ 
tice in Connecticut and then 
became an executive with a 
New York medical informa¬ 
tion company until his retire¬ 
ment in 1981. Kaufman served 
for many years as American 
editor-in-chief of the Interna¬ 
tional Archives of Allergy and 
Applied Immunology. 
Robert I. Levy, m.d. ’61, an 
international authority in lipid 
metabolism and a research 
visionary who linked choles¬ 
terol reduction to the preven¬ 
tion of coronary disease, died 
of pancreatic cancer on Oct. 
28 at a New York hospital. He 
was 63. 
Levy, born in the Bronx 
and a resident of Morristown, 
N.J., was a graduate of Cor¬ 
nell University and Yale 
School of Medicine. He joined 
the National Heart, Lung and 
Blood Institute at the NIH in 
1963 and served as its director 
from 1975 to 1981. At the NIH 
he studied lipid disorders and 
atherosclerosis. He was a co¬ 
discoverer of the internationally 
used classification system of 
hypercholesterolemia, describ¬ 
ing five distinct types. When 
awarding him a public health 
award in 1980, the Lasker Foun¬ 
dation cited his work in the 
Hypertension and Follow-up 
Program, which proved that the 
treatment of even mildly hyper¬ 
tensive patients was lifesaving. 
Levy’s unique professional 
experience and expertise led 
him to serve as a vital link and 
advisor to government, acade¬ 
mia and industry. He was an 
active member of the Institute 
of Medicine of the National 
Academy of Sciences. 
In 1981, Levy joined Tufts 
University School of Medicine 
as vice president and dean. He 
was also vice president lot 
health sciences and professor 
of medicine at the Columbia 
University College of Physi¬ 
cians and Surgeons. From 1988 
to 1992, he served as president 
of the Sandoz Research Insti¬ 
tute, and in 1992, he joined 
American Home Products 
Corp. (ahp) as president of its 
Wyeth-Ayerst research divi¬ 
sion. In 1998 he was named 
senior vice president for science 
and technology at ahp. 
Margaret S. Lyman, m.d. ’50, 
died Nov. 17 at the Middlesex 
Convalescent Center in Mid¬ 
dletown, Conn. She was 76. 
Born in Middlefield, Conn., 
Lyman graduated from Smith 
College before entering the 
Yale School of Medicine. In 
1964 Lyman joined the faculty 
at New York University Med¬ 
ical Center as an assistant pro¬ 
fessor of pediatrics. From 1968 
until her retirement in 1992, 
she was an associate clinical 
professor of pediatrics. She 
was also on the staff at Belle¬ 
vue Hospital. 
She provided pediatric care 
to the children of recovering 
addicts at Odyssey House and 
volunteered her time provid¬ 
ing recreational activities for 
residents of the Queens Con¬ 
valescent Home, now High 
View Health Care Center. 
Lyman was on the board of 
directors of the Lyman Farm in 
Connecticut and wrote a sup¬ 
plement to the genealogy of 
the Lyman family. 
Joseph L. Melnick, ph.d. ’39, a 
founder of modern virology 
who taught epidemiology at 
Yale, died of Alzheimer’s dis¬ 
ease on Jan. 6 in Houston. He 
was 86. 
Melnick was born in Boston 
and moved to New Haven as a 
boy. He graduated from Wes¬ 
leyan University in 1936 and 
then earned a PH.D. in physio¬ 
logical chemistry at Yale. Mel¬ 
nick stayed at Yale, becoming 
a professor of epidemiology in 
1954. He became a chief virol¬ 
ogist at the division of biologi¬ 
cal standards at the National 
Institutes of Health in 1957. 
He moved to Baylor Universi¬ 
ty in 1958, where he became 
the founding chair of the 
medical school’s Department 
of Virology and Epidemiology. 
A pioneer in polio research 
and a leader in environmental 
science, Melnick was among 
the first to discover that the 
polio virus belonged to a larger 
group known as the entero¬ 
viruses and that these viruses 
only rarely invade the central 
nervous system. In the early 
1940S, Melnick found that the 
virus appeared in sewage when 
new polio infections peaked in 
the summer, but dwindled at 
other times of the year. That 
insight pushed him to the 
forefront of environmental 
virology work. 
Melnick began his scientific 
career at Yale under polio expert 
John R. Paul, M.D. Melnick 
died five days before Dorothy 
M. Horstmann, M.D., another 
polio pioneer and Yale col¬ 
league with whom he wrote 
scientific papers. 
James J. Smith, m.d. ’40, died 
Sept. 9 in Washington D.C. 
He was 88. 
At the age of 14 Smith 
joined the Brothers of the 
Christian Schools to prepare 
for a career in teaching and 
philosophy. His study of the 
scholastic philosophers and 
their dictum “a healthy mind 
in a healthy body” led him to 
petition the Vatican for a 
release from his vows so that 
he could study medicine. 
While at Yale School of Medi¬ 
cine he married classmate 
Beatrix Goldzieher, who was 
his professional collaborator 
for 56 years. 
Smith served his internship 
at Bellevue Hospital and was a 
medical officer at the U.S. 
Army First General Hospital 
during World War II. He was 
later appointed chief of medical 
intelligence for the Office of 
Strategic Services in Europe. 
He returned to New York, 
where he founded and directed 
two research laboratories and 
an outpatient clinic at New 
York University-Bellevue Med¬ 
ical Center. 
In 1946 Smith began a pri¬ 
vate practice in internal medi¬ 
cine and endocrinology. He 
also developed and promoted 
the uses of ultrasound and 
received a Pioneer Award from 
the American Institute of 
Ultrasound in Medicine. 
Smith held faculty appoint¬ 
ments at George Washington 
University School of Medicine 
and Georgetown University’s 
Center for the Advanced 
Study of Ethics. From 1972 to 
1985, as director of the Nuclear 
Medicine Service for the Vet¬ 
erans Administration (VA), he 
devoted considerable energy to 
developing a state-of-the-art 
service for the VA network of 
172 hospitals. In 1982, a wing 
of the Salt Lake City VA hos¬ 
pital was dedicated to him. 
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Expanded Web offerings 
Yale Medicine magazine and the Association of Yale Alumni in Medicine (AYAM) 
have added to the resources available to alumni on the Web. Browse Yale Medicine 
in simple html format or download a pdf file complete with graphics. View or 
listen to multimedia content accompanying selected articles. Search back issues 
of the magazine on our archive page. The address is: 
http://i nfo. med.ya le.ed u/ym m 
Visit the main AYAM site at: 
http://info.med.yale.edu/ayam 
to update your mailing address, check the reunion schedule and calendar of 
events, submit news for the Alumni Notes column of Yale Medicine, or arrange 
for a lifelong Yale e-mail alias through the Virtual Yale Station. 
Spread the news! 
Yale Medicine can help you stay connected with fellow alumni of the School of 
Medicine and its programs in Epidemiology and Public Health, the Graduate School 
of Arts and Sciences, and residency, fellowship and physician associate training. 
Share your personal and professional news for publication in the Alumni Notes 
column of Yale Medicine and on the Web, using this card or the online form 
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instead—and proved the worth of one 
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A decade later, countless lives have been . 
saved as a result. > > > 
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CHRONICLE 
From Kosovo to college, with 
a detour near Cedar Street 
Two years ago, when a group 
ot Yale medical students vol¬ 
unteered at a camp for Kosovo 
refugees, second-years Aaron 
Covey and Seth Goldbarg 
found themselves working tri¬ 
age in the camp hospital. As 
new arrivals stepped off the 
buses at Senekos, a makeshift 
cit)^ of white tents in neigh¬ 
boring Macedonia, the stu¬ 
dents assessed the refugees 
and directed those who were 
ill to medical care. 
When they met 18-year-old 
Irfan Baffin, who had been in 
the camp for several days and 
had come to the triage center 
simply to make himself useful, 
there was a little confusion. 
“I kept trying to help,” Irfan 
recalled, “and Aaron kept 
trying to give me water.” 
But soon Irfan and his 
younger brother, Bafti, then 
15, were close to indispensa¬ 
ble. “They helped us with 
every project we did in 
the camp,” said Margaret 
Bourdeaux, another of the six 
Yale students who were assist¬ 
ing the camp’s medical staff 
(“Kosovo Journal,” Summer 
1999). Irfan and Bafti, who 
had learned English from 
watching American television 
and movies, translated for 
patients and doctors, worked 
on a tent-to-tent health survey 
and a nutritional assessment 
of the children in the camp, 
and helped organize a soccer 
tournament and a theatrical 
production. “From rhe minute 
we met them,” said Covey, “we 
realized they were incredibly 
bright, with so much potential 
and such a desire to help.” 
A year later, the two boys 
were a world away from bat¬ 
tered Kosovo, enrolled at a 
New England boarding school 
and living less than an hour’s 
drive from their medical- 
student mentors in New 
Haven. The combined efforts 
of many—the boys’ American 
sponsor (an emergency physi¬ 
cian from Ohio whom they 
met in the camp), the medical 
With help from Yale medical students 
and administrators, the Loomis Chaffee 
School and an emergency physician in 
Ohio, two brothers from Kosovo spent 
the past year in Connecticut preparing 
for college. Bafti, left in top photo, and 
Irfan Baftiu are now headed for Oak¬ 
land Community College in Michigan. 
Above: Bafti with Yale student Vivian 
Lombillo two years ago in the refugee 
camp in Senekos, Macedonia. 
school dean’s office, the 
Loomis Chaffee School in 
nearby Windsor, Conn., and 
the medical students—re¬ 
sulted in student visas for 
Irfan and Bafti and a year of 
study to help them prepare 
for college. Loomis Chaffee 
provided full scholarships 
with room and board for the 
boys to attend a summer pro¬ 
gram as well as their final 
year of high school. 
This summer the brothers 
moved to Cleveland and the 
home of their sponsor, Pamela 
Grim, M.D. In the fall, they 
will study at Oakland Com¬ 
munity College in Michigan, 
work on their written English 
skills and think about rhe 
future. Bafti, who had a good 
year in math, is thinking 
about business. 
His brother hopes to be¬ 
come a physician. “I saw a lot 
of things in Kosovo and in the 
camp that are pushing me in 
that direction,” Irfan said in 
April. “I saw victims of land 
mines. I saw the operating 
room and what they could do 
for them. And I know that I 
really want to help people.” 
Emergency Department opens its doors for Learning Channel documentary 
When a 37-year-old New Hav¬ 
en man leaped from the third 
story of a burning building 
and was rushed to Yale-New 
Haven Hospital, filmmakers 
from The Learning Channel 
met him at the E.R. door 
alongside the trauma team. 
The story of the injured 
man was among dozens of 
trauma and emergency room 
cases followed by “shooters” 
from TLC’s reality TV show, 
Trauma: Life in the E.R. 
To gather raw footage for 
the show, a producer and 
three video journalists en¬ 
dured schedules to rival a 
resident’s, recording life in 
the Emergency Department 
24 hours a day, seven days a 
week, for a month this spring. 
From 250 hours of video¬ 
tape recorded on hand-held 
cameras, producer Penny 
Fearon will distill two 47- 
minute documentaries, one 
to be aired this fall and the 
other sometime in 2002. The 
award-winning show attracts 
an average audience of 1.5 mil¬ 
lion on Tuesday nights at 
8 p.m., according to Nielsen 
Media Research. 
Yale-New Haven Hospital 
will be the first in New 
England to be featured on 
the five-year-old show. Series 
producer Brian Seligson said 
Yale-New Haven appealed to 
him because of the contrasts 
afforded—“on the one hand. 
Yale University and every¬ 
thing it represents, and on 
the other hand, the fact that 
it’s an inner-city hospital 
dealing with an inner- 
city population.” 
How the film will be ed¬ 
ited, and consequently how 
the hospital will be portrayed, 
is in the hands of The Learn¬ 
ing Channel, said Reuven 
Rabinovici, M.D., professor 
of surgery and chief of the 
section of trauma and surgical 
2 
Clinical development fund makes first round of awards 
Two years ago, when Yale Uni¬ 
versity and the Yale New 
Haven Health System signed 
their first formal affiliation 
agreement, one of its provi¬ 
sions was a fund to expand the 
joint clinical programs of the 
School of Medicine and Yale- 
New Haven Hospital. 
In May, the two institu¬ 
tions announced the first 
awards from this new Clinical 
Program Development Fund, 
directing $17.6 million this 
year to ii programs in brain 
disorders, cancer, cardiovascu¬ 
lar disease, developmental dis¬ 
orders and organ transplant¬ 
ation. These areas have been 
designated clinical priorities 
by the school and hospital. 
“We want to position the 
medical center at the top of 
the field in as many tatget 
areas as possible,” said Richard 
L. Edelson, m.d. ’70, co-chair 
of the fund and deputy dean 
for clinical affairs. “[This 
investment] is intended to 
allow these programs to push 
the envelope and, in some 
cases, to define the frontier.” 
The funded proposals and 
investigators include: 
Brain Disorders 
• Clinical Neuroscience 
Center for Epilepsy and 
Neurovascular Diseases, 
Dennis Spencer, M.D. 
• Yale-New Haven Med¬ 
ical Center Brain Tumor 
Center, Joseph Piepmeier, 
M.D., HS ’82. 
Cancer 
• Transimmunization: A 
New Method for Treatment 
of Graft vs. Host Disease, 
Prevention of Graft Rejec¬ 
tion and Immunization 
against Tumor Antigens, 
Michael Girardi, M.D. ’92. 
• Expansion of the Yale 
Gancer Center Clinical 
Trials Office, Leonard 
Farber, M.D. 
• New Infrastructure and 
Organization for the NCI- 
Approved Yale Comprehen¬ 
sive Cancer Center, Vincent 
DeVita Jr., M.D., HS ’66. 
• Innovations of Head and 
Neck Management, Clarence 
Sasaki, M.D. ’66, HS ’73. 
Cardiovascular Disease 
• Yale-New Haven Medical 
Center Endovascular Center, 
Bauer Sumpio, M.D., HS ’86. 
• Integrated Program for 
the Treatment of End- 
Stage Heart Disease, Barry 
Zaret, M.D. 
• Endovascular Brachytherapy, 
Kenneth Roberts, M.D. 
Developmental Disorders 
• Yale-New Haven Medical 
Center Oncofertility Cen¬ 
ter, Steven Palter, M.D. 
Organ Replacement 
• Transplantation, 
Marc Lorber, M.D. 
The fund received 23 pro¬ 
posals in the first round with 
requests totaling $69.1 million 
and awarded $17.6 of the $18 
million available. Two com¬ 
mittees, co-chaired by Edelson 
and Peter Herbert, M.D. ’67, 
HS ’69, chief of staff at Yale- 
New Haven Hospital, are now 
reviewing a second round of 
applications for $11.5 million 
in support. 
critical care. The confluence 
of The Learning Channel’s 
real-life depiction of the 
trauma world and his team’s 
ability to provide cutting- 
edge trauma care leaves him 
confident the team will come 
across positively. 
“To care for a trauma 
patient, you need to have an 
endogenous sense of mission 
and responsibility, because it’s 
very intense. The people in¬ 
volved are doing their best to 
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provide optimal care, whether 
they are on camera or off” 
Producer Fearon will 
choose a few people to fol¬ 
low-physicians, nurses, 
patients—to create two shows 
with recognizable characters 
and coherent plot lines. She 
said the “shooting ratio” of 
tape to finished product is 
luxurious, at more than 150 
hours to I compared to the 
50-to-i ratio typical for reality 
TV documentaries. One show 
will document the story of 
the man who jumped from 
the building, following him 
as he is treated for smoke 
inhalation and through sur¬ 
gery for a broken femur and 
heel until, after three weeks 
at Yale-New Haven, he heads 
out the door. 
THREE JOIN NATIONAL ACADEMY 
OF SCIENCES Three School of 
Medicine faculty members were 
elected to the National Academy 
of Sciences (NAS) in May, bringing 
the total for the school to 28. The 
new members are Peter Cresswell, 
Ph.D., professor of immunobiol¬ 
ogy and dermatology; Pietro De 
Camilli, M.D., professor of cell biol¬ 
ogy; and Richard P. Lifton, M.D., 
Ph.D., professor of genetics, medi¬ 
cine, and molecular biophysics 
and biochemistry, and chair of the 
Department of Genetics. All three 
are Howard Hughes Medical Insti¬ 
tute investigators. Election to the 
NAS, which was established in 
1863 by congressional charter, is 
one of the nation’s highest scien¬ 
tific honors. The academy has 
1,874 active members and 325 
foreign associates. 
YALE 300 HITS THE HOME 
STRETCH Yale’s observance of 
its 300th year began last October 
with a weekend focused on the 
University’s ever-strongerties 
with New Haven [“Med School 
Invites Neighbors to Join in Ter¬ 
centennial Celebration,’’ Fall 
2000|Winter200i] and continued 
this spring with a two-day pro¬ 
gram exploring“30o Years of Crea¬ 
tivity and Discovery.”The April 
convocation featured a dozen 
medical school faculty members, 
who led seminars on topics from 
biotechnology to global health to 
child development to cancer 
research. They were in good com¬ 
pany; other sessions spotlighted 
the experiences and contributions 
of returning alumni, including 
former President George H.W. 
Bush, former Treasury Secretary 
Robert Rubin, Carnegie Institution 
President Maxine F. Singer, Palm 
Computing and Handspring co¬ 
founder Donna Dubinsky, novelist 
Tom Wolfe and cartoonist Garry 
Trudeau. The Tercentennial year 
will culminate Oct. 5 and 6 with 
an academic convocation on Old 
Campus and a public celebration 
in the Yale Bowl. For updates, visit 
www.yale.edu/yale300. 
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The Ciff tackles “retirement” 
A former dean spends his days teaching science 
to grade-schoolers in New Haven’s Hill neighborhood 
On a Wednesday morning 
in early January, Robert H. 
Giftord, M.D., HS ’67, took 
nine of his eighth-grade stu¬ 
dents out onto New Haven’s 
Columbus Avenue tor an ex¬ 
periment. Braving a wind 
chill of 4 degrees, they meas¬ 
ured the length of the block in 
front of Sacred Heart/St. Peter 
School and prepared to calcu¬ 
late the speed of passing cars. 
The parochial school is the 
last of several serving the Hill 
neighborhood, which borders 
the medical school campus 
to the south and west, and 
Gifford, the former deputy 
dean of education at Yale, 
is the school’s new science 
teacher. In fact, he is its only 
kill-time science teacher. 
The hours are long, the 
work is challenging and the 
pay is modest. (Gifford, who 
volunteered his services during 
his hrst semester at the school, 
now receives a small salary.) 
But it fulfills the goal he set 
several years before his retire¬ 
ment in 1999 [“Goodbye, Dr. 
Gifford,” Fall i999lWinter 
2000] of teaching science to 
children in New Haven’s inner 
city. The lack of a required 
state teaching certificate 
thwarted Gifford’s original 
plan to teach in city public 
schools. But his name came 
to the attention of Geraldine 
Giaimo, M.S., the principal of 
Sacred Heart/St. Peter, who 
was looking for a way to offer 
students more science than the 
classroom teachers could in¬ 
corporate into their lessons. 
Although Sacred Heart/St. 
Peter is a parochial school, 
only about 30 percent of its 
students are Roman Catholic. 
Of the 224 students enrolled, 
96 percent are African-Ameri¬ 
can or Latino and 62 percent 
meet federal guidelines for free 
or reduced-rate breakfasts and 
lunches at the school. “We 
were actually in tears when 
[Gifford] said he would come 
here,” said Giaimo, herself 
an alumna of Sacred Heart, 
which merged with St. Peter 
School in 1994. “He’s not just 
the science teacher. He’s the 
science department.” 
Both Gifford and his 
students, who are in grades 
four through eight, have 
made some adjustments. For 
Gilford, Giaimo said, “It’s 
very challenging dealing with 
young people.” And for the 
students? “The work is hard,” 
she said. “He expects a lot 
from them.” 
Gifford’s main teaching 
tool is a multimedia computer 
that allows him to project Web 
pages onto a screen. His cur¬ 
riculum, which he wrote last 
summer, is based on national 
standards for science education 
and has no textbook. “This 
way I can go in any direction 
I really want to,” he said. The 
direction usually involves an 
experiment, because he wants 
the students to learn by doing 
and thinking. The program’s 
objective, he wrote in his cur¬ 
riculum, is for students to 
develop an enthusiasm for the 
natural world and an apprecia¬ 
tion of scientific thought. 
With donated funds, he 
bought science kits that al¬ 
low the students to carry 
out the experiments that 
underpin his teaching. 
Which explains why 
Gifford and nine students 
were freezing outside the 
school, armed with notepads, 
stopwatches and a tape meas¬ 
ure. Their hypothesis was that 
few drivers passing the school 
adhered to the posted 25-mile- 
per-hour speed limit. The 
students further hypothe¬ 
sized that men were more 
likely to disregard the limit 
than women. 
Before leaving the warmth 
of the classroom, Gifford 
reviewed the required math, 
leading them through the 
calculations necessary to trans¬ 
late feet per second into miles 
per hour. “Tomorrow,” said 
Gifford, “we’re going to con¬ 
struct a graph that will allow 
us to know, so we don’t have 
to calculate it all the time.” 
After measuring the speed of 
three cars, Gifford and the 
students gave in to the cold 
and went inside, vowing to 
return another day to collect 
more data. “No one’s going 
the speed limit, that’s for 
sure,” Gifford said, noting 
that a much larger sample 
was needed for the study. 
In January, Robert Gifford and his stu¬ 
dents measured the speed of passing 
cars on New Haven’s Columbus Ave¬ 
nue to test a hypothesis. 
“We need a lot of cars. We 
need well over 100 cars.” 
At a school science fair in 
February, the students pre¬ 
sented their results. They sur¬ 
veyed 206 cars and found that 
81 percent exceeded the speed 
limit, that 85 percent of female 
drivers and 79 percent of male 
drivers exceeded the limit, that 
all westbound cars and 91 per¬ 
cent of eastbound drivers were 
speeding and that the average 
speed was 35 miles per hour. 
At Sacred Heart/St. Peter, 
his last class is over by 
12:35 p-m., but Gifford often 
spends afternoons at the 
school. He arranges for after¬ 
school tutoring for students 
who need it. He recently 
offered his fellow teachers in- 
service training on classroom 
applications of the Internet. 
And he’s working with K—3 
teachers to develop a science 
curriculum they can use in the 
classroom. “I felt I could bring 
something to the school they 
didn’t have,” Gifford said, ex¬ 
plaining his decision to volun¬ 
teer as a teacher. “It was an 
opportunity.” Giaimo couldn’t 
agree more. “He is laying a 
foundation,” she said, “in a 
way that I don’t think anyone 
else could.” 
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Smart cards for health care’s future? 
Before the end of the decade, 
patients may be arriving at 
the doctor’s office with their 
personal genetic information 
encoded on a smart card to 
help their physicians tailor 
their treatment. But who else 
will have access to that person¬ 
al information? Those were 
among the visions and con¬ 
cerns for the future of health 
care presented at the fourth 
annual Pharmacogenetics and 
Medicine Lectures at the 
School of Medicine in early 
April. The conference brought 
together experts in genomics, 
medicine and policy to dis¬ 
cuss the changes in medicine 
resulting from emerging infor¬ 
mation about the relation¬ 
ship between an individual’s 
genetic makeup and both the 
health benefits and detrimen¬ 
tal side effects of medications. 
Pharmacogenetics is the 
rapidly developing field that 
applies new tools based on 
genetic differences to drug 
development and, eventually, 
to choosing the best treat¬ 
ments for patients. The 
morning-long event in Hark- 
ness Auditorium drew 
nearly 200 attendees from 
the medical school and from 
biotechnology, pharmaceutical 
and venture capital firms 
around the Northeast. 
Gualberto Ruano, PH.D. 
’92, M.D. ’97, is chief executive 
officer of the conference spon¬ 
sor, Genaissance Pharmaceuti¬ 
cals, a New Haven firm that 
is discovering the associations 
between genetic variations and 
clinical outcomes that will 
make those smart cards possi¬ 
ble. He predicted that within 
the next five to six years smart 
cards will begin to be a part of 
health care practices and will 
quickly become standard med¬ 
ical technology for prescribing 
medications. Genomics, he 
said, can be predictive. “At 
the end of the day, our pur¬ 
pose is to create a genetic 
PDR” the equivalent of the 
Physician’s Desk Reference used 
by doctors for guidance in 
prescribing medications. 
Gail Wilensky, PH.D., is a 
senior fellow at the Center for 
Health Affairs/Project hope, 
an international health foun¬ 
dation, and chair of the Med¬ 
icare Payment Advisory 
Commission, which advises 
Congress on Medicare issues. 
She pointed out that there is 
a great deal of skepticism 
about the current value of 
health care relative to costs. 
David Feigal Jr., director of the FDA’s 
Center for Devices and Radiological 
Health, was among the speakers at 
the fourth annual Pharmacogenetics 
and Medicine Lectures at the School 
of Medicine. 
but was optimistic that phar¬ 
macogenetics will receive sup¬ 
port. “The promise of better 
targeting of pharmaceuticals,” 
she said, is “better value for 
our money.” 
Medical ethicist and Profes¬ 
sor of Medicine Robert J. 
Levine, M.D., HS ’63, noted 
the importance of maintaining 
patient privacy and making 
improvements in health care 
as a result of pharmacogenetic 
advances becoming widely 
accessible. Without dealing 
with public fears, achieving 
personalized medicine may 
not be so easy, warned Alan 
McGowen, president of the 
Gene Media Forum, a public 
information organization that 
focuses on biomedical science. 
“We can avoid the pitfalls,” 
he said, “if we take a very 
strong stance in educating the 
public about the benefits and 
are honest about the risks in 
this research.” 
Talking about health 
Students from Yale’s health professions joined with city and state health officials 
for Spring Into Health Fair on Communiversity Day in April. At tables set out on 
the University’s Old Campus, students in medicine, public health, nursing and the 
Physician Associate Program offered information about a variety of health topics 
including smoking prevention and cessation, asthma and dental health.They 
also provided information about nutrition and health insurance as well as blood 
pressure screenings. Among the hands-on events was a chance to learn CPR with 
a mannequin. Organizers hope this will become an annual event and timed it 
to coincide with Communiversity Day on April 7. "Given that there are going to 
be hundreds of people here, it’s an incredible public health opportunity,” said 
Sara Schulman,M.P.H. ’01, co-chair of the event with second-year medical 
student Grace Suh. 
A CALL TO ARMS ON AIDS Yale 
students who previously cam¬ 
paigned for price and patent relief 
for an AIDS drug developed here 
turned their attention this spring 
to the United Nations General 
Assembly’s Special Session on 
HIV/AIDS.The students called on 
the United States to contribute up 
to a quarter of the $7 to $10 billion 
sought by UN Secretary-General 
Kofi Annan for a Global Fund for 
HIV/AlDS.The United States has 
offered $200 million. “If that’s 
how much we give, the fund will 
fail,’’said medical student Kyeen 
Mesesan, one of the authors of a 
petition circulated by students of 
medicine, public health, divinity 
and law. Signed by more than 
150 faculty members and stu¬ 
dents, the petition asked Presi¬ 
dent Bush to take the lead not 
only in funding, but in seeking 
a strengthened declaration of 
principles that links treatment 
and prevention and affirms 
respect for human rights as “a 
necessary part of the response 
to the HIV/AIDS pandemic.” 
HOPE SPRINGS FROM UN CON¬ 
FERENCE One of the participants 
at the UN’s special session in June 
was an AIDS-conference veteran 
who believes that too few of the 
previous international gatherings 
have led to action. Michael H. 
Merson, M.D., dean of public 
health at Yale and a former direc¬ 
tor of the World Health Organiza¬ 
tion’s Global Programme on AIDS, 
said, "I watched leader after 
leader sign a declaration in Paris 
[in 1994] and go home, and noth¬ 
ing changed."This time, however, 
he saw reason for hope. “What 
is different now is that you have a 
conference being held at the UN 
and you have a secretary-general 
providing leadership, putting him¬ 
self in charge of mobilizing an 
international effort. You have 
many more years of experience 
and excellent examples of success 
with prevention. And you have an 
opportunity to offer treatment to 
millions of persons infected with 
the virus. We need to see this as a 
new beginning, no doubt the best 
chance we have ever had to con¬ 
trol this devastating pandemic.” 
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Vaccine may spell 
the end of chicke 
When the new vaccine against 
varicella infection, or chicken- 
pox, was approved hy the U.S. 
Food and Drug Administra¬ 
tion in 1995, many wondered 
how effective it would be. 
According to the largest study 
to date, Yale researchers have 
found that it prevents the dis¬ 
ease 85 percent of the time, 
and even in those who develop 
the disease, symptoms are 
almost always very mild. If 
most children get the vaccine, 
the investigators believe that 
it could one day wipe out 
chickenpox altogether. 
The study, published in the 
March 29 issue of The New 
England Journal ofMedicine, 
sur\'eyed 591 children at pedi¬ 
atric practices in New Haven. 
The study showed that the 
vaccine worked as well as 
predicted and was especially 
effective—97 percent—at 
eliminating severe cases of 
the disease, which formerly 
caused 11,000 hospitaliza¬ 
tions and some 100 deaths 
each year. 
According to study 
director Marietta Vazquez, 
M.D., a postdoctoral fellow 
in pediatric infectious dis¬ 
eases, “The effectiveness of 
the vaccine as it is used in 
actual practice is excellent, 
at least in the short term. If 
its use is fairly widespread, 
the potential is there for 
complete eradication of the 
disease.” She notes that 
some questions remain about 
what will happen as the 
prevalence of the disease 
wanes. “Exposure to chicken- 
pox tends to boost immunity 
against chickenpox.” 
She said that it may be too 
soon to assess the long-term 
effectiveness of the vaccine. 
Vazquez and her colleagues 
plan to continue their study to 
determine whether the vaccine 
will continue to work as well 
over time. For now, she said, 
“I recommend that every 
healthy child a year or older, 
as well as adults with no previ¬ 
ous history of chickenpox, 
receive the vaccine.” 
Nearly 600 New Haven-area children 
took part in a study gauging the effi¬ 
cacy of the chickenpox vaccine, which 
was shown to be 85 percent effective. 
The vaccine also eased the symptoms 
of those who did develop the disease. 
Depression hastens death for women with HIV 
For women with HIV, depres¬ 
sion can be deadly. A Yale 
study of women with the AIDS 
virus found that death rates 
for those with chronic depres¬ 
sive symptoms were two times 
higher than for those with 
no depressive symptoms. 
Chronic depression was also 
associated with significantly 
greater decline in CD4-t count, 
an important measure of 
immune function. 
Clinical levels of depression 
have been reported by 30 to 60 
percent of women with HIV. 
In the first study to look at the 
association between depression 
and the course of AIDS in wo¬ 
men, 765 women from four 
regions of the United States 
were followed over a period of 
seven years as part of the HIV 
Epidemiological Research 
Study. The findings were pub¬ 
lished in the March 21 issue 
of JAMA: The Journal of the 
American Medical Association. 
The study leader, Jeannette R. 
Ickovics, PH.D., associate pro¬ 
fessor of epidemiology and 
public health, said that 
“although the mechanism for 
this effect is not fully under¬ 
stood, it is clear that depres¬ 
sion causes more advanced 
disease progression. We saw 
such high rates that either 
these women were not getting 
treatment or the treatment 
they received was inadequate. 
Yet depression is a treatable 
chronic disease. If we identify 
and treat depression among 
women with HIV, we have the 
opportunity to enhance their 
emotional well-being as well as 
extend their years of life.” 
Women in the general pop¬ 
ulation have higher rates of 
depression than men, and 
women with advanced HIV 
were found to be particularly 
vulnerable to the effects of 
depression, according to the 
new study. The findings show 
that “mental health services 
should be routinely integrated 
with primary care for HIV,” 
Ickovics said. 
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DRUG-COATED STENT APPEARS 
Unking genes to addiction 
Investigators have long known 
that genetic inheritance makes 
a contribution both to the 
likelihood that someone who 
takes cocaine, heroin, other 
opiate drugs and tobacco will 
become addicted and to 
whether a person will try the 
drug in the first place. Recent 
advances in genomics have 
made it possible to begin to 
track down the genes responsi¬ 
ble for the increased risk of 
addiction. From there, scien¬ 
tists hope to be better posi¬ 
tioned to develop new and 
more effective treatments for 
drug abuse. Two recent, sepa¬ 
rate grants to Yale totaling $9 
million from the National 
Institute of Drug Abuse 
(nida) are supporting the 
first-ever large-scale, multi¬ 
center study to identify 
those genes. 
NIDA gave Yale $6 million 
to study cocaine dependence 
Coming soon to an 
near you: HDTV 
Most people think of high- 
definition television (hdtv) 
as a technology that will 
make their favorite programs 
appear sharper and more 
realistic looking, but an 
emerging medical use for an 
HDTV camera system could 
Steven Palter is studying the value of 
high-definition television technology 
in endoscopic surgery. 
in 1999 and then an additional 
$3 million last August to study 
opioid addictions. Tobacco 
addiction will also be studied 
because of the high frequency 
with which it can occur with 
abuse of the other drugs. 
According to the studies’ prin¬ 
cipal investigator, Joel E. 
Gelernter, M.D., associate pro¬ 
fessor of psychiatry, the project 
represents a landmark oppor¬ 
tunity to find the genetic 
basis for the addictions. “The 
fact,” he said, “that the genetic 
contribution [to drug addic¬ 
tion] is so high means that the 
odds of us finding something 
in terms of specific genes 
are very good.” 
To make such a finding, 
however, requires recruitment 
of some 750 families at several 
different sites around the 
country. The goal is to recruit 
addicted sibling pairs and type 
markers throughout the entire 
have a revolutionary impact 
on surgery. 
Steven F. Palter, M.D., 
assistant professor of obstetrics 
and gynecology, used a proto¬ 
type, miniaturized HDTV sys¬ 
tem during a pilot study in 
five endoscopic procedures. 
He said it was “like looking 
through a window when 
looking at the monitor. The 
image was as good as looking 
directly in the incision as 
opposed to through the endo¬ 
scope in the incision.” He 
believes the benefits of the new 
system will be felt in many 
medical specialties. 
HDTV has two to three 
times the normal number of 
lines on the screen and two 
to three times the resolution 
of video equipment currently 
genome. This will give the 
investigators a good chance to 
identify the more important 
genes that influence risk for 
drug dependence. 
Eventually, the study 
should result in a better under¬ 
standing of the physiological 
basis of addiction. “The fan¬ 
tasy,” said Gelernter, “would 
be that we could do a simple 
DNA test of someone whom 
we thought was at risk early 
on, and then do some type 
of modification of the environ¬ 
ment that might be protective. 
Or we could put the person 
on some type of medication 
before he or she was ever 
exposed to cocaine to modify 
what the risk would be.” 
One such medication based 
on the work of Yale scientists, 
a vaccine that can prevent 
cocaine from getting the user 
high, is currently being stud¬ 
ied in clinical ttials. 
used in endoscopic surgeries. 
Until the development of the 
prototype system, however, the 
HDTV camera was not suffi¬ 
ciently small or affordable to 
be useful in endoscopic proce¬ 
dures. The new system’s devel¬ 
oper, the JVC company, expects 
to bring it to market sometime 
this year. 
Palter believes the value 
of using HDTV will go well 
beyond the shatper image. He 
is currently doing a larger, 
follow-up study to see wheth¬ 
er the system has benefits of 
increased accuracy, reduced 
surgeon fatigue and better 
visualization of disease. He 
says, “It is not just the next 
phase in technology. It will 
become the standard for all 
kinds of endoscopic surgery.” 
operating room 
PROMISING Physicians at Yale 
and other medical centers have 
begun testing a new stent coated 
with a drug to help prevent scar 
tissue from forming in blocked 
blood vessels that have been 
reopened through angioplasty. 
Reclogging of the vessel by scar 
tissue occurs following about 
20 percent of the 500,000 proce¬ 
dures performed in this country 
each year. “The initial data is just 
amazing,” Michael W. Cleman, 
M.D., professor of medicine (cardi¬ 
ology), told The Hartford Courant 
in April. “If this tends to work out, 
I would anticipate that we’d be 
looking at a whole new era of 
stenting.”The clinical trial looks 
at the effectiveness of stents that 
have been coated with Sirolimus, 
a drug already being used to help 
prevent kidney transplant re¬ 
jection. So far, the medication 
appears to keep scar tissue from 
forming around the implanted 
stent and to reduce the frequency 
with which vessels become 
blocked again. 
RAISING BLOOD PRESSURE TO 
SAVE LIVES Severe low blood 
pressure affects as many as half 
of kidney disease sufferers under¬ 
going dialysis. Their intradialytic 
hypotension (IDH), or very low 
blood pressure, can become 
so serious that it causes life- 
threatening symptoms, such 
as abnormal heart function and 
low blood supply to the brain, 
and it leads some patients to pre¬ 
maturely end their life-prolonging 
treatments. In studies presented 
at the National Kidney Foundation 
Meeting in Orlando in April and 
published in the American Journal 
of Kidney Diseases, Mark A. 
Perazella, M.D., associate profes¬ 
sor of medicine and director of 
the Acute Dialysis Services, found 
that midodrine hydrochloride 
could significantly and safely re¬ 
duce IDH among dialysis patients, 
even among those who did not 
respond to other treatments. 
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FINDINGS 
A new threat 
from Lyme-disease ticks 
y - j 
\ector Borne and 
Zoonotic Diseases 
The newly discovered spirochete, 
above, was identified in deer 
ticks that also carry the infectious 
agent for Lyme disease. It is not 
known what symptoms, if any, 
the bacterium might cause 
in humans. 
The small, unobtrusive tick 
called Ixodes scapidaris re¬ 
ceived worldwide medical 
attention almost 20 years ago, 
when it was found to play a 
crucial role in the transmission 
of Lyme disease. Although the 
ticks themselves pose no great 
threat to humans, they carry 
the disease-causing spirochete 
Borrelia burgdorferi and pro¬ 
vide the route of human 
infection through their bites. 
But their culpability doesn’t 
end there. In the inaugural 
issue of the journal Vector 
Borne and Zoonotic Diseases, 
Durland Fish, PH.D., and sev¬ 
eral colleagues describe a spiro¬ 
chete from /. scapularis that 
closely resembles B. burg¬ 
dorferi but does not match it 
in highly sensitive DNA tests 
carried out by polymerase 
chain reaction. The new 
species of Borrelia was discov¬ 
ered in /. scapularis nymphs 
that had previously been fed 
on mice known to be free of 
B. burgdorferi infection. The 
yet-unnamed spirochete may 
infect humans as well, since 
“all the other organisms that 
this tick transmits to mice can 
also infect people,” according 
to Fish, an associate professor 
of epidemiology. It is not 
known what symptoms, if 
any, such an infection would 
cause in humans. 
“Our sampling of I. scapu¬ 
laris ... from the field suggests 
that this novel Borrelia is 
widely distributed in nature,” 
the study’s authors wrote, and 
its prevalence is “surprisingly 
high in proportion to the total 
number of Borrelia species 
found in these ticks.” They 
concluded, “These data sug¬ 
gest that a significant propor¬ 
tion of spirochete-positive 
ticks previously thought to be 
B. burgdorferi by microscopy 
is instead this novel Borrelia." 
Infection with B. burgdorferi 
is responsible for more than 
15,000 cases of Lyme disease 
each year. Infection with the 
new Borrelia organism cannot 
be found by current Lyme- 
disease diagnostics—Yale scien¬ 
tists are now working on a 
specific test—but it might well 
respond to the same treat¬ 
ments as Lyme disease. 
may dull responsiveness to brain signals Chronic cocaine use 
In a study measuring the 
brain’s degree of excitability, 
the brains of cocaine- 
dependent people show an 
abnormally low response 
to signals in the region respon¬ 
sible for muscle movement, 
according to a recent article 
in Biological Psychiatry. The 
authors, led by Nashatt N. 
Boutros, M.D., associate 
professor of psychiatry, report¬ 
ed that cocaine addicts and 
longtime users require signifi¬ 
cantly more stimulus to the 
motor cortex in order to 
cause the muscles of their 
fingers and hands to move. 
The signals in this study were 
delivered on the scalp in the 
form of transcranial magnetic 
stimulation, rapid magnetic 
pulses from a handheld coil. 
The motor threshold, the min¬ 
imum amount of stimulation 
needed to produce movement, 
ran at a mean of about 41 per¬ 
cent in normal subjects but 
about 65 percent in chronic 
cocaine users. 
Cocaine itself is well known 
as a drug that excites the 
brain’s signaling pathways 
rather than impeding them, 
so one might expect that long¬ 
time users of the drug would 
have the most signal-sensitive 
brains of all. Boutros and his 
colleagues offered two possible 
explanations for the higher 
motor threshold seen in 
cocaine-dependent brains. It 
may reflect either “an adapta¬ 
tion to those effects of cocaine 
intoxication that promote cor¬ 
tical excitability and seizures,” 
they said, or else tissue damage 
that has left this brain region 
less responsive. In other words, 
by becoming less sensitive to 
signals or less well able to 
respond to them, the brain 
may be attempting to balance 
out the dangerous hyper¬ 
responsiveness that comes with 
cocaine use. The next step, 
said Boutros, will be to repli¬ 
cate these results in additional 
cocaine-dependent subjects, 
using several different meas¬ 
ures of cortical responsiveness. 
8 
Snyderman Lederberg Oes Jarlais Moreno 
Patterns of the AIDS epidemic 
With globalization of the world’s economy making the trans¬ 
fer of money, people and products easier, drugs and disease 
are also crossing international borders, said Don Des Jarlais, 
PH.D., director of research at the Chemical Dependency Insti¬ 
tute at Beth Israel Medical Center in New York. In a talk to 
researchers at the Yale AIDS Colloquium Series, Des Jarlais 
noted that an estimated lo percent of all international trade is 
in illicit psychoactive drugs. “We are not going to be able to 
return to the ’50s, ’40s or ’30s or some other age of innocence 
when illegal drugs were hard to find,” he said. “We are clearly 
not moving towards a drug-free world. We are clearly not 
moving towards an AIDS-free world. Both of these are ex¬ 
panding rapidly.” 
Nimble bugs outmaneuver slow-moving humans 
In the battle against infectious disease, microbes have the 
upper hand, said Joshua Lederberg, ph.d. ’47, who shared the 
1958 Nobel Prize in Physiology or Medicine for his studies of 
bacterial genetics. In an address to the Associates of the Cush¬ 
ing/Whitney Medical Library in April, Lederberg noted that 
while the human immune system was set in stone between 50 
and too million years ago, bacteria can evolve every few years. 
“The pace of microbial evolution vastly outstrips that of large, 
ponderous, slow-reproducing multicellular organisms like 
ourselves,” he said. Humans, he continued, must find a way 
to coexist in “domesticated equilibrium” with microbes. “We 
ought to be looking at the world from the bug’s eye view if 
we want to figure out how to live with them.” 
Cold War qualms spawned bioethics 
When Nazi war criminals were put on trial in Nuremberg 
for performing medical experiments on concentration camp 
prisoners, they pointed in their defense to the United States, 
where prison inmates had been exposed to mosquitoes to test 
antimalaria drugs. The Nazi experiments had a military 
purpose—to gauge the effects of low atmospheric pressure 
and freezing water on pilots. But there was a moral dif¬ 
ference, according to Jonathan D. Moreno, ph.d., director 
of the Center for Biomedical Ethics at the University of 
Virginia. “Death was not an acceptable outcome in the U.S. 
experiments,” Moreno said in an April talk titled “Secret 
State Experiments on Humans” for the Bioethics and Public 
Policy Seminar Series at Yale. Nevertheless, American officials 
engaged in questionable practices following World War ll. 
They deliberately released radioactivity into the atmosphere, 
injected plutonium into people and spiked the drinks of un¬ 
suspecting victims with LSD, activities that caused unease 
among some Pentagon officials. “The prehistory of bioethics 
is deeply related to activities undertaken during the Cold 
War, often in secret,” Moreno said. 
When physicians meet the press 
“With added [academic] degrees, something happens to one’s 
ability to speak English,” said Nancy L. Snyderman, M.D., 
who, as a practicing surgeon and medical correspondent for 
ABC News, straddles the line between medicine and the 
media. Speaking to doctors and residents at medical grand 
rounds in March, she offered some basic advice for dealing 
with the press: “Keep it simple.” On a video screen she showed 
a clip of an M.D./PH.D. who was unable to shed the jargon 
of her work throughout an hour-long interview. “She’s bril¬ 
liant,” Snyderman said. “She never made it on television.” 
In our sound-bite society, the average news piece is 90 seconds. 
Snyderman’s recommendation: “You should know in your head 
the three things you want to get out. If there are things that 
you really have to explain for someone to get it, skip it. It is 
either going to get reported incorrectly or it will take you 
down the wrong path.” 
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What the needles said > > > 
By John Curtis 
> > > On a balmy day in Novem¬ 
ber 1990, a battered van that 
once delivered loaves of bread to 
Yale University dining halls set 
off on a voyage through New 
Haven’s inner-city neighbor¬ 
hoods. Its cargo? Clean syringes 
for the city’s drug users, no one knew 
whether needle exchange would do what was ex¬ 
pected of it—slow the spread of AIDS—because sup¬ 
porters lacked the scientific evidence to confirm 
what intuitively made sense, that clean needles 
were less likely to spread disease. What they did 
know was that other approaches had fallen short. 
They’d been handing out condoms, bleach kits for 
cleaning needles, and brochures with advice on 
preventing HIV infection. But drug users who used 
needles still made up 80 percent of the AIDS cases 
in New Haven. 
A lot was riding on the program. It had taken 
three years of coalition and consensus building to 
persuade a wary state legislature to pass a bill 
exempting the program from laws that made nee¬ 
dle possession a crime. Scientific data on the effi¬ 
cacy of clean needles were scarce and weak, and 
distributing clean needles was a political minefield. 
To succeed, the needle exchange had to win the 
trust of New Haven’s drug users. That’s why the out¬ 
reach workers on the van were elated that day, 
November 13, as they reached their first stop on 
Congress Avenue in the Hill neighborhood. “We 
had people waiting for us,’’ remembered Dominick 
Maldonado, one of the city’s first AIDS outreach 
workers. Kaveh Khoshnood, Ph.D., assistant profes¬ 
sor of epidemiology, then a graduate student in 
public health, was also on the van. “We had no idea 
whether people were going to come to this official 
program but, indeed, they came,” he recalled. "The 
word got out rather quickly that this program was 
legit, that you wouldn’t get arrested by the cops. 
It was reassuring to know that people trusted the 
program and trusted the staff.” 
Before a year had passed, needle exchange 
proponents would have more cause for elation. 
A study by Yale faculty would prove that the pro¬ 
gram reduced the incidence of new HIV infections 
by a third. The study would be a watershed in the 
history not only of needle exchange, but also of 
public health—the first that addressed the key 
question of whether clean needles would prevent 
AIDS. Other communities across the country would 
follow New Haven’s example. The reaction would 
not be entirely positive. The coalition that came 
together around needle exchange—local politicians, 
local health officials and Yale students and faculty— 
would withstand pressure from federal officials 
who felt that distributing syringes encouraged 
drug use. 
Last November, city officials and Health Depart¬ 
ment staff joined Yale faculty to celebrate 10 years 
of New Haven’s needle exchange program. Over the 
past decade the rate of infected needles in the city 
has dropped from 65 percent to below 40 percent. 
More than i,ooo drug users have found their way 
into treatment through the needle exchange pro¬ 
gram. And the drop in the number of new AIDS 
cases, from 121 in 1991 to 38 in the fiscal year end¬ 
ing July 2000, is due in large part to programs such 
as the needle exchange. New Haven’s needle ex¬ 
change van still plies the streets of the city, offering 
syringes on its regular route. Nationally, the number 
of needle exchange programs has grown to more 
than 150, according to the North American Syringe 
Exchange Network, a support organization based 
in Tacoma, Wash. 
The New Haven program’s beginnings go back 
to the mid-1980s. “Very little was being done to 
educate the drug users on the street about the 
dangers of HIV,” said Maldonado, then a drug coun¬ 
selor. At the urging of Alvin Novick, M.D., a Yale 
professor of biology, then-Mayor Biagio DiLieto 
created the Mayor’s Task Force on AIDS in 1986. He 
provided funding and a full-time coordinator. Soon 
the city health department hired three full-time 
outreach workers to work with drug users, one of 
whom was Maldonado.“lmmediately we hit the 
streets,” Maldonado said. “At the time we Just had 
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John Curtis is the associate editor of Yale Medicine. 
'We were called crazy,” 
Maldonado said."We were 
told it was political suicide, 
that this would never happen 
in Connecticut.” 
BACKGROUND The AIDS 
Brigade, the first needle 
exchange in the United States, 
traded clean needles for used 
ones in New Haven and Boston. 
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the bleach, the water, the pamphlets and the con¬ 
doms.” But the health workers had begun to think 
about needle exchange.“We were called crazy,” 
Maldonado said. “We were told it was poiitical sui¬ 
cide, that this would never happen in Connecticut.” 
The model for needle exchange came in 1984 
from Amsterdam, a city known for its tolerant 
attitude toward drug use. When an inner-city 
pharmacist stopped selling syringes, the city’s 
Junkie Union, worried about hepatitis B infection, 
organized its own syringe exchange. Two years 
later needle exchange remained a radical idea in 
the United States, and only one such program was 
operating here.The AIDS Brigade, the nation’s first 
needle exchange, was a rag-tag, underground 
operation run by a Yale student of public health. 
And it was based in New Haven. 
Jon Stuen-Parker is a testament to the eclectic 
admissions policies of the School of Medicine. In his 
self-published autobiography. From Jail to Yale, he 
describes his transformation from an addict who 
broke into pharmacies to steal drugs, to convict, to 
medical student. His tenure at Yaie was anything 
but conventional. He started in 1980, and by 1983 
he and feliow medical students had begun educa¬ 
tional outreach to drug users. In his hometown of 
Boston, Stuen-Parker had begun another outreach 
program, again trying to educate drug users about 
the dangers of AIDS.The spark to his activism, he 
said, was a guest speaker at the medical school 
who angered him by saying, “Don’t waste your time 
trying to educate the addicts. They’ll never change 
their behavior.” 
By 1986 Stuen-Parker and some of his class¬ 
mates had opened a storefront outreach center for 
drug users on York Street in New Haven. Later that 
year Stuen-Parker was asked to leave the medical 
school after failing Step I of the medical boards 
three times. He attributed his failure to dyslexia, 
but school officials recommended that he spend 
more time hitting the books and less time on his 
outside activities. Stuen-Parker said that before his 
expulsion, he refused a request from school officials 
to shut down his outreach center. He continued his 
studies toward a public health degree, which he 
received in 1992. He also continued his outreach 
until a Boston drug user’s act of generosity showed 
him another approach to harm reduction. At an 
I outreach meeting the drug user handed out seven 
ciean syringes. “They were going for $5 apiece, but 
he felt he wanted to give something back,” said 
Stuen-Parker. Soon Stuen-Parker was using his 
earnings as a Boston cabbie to buy syringes legally 
in Vermont and exchange them in Boston and New 
Haven shooting galleries.“You’d walk in the door 
and people would be sitting there with needles 
in their arms,” Stuen-Parker said. 
Khoshnood,then a public health student inter¬ 
ested in AIDS prevention, recailed meeting Stuen- 
Parker on a Friday night in 1988 at the corner of 
Chapel and College streets to discuss needle ex¬ 
change. “I wasn’t ready to go out on the street. 
I just wanted information, but Jon wasn’t going 
to spend a lot of time expiaining things to me,” 
Khoshnood said. Instead, Stuen-Parker took Khosh- 
nood to a housing project on Dixwell Avenue, 
where Stuen-Parker handed out clean needles and 
collected dirty syringes in a bucket. The bucketful 
of needles sat in a corner of the storefront outreach 
center on York Street. “We weren’t that careful, 
now that I think back,” Khoshnood said. “We did 
start using thick gloves.” Much later those needles 
would play a role in the government-sanctioned 
needle exchange program. 
City heaith officials were aware of the under¬ 
ground exchange, but were taking a different 
course. Where Stuen-Parker could be provocative— 
he courted arrest by handing out needles in sight 
of police officers—the city’s AIDS workers wanted 
to build support for needle exchange.To those 
promoting needle exchange, Stuen-Parker was a 
mixed blessing. “He took chances before we did,” 
said Maldonado. “But Jon became very possessive 
of needle exchange. He felt no one could do it but 
him.”Stuen-Parker, however, said his AIDS Brigade 
was always open to working with others. “We 
hoped our actions would create a green light for 
others to do needle exchange,” he said. “We wanted 
to get others involved.” But he felt the New Haven 
outreach workers weren’t doing enough, that they 
seldom appeared in the drug-using community. 
When it came time to approach the state 
legislature for permission to embark on a needle 
exchange program, city officials kept Stuen-Parker 
at arm’s length. “We weren’t about to be extolling 
the virtues of the underground exchange,” said 
Elaine O’Keefe, who headed the city Health Depart¬ 
ment’s AIDS division and is now health director for 
the town of Stratford. “Even if we felt their work 
had pubiic health merit, aligning with the radical 
fringe would have diminished our credibility in the 
state legislature and with other decision makers 
whose support was critical.”Tensions persisted 
between Stuen-Parker and the city’s AIDS workers. 
Two members of the AIDS Brigade, Khoshnood 
and Peter Fisher, left to form their own needle 
exchange, AIDS Community Educators, which col¬ 
laborated with the city program. Stuen-Parker 
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eventually returned to Boston, where he runs 
the National AIDS Brigade, which provides clean 
syringes and runs education programs around 
the country and abroad. 
To make their case before the legislature, 
Maldonado, O’Keefe and AIDS task force coordina¬ 
tor Sher Horosko enlisted as much support as 
possible, even from the city’s drug users. The city 
health workers wanted to know why addicts 
shared needles. The answer was disarmingly simple. 
Needles were hard to come by, and mere possession 
could land a drug user in jail. “They told us,‘We 
share needles because we don’t have access to 
them. If we had them there would be no need for 
sharing,’ ’’ Maldonado said. 
The group had a tough sell even in New Haven, 
where the task force itself was divided on the issue. 
Resistance to needle exchange was strongest 
among clergy in the African-American communities 
hardest hit by drugs. “It had the appearance of giv¬ 
ing approval to drug use,’’ said State Rep. Bill Dyson, 
a New Haven Democrat who shepherded the needle 
exchange bill through the state legislature. Never¬ 
theless, advocates built a consensus. In the winter 
of 1989 a delegation of public health officials, out¬ 
reach workers, expert witnesses and city leaders 
made the case for needle exchange before the state 
legislature’s health committee. The committee 
turned them down. “We were told not to come 
back,” O’Keefe recalled. 
Over the next year the group marshaled more 
support. Quick to come on board was the new 
police chief, Nicholas Pastore. “We wanted to do 
our best to take dirty needles off the streets so they 
wouldn’t endanger children or police and firefight¬ 
ers," said Pastore, now a research fellow in New 
Haven for the Washington-based Criminal Justice 
Policy Foundation. “I also believe fewer people 
should be coming into the criminal justice system 
for these kinds of reasons.” 
In the summer of 1990, New Haven needle 
exchange advocates returned to Hartford. “There 
was just a larger coalition,” said Khoshnood.“We 
had physicians, we had public health officials, we 
had the police, we had policy makers. It was a criti¬ 
cal mass.” The health committee reversed itself and 
the full legislature approved a needle exchange 
program in New Haven, with funding of $25,000. 
But there were strings attached. The program would 
have to evaluate its results within a year. The legis¬ 
lature wanted to know how many needles came 
back to the program, whether the program led to 
changes in drug users’ behavior, how many users 
entered treatment and whether the program 
encouraged drug use. 
At the time there were scarce data on needle 
exchanges. A handful of programs were operating 
in the United States—in Washington, Colorado, Ore¬ 
gon, California and New York—but most evaluations 
came from abroad. “The research that was done in 
Britain and Australia was often based on self- 
reported behavior, often based on small sample 
sizes and often unpublished,” said Peter Lurie, M.D., 
M.P.H., a leading researcher on the public health 
implications of the AIDS epidemic. When the 
evaluation of New Haven’s needle exchange was 
published, Lurie was working with the Prevention 
Sciences Group at the University of California- 
San Francisco. 
Novick, who chaired the city’s AIDS task force, 
went to his friend Edward H. Kaplan, Ph.D., then an 
assistant professor in the School of Management. 
Kaplan’s mathematical modeling approach to HIV 
infection had caught Novick’s eye and the two had 
become collaborators. City health officials, more 
concerned with implementing the program than 
analyzing it, reluctantly asked Yale to evaluate their 
program. “We were very against the evaluation,” 
Maldonado said. “We didn’t feel it was a time to 
do research.” 
The city health workers imposed two conditions 
that shaped Kaplan’s study. Drug users could not be 
tested for HIV infection.“The fear was you would 
scare people away,” Kaplan said. The next condition, 
he recalled, went roughly like this: “You can’t have 
a whole bunch of Yale students climbing all over 
the clients with surveys the size of telephone 
books.” In other words, the people who would use 
the exchange, benefit from it and serve as the 
prime source of information about its effects on 
their behavior were off limits. And, in addition to 
the other restrictions, the $25,000 the state had 
allocated for the program was barely enough 
to cover costs, let alone fund a study. 
For Kaplan, who had written a paper entitled 
“Needles That Kill,” the solution was obvious. 
“You want to look at this from the perspective of 
the needles,” he said. “It was like looking at malaria 
from the perspective of the mosquito.” His idea? 
“We can’t test people,” he said. “Is it OK if we test 
needles?” If needle exchange reduced the number 
of new HIV infections, it stood to reason that used 
needles would be less likely to carry traces of HIV. 
There was only one problem. Kaplan didn’t 
know whether laboratory science was up to the 
task. He sought help from Edwin C. Cadman, M.D., 
then chair of the Department of Internal Medicine 
at the medical school. Cadman, in turn, went to an 
epidemiologist who was struggling with his post¬ 
doctoral work and looking for a new project. 
Cadman, now dean of the John A. Burns School 
of Medicine at the University of Hawaii at Manoa, 
offered to find a lab and money in his budget 
for the needle exchange evaluation. The postdoc 
mulled over the proposal for about an hour. “We 
decided,” said Robert Heimer, Ph.D., now associate 
professor of epidemiology, “that using the very 
newly emerging polymerase chain reaction tech¬ 
nology would be a feasible and scientifically excit¬ 
ing way to try to do this. Nobody had tried to look 
Qm 
"You can't have a whole bunch 
of Yale students climbing all over 
the clients with surveys the size 
of telephone books.” 
at HIV in white blood cells sitting for who knows 
how long in the barrel of a needle.”To see if it could 
be done, Heimer turned to the bucket of needles 
that had been gathering dust in a corner of the 
AIDS Brigade’s storefront. 
Working with the needle exchange team, 
Kaplan and Heimer devised an elaborate system 
to track the needles. They bought 
European-made syringes that would 
stand apart from domestic ones. 
Each needle had an ID number. 
Drug users signed up for the pro¬ 
gram anonymously and were given 
an identity of their choosing, often 
a pseudonym that showed some 
humor, such as “Bugs Bunny” or 
“Dan Quayle.” Khoshnood, who 
' knew many drug users from his 
Dirty needles traveled from 
this collection bucket to a cor¬ 
ner of a storefront outreach 
c^ter to,'Robert Heimer’s lab 
a^Yale, vJhere they played a 
Acial role in determining the 
^ectiyeness of the New Haven 
peWle^xchangi. 
years with the underground exchange, conducted 
; a brief interview with each client to gather demo- 
■ graphic data. Users received one clean syringe 
for each dirty syringe they returned to the van. 
Logbooks recorded who took a needle and who 
returned it, when and where the needle left the van 
and when and where it was returned. Incoming 
needles went to Heimer’s lab for testing. Once a 
week, data from the lab went to Kaplan’s office. 
“The level of infection went down as the number of 
needles in circulation went up,” Kaplan said. He 
found another correlation. The longer a needle was 
in circulation, the more likely it was to come back 
HIV positive. “The most compelling data were 
the testing data, which demonstrated that the per¬ 
centage of infected needles had decreased,” said 
Heimer. “Ed, with his mathematical modeling, 
had concluded that there was a one-third reduc¬ 
tion in new infections.” 
About 700 of the city’s estimated 2,000 injec¬ 
tion drug users participated in the needle exchange. 
Kaplan used a statistical sampling design, then 
applied “circulation theory” to gauge the impact 
of clean needles. Preliminary results found that 44 
of 48 needles—92 percent—from a shooting gallery 
tested positive for HIV. A test of 160 needles from 
the street found 67.5 percent to contain HIV. As the 
program continued, a sampling of 581 street needles 
found that only half tested positive. Six months 
after the exchange began, 26 percent of needles 
returned to the program showed traces of HIV. 
New infections, Kaplan reported, had dropped by 
a third. Without needle exchange, he projected, 
64 drug users out of a thousand would become 
infected with HIV. Once syringes became available 
through needle exchange, HIV would infect only 
43 in a thousand. 
In July 1991, Heimer and Kaplan announced 
their results. “When the report came out and hit 
the front page of The New York Times, that was a 
huge deal,” said Lurie, now deputy director of Public 
Citizen’s Health Research Group in Washington, D.C. 
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“The most compelling data were 
the testing data, which demon¬ 
strated that the percentage of 
infected needles had decreased,” 
said Heimer. “Ed [Kaplan], with 
his mathematical modeling, had 
. concluded that there was a one- 
third reduction in new infections ” 
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Through the city’s needle 
exchange program, drug users 
obtained clean syringes in 
exchange for used ones. Yale 
scientist Robert Heimer then 
used a new technology, poly¬ 
merase chain reaction, to 
measure the level of HIV in 
used syringes. Heimer’s col- 
i league Edward Kaplan applied 
mathematical models to trans¬ 
late the raw data into a quan¬ 
tifiable result. Kaplan’s formula 
led him to conclude that New 
Haven’s needle exchange 
reduced the rate of new infec¬ 
tions by a third. 
“That put needle exchange research and the pro¬ 
grams themselves on a vastly more secure footing. 
It added a measure of credibility to the programs 
and provided a scientific basis that had not been 
there before. It provided a number that people 
could use, and still do use, as an estimate of the 
effectiveness of needle exchange—the well- 
known one-third reduction." Other communities 
approached New Haven for help in starting their 
own needle exchanges. “We could have been on the 
road every other week,” said O’Keefe, the former 
AIDS division director.“There was a heavy demand 
placed on the New Haven program to go out and 
“I don’t think we were quite prepared for the 
politics of it all,” said Kaplan. “The program gener¬ 
ated data that suggested it did work. That led to 
Rob [Heimer] and myself being painted as activists 
and advocates.” Kaplan offered to 
discuss his findings with officials 
at the Office of National Drug 
Policy, but received no reply. 
“When we began the work, 
people opposed to needle ex¬ 
change said there is no evidence 
it works,” Heimer said. “After 
our report they had to modify 
Kaplan and Heimer's 
methodology remains 
a landmark in evaluating 
needle exchanges. 
speak to other communities and groups that were 
trying to get needle exchanges in place.”The Yale 
study led David Dinkins, mayor of New York City at 
the time, to reverse his opposition to needle 
exchange. Kaplan and then-AAayor John Daniels of 
New Haven, a former opponent of needle exchange, 
sang its praises on national television programs. 
But attacks quickly followed. Bob Martinez, the 
nation’s drug czar in the early iggos, weighed in 
against the Yale study and its authors. He called the 
study flawed and said that there was no evidence 
the needle exchange slowed the spread of AIDS. 
Charles Rangel, a Democratic congressman from 
New York City and a critic of needle exchanges, 
asked the General Accounting Office to review 
Heimer and Kaplan’s research. The Centers for Dis¬ 
ease Control and Prevention (CDC) commissioned 
a report on needle exchange from scientists at the 
University of California. Their report, with Lurie 
among the authors, included a chapter on the New 
Haven evaluation project. Both reviews confirmed 
the study’s conclusions. The CDC report went 
further, saying the Yale study understated the value 
of needle exchange. Kaplan’s modeling approach 
won him the prestigious Franz Edelman Award from 
the Institute of Management Sciences. But the 
attacks continued. 
that statement to say there is 
no good scientific evidence. 
After the various panels of inquiry had concluded 
that our work was scientifically valid and inde¬ 
pendently verified, they were left saying that 
needle exchange sends the wrong message. 
The debate had been taken out of the realm of 
science and placed entirely in the realm of 
politics and morality.” 
The years that followed saw a few victories for 
needle exchange. The state of Connecticut imple¬ 
mented five other programs and legalized over-the- 
counter sales of syringes. Other communities, most 
notably New York City, followed New Haven’s exam¬ 
ple. As of last year 158 needle exchanges were 
operating in 36 states, the District of Columbia and 
Puerto Rico, the North American Syringe Exchange 
Network reports. In 1998, however. President Bill 
Clinton disappointed advocates by refusing to allow 
federal funding of needle exchanges. And threats to 
the availability of clean needles remain. Bridgeport 
police argued that the 1992 state law legalizing 
over-the-counter sale of needles covered only drug 
users participating in needle exchange programs. 
A federal judge found otherwise and in January 
2001 enjoined the police from arresting people 
for possession of syringes. 
In 1991, shortly after New Haven 
started one of the nation’s first 
sanctioned needle exchange 
programs, its organizers and 
outreach workers posed for 
a photo. From left; Edwin Cad- 
man, Elaine O'Keefe, Edward 
Kaplan, George Edwards, 
Dominick Maldonado, Robert 
Heimer, Chris Brewer, Sonia 
Lugo, Kaveh Khoshnood 
and Alvin Novick. 
The New Haven needle exchange program has 
left a legacy of lessons for other communities as 
well. The long period of consensus building and the 
support of Daniels, the city’s first African-American 
mayor, and police chief Pastore were crucial to the 
program’s success. And there were by-products. The 
van offered more than needles. About one in seven 
of the original 700 program participants entered 
drug treatment, according to city officials. And 
there was no evidence that the needle exchange 
encouraged drug use. The van’s client base, which 
included people of all social classes from 26 com¬ 
munities in Connecticut, remained stable. 
Kaplan and Heimer’s methodology remains a 
landmark in evaluating needle exchanges. “In terms 
of proving the efficacy of needle exchange, I don’t 
think it gets much better than this,” said Lurie. "The 
Yale research was, for its time and in some ways 
still, the most sophisticated attempt to evaluate 
needle exchange, not only because the methods 
were sophisticated, but also because it tried to 
answer the central question around needle ex¬ 
change—whether the programs really reduced the 
incidence of HIV.” 
“This was as good a documentation of effec¬ 
tiveness as had ever been seen,” said Michael H. 
Merson, M.D., dean of public health at the medical 
school, recalling the excitement generated by the 
New Haven study. In 1991, when Kaplan and Heimer 
announced their results, Merson was working 
on international AIDS programs at the World 
Health Organization. 
Despite their effectiveness, Merson sees little 
willingness in this country to embrace needle 
exchange programs as part of federal harm reduc¬ 
tion measures. Although the Clinton administration 
declined to fund them, federal officials endorsed 
needle exchanges as an effective prevention meas¬ 
ure. Merson expects little support from the Bush 
administration. “It’s evident, at least for the fore¬ 
seeable future, that there isn’t going to be any 
change in federal policy that would allow federal 
funds to be used for needle exchange programs,” 
Merson said. “What is unfortunate is that there are 
effective prevention interventions against HIV, such 
as needle exchange programs or distributing con¬ 
doms in schools, which are judged morally rather 
than from the public health perspective. That is why 
this epidemic continues to be a major problem in 
this country.” 
Although the New Haven program is active, 
the city’s original needle exchange van is long gone. 
Painted with bright murals by a Yale librarian and 
city high school students to cover its police-blue 
hue, the first van has been replaced several times. 
The new van runs a regular route five days a week 
through the city’s neighborhoods and even makes 
house calls. From July to September of 2000,518 
drug users availed themselves of the van. The num¬ 
ber of people using the van may have declined since 
passage of the 1992 state law that allows pharma¬ 
cists to sell syringes without prescriptions. The van 
still leads drug users to treatment programs and 
since 1997 it has operated with the Community 
Health Care Van, staffed by a physician assistant 
and outreach workers. “It is clear that needle 
exchange does have an impact,” said Matthew F. 
Lopes, M.P.H. ’77, director of the city Health Depart¬ 
ment’s AIDS division. “Connecticut has been for¬ 
ward thinking in allowing it to exist for 10 years.” 
Kaplan was even more emphatic when he spoke 
at the ceremony marking the program’s 10th 
anniversary last fall.“In simple terms,” he said, 
“the program has saved lives.” 
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STUDENT NEWS 
For this year's 
graduates, a bit of 
pomp and controversy 
For Associate Dean Ruth J. Katz, J.D., M.P.H., 
the Class of 2001 will always be her first class. 
As its chosen speaker at Commencement this 
year, Katz recalled arriving at Yale in 1997 with 
this year’s graduates and learning with them. 
“I practiced on you as a rookie dean,” she told 
the 79 graduates. “We experimented together 
and discovered the marvels of this place and 
identified some of its ... let’s just call them im¬ 
perfections. We worked in small groups and 
went beyond simple problem-solving and 
critical thinking and helped to make signifi¬ 
cant institutional reforms. We sang, we 
danced and we laughed our way through 
the Second-Year Show. 
“The Class of 2001 will always claim a piece 
of both my heart and my mind,” Katz contin¬ 
ued. “1 am honored to have been with you 
from the beginning. I am humbled that you 
have asked me to be with you in such a 
meaningful way at the closing.” 
The medical school Commencement fol¬ 
lowed a University-wide ceremony that fea¬ 
tured an address by President Bush, a 1968 
Yale College alumnus and one of 12 people to 
receive an honorary doctorate. Sharing the 
stage with luminaries including actor Sam 
Waterston, former Treasury Secretary Richard 
Rubin and Nobel Laureate Harold Varmus, 
M.D., Bush spoke ol his years as a Yale under¬ 
graduate. Before his arrival, scores of faculty 
members signed a petition protesting the 
awarding of the doctorate. They argued that 
it was too early in Bush’s term for him to have 
distinguished himself, and they objected to 
most of his policies, particularly on the envi¬ 
ronment. Some students agreed, and during 
the Commencement on Old Campus, they 
held up protest signs, booed and turned 
their backs on the president, while others 
cheered him. 
—John Curtis 
Students began the Commencement 
procession May 2i from the Sterling 
Hall of Medicine to Harkness Lawn. 
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TOP LEFT President Bush drew mixed 
reviews for his jokes about his educa¬ 
tion at Yale. Some students protested 
his policies while others laughed at his 
self-deprecating humor. 
TOP RIGHT Former NIH Director Harold 
Varmus received an honorary degree 
for his contributions to cancer re¬ 
search. Varmus won the Nobel Prize 
in Physiology or Medicine in 1989 for 
his discovery of the cellular origin 
of retroviral oncogenes, which can 
turn normal cells into tumor cells. 
ABOVE Ben Huffard, with his sons 
Mac and Jed, waited his turn to 
receive his diploma. 
The following prizes were awarded 
to School of Medicine faculty and 
students at Commencement: 
Bohmfalk Prize 
Emile Boulpaep, M.D. 
Kathleen White, M.D. 
Healthcare Foundation of New Jersey 
Humanism in Medicine Faculty Award 
Jonathan Gage, M.D. 
Leah M. Lowenstein Prize 
Gail D'Onofrio, M.D. 
Francis Gilman Blake Award 
David Coleman, M.D. 
Laura Ment, M.D. 
Betsy Winters House Staff Award 
Stephen Fossick, M.D. 
Parker Prize 
Jessica L. Mega 
Miriam Kathieen Dasey Award 
Garth N.Graham 
Norma Bailey Berniker Prize 
Benjamin D. Smith 
Dean’s Prize for Community Service 
Sharon A. Chekijian 
Caroline N. Harada 
Healthcare Foundation of New Jersey 
Humanism in Medicine Student Award 
Caroline N. Harada 
Melissa S. Lee 
Campbell Prize 
Heather C. Yun 
Perkins Prize 
Jerry Wu 
Merck Book Award 
Carl V. Crawford 
Michael Z. David 
M.D./Ph.D. Award 
Matthew H. Levine 
Daniel H.Wolf 
Connecticut Society of the 
American Board of Obstetricians 
and Gynecologists Prize 
Jennifer M. Lucero 
New England Pediatric Society Prize 
Patricia L. Birgeneau Prince 
Society for Academic Emergency 
Medicine Award 
Rockman F. Ferrigno 
Department of Surgery Awards 
of Distinction: 
Award for Outstanding 
Clinical Performance 
Ajay V. Maker 
Award for Outstanding Research 
Matthew A. Gutierrez 
Association for Academic 
Surgery Award 
Ryan R. Davies 
Connecticut Chapter of American 
College of Surgeons Prize 
Anthony Lemaire 
Peter A.T. Grannum Award 
Carl V. Crawford 
Lauren Weinstein Award 
Jennifer M. Lucero 
The Courtlandt Van Rensselaer 
Creed Award 
La Lisa A. Anderson 
Stephanie A. Boykin 
ACP-ASIM Internal Medicine Award 
Harry H.Yoon 
The Patricia Nez Award 
Jennifer M. Lucero 
The C. Winternitz Prize in Pathology 
Benjamin D. Smith 
John C.Tilton 
The Ralph W. Ellison Prize 
LaLisa A. Anderson 
The William and Charlotte 
Cadbury Award 
Michele M. Johnson 
The Wyeth-Ayerst Laboratories 
Prize in Women’s Health 
Jennifer M. Lucero 
Michael Vaughn, Sara Erickson, 
Barbara Coren and Geoff Emerson 
chatted with Dean David Kessler, left, 
and Irwin Birnbaum, the school’s 
chief operating officer, on Cross Cam¬ 
pus before Commencement. 
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Challenges abound in 
public health, surgeon 
general tells graduates 
i^f(VATT 
EPH COMMENCEMENT 
Citing too years of advances in science, such as 
the eradication of smallpox, a 30-year increase 
in longevity and widespread immunization for 
childhood diseases. Surgeon General David 
Satcher, M.D., PH.D., told the EPH Com¬ 
mencement audience that much remains to 
be done in this century. Among the challenges 
facing the 78 graduates in public health, 
Satcher said, are hiv/aids, an aging popula¬ 
tion and racial and ethnic disparities in health 
care. “How can we continue to improve the 
quality of life for all Americans?” he asked. 
“To the extent that we respond ro the needs 
of the most vulnerable among us, we respond 
to the health needs of the nation.” 
Satcher called for a balance among rhe 
basic, biomedical and clinical sciences and for 
partnerships between public health and sci¬ 
ence. “We have to make sure we write policies 
that are consistent with the best available 
science,” he said. 
Student speaker Matthew Freeman, 
M.P.H. ’01, asked his classmates to heed the 
admonition of Ralph Waldo Emerson “to leave 
the world a little better.” “I, too, hope that we 
will find success by Emerson’s definition,” 
Ereeman said, “by improving the health of 
the people, keeping the environment clean 
and seeking the most effective ways to pre¬ 
vent and treat disease.” 
2001 
TOP Surgeon General David Satcher, 
speaking at the School of Public Health 
Commencement ceremony in Battell 
Chapel, told graduates they would face 
the challenges of an aging population 
and disparities in health care. 
ABOVE LEFT As they marched to Com¬ 
mencement, public health graduates 
Elizabeth Tong and Allison Stockman 
carried messages for President Bush. 
ABOVE RIGHT The School of Public 
Health’s first ceremonial mace, carried 
by Professor Curtis Patton, made its 
debut at Commencement this year. 
The mace is a mahogany staff adorned 
with the school’s heraldic shield en¬ 
circling a hollow globe. 
The following prizes were awarded to 
faculty and students of the School of 
Public Health at Commencement: 
Award for Excellence in Teaching 
Elizabeth H. Bradley, Ph.D. 
Dean’s Prize for Outstanding Thesis 
Arvind Bakhru for "Smoking 
Cessation and Changes in the 
Acute Phase Response" 
Pedram Fatehi for "Comparing the 
Predictive Value of Plasma 
Glucose Tests" 
James Martin Kessler for "West 
Nile Disease: An Evaluation of the 
2000 New York City Department 
of Health Active Physician-Based 
Surveillance System" 
Martin David Slade for "Effect of DNA 
Vaccine and Granulocyte 
Macrophage-Colony Stimulating 
Factor on Cottontail Rabbit 
Papillomavirus Growth" 
The Henry J. (Sam) Chauncey Jr. Inspira¬ 
tion Award (awarded by alumni of the 
Health Management Program to a stu¬ 
dent who exemplifies Mr. Chauncey's 
ideals of innovation, integrity leadership 
and community service) 
Trisha Marie Lollo 
The Courtlandt Van Rensselaer 
Creed Award 
Angela Marcia Williams 
On Student Research Day, 
a chance to share 
observations and conclusions 
Three years ago, when Jacqueline C. Dolev 
signed up for a course to improve her clinical 
observation skills, she didn’t expect to spend 
class time in an art museum—nor, for that mat¬ 
ter, to find the topic of her thesis in the exer¬ 
cise. But both things happened, and in April 
Dolev was standing in the lobby of the Jane 
Ellen Hope Building explaining her research 
to those attending Student Research Day. 
Her project, “Enhancing Medical Observa¬ 
tional Skills through Eine Arts; A Randomized 
Controlled Study,” was a scientific evaluation 
of the course, taught by dermatology professor 
Irwin M. Braverman, M.D. ’55, HS ’56, and 
staff at the Yale Center for British Art. 
Dolev assessed students’ written descrip¬ 
tions of photographs from before and after the 
course and had them perform a visual search 
task. “The students who took the course were 
much better in their descriptive ability than the 
control group,” she said while standing next to 
her display amid the buzz of the poster session. 
“They learned to look at the photographs of 
medical disorders for both global attributes and 
details.” The control group, on the other hand, 
was more haphazard in its descriptions and 
more likely to see either the big picture or fine 
detail, but not both. 
Dolev was among 50 medical, public health 
and M.D./PH.D. students presenting work at 
the school’s 15th annual scientific poster session 
on April 20. Thesis topics ranged from the 
epidemiology of tuberculosis in Moscow from 
1906 to 1936, to the role of cytokines and 
Damani Piggott, right, asks Michael 
Singer a question about his research, 
which examined “Barriers to Health 
Care for Pakistani Girls.” 
chemokines in leishmaniasis, to the role of 
religion and spirituality in the care of patients 
with HIV. 
Although the postet session is a relatively 
new tradition at Yale, the thesis is an old one, 
dating to at least 1839, when first mention 
of the requirement is made in the medical 
school Bulletin. According to Director of 
Student Research John N. Forrest Jr., M.D., 
HS ’67, Yale is the only medical school to 
require all students to write a thesis based 
on original research. 
Has the nature of the thesis changed 
much? Not according to Braverman, leader 
of the observation course, Dolev’s advisor 
and a 1955 graduate of the School of Medicine. 
Braverman’s own thesis, published 46 years 
ago, was on “microglial response in West 
Nile virus encephalitis,” a topic that would 
have a good deal of resonance in New Haven 
in 1999 when the virus appeared in the 
United States. 
Students today pursue the same types of 
topics that they did in the 1950s, Braverman 
said. “Then, it ran the gamut of whatever was 
cutting-edge science—proteins and biochem¬ 
istry for the most part—to the history of 
medicine, social topics and psychiatry,” he 
said. “It’s the same today. The thesis reflects 
what’s going on in science.” 
The scheduled speaker at the 14th Annual 
Farr Lecture, Paul Greengard, M.D., PH.D., 
who shared the 2000 Nobel Prize in Physiol¬ 
ogy or Medicine for his work on signal trans¬ 
duction in the nervous system, had to bow 
out after he broke his leg during a trip to 
Japan. Replacing Greengard, who taught psy¬ 
chiatry and pharmacology at Yale from 1958 
to 1983, was Richard P. Lifton, M.D., PH.D., 
chair of the Department of Genetics. 
A quarter-century ago, Lifton said, there 
were virtually no tools to link genetics to the 
practice of medicine. Now, the human genome 
has created a revolution in medicine. “We are 
only beginning to see the outlines of where 
that will lead us; the future impact promises 
to be extraordinary.” 
TOP Ajay Maker explains his project, 
“Studies on the Molecular Mechanics 
of Insulin Resistance in Pancreatogenic 
Diabetes,” to Reena Rupani, left, and 
Rupali Gandhi. 
ABOVE Winnie Au, center, worked 
with her thesis advisor, Charles Greer, 
left, on her study of “Sublaminar 
Organization of the Olfactory Bulb 
Nerve Layer.” 
—Michael Fitzsousa 
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Exuberance rules the day 
as residency placements 
are revealed 
Even before noon on March 22, it was clear 
that the crowd gathering outside the mailroom 
at Harkness Dormitory was smaller than in 
years past. With more students taking a fifth 
year For research or other activities, the original 
class oF 106 was whittled down to 79 by Com¬ 
mencement this spring and five of the 79 chose 
to pursue activities other than a residency. 
Just the same, the smaller group made a 
large-enough stir. A few minutes after noon, 
as students came out of the mailroom clutch¬ 
ing letters, screams and tears of joy erupted. 
Anthony Lemaire danced around the hallway 
next to the mailroom with third-year student 
Kate Lally. In the embrace, Lally said, “I lost 
a shoe and an earring. It was overwhelming.” 
Lemaire was headed for Duke University 
Medical Center, his first choice, for a res¬ 
idency in surgery. 
Melissa Lee got on her cell phone to tell 
her brother and father in New York City that 
she’d be going to the Harvard Combined 
Medicine/Pediatrics Program. “They were 
hoping I would stay on the East Coast,” she 
said. Christopher James was thrilled to be 
going to New York Presbyterian Hospital- 
Cornell for a residency in neurosurgery. “It’s 
an up-and-coming program. It has a great 
reputation,” he said, noting personal reasons 
for choosing Cornell. “I’m from New York 
and I went to Cornell as an undergrad.” 
As in previous years, the students’ greatest 
preference was for internal medicine—38 per¬ 
cent chose that field. Nationwide, the National 
Resident Matching Program reported a shift 
away from family practice positions among the 
24,000 medical students who participated. 
Slightly fewer than half matched to a residency 
in one of the generalist disciplines—internal 
medicine, pediatrics and family practice. The 
Yale placements appear on the opposite page. 
—John Curtis 
TOP Roger Fan cheers his acceptance 
to the internal medicine residency 
program at Brigham and Women’s 
Hospital in Boston. 
ABOVE Melissa Lee called her family in 
New York with the good news that [ 
she’d stay on the East Coast. She 
matched at the Harvard Combined 
Medicine/Pediatrics Program. 
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2001 residency placements 
for Yale medical students 
The Office of Student Affairs has 
provided the following list, which 
outlines the results of the National 
Resident Matching Program for 
Yale’s medical graduates. Some names 
appear twice because the graduate 
is entering a one-year program before 
beginning a specialty residency. The 
transitional designation is a one-year 
program with three-month rotations 
in different specialties. 
CALIFORNIA 
Alameda County Medical 
Center, Oakland 
Matthew Gutierrez, transitional 
Kaiser Permanente Medical Croup, 
Santa Clara 
Allen Chen, medicine 
Saint Mary’s Medical Center, 
San Francisco 
Artis Montague, medicine 
Stanford University Programs 
Jacqueline Dolev, internal medicine 
Emily Finkelstein, internal medicine 
Artis Montague, ophthalmology 
University of California - Davis 
Medical Center, Sacramento 
Andrea Ciaranello, internal medicine 
University of California Medical 
Center - Los Angeles 
Eon Shin, orthopaedics 
Brian Woods, internal medicine 
University ofCaiifornia - San Francisco 
Sara Erickson, internal medicine 
Jennifer Lucero, obstetrics and 
gynecology 
COLORADO 
University of Colorado School of 
Medicine, Denver 
Lucy Budde,family practice 
CONNECTICUT 
Hospital of Saint Raphael, New Haven 
Geoffrey Emerson, medicine 
Brian Lester, medicine 
Yale-New Haven Hospital 
Esther Choo, medicine 
Michael David, internal medicine 
Oleg Drozhinin, medicine 
Jonathan Erulkar, orthopaedics 
Rockman Ferrigno, emergency 
medicine 
Kira Giovanielli, medicine, dermatology 
Avery Crauer, internal medicine 
Sung Kim, medicine/primary 
Pinar Kodaman, obstetrics and 
gynecology 
Darren Lish, psychiatry 
Gregory Merrell, orthopaedics 
Dan Negoianu, internal medicine 
Dena Rifkin, internal medicine 
J. Mark Sloan, internal medicine 
Benjamin Smith, medicine, 
radiation oncology 
Andrew White, orthopaedics 
Fiarry Yoon, internal medicine 
GEORGIA 
Emory University School of 
Medicine, Atlanta 
Michele Johnson, surgery, neurosurgery 
HAWAII 
University of Hawaii School of 
Medicine, Honolulu 
M. Vaughn Emerson, medicine 
ILLINOIS 
McCaw Medical Center - Northwestern 
University, Chicago 
Benson Yang, surgery, neurosurgery 
University of Chicago Hospitals 
Caroline Harada, internal medicine 
IOWA 
University of Iowa Hospitals and 
Clinics, Iowa City 
Kirk Clifford, orthopaedics 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
Patricia Moore, obstetrics and 
gynecology 
Johns Hopkins University - Wiimer 
Eye Center, Baltimore 
Geoffrey Emerson, ophthalmology 
M.Vaughn Emerson,ophthalmology 
MASSACHUSETTS 
Beth Israel Deaconess Medical 
Center, Boston 
Oleg Drozhinin, anesthesiology 
Anna Paszczuk, internal medicine 
John Yang, internal medicine 
Boston Combined Pediatrics Program 
Patty Birgeneau Prince, 
pediatrics/primary 
Fabienne Bourgeois, pediatrics 
Boston University Medical Center 
Esther Choo, emergency medicine 
Brigham and Women’s Hospital, Boston 
Barbara Coren, internal medicine 
Roger Fan, internal medicine 
Melissa Fuchs, internal medicine 
Ajay Maker, general surgery 
Jessica Mega, internal medicine 
Lamioko Pappoe, internal medicine 
Harvard Combined Medicine/Pediatrics 
Program, Boston 
Ami Bhatt, medicine/pediatrics 
Melissa Lee, medicine/pediatrics 
Harvard Medical School 
Neal Chen, orthopaedics 
Massachusetts General Hospital, Boston 
Garth Graham, internal medicine 
Matthew Levine, general surgery 
Daniel Wolf, psychiatry 
MINNESOTA 
Mayo Graduate School of 
Medicine, Rochester 
Natalie Holt, surgery, urology 
University of Minnesota, Minneapolis 
Matthew Goodwin, general surgery 
NEW JERSEY 
UMDNJ - New Jersey Medical 
School, Newark 
Ron Samet, internal medicine 
NEW YORK 
Albany Medical Center Hospital 
Dinakar Shenbagamurthi, 
orthopaedics 
Hospital for Special Surgery, New York 
Benjamin Huffard, orthopaedics 
Mount Sinai Hospital, New York 
Joshua Gibson, internal medicine 
Carmit Steren, obstetrics and 
gynecology 
New York Presbyterian 
Hospital - Columbia 
Winnie Au, diagnostic radiology 
Ryan Davies, general surgery 
Allison Stewart, pediatrics 
New York Presbyterian 
Hospital - Cornell 
Carl Crawford, internal medicine 
Christopher James,surgery and 
neurosurgery 
North Shore University 
Hospital, Manhasset 
Joy Weinberg, medicine 
OREGON 
Oregon Health Sciences 
University, Portland 
Samuel Kim, emergency medicine 
PENNSYLVANIA 
Albert Einstein Medical 
Center, Philadelphia 
Daniel Wolf transitional 
Hospital of the University of 
Pennsylvania, Philadelphia 
Sharon Chekijian, general surgery 
RHODE ISLAND 
Rhode Island Hospital - Brown 
University, Providence 
Brian Lester, dermatology 
TEXAS 
University of Texas - MD Anderson 
Cancer Center, Houston 
Allen Chen, radiation oncology 
Wilford Hall Medical Center 
(Lackland AFB), San Antonio 
Heather Yun, internal medicine 
WASHINGTON 
University of Washington 
Affiliated Hospitals, Seattle 
Frederick Cobey, general surgery 
BELOW With friend Kate tally, 
Ami Bhatt celebrated her match at 
Harvard Combined Medicine/ 
Pediatrics Program. 
BOTTOM Cyrus Kapadia congratulated 
Carl Crawford, who’s headed to New 
York Presbyterian Hospital - Cornell 
for a residency in internal medicine. 
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St. Vincent’s Hospital, New York 
Winnie Au, transitional 
University of Rochester/Strong 
Memorial Hospital, Rochester 
Hong Zhang, medicine, 
radiation oncology 
NORTH CAROLINA 
Duke University Medical 
Center, Durham 
Stephenie Boykin, pediatrics 
Anthony Lemaire, general surgery 
OHIO 
University Hospitals of Cleveland 
Heidi Smith, pediatrics 
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Psychiatrist Aaron T. Beck, 
M.D. ’46, world renowned as 
the “father of cognitive ther¬ 
apy,” received the $250,000 
Heinz Award in the human 
condition category for his early 
development of techniques 
used to treat millions of indi¬ 
viduals suffering mental and 
behavioral health challenges. 
The award was made by the 
Heinz Family Foundation, a 
charitable trust established by 
Mrs. John Heinz in 1993 in 
honor of her late husband. 
Sen. John Heinz ot Pennsylva¬ 
nia. Beck is professor emeritus 
of psychiatry at the University 
of Pennsylvania and president 
of the Beck Institute for Cog¬ 
nitive Therapy and Research. 
Previous recipients of the 
award include Yale faculty 
members James P. Comer, 
M.D., HS ’66, and Edward 
F. Zigler, PH.D. 
90s 
Antonio F. 
Vinals, M.D. 
’93, wrote to 
say that he has 
completed a 
residency in 
ophthalmology and a fellow¬ 
ship in corneal and refractive 
surgery at Harvard Medical 
School. He is a clinical instruc¬ 
tor at the Manhattan Eye, Ear 
and Throat Hospital and in 
private practice in Manhattan. 
Vinals is married to Eiselotte 
Pieroth, M.D., a second-year 
ophthalmology resident at 
Columbia-Presbyterian Hospi¬ 
tal, who was a visiting inter¬ 
national medical student and 
resident at Yale. 
Ramsey Alsarraf, m.d. ’94, 
M.P.H., PC, was named direc¬ 
tor of The Newbury Center 
for Cosmetic Facial Plastic 
Surgery in Boston. Alsarraf 
completed an American Acad¬ 
emy of Facial Plastic and 
Reconstructive Surgery sub¬ 
specialty fellowship with 
Calvin M. Johnson Jr. and 
is a co-author with Johnson 
of the soon-to-be released text, 
The Aging Face: A Systematic 
Approach. He is also serving as 
a guest editor for a special 
outcomes research edition of 
Facial Plastic Surgery, the 
official journal of the Euro¬ 
pean Academy of Eacial 
Plastic Surgery. 
Physical medi¬ 
cine specialist 
Anthony S. 
Burns, M.D. 
’94, has joined 
the Regional 
Spinal Cord Injury Center of 
the Delaware Valley at Thomas 
Jefferson University Hospital 
as assistant director. He was 
also appointed assistant profes¬ 
sor of rehabilitation medicine 
at Jefferson Medical College at 
Thomas Jefferson University. 
Burns was the recipient of the 
Arthur A. Siemens Memorial 
Award, presented to a senior 
resident in the Johns Hop¬ 
kins/Sinai Hospital rehabilita¬ 
tion medicine residency 
program for excellence in 
academic pursuits and devo¬ 
tion to patient care. 
Send alumni news items to: 
Claire Bessinger, Yale Medicine 
Publications, P.O. Box 7612, 
New Haven, CT 06519-0612. 
William E. Bloomer, m.d. ’42, 
HS ’52, of Pasadena, Calif, 
who served for a short time on 
the Yale faculty, died of cancer 
on Jan. 14 at Eong Beach 
(Calif) Memorial Medical 
Center. He was 84. 
A graduate of Stanford 
University, Bloomer earned his 
medical degree at Yale in 1942. 
After an internship at Stanford 
University Hospital and serv¬ 
ice in the U.S. Army Medical 
Corps, he returned to New 
Haven in 1946 as a fellow in 
thoracic surgery and com¬ 
pleted his residency at Yale- 
New Haven Hospital. 
He was assistant professor 
at the School of Medicine for 
five years before moving to 
California, where he contin¬ 
ued his lifelong career in 
thoracic and cardiovascular 
surgery and developed in¬ 
novative techniques using 
injection-molded plastics to 
study the anatomy of the lung. 
Bloomer continued to teach, 
and at the time of his death 
was associate clinical professor 
of surgery at the University of 
California at Los Angeles 
School of Medicine. 
Howard E. Hornstein, d.m.d., 
of Guilford, Conn., a former 
faculty member at the School 
of Medicine, died March 9. 
He was 57. 
A 1963 graduate of Boston 
University, Hornstein received 
his D.M.D. from the University 
of Pennsylvania School of 
Dental Medicine in 1967 and 
a master’s degree from the 
University of Rochester 
in 1971. 
Hornstein, a pediatric den¬ 
tist and orthodontist, had a 
practice in New Haven until 
1970, when he relocated to 
Guilford. He also was on the 
faculty at Yale as a clinical 
instructor in surgery from 1974 
until 1981. Hornstein directed 
the section of pedodontics in 
the outpatient department at 
Yale-New Haven Hospital in 
1974 and established an inpa¬ 
tient service for the retarded 
and physically handicapped. In 
addition, he was an author, a 
publisher and a musician. 
Theodore Lidz, m.d., who 
served on the Yale faculty for 
half a century, died Feb. 16 
at his home in Hamden. He 
was 90. 
A native New Yorker, Lidz 
earned his bachelor’s degree in 
1931 and his medical degree in 
1936, both from Columbia 
University. He served in World 
War II as a lieutenant colonel 
in the Army at hospitals in 
New Zealand, Fiji and Burma. 
He also tended to several hun¬ 
dred psychiatric casualties of 
the fighting on Guadalcanal. 
Lidz came to Yale as a pro¬ 
fessor of psychiatry in 1951. He 
was chair of the Department 
of Psychiatry from 1967 to 
1968. He gained emeritus sta¬ 
tus in 1978 and continued to 
publish, lecture and see 
patients into the mid-1990s. 
Lidz explored the background 
causes of schizophrenia and 
specialized in the treatment of 
the illness. He wrote exten¬ 
sively on the subject of schizo¬ 
phrenia in journals and books. 
He went beyond his patients’ 
personal histories to under¬ 
stand the familial, social and 
cultural factors. One of his 
longtime collaborators was his 
wife, Ruth Wilmanns Lidz, 
M.D., who died in 1995. 
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Expanded Web offerings 
Yale Medicine magazine and the Association of Yale Alumni in Medicine (AYAM) 
have added to the resources available to alumni on the Web. Browse Yale Medicine 
in simple html format or download a pdf file complete with graphics. View or 
listen to multimedia content accompanying selected articles. Search back issues 
of the magazine on our archive page. The address is: 
http://info.med.yale.edu/ymm 
Visit the main AYAM site at: 
http://info.med.yale.edu/ayam 
to update your mailing address, check the reunion schedule and calendar of 
events, submit news for the Alumni Notes column of Yale Medicine, or arrange 
for a lifelong Yale e-mail alias through the Virtual Yale Station. 
Spread the news! 
Yale Medicine can help you stay connected with fellow alumni of the School of 
Medicine and its programs in Epidemiology and Public Health, the Graduate School 
of Arts and Sciences, and residency, fellowship and physician associate training. 
Share your personal and professional news for publication in the Alumni Notes 
column of Yale Medicine and on the Web, using this card or the online form 
at http://info.med.yale.edu/ayam/alumni_notes.html. Please provide a recent 
photograph if possible. 
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